<SUBMISSION>
<ACCESSION-NUMBER>0000950130-03-003206
<TYPE>DEF 14A
<PUBLIC-DOCUMENT-COUNT>5
<PERIOD>20030514
<FILING-DATE>20030414
<EFFECTIVENESS-DATE>20030414
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>LABORATORY CORP OF AMERICA HOLDINGS
<CIK>0000920148
<ASSIGNED-SIC>8071
<IRS-NUMBER>133757370
<STATE-OF-INCORPORATION>DE
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>DEF 14A
<ACT>34
<FILE-NUMBER>001-11353
<FILM-NUMBER>03649235
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>358 S MAIN ST
<CITY>BURLINGTON
<STATE>NC
<ZIP>27215
<PHONE>3362291127
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>358 S MAIN ST
<CITY>BURLINGTON
<STATE>NC
<ZIP>27215
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>NATIONAL HEALTH LABORATORIES HOLDINGS INC
<DATE-CHANGED>19940314
</FORMER-COMPANY>
</FILER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>ddef14a.htm
<DESCRIPTION>NOTICE & PROXY STATEMENT
<TEXT>
<HTML><HEAD>
<TITLE>Notice &amp; Proxy Statement</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left"><P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="4" COLOR="#000000"><B>SCHEDULE 14A </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"><B>(RULE 14a-101) </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"
COLOR="#000000"><B>INFORMATION REQUIRED IN PROXY STATEMENT </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3" COLOR="#000000"><B>SCHEDULE 14A INFORMATION </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3" COLOR="#000000"><B>Proxy Statement Pursuant to Section 14(a) </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3" COLOR="#000000"><B>of the Securities Exchange Act of 1934 </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Filed by the Registrant <FONT FACE="WINGDINGS">&#120;</FONT> </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Filed by a Party other than the Registrant
</FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"> </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Check the appropriate box: </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"> Preliminary Proxy Statement </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"> CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14A-6(E)(2)) </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><FONT FACE="WINGDINGS">&#120;</FONT>
Definitive Proxy Statement </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"> Definitive Additional Materials </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"> Soliciting Material </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="5" COLOR="#000000"><B>Laboratory Corporation of America Holdings </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>(Name of Registrant as Specified In Its
Charter) </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>(Name of Person(s) Filing Proxy
Statement, if other than the Registrant) </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Payment of Filing Fee (Check the appropriate box): </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><FONT FACE="WINGDINGS">&#120;</FONT> No fee required </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"> Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Title of each class of securities to which transaction applies: </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Aggregate number of securities to which transaction applies: </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and
state how it was determined): </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(4)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Proposed maximum aggregate value of transaction: </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(5)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Total fee paid: </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"> Fee paid previously with preliminary materials. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"> Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing &nbsp;for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, &nbsp;or the Form or Schedule and the date of its filing. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Amount Previously Paid: </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Form, Schedule or Registration Statement No.: </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Filing Party: </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(4)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Date Filed: </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"
ALIGN="left"><HR SIZE="1" NOSHADE COLOR="#000000" ALIGN="left">

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>

<IMG SRC="g22611g40f84.jpg" ALT="LOGO"> </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD VALIGN="bottom" WIDTH="100%" ALIGN="right"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000">Laboratory Corporation of America<SUP>&reg;</SUP> Holdings</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="100%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:64%"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000">358 South Main Street</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="100%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:64%"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000">Burlington, NC 27215</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="100%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:64%"><FONT FACE="ARIAL" SIZE="1" COLOR="#000000">Telephone: 336-229-1127</FONT></P></TD></TR>
</TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">April 14,
2003 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Dear Stockholder: </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">You are cordially invited to attend the 2003 Annual Meeting
of Stockholders of Laboratory Corporation of America Holdings. The meeting will be held at The Paramount Theater, 128 East Front Street, Burlington, NC 27215, on Wednesday, May 14, 2003 at 9:00 a.m., Eastern Daylight Time. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The attached Notice of the Annual Meeting and Proxy Statement
provide information concerning the matters to be considered at the meeting. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">The Board of Directors unanimously recommends that the Company&#146;s stockholders approve each of the proposals set forth in the Notice. The enclosed Proxy Statement sets forth more detailed
information regarding these proposals. Please carefully review the information in the Proxy Statement. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Whether or not you plan to attend the meeting in person, your shares should be represented and voted at the meeting. Accordingly, after
reading the enclosed Proxy Statement, kindly mark the proxy card to indicate your vote, date and sign the proxy card, and return it in the enclosed, postage-paid envelope as soon as conveniently possible. If you desire to vote in accordance with the
Board of Directors&#146; recommendations, you need not mark your votes on the proxy card, but you do need to sign, date, and return it in the enclosed postage-paid envelope in order to record your vote. Proxy voting via the Internet or telephone is
now available to many stockholders. <B>Using the Internet or telephone to vote results in substantial savings on return postage for the Company.</B> Your enclosed proxy card will indicate whether these voting options are available to you and how to
use them. You may revoke your proxy at any time before it is exercised by sending us a written notice that you would like to revoke your proxy, by submitting a new proxy, or by attending the meeting and voting in person. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Sincerely, </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">

<IMG SRC="g22611g72g60.jpg" ALT="LOGO"> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Thomas P. Mac Mahon </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>Chairman of the Board, President and </I></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>Chief Executive Officer </I></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">

<IMG SRC="g22611g40f84.jpg" ALT="LOGO"> </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="4" COLOR="#000000"><B>LABORATORY
CORPORATION OF AMERICA HOLDINGS </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="68%" SIZE="1" NOSHADE COLOR="#000000"><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3" COLOR="#000000"><B>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><HR WIDTH="68%" SIZE="1" NOSHADE COLOR="#000000"><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"><B>To the Stockholders of </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Laboratory Corporation of America Holdings: </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Notice is hereby given that the 2003 Annual Meeting (the
&#147;Annual Meeting&#148;) of the Stockholders of Laboratory Corporation of America Holdings (the &#147;Company&#148;) will be held at The Paramount Theater, 128 East Front Street, Burlington, NC 27215, on Wednesday, May 14, 2003 at 9:00 a.m.,
Eastern Daylight Time, for the following purposes: </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">1. To elect the members of the Company&#146;s Board of Directors to serve until the Company&#146;s next annual meeting and until such directors&#146; successors are elected and shall have qualified; </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">2. To approve an amendment to the Company&#146;s 2000 Stock Incentive Plan (the &#147;Stock Plan Amendment&#148;) to increase the fair market value of the shares of stock subject to the annual stock
option grant to non-employee directors from $65,000 to $77,000; </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">3. To approve amendments to the Management Incentive Bonus Plan, formerly known as the Annual Bonus Incentive Plan, to reflect changes in the Company&#146;s compensation and executive compensation
plans (the &#147;Incentive Plan Amendment&#148;). </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4. To ratify the appointment by the Board of Directors of PricewaterhouseCoopers LLP as the Company&#146;s independent
accountants for the year ending December 31, 2003; and </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5. To transact such other business as may properly come before the Annual Meeting or at any adjournments thereof.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">A proxy statement describing the matters to be
considered at the Annual Meeting is attached to this notice. Only stockholders of record at the close of business on April 11, 2003 are entitled to notice of, and to vote at, the Annual Meeting and at any adjournments thereof. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">A copy of the Annual Report of the Company for the fiscal year
ended December 31, 2002 has either preceded or accompanies this notice. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">By Order of the Board of Directors </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">

<IMG SRC="g22611g61o27.jpg" ALT="LOGO"> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Bradford T. Smith </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>Secretary </I></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">April 14, 2003 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>PLEASE COMPLETE, SIGN, AND DATE THE ACCOMPANYING PROXY CARD, AND RETURN IT PROMPTLY IN THE ENCLOSED ENVELOPE. THIS WILL ENSURE THAT
YOUR SHARES ARE VOTED IN ACCORDANCE WITH YOUR WISHES. </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="4" COLOR="#000000"><B>LABORATORY
CORPORATION OF AMERICA HOLDINGS </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>358 SOUTH MAIN STREET </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>BURLINGTON, NORTH CAROLINA 27215 </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="21%" SIZE="1" NOSHADE COLOR="#000000"><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>PROXY STATEMENT </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><HR WIDTH="21%" SIZE="1" NOSHADE COLOR="#000000"><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">This Proxy Statement is being furnished in connection with the solicitation by the Board of Directors of Laboratory Corporation of America
Holdings, a Delaware corporation (the &#147;Company&#148;), of proxies to be voted at the 2003 Annual Meeting of Stockholders to be held at The Paramount Theater, 128 East Front Street, Burlington, NC 27215, on Wednesday, May 14, 2003 at 9:00 a.m.,
Eastern Daylight Time, and at any adjournments thereof (the &#147;Annual Meeting&#148;). The Notice of Annual Meeting, this Proxy Statement, and the accompanying proxy card are first being mailed to stockholders on or about April 14, 2003.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">At the Annual Meeting, the Company&#146;s
stockholders will be asked (i) to elect the following persons as directors of the Company to serve until the Company&#146;s next annual meeting and until such directors&#146; successors are elected and shall have qualified: Thomas P. Mac Mahon,
Jean-Luc B&eacute;lingard, Wendy E. Lane, Robert E. Mittelstaedt, Jr., James B. Powell, M.D., and Andrew G. Wallace, M.D.; (ii) to approve an amendment to the Company&#146;s 2000 Stock Incentive Plan to increase the fair market value of the shares
of stock subject to the annual stock option grant to non-employee directors from $65,000 to $77,000 (the &#147;Stock Plan Amendment&#148;); (iii) to approve amendments to the Company&#146;s Management Incentive Bonus Plan to reflect changes in the
Company&#146;s compensation and executive compensation plans (the &#147;Incentive Plan Amendment&#148;); (iv) to ratify the appointment by the Board of Directors of PricewaterhouseCoopers LLP as the Company&#146;s independent accountants for the
year ending December 31, 2003; and (v) to take such other action as may properly come before the Annual Meeting or any adjournments thereof. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Unless otherwise indicated, all share amounts set forth in this Proxy Statement and related proxy materials have been adjusted to reflect
the 1-for-10 reverse stock split of the Company&#146;s Common Stock, effective May 4, 2000 and the 2-for-1 forward stock splits in the form of a stock dividend, effective June 11, 2001 and May 10, 2002. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>GENERAL INFORMATION </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Solicitation and Voting of Proxies; Revocation; Record Date
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">All proxies duly executed and received by
the Company will be voted on all matters presented at the Annual Meeting in accordance with the instructions given therein by the person executing such proxy or, in the absence of such instructions, will be voted in favor of the election to the
Company&#146;s Board of Directors of the six nominees for director identified in this Proxy Statement, the approval of the Stock Plan Amendment, the approval of the Incentive Plan Amendment, and the ratification of the appointment of
PricewaterhouseCoopers LLP as the Company&#146;s independent accountants for 2003. Any stockholder may revoke his/her proxy at any time prior to the Annual Meeting before it is voted by written notice to such effect delivered to the Company at 358
South Main Street, Burlington, North Carolina 27215, Attention: Bradford T. Smith, Secretary, by delivery prior to the Annual Meeting of a properly executed and subsequently dated proxy or by attending the Annual Meeting and voting in person.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Solicitation of proxies may be made by mail and
may also be made by personal interview, telephone and facsimile transmission, and by directors, officers, and regular employees of the Company without special compensation therefor. The Company will bear the expenses to prepare proxy materials and
to solicit proxies for the Annual Meeting. The Company expects to reimburse banks, brokers, and other persons for their reasonable, out-of-pocket expenses in handling proxy materials for beneficial owners. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Only holders
of record of common stock of the Company (the &#147;Common Stock&#148;) at the close of business on April 11, 2003 (the &#147;Record Date&#148;) will be entitled to notice of, and to vote at, the Annual Meeting. At the close of business on the
Record Date, there were issued and outstanding 146,501,837 shares of Common Stock. Holders of Common Stock as of the Record Date will be entitled to one vote per share at the Annual Meeting. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">A quorum for the Annual Meeting consists of a majority of the
total number of shares of Common Stock outstanding on the Record Date and entitled to vote, present in person or represented by proxy. Directors of the Company will be elected by a plurality vote of the shares of Common Stock represented at the
Annual Meeting and entitled to vote. The affirmative vote of a majority of shares of Common Stock represented at the Annual Meeting and entitled to vote is required for approval of the Stock Plan Amendment, the Incentive Plan Amendment, and the
ratification of the appointment of PricewaterhouseCoopers LLP as the Company&#146;s independent accountants for the year ending December 31, 2003. An abstention or broker non-vote will have no effect on the election of the directors or the vote to
approve and adopt the Stock Plan Amendment, the Incentive Plan Amendment, and to ratify the appointment of independent accountants. As of March 31, 2003, the directors and executive officers of the Company beneficially owned an aggregate of
2,865,483 shares of Common Stock, representing approximately 1.9% of the total number of shares of Common Stock outstanding and entitled to vote. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>The Board of Directors of the Company recommends that stockholders vote &#147;FOR&#148; the election of each of the nominees for
director of the Company (as specified below), the approval of the Stock Plan Amendment, the approval of the Incentive Plan Amendment, and the ratification of the appointment of PricewaterhouseCoopers LLP as the Company&#146;s independent accountants
for 2003. </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>ITEM
ONE:&nbsp;&nbsp;&nbsp;&nbsp;ELECTION OF DIRECTORS </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">The Company&#146;s directors will be elected at the Annual Meeting to serve until the next succeeding annual meeting of the Company and until their successors are elected and shall have been qualified. All of the nominees listed
below are currently serving as members of the Board of Directors. Except as herein stated, the proxies solicited hereby will be voted FOR the election of such nominees unless the completed proxy card directs otherwise. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">In 1995, the Company and affiliates of Roche Holdings, Inc.,
an affiliate of Roche Holdings Ltd (&#147;Roche&#148;), entered into a stockholder agreement (the &#147;Stockholder Agreement&#148;). The Stockholder Agreement contained certain provisions relating to Roche&#146;s right to designate for nomination
candidates for director as long as Roche owned at least 10% of the Company&#146;s Common Stock. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">On March 12, 2002, Roche&#146;s ownership of the Company&#146;s Common Stock fell below 5% and therefore, Roche no longer has the right to designate candidates for nomination to the Board of Directors.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Dr. David B. Skinner served as a Director of the
Company since August 28, 1995 and during the last fiscal year, was Chairman of the Audit Committee and a member of the Compensation Committee. Dr. Skinner passed away in January 2003 and the Company would like to express its appreciation for his
hard work and dedication to the Company. We will miss his leadership on our Audit Committee and his contributions to our corporate governance policies. Dr. Skinner&#146;s seat on the Board is currently vacant and the Company is looking for suitable
candidates to fill it. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Board of Directors
has considered the independence of its members and has concluded that Mr. B&eacute;lingard, Ms. Lane, Mr. Mittelstaedt, Dr. Powell, and Dr. Wallace each qualify as &#147;independent directors&#148; as defined in Sections 303.01(B)(2)(a) and (B)(3)
of the New York Stock Exchange (&#147;NYSE&#148;) Listing Standards (the &#147;Listing Standards&#148;). There are no material commercial relationships between the Company and the organizations employing our directors. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Board of
Directors has been informed that all of the nominees listed below are willing to serve as directors, but if any of them should decline or be unable to act as a director, the individuals named in the proxies may vote for a substitute designated by
the Board of Directors. The Company has no reason to believe that any nominee will be unable or unwilling to serve. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Nominees For Election As Directors </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The name, age as of April 4, 2003, principal occupation for the last five years, selected biographical information, and period of service
as a director of the Company of each nominee are set forth below: </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000"><B>Thomas P. Mac Mahon</B> (56) has served as Chairman of the Board and a director since April 28, 1996. Prior to such date and since April 28, 1995, the date of the merger of Roche Biomedical Laboratories (&#147;RBL&#148;)
and the Company (the &#147;Merger&#148;), he served as the Vice Chairman and a director. Mr. Mac Mahon has been President and Chief Executive Officer and a member of the Executive and Management Committees of the Company since January 1997. Mr. Mac
Mahon was Senior Vice President of Hoffmann-La Roche Inc. (&#147;Hoffmann-La Roche&#148;) from 1993 to December 1996 and President of Roche Diagnostics Group and a director and member of the Executive Committee of Hoffmann-La Roche from 1988 to
December 1996. Mr. Mac Mahon is a director and Audit Committee member of Express Scripts, Inc. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Jean-Luc B&eacute;lingard</B> (54) has served as a director of the Company since the Merger, April 28, 1995. Mr. B&eacute;lingard is Chief Executive Officer of Beaufour Ipsen SA, a diversified
French health care holding company. Prior to this position, Mr. B&eacute;lingard was Chief Executive Officer from 1999 to 2001 of bioM&eacute;rieux-Pierre Fabre, a diversified French health care holding company, where his responsibilities included
the management of the company&#146;s worldwide pharmaceutical and cosmetic business. Prior to bioM&eacute;rieux-Pierre Fabre, Mr. B&eacute;lingard joined F. Hoffmann-La Roche Ltd, Basel, Switzerland, a subsidiary of Roche in 1982 where he held
various positions, including Director General of the Diagnostics Division and was a member of the Executive Committee. Mr. B&eacute;lingard is also a director of Applera Corporation, Norwalk, Connecticut, a director and member of the Compensation
Committee of ExonHit (France) and a director and member of the Compensation Committee of Nicox (France). </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Wendy E. Lane</B> (51) has been a director of the Company since November 1996. Ms. Lane has been Chairman of Lane Holdings, Inc., an
investment firm, since 1992. Prior to forming Lane Holdings, Inc., Ms. Lane was a Principal and Managing Director of Donaldson, Lufkin &amp; Jenrette, an investment banking firm, serving in these and other positions from 1980 to 1992. Ms. Lane was a
director of Tyco International, Ltd. until early March 2003. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"><B>Robert E. Mittelstaedt, Jr.</B> (59) has been a director of the Company since November 1996. Mr. Mittelstaedt is Vice Dean, Executive Education of The Wharton School of the University of Pennsylvania and director of the Aresty
Institute of Executive Education. Mr. Mittelstaedt has served with The Wharton School since 1973, with the exception of the period from 1985 to 1989 when he founded, served as President and Chief Executive Officer, and sold Intellego, Inc., a
company engaged in practice management, systems development, and service bureau billing operations in the medical industry. Mr. Mittelstaedt also serves as a director and member of the Compensation Committee of Innovative Solutions &amp; Support,
Inc. and a director of HIP Foundation, Inc. Mr. Mittelstaedt was formerly a director of A.G. Simpson Automotive, Inc. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>James B. Powell, M.D.</B> (64) has served as a director of the Company since the Merger, April 28, 1995. From the Merger to January
1997, Dr. Powell served as President and Chief Executive Officer of the Company. Previously, Dr. Powell was President of RBL from 1982 until the Merger. Dr. Powell was President and Chief Executive Officer of TriPath Imaging, Inc., a developer of
analytical systems for cytology and pathology, from January 1997 to August 28, 2000. He is a medical doctor and became Board Certified in anatomic and clinical pathology in 1969. Dr. Powell serves as a director and Audit Committee member of U.S.
Trust Co. of N.C. and a director of Warren Land Co., Carolina Doctors Care, Mid-Carolina Bank, Green Cap Finance, and MercuryMD. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Andrew G.
Wallace, M.D.</B> (68) has served as a director of the Company since the Merger, April 28, 1995. Dr. Wallace has served as both the Dean of Dartmouth Medical School and Vice President for Health Affairs at Dartmouth College from 1990 to 1998. He was
the Vice Chancellor for Health Affairs at Duke University and the Chief Executive Officer of Duke Hospital from 1981 to 1990. Dr. Wallace also serves as a director for Welch Allyn, Inc., Dorothy Rider Poole Trust, The Durham Health Partners, and The
Sarnoff Endowment for Cardiovascular Science. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"><B>The Board of Directors of the Company recommends that stockholders vote &#147;FOR&#148; the election of each of the nominees for director listed above. </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Board of Directors and its Committees </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Board of Directors has an Audit Committee, a Compensation Committee, an Ethics and Quality Assurance
Committee, and a Nominating and Corporate Governance Committee, the Charters for which are attached hereto as Annexes I, II, III, and IV, respectively. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee, currently consisting of Ms. Lane, Mr. Mittelstaedt, and Dr. Powell, is directly responsible for the selection,
appointment, compensation and oversight of the work of any registered public accounting firm employed by the Company and assists in Board oversight of the integrity of the financial statements of the Company; the compliance by the Company with legal
and regulatory requirements; the qualifications and independence of the Company&#146;s independent auditors and the performance of the Company&#146;s internal audit functions, internal controls, and independent auditors. At December 31, 2002, the
Audit Committee was composed of Dr. Skinner, Ms. Lane, and Mr. Mittelstaedt. Dr. Powell joined the Committee after Dr. Skinner passed away in January 2003. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Compensation Committee, previously known as the Employee Benefits Committee, currently consisting of Mr. B&eacute;lingard, Ms. Lane,
and Dr. Wallace, reviews and recommends to the full Board for its approval compensation and benefit policies and objectives; determines whether officers, directors and employees are compensated according to these policies and objectives; and carries
out the board&#146;s responsibilities relating to the compensation of executives and directors. At December 31, 2002, the Compensation Committee was composed of Ms. Lane, Mr. B&eacute;lingard, and Dr. Skinner. Dr. Wallace joined the Committee after
Dr. Skinner passed away in January 2003. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The
Ethics and Quality Assurance Committee, currently and at December 31, 2002 made up of Dr. Powell, Mr. B&eacute;lingard, and Dr. Wallace, is responsible for ensuring that the Company adopts and implements procedures that require the Company&#146;s
employees to act in accordance with high ethical standards and to deliver high quality services. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">The Nominating and Corporate Governance Committee, currently and at December 31, 2002 made up of Mr. Mittelstaedt, Ms. Lane, Dr. Powell and Dr. Wallace, is responsible for assisting the Board by
identifying individuals qualified to become Board members and by recommending to the Board the director nominees for the next annual meeting of stockholders; for developing and recommending to the Board a set of corporate governance principles
applicable to the Company; for leading the Board in its annual review of the Board&#146;s performance; and for recommending to the Board director nominees for each Board committee. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Nominating and Corporate Governance Committee will consider suggestions for Board nominees made by
stockholders. A stockholder may recommend a person for nomination to the Board at the 2004 annual meeting of stockholders by giving notice thereof and providing certain information set forth in the Company&#146;s By-Laws, in writing, to the
Secretary of the Company at 358 S. Main Street, Burlington, NC 27215. Such nominations must be received no earlier than December 17, 2003 and no later than February 20, 2004. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">During 2002,
the Board of Directors held fourteen meetings, each in accordance with the Company&#146;s By-Laws and applicable Delaware corporation law and acted once by unanimous written consent. The Compensation Committee held four meetings; the Audit Committee
held nine meetings; and the Nominating and Corporate Governance Committee held one meeting and acted once by unanimous written consent in 2002. The Ethics and Quality Assurance Committee held no meetings in 2002, but its issues were handled during
Board meetings. During 2002, none of the directors attended fewer than 75% of the total meetings of the Board of Directors and the committees of which he or she was a member. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">On October 16, 2002, the Board of Directors began holding executive sessions without Company management or
non-independent director participation. These sessions are held at each regularly scheduled meeting of the Board of Directors and at each special meeting upon the request of a majority of the independent directors attending the special meeting. The
director presiding over each executive session is selected on a rotating basis, beginning with the Chair of the Audit Committee, followed by the Chairs of the Compensation Committee, the Ethics and Quality Assurance Committee, and the Nominating and
Corporate Governance Committee. In 2002, the Board held two executive sessions. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"><B>Compensation of Directors </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">In 2002, directors who were currently not receiving compensation as officers or employees of the Company were paid an annual retainer of $30,000, payable in monthly installments, a fee of $1,000 for each meeting of the Board of
Directors or of any Committee thereof that they attended, and received reimbursement of expenses they incurred for attending any meeting. Pursuant to the 1995 Stock Plan for Non-Employee Directors (the &#147;Director Plan&#148;) approved by the
stockholders of the Company, 50% of such annual retainer was payable in cash and 50% was payable in Common Stock of the Company. In 2002, Mr. B&eacute;lingard, Ms. Lane, Mr. Mittelstaedt, Dr. Powell, Dr. Skinner, and Dr. Wallace each earned 427
shares of Common Stock under the Director Plan. As set forth in the 2000 Stock Incentive Plan, non-employee directors were also automatically granted annual option awards on the date of the Annual Meeting of Stockholders with respect to shares
having a Fair Market Value equal to $65,000 at the time of grant. The annual option awards vest in equal one-third increments over three years, beginning on the first anniversary of the grant date, and if unexercised, expire 10 years after the date
of grant, subject to their earlier termination. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">In 2002, an outside compensation and benefits firm was selected to review the Company&#146;s non-employee director compensation plan, which had not been updated for over six years. On October 16, 2002, a new director compensation
plan was adopted effective January 1, 2003 to compensate directors for their additional responsibilities under the NYSE regulations and the Sarbanes-Oxley Act of 2002 and to move toward better pay alignment with the Company&#146;s peer group. This
compensation plan will be monitored to ensure alignment with best practices and long-term shareholder interests. Under the new plan, directors who do not receive compensation as officers or employees of the Company will receive an annual retainer of
$40,000, payable in monthly installments, fifty percent (50%) of such annual retainer payable in cash and fifty percent (50%) payable in common stock pursuant to the Director Plan. An annual Committee Chair retainer of $10,000 in cash for the
Chairperson of each of the Board of Directors&#146; committees will be paid in equal monthly installments throughout the year. A payment of $1,500 in cash will be made to each non-employee director for each meeting of the Board of Directors or of
any Committee thereof attended, whether in person or by telephone, and reasonable expenses incurred in connection with such member&#146;s attendance at meetings of the Board of Directors and committees thereof will be reimbursed. Subject to
shareholder approval, non-employee directors will receive in 2003 a restricted stock award with a Fair Market Value of $50,000; the restricted stock awards vest in equal one-third increments beginning on the first anniversary of the grant date. As
set forth in the 2000 Stock Incentive Plan, on the date of the Annual Meeting of Stockholders, non-employee directors will also be automatically granted annual option awards with respect to shares having a Fair Market Value equal to $77,000 at the
time of grant ($50,000 present value), replacing the previous $65,000 annual option award grant, subject to the approval of the amendment to the 2000 Stock Incentive Plan. The annual option awards vest in equal one-third increments over three years,
beginning on the first anniversary of the grant date, and if unexercised, expire 10 years after the date of grant, subject to their earlier termination. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>EXECUTIVE
OFFICERS </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The following table sets forth as
of the date hereof the Executive Officers of the Company. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD VALIGN="bottom" WIDTH="25%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Name</B></FONT></P><HR WIDTH="30" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Age</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Office</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="25%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Thomas P. Mac Mahon</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="5%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">56</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="69%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Chairman of the Board, President, and Chief Executive Officer</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="25%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Wesley R. Elingburg</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="5%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">46</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="69%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Executive Vice President, Chief Financial Officer, and Treasurer</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="25%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Myla P. Lai-Goldman, M.D.</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="5%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">45</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="69%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Executive Vice President, Chief Scientific Officer, and Medical Director</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="25%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Richard L. Novak</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="5%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">62</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="69%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Executive Vice President and Chief Operating Officer</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="25%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Bradford T. Smith</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="5%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">49</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="69%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Executive Vice President of Public Affairs, Human Resources, Law, Compliance, Licensing, Audit, and
Secretary</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="25%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Stevan R. Stark</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="5%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">55</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="69%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Executive Vice President of Sales and Marketing</FONT></P></TD></TR>
</TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"><B>Thomas P. Mac Mahon</B> has served as Chairman of the Board and a director since April 28, 1996. Prior to such date and since the Merger on April 28, 1995, he served as Vice Chairman and a director. Mr. Mac Mahon has been
President and Chief Executive Officer and a member of the Executive and Management Committees of the Company since January 1997. Mr. Mac Mahon was Senior Vice President of Hoffmann-La Roche from 1993 to January 1997 and President of Roche
Diagnostics Group and a director and member of the Executive Committee of Hoffmann-La Roche from 1988 to December 1996. Mr. Mac Mahon is a director and Audit Committee member of Express Scripts, Inc. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Wesley R. Elingburg</B> has served as Executive Vice
President, Chief Financial Officer, and Treasurer since October 1996. Mr. Elingburg is a member of the Executive and Management Committees of the Company. Prior to October 1996, and since the Merger on April 28, 1995, Mr. Elingburg was Senior Vice
President-Finance. Mr. Elingburg is responsible for the day-to-day supervision of the finance functions of the Company, including Billing and Treasury functions. Previously, Mr. Elingburg served as Senior Vice President-Finance and Treasurer of RBL
from 1988 through April 1995 and Assistant Vice President of Hoffmann-La Roche from 1989 until the Merger. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Myla P. Lai-Goldman, M.D.</B> was appointed Executive Vice President, Chief Scientific Officer, and Medical Director in April 1998. Dr.
Lai-Goldman manages the Center for Molecular Biology and Pathology at the Company&#146;s Research Triangle Park, NC facility; National Genetics Institute, Inc. in Los Angeles, CA; and Viro-Med Laboratories, Inc. in Minneapolis, MN. Dr. Lai-Goldman
is Board Certified in Anatomic and Clinical Pathology and serves as a member of the Executive and Management Committees of the Company. Dr. Lai-Goldman, who holds a medical degree from Columbia University, was named Senior Vice President of the
Company in 1997 and has held the position of Medical Director for the Center for Molecular Biology and Pathology since 1991 (with RBL and subsequently the Company). Dr. Lai-Goldman joined RBL in 1990. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Richard L. Novak</B> has served as Executive Vice President
and Chief Operating Officer of the Company since January 1999. Prior to this date and since his hire in March 1997, Mr. Novak served as Executive Vice President and oversaw the Company&#146;s Eastern Operations which included the Mid-Atlantic,
Northeast, South, Florida, and South Atlantic Divisions. Mr. Novak is a member of the Executive and Management Committees of the Company. Prior to joining the Company, Mr. Novak was employed by SmithKline Beecham Clinical Laboratories serving in a
variety of senior management positions including Senior Vice President, U.S. Operations and President, International. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Bradford T. Smith</B> has served as Executive Vice President, Chief Legal Officer, and Secretary since September 2001 and previously as
Executive Vice President, General Counsel, and Secretary since the Merger. He was Chief Compliance Officer from August 1996 to September 2001. Mr. Smith also oversees the Company&#146;s Public Affairs, Human Resources, Law, Compliance, Licensing,
and Audit operations. Mr. Smith is a member of the Executive and Management Committees of the Company. Previously, Mr. Smith served as Assistant General Counsel of Hoffmann-La Roche, Division Counsel of RBL and Assistant Secretary and </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">member of RBL&#146;s Senior Management Committee from 1988 until April 1995. Mr. Smith served as Assistant Secretary of Hoffmann-La Roche
from 1989 until the Merger and as an Assistant Vice President of Hoffmann-La Roche during 1992 and 1993. He has served as a director of Gensys Software, Inc. since August 2000. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Stevan R. Stark</B> has served as Executive Vice President since October 1996 and was Senior Vice
President, New York Division, Cranford Division, and Alliance/Hospital Division since the Merger on April 28, 1995. Mr. Stark oversees the Company&#146;s sales and marketing operations including business alliances, managed care, and new business
development. Mr. Stark is a member of the Executive and Management Committees of the Company. Previously, Mr. Stark was a Vice President and Division Manager from 1991 to 1995 and a Division Manager from 1986 to 1991. Mr. Stark served as a director
for Universal Standard Healthcare; the directorship ended on March 30, 1999. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>EXECUTIVE COMPENSATION AND BENEFIT PLANS </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Executive Compensation </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">The compensation paid by the Company during the years ended December 31, 2002, 2001, and 2000 to the Chief Executive Officer and the four other most highly compensated Executive Officers serving at
year end is set forth below. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Summary
Compensation Table </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Long-Term</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Compensation Awards</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Annual Compensation(1)(2)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Restricted Stock Awards(5)($)</B></FONT></P><HR SIZE="1" NOSHADE
COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Securities Underlying Options/SARs(6)(#)</B></FONT></P><HR SIZE="1" NOSHADE
COLOR="#000000"></TD></TR>
<TR>
<TD VALIGN="bottom" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Name and Principal Position</B></FONT></P><HR WIDTH="198" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Year</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Salary(3)($)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Bonus(4)($)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Thomas P. Mac Mahon</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2002</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">825,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1,463,671</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">14,159,036</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">491,400</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">President and Chief Executive</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2001</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">812,500</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1,850,295</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4,906,475</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">445,600</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Officer</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">741,667</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">726,311</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3,462,344</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">362,400</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Richard L. Novak</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2002</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">454,667</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">647,919</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6,653,110</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">230,800</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Executive Vice President and</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2001</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">433,333</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">691,728</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1,983,750</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">194,400</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Chief Operating Officer</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">391,667</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">427,200</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1,695,219</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">138,400</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Wesley R. Elingburg</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2002</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">387,500</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">480,763</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5,155,072</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">178,800</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Executive Vice President, Chief</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2001</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">365,833</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">573,576</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1,587,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">140,000</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Financial Officer, and Treasurer</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">313,333</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">254,400</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">758,300</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">79,200</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Bradford T. Smith</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2002</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">387,500</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">503,623</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5,155,072</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">178,800</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Executive Vice President, Chief</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2001</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">365,833</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">532,554</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1,587,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">140,000</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Legal Officer, and Secretary</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">313,333</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">245,400</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">758,300</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">79,200</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Myla P. Lai-Goldman</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2002</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">299,667</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">271,920</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2,468,548</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">85,800</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Executive Vice President, Chief</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2001</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">285,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">298,706</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">595,125</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">54,400</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Scientific Officer, and Medical Director</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="6%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">256,667</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">209,381</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">388,625</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="16%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">56,400</FONT></P></TD></TR>
</TABLE><HR WIDTH="10%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left">
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">No officer was paid other annual compensation in excess of the lesser of either $50,000 or 10% of the total of annual salary and bonus reported above.
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Does not include amounts that may be received by Messrs. Mac Mahon, Elingburg and Smith under certain whole life insurance policies. Under the terms of the policies,
Messrs. Mac Mahon, Elingburg and Smith, upon termination of their employment, may elect to continue coverage by paying the annual premium, elect to receive the cash value of the policy, or elect to receive a paid-up policy based on premiums paid
through the end of the policy year. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Includes salary paid or accrued for each indicated year. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(4)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Includes bonus accrued or paid for each indicated year and other payments, excluding severance, made pursuant to employment agreements. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(5)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Represents the value of restricted stock awarded during the year indicated under the Company&#146;s 2000 Stock Incentive Plan as of the date of grant and includes a
special grant made to the Executive Officers (see &#147;Special Grants in 2002&#148; in the &#147;Compensation Committee Report on Executive Compensation&#148; section below). The restricted stock awards from this special grant have a four-year
vesting period, with accelerated vesting of outstanding shares in percentages ranging from 33.3% to 100%, if certain predefined cumulative profitability targets are achieved as of December 31, 2003 for the years ended December 31, 2002 and 2003. The
value of these special awards at the date of grant were: for Mr. Mac Mahon, 136,400 shares valued at $5,365,976; Mr. Novak, 64,000 shares valued at $2,517,760; Mr. Elingburg, 49,600 shares valued at $1,951,264; Mr. Smith, 49,600 shares valued at
$1,951,264; and Dr. Lai-Goldman, 23,800 shares valued at $936,292. The regular restricted stock awards granted in 2002 have a six-year vesting period, with accelerated vesting of outstanding shares in percentages ranging from 33.3% to 100%, if
certain predefined cumulative profitability targets are achieved as of December 31, 2004 for the years ended December 31, 2002, 2003, and 2004. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:3%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Aggregate outstanding restricted stock awards and their value at December 31, 2002 were: for Mr. Mac Mahon, 677,200 shares valued at
$15,738,128; Mr. Novak, 299,000 shares valued at $6,948,760; Mr. Elingburg, 215,200 shares valued at $5,001,248; Mr. Smith, 215,200 shares valued at $5,001,248; and Dr. Lai-Goldman, 102,600 shares valued at $2,384,424. No dividends are paid on
restricted stock awards during the restriction period. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(6)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Represents the number of stock options awarded during the year indicated under the Company&#146;s 2000 Stock Incentive Plan. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:3%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The total number of options indicated in this column for 2002
includes a special grant made to the Executive Officers (see Special Grants in 2002 in the Compensation Committee Report on Executive Compensation). The stock option awards from this special grant vest in equal one-third increments over a three year
period, beginning on the first anniversary of the date of grant and if unexercised, expire 10 years after the date of grant, subject to their earlier termination. The number of securities underlying the special options awarded were: for Mr. Mac
Mahon, 203,000 shares; Mr. Novak, 95,400 shares; Mr. Elingburg, 73,800 shares; Mr. Smith, 73,800 shares; and Dr. Lai-Goldman, 35,400 shares. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Restricted Stock Grants in 2002 </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">During 2002, the following restricted stock grants, the aggregate value of which are reflected in the Summary Compensation Table, were
made under the 2000 Stock Incentive Plan for the current Executive Officers named in the Summary Compensation Table: </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Restricted Stock Awards in 2002 </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD VALIGN="bottom" WIDTH="54%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Name</B></FONT></P><HR WIDTH="40" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Number of Shares Granted(1)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Performance Period Until Maturation (1)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Price on Date of Grant($/Sh)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>

<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Price on 12/31/02 ($/Sh)</B></FONT></P><HR SIZE="1" NOSHADE
COLOR="#000000"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="54%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Thomas P. Mac Mahon</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">136,400</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4&nbsp;years</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">39.34</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">23.24</FONT></P></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">202,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6 years</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">43.53</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">23.24</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="54%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Richard L. Novak</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">64,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4 years</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">39.34</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">23.24</FONT></P></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">95,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6 years</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">43.53</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">23.24</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="54%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Wesley R. Elingburg</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">49,600</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4 years</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">39.34</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">23.24</FONT></P></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">73,600</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6 years</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">43.53</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">23.24</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="54%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Bradford T. Smith</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">49,600</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4 years</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">39.34</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">23.24</FONT></P></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">73,600</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6 years</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">43.53</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">23.24</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="54%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Myla P. Lai-Goldman</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">23,800</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4 years</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">39.34</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">23.24</FONT></P></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">35,200</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6 years</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">43.53</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">23.24</FONT></P></TD></TR>
</TABLE><HR WIDTH="10%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left">
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Restrictions limit the sale or transfer of these shares during the four-year or six-year period in which the restrictions lapse. The plan provides for
accelerated vesting of outstanding shares in percentages ranging from 33.3% to 100%, if certain predefined cumulative profitability targets are achieved as of December 31, 2003 for the years ended </FONT>
</P></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%; text-indent:1%">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">December&nbsp;31, 2002 and 2003 for the four-year awards or achieved as of December 31, 2004 for the years ended December 31, 2002, 2003, and
2004 for the six-year awards. The restricted stock granted with a 4 year maturity represents awards that were part of the Special Grants in 2002 (see &#147;Special Grants in 2002&#148; in the &#147;Compensation Committee Report on Executive
Compensation&#148; section below). </FONT></P></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Stock
Option Transactions in 2002 </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">During 2002,
the following grants were made under the 2000 Stock Incentive Plan for the Executive Officers named in the Summary Compensation Table: </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Option/SAR Grants in 2002 </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD VALIGN="bottom" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Name</B></FONT></P><HR WIDTH="40" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Number of Securities Underlying Options/SARs Granted(1)</B></FONT></P><HR SIZE="1" NOSHADE
COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Percentage of Total Options/SARs Granted to Employees in 2002</B></FONT></P><HR SIZE="1" NOSHADE
COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Exercise or Base Price($/Sh)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>

<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Expiration Date</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Grant Date Present Value ($)(2)</B></FONT></P><HR SIZE="1" NOSHADE
COLOR="#000000"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Thomas P. Mac Mahon</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">203,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">9&nbsp;</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">39.34</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1/7/2012</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4,575,849</FONT></P></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">288,400</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">13&nbsp;</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">43.53</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2/14/2012</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">7,188,830</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Richard L. Novak</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">95,400</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4&nbsp;</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">39.34</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1/7/2012</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2,150,424</FONT></P></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">135,400</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6&nbsp;</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">43.53</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2/14/2012</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3,375,060</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Wesley R. Elingburg</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">73,800</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3&nbsp;</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">39.34</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1/7/2012</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1,663,536</FONT></P></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">105,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5&nbsp;</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">43.53</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2/14/2012</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2,617,293</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Bradford T. Smith</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">73,800</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3&nbsp;</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">39.34</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1/7/2012</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1,663,536</FONT></P></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">105,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5&nbsp;</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">43.53</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2/14/2012</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2,617,293</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="40%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Myla P. Lai-Goldman</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">35,400</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2&nbsp;</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">39.34</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1/7/2012</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">797,956</FONT></P></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">50,400</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2&nbsp;</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">%</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">43.53</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2/14/2012</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1,256,300</FONT></P></TD></TR>
</TABLE><HR WIDTH="10%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left">
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">For each grant of non-qualified options made in 2002, the exercise price is equivalent to the fair market value per share on the date of the grant as defined in the
2000 Stock Incentive Plan. The options will vest with respect to one-third of the option shares on the first anniversary of the date of grant and an additional one-third will vest on each of the second and third anniversaries of such date, subject
to their earlier termination. The options granted with an exercise price of $39.34 per share represent awards that were part of the Special Grants in 2002 (see &#147;Special Grants in 2002&#148; in the &#147;Compensation Committee Report on
Executive Compensation&#148; section below). </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Valuation based upon the Black-Scholes option pricing model with the following assumptions: expected dividend yield 0.0%, volatility of 0.541, risk-free interest
rate of 2.99%, and an expected life of seven years. Using the Black-Scholes option pricing model, the assumed exercise or base price per share on January 7, 2002 and February 14, 2002 were approximately $22.54 and $24.93, respectively.
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The following
chart shows, for 2002, the number of stock options exercised and the 2002 year-end value of the options held by the Executive Officers named in the Summary Compensation Table: </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Aggregated Option/SAR Exercises in 2002 </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>and Year-End 2002 Option/SAR Values </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Shares Acquired on Exercise(#)</B></FONT></P><HR SIZE="1" NOSHADE
COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Value Realized($)</B></FONT></P><HR SIZE="1" NOSHADE
COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Number of Securities underlying Options/SARs at Year-End</B></FONT></P><HR SIZE="1"
NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="5" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Value of Unexercised In-the-Money Options/SARs at Year-End ($)(1)</B></FONT></P><HR
SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR>
<TD VALIGN="bottom" WIDTH="30%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Name</B></FONT></P><HR WIDTH="40" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Exercisable</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Unexercisable</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Exercisable</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Unexercisable</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="30%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Thomas P. Mac Mahon</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">75,466</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2,296,243</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">239,201</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">909,265</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">0</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">975,587</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="30%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Richard L. Novak</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">26,134</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">760,495</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">90,933</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">406,533</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">0</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">258,550</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="30%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Wesley R. Elingburg</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">41,956</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">908,205</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">50,311</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">298,533</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">0</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">222,353</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="30%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Bradford T. Smith</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">75,868</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1,170,611</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">9,200</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">298,532</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">0</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">222,353</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="30%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Myla P. Lai-Goldman</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">29,600</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">915,750</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="10%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">29,134</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">140,866</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">0</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">191,327</FONT></P></TD></TR>
</TABLE><HR WIDTH="10%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left">
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Calculated using the actual December 31, 2002 closing price per common share on the NYSE Composite Tape of $23.24, less the applicable aggregate option exercise
price of in-the-money options, multiplied by the number of unexercised in-the-money options that are exercisable and unexercisable, respectively. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Equity Compensation Plan Information </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The following table summarizes our equity compensation plan information as of December 31, 2002. All equity compensation plans have been
approved by Company shareholders, except in the case of equity compensation plans approved by shareholders of companies acquired by the Company as described in footnote (1) below. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD VALIGN="bottom" WIDTH="34%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Plan Category</B></FONT></P><HR WIDTH="100" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Common shares to be issued upon exercise of outstanding options, warrants, and
rights</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Weighted-average exercise price of outstanding options, warrants and
rights</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Common shares available for future issuance under equity compensation plans (excluding securities
reflected in column A)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>A</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>B</B></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>C</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="34%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Equity compensation plans approved by Company shareholders (1)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5,173,006</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">33.11</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">9,004,321</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3)</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="34%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Equity compensation plans not approved by Company shareholders</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">0</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">0</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">0</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD></TR>
</TABLE><HR WIDTH="10%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left">
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Not included in this total are stock option awards from Dynacare, Inc. representing 276,990 shares of underlying common stock, which were assumed in connection with
acquisition transactions by the Company. These options were issued under the Dynacare, Inc. Amended and Restated Employee Stock Option Plan, which were approved by Dynacare, Inc. shareholders when the plan was initially implemented. At December 31,
2002, there were 179,000 shares outstanding under this plan and the weighted-average exercise price of outstanding options was $21.52. The Company does not intend to continue to issue awards under this plan. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Includes options to purchase shares outstanding under the Laboratory Corporation of America Holdings 2000 Stock Incentive Plan, the Laboratory Corporation of America
Holdings Amended and Restated 1999 Stock Incentive Plan, the Laboratory Corporation of America Holdings 1994 Stock Option Plan, and the Laboratory Corporation of America Holdings 1988 Stock Option Plan. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Includes shares available for future issuance under the Laboratory Corporation of America Holdings 2000 Stock Incentive Plan, the Laboratory Corporation of America
Holdings Amended and Restated 1999 Stock Incentive Plan, the Laboratory Corporation of America Holdings 1994 Stock Option Plan, the Laboratory Corporation of America Holdings 1997 Employee Stock Purchase Plan, and the Laboratory Corporation of
America Holdings 1995 Stock Plan for Non-employee Directors. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">10 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Retirement Benefits and
Savings Plan </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The following tables set forth
the estimated annual retirement benefits payable at age 65 to persons retiring with the indicated average direct compensation and years of credited service, on a straight life annuity basis after Social Security offset, under the Company&#146;s
Employees&#146; Retirement Plan, as supplemented by the Company&#146;s Pension Equalization Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Pension Plan Table(1) </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Wesley R. Elingburg </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD VALIGN="bottom" WIDTH="50%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Five-year average Compensation(2)</B></FONT></P><HR WIDTH="252" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD>

<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>10 Years(3)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>15 Years(3)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>20 Years(3)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>25 Years(3)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>30 Years(3)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="50%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$&nbsp;&nbsp;50,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">7,686</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">10,922</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">14,158</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">17,394</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">17,394</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="50%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;100,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">17,230</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">25,238</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">33,246</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">41,254</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">41,254</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="50%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;150,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">27,230</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">40,238</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">53,246</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">66,254</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">66,254</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="50%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;200,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">37,230</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">55,238</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">73,246</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">91,254</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">91,254</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="50%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;250,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">47,230</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">70,238</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">93,246</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">116,254</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">116,254</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="50%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;300,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">57,230</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">85,238</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">113,246</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">141,254</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">141,254</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="50%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;348,868</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">67,004</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">99,898</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">132,793</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">165,688</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">165,688</FONT></P></TD></TR>
</TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"><B>Pension Plan Table(4) </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Thomas P. Mac Mahon, Richard L. Novak, Bradford T. Smith, and Myla P.
Lai-Goldman </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD VALIGN="bottom" WIDTH="50%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Five-year average Compensation(2)</B></FONT></P><HR WIDTH="252" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD>

<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>10 Years(3)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>15 Years(3)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>20 Years(3)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>25 Years(3)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>30 Years(3)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="50%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$&nbsp;&nbsp;50,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6,185</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">9,277</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">12,370</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">15,462</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">18,554</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="50%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;100,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">15,134</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">22,702</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">30,269</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">37,836</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">45,403</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="50%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;150,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">24,494</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">36,742</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">48,989</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">61,236</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">73,483</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="50%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;200,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">33,854</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">50,782</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">67,709</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">84,636</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">101,563</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="50%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;250,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">43,214</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">64,822</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">86,429</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">108,036</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">129,643</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="50%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;300,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">52,574</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">78,862</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">105,149</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">131,436</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">157,723</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="50%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;&nbsp;348,868</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">61,722</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">92,584</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">123,445</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">154,306</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">185,167</FONT></P></TD></TR>
</TABLE><HR WIDTH="10%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left">
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Retirement Plan, as supplemented by the Pension Equalization Plan, is a defined benefit pension plan designed, in conjunction with the Company&#146;s Pension
Equalization Plan, to provide an employee, covered under the Roche Biomedical Laboratories, Inc. Supplemental Executive Retirement Plan, having 25 years of credited service with an annuity equal to 50% of final average compensation less 50% of
estimated individual Social Security benefits. The benefit is then converted from a life annuity to an actuarially equivalent life annuity with a ten-year guarantee. In addition, following retirement from active service, an additional benefit is
paid from the Pension Equalization Plan designed to provide for a portion of the Executive Officer&#146;s postretirement medical benefit. For 2002, this additional benefit amounted to $1,214 per year, based on a retiree over age 65, with a dependent
under the age of 65. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Highest consecutive five-year average base compensation during final ten years. Compensation considered for this five-year average is reflected in the Summary
Compensation Table under the heading &#147;Salary.&#148; Under the Pension Equalization Plan, a maximum of $300,000 final average compensation is considered for benefit calculation indexed beginning in 1997 based on the percentage change in the
unrounded compensation limit under Section 401 (a)(17) of the Internal Revenue Code. For 2002, this limit is $348,868. No bonuses are considered. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Under the plans, the normal form of benefit for an unmarried participant is a life annuity with a guaranteed minimum payment for ten years. For a married
participant, the normal form is a 50% joint and survivor annuity, which is actuarially equivalent to the normal form for an unmarried participant. The above tables are determined with regard to a life only form of payment; thus, payment using a
ten-year guarantee would produce a lower annual benefit. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">11 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(4)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Retirement Plan, as supplemented by the Pension Equalization Plan, is a defined benefit pension plan designed, in conjunction with the Company&#146;s Pension
Equalization Plan, to provide an employee having 30 years of credited service with an annuity equal to 52% of final average compensation less 50% of estimated individual Social Security benefits. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Credited service is defined generally as all periods of
employment with the Company, a participating subsidiary or with National Health Laboratories, Inc. or its subsidiaries prior to 1992, or RBL or an affiliate, after attainment of age 21 and completion of one year of service (age 25 and completion of
one year of service if hired before January 1, 1985). Final average compensation is defined as average annual base salary during the five consecutive years in which base salary was highest out of the last ten years prior to normal retirement age or
earlier termination. The Employee Retirement Income Security Act of 1974, as amended, places certain maximum limitations upon the annual benefit payable under all qualified plans of an employer to any one individual. The limitation solely with
respect to defined benefit pension plans was $160,000 for 2002 and will be subject to cost of living adjustments for future years. In addition, the Tax Reform Act of 1986 limits the amount of compensation that can be considered in determining the
level of benefits under qualified plans. The applicable limit for 2002 was $200,000. The Company believes that, with respect to certain employees, annual retirement benefits computed in accordance with the Retirement Plan&#146;s benefit formula may
be greater than those which would be provided with regard to such qualified plan limitation. The Company&#146;s non-qualified, unfunded, Pension Equalization Plan is designed to provide for the payment of the difference, if any, between the amount
of such maximum limitation and the annual benefit that would be payable under the Retirement Plans but for such limitation, subject to the allowed maximum compensation limit under the Pension Equalization Plan. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">As of December 31, 2002, credited years of service under the
retirement plans for the following individuals are for Mr. Mac Mahon&#151;5.0 years, Mr. Elingburg&#151;21.4 years, Mr. Smith&#151;19.9 years, Dr. Lai-Goldman&#151;11.4 years, and Mr. Novak&#151;4.5 years. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Compensation Plans and Arrangement </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">On April 17, 1996, the Board of Directors approved the Master
Senior Executive Severance Plan (the &#147;Severance Plan&#148;), which provides severance payments to certain key employees. The Severance Plan provides for severance payments of three times annual salary and targeted bonus then in effect for a
change in control (as defined in the Severance Plan) and two times annual salary and targeted bonus then in effect for all other qualifying terminations for the President and Chief Executive Officer and the Executive Vice Presidents of the Company.
The Severance Plan also provides severance payments of one times annual salary and targeted bonus then in effect for Senior Vice Presidents upon the occurrence of a qualifying termination. Qualifying termination is generally defined as involuntary
termination without cause or voluntary termination with Good Reason, as defined. &#147;Good Reason&#148; is defined as a reduction in base salary or targeted bonus as a percentage of salary, relocation to an office location more than 75 miles from
the employee&#146;s current office without consent of the employee, or a material reduction in job responsibilities or transfer to another job without the consent of the employee. Good Reason does not include a reduction in base salary or targeted
bonus where such reduction is pursuant to a Company-wide reduction of base salaries and/or targeted bonuses. In addition, the Severance Plan may not be amended or terminated within 36 months of a change in control, as defined. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Compensation Committee Report on Executive Compensation </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Compensation Committee of the Board of Directors (for the
purposes of this section, the &#147;Committee&#148;), comprised entirely of independent directors, reviews and recommends to the full Board for its approval compensation and benefit policies and objectives; determines whether officers, directors and
employees are compensated according to these policies and objectives; and carries out the board&#146;s responsibilities relating to the compensation of executives and directors as described above under &#147;Item One: Election of Directors.&#148;
The charter of the Compensation Committee was adopted on September 18, 2002, and is attached hereto as Annex II. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">12 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">During 2002,
the Committee held four meetings to review and evaluate executive and director compensation and benefit programs, including information provided to the Company by independent compensation and benefit consultants. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>Executive Officer Compensation
Policies.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Committee&#146;s executive compensation policies are designed to (a) attract and retain the best individuals critical to the success of the Company, (b) motivate and reward such individuals based on
corporate, business unit and individual performance, and (c) align executives&#146; and stockholders&#146; interests through equity-based incentives. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Compensation for executives is based on the following principles: variable compensation should comprise a significant part of an
executive&#146;s compensation, with the percentage at-risk highest for the executive officers; both compensation opportunities provided to executive officers and the realizable values of those opportunities should significantly vary with performance
achievements; an emphasis on stock-based compensation aligns the long-term interests of executive officers and stockholders; compensation opportunities for executive officers must be evaluated against that offered by companies similar in size and
scope of operations; and differences in executive compensation within the Company should reflect varying levels of responsibility and/or performance. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">A key reference in determining the overall levels of executive officer compensation is an assessment of pay practices within a group of
public companies in the health care services industries that are comparable in size and scope to the Company (the &#147;peer group&#148;). Companies in the peer group were selected by the Committee based on recommendations from the Committee&#146;s
independent compensation and benefit consultants. Some of these companies are included in the peer group used for stock price comparisons (see &#147;Common Stock Performance&#148; below). </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">This peer group was changed in 2001 as part of a thorough review of executive officer compensation conducted
by the Committee. The new peer group includes other organizations in the health care services industries that engage in diagnostics and genomic research. The Committee believes this new peer group better reflects the Company&#146;s market for
executive talent as the Company expands its operations beyond traditional clinical testing. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>2002 Executive Officer Compensation</I>.&nbsp;&nbsp;&nbsp;&nbsp;There are three components to the Company&#146;s executive compensation program: base salary, annual incentive compensation, and
long-term incentive compensation. The more senior the position, the greater the portion of total compensation that varies with performance results. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Base salaries are set by the Committee and are designed to be competitive with the peer group companies described above. Generally, the
Committee has targeted salary levels of the executive officers at the median of peer group practices, with any variations reflecting the individual&#146;s job experience and responsibility. Annual changes in base salaries are based on the peer
group&#146;s practices, the Company&#146;s performance, the individual&#146;s performance, and increases in cost of living indexes. For 2002, the average salary increase for executive officers was 4 percent, not including the CEO, as the CEO&#146;s
salary was deemed competitive for the year. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Under the Company&#146;s Management Incentive Bonus Plan, originally adopted by the stockholders in 1995, annual incentive compensation for executive officers is paid in the form of a cash bonus. Earned bonus amounts generally are
based on the attainment of specific performance goals, which were approved by the Chair of the Committee at the beginning of 2002. The primary measures used for executive officer bonuses in 2002 were earnings before interest, taxes, depreciation and
amortization (&#147;EBITDA&#148;), days sales outstanding, revenue growth, and certain other specific measures. Each executive officer has a target bonus expressed as a percentage of salary. The Committee generally sets bonus opportunities so that
total cash compensation for Executive Officers will approximate the peer group&#146;s 75th percentile if performance results warrant such an outcome. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">13 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The
Company&#146;s annual performance results in 2002 generally satisfied the goals set by the Committee for the year and resulted in bonuses for executive officers that were slightly above the target amount (see &#147;Summary Compensation Table&#148;
for amounts paid to certain executive officers under the plan). These bonuses were lower than the bonuses earned by executive officers for 2001, when performance results substantially exceeded the goals set by the Committee for the year.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Long-term incentive compensation is provided
through the granting of stock options and restricted stock under the Company&#146;s Stock Option Plans. The Committee believes that grants of stock options and restricted stock align stockholder and executive officer interests and serve as an
effective retention tool. Generally, the Committee approves stock option grants at the beginning of the year with the size of grants determined by each executive officer&#146;s level of responsibility after comparison to the equity grant practices
of the peer group. Competitive grant practices are evaluated in terms of both annualized expected value and percentage of common shares outstanding, and the size of grants to Company executive officers reflect the Committee&#146;s evaluation of the
Company&#146;s performance as compared to the peer group. As provided in the Company&#146;s Stock Option Plans, stock options are granted with an exercise price equal to the Fair Market Value (as defined in the Company&#146;s Stock Option Plans) per
share on the date of grant. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">For 2002, the
Committee decided to change from making annual grants of restricted stock and instead made one grant that will represent the entire restricted stock opportunity for executive officers for the three-year period from 2002 through 2004. Moving from an
annual to a three-year plan is intended to remove the issues related to the volatility of the Company&#146;s share price in determining the size of the grants. Grants of restricted stock will vest on the sixth anniversary of grant, although vesting
of shares granted in 2002 may be accelerated if certain predefined profitability targets are achieved as of December 31, 2004. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The mix between stock options and restricted stock is such that a majority of the expected value is delivered through the granting of
stock options. No stock option or restricted stock awards are made in the absence of satisfactory performance, which is evaluated by the Committee based on the executive&#146;s individual contribution to the long-term health and growth of the
Company. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>Special Grants in
2002</I>.&nbsp;&nbsp;&nbsp;&nbsp;As part of its thorough review of executive officers compensation during 2001, the Committee, together with its independent compensation and benefits advisor, evaluated the values generated from the Company&#146;s
compensation program since 1997 and compared those values to what had been generated for executives at peer group companies. The Committee also considered performance results of the Company in such areas as earnings growth, operating margins, return
on investment, and total shareholder return. These results were also compared to performance achievements at peer group companies during that same period. The Company&#146;s annualized rate of return to shareholders during this five-year period was
41.2 percent, exceeding the return rates of nearly all of the peer group companies and far greater than the 9.2 percent annualized return of the S&amp;P 500 during this period. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">To recognize the superior performance achievements of the Company during the 1997-2001 period and to provide
additional incentive for continued success in future years, the Committee decided to make a special, one-time grant of stock options and performance-based restricted stock to executive officers in January 2002. The number of stock options and
restricted shares granted was based in part on the results from historical compensation and performance analyses of peer group companies. The special grants of restricted stock will vest on the fourth anniversary of grant, but vesting may be
accelerated if certain predefined profitability targets are achieved as of December 31, 2003. These special grants are identified in the &#147;Restricted Stock Transactions in 2002&#148; and the &#147;Stock Option Transactions in 2002&#148; sections
above. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>2002 Chief Executive Officer
Compensation</I>.&nbsp;&nbsp;&nbsp;&nbsp;The Committee reviewed Mr. Mac Mahon&#146;s base salary, annual incentive and long-term incentive compensation in the same manner as described above for other Executive Officers. The Committee did not
increase Mr. Mac Mahon&#146;s base salary from 2001 to 2002, as it was deemed competitive for 2002, so it remained at $825,000. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">14 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Committee
believes that Mr. Mac Mahon&#146;s leadership and individual performance have significantly contributed to the achievement of remarkable growth in earnings and stockholder value for the Company during his tenure as CEO. Mr. Mac Mahon&#146;s annual
target bonus opportunity during 2002 was 150 percent of salary, the same as in 2001. Based on the Company&#146;s performance achievements during 2002, Mr. Mac Mahon received an annual bonus payment that was approximately 177 percent of his 2002
salary. This represented a reduction of approximately 21 percent from his 2001 earned bonus amount and resulted in total cash compensation for 2002 that was approximately 14 percent lower than his total cash compensation for 2001. As for the other
Executive Officers, this result reflected that while the Company generally achieved the goals for 2002, performance results did not exceed the Committee&#146;s goals as significantly as was the case in 2001. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The majority of Mr. Mac Mahon&#146;s compensation opportunity
for 2002 was delivered through equity-based vehicles linked directly to the interests of stockholders. In 2002, Mr. Mac Mahon received an annual grant of 288,400 stock options and 202,000 shares of restricted stock. The Committee determined the size
of these grants after reviewing competitive equity grants to peer group CEOs and they reflect the Committee&#146;s assessment that the performance of both the Company and Mr. Mac Mahon have been outstanding. As with the grants of restricted stock to
other executive officers, these shares represent a grant covering the 2002-2004 period and will vest on the sixth anniversary of grant, but vesting may be accelerated if certain predefined profitability targets are achieved as of December 31, 2004.
The stock options will vest in equal one-third increments over a three-year period beginning on the first anniversary of the grant date and if unexercised, will expire ten years from the date of grant, subject to their earlier termination.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">In 2002, Mr. Mac Mahon also received a special,
one-time grant of 203,000 stock options and 136,400 shares of restricted stock for reasons described in the above section entitled &#147;Special Grants in 2002&#148;. These shares of restricted stock will vest on the fourth anniversary of grant, but
vesting may be accelerated if certain predefined cumulative profitability targets are achieved as of December 31, 2003. The stock options will vest in equal one-third increments over a three-year period beginning on the first anniversary of the
grant date and if unexercised, will expire ten years from the date of grant, subject to their earlier termination. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Mr. Mac Mahon became eligible to participate in the Company&#146;s Retirement Benefits and Savings Plan in 1998. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>Limit on Deductibility of
Compensation.</I>&nbsp;&nbsp;&nbsp;&nbsp;Section 162(m) of the Internal Revenue Code limits the corporate federal income tax deduction for certain &#147;non-performance based&#148; compensation paid to the chief executive officer and each of the
four highest paid employees of public companies to $1 million per year. The Committee has carefully considered the Corporation&#146;s executive compensation program in light of the applicable tax rules. Accordingly, the Company&#146;s 2000 Stock
Incentive Plan has been structured to meet the requirements of Section 162(m), and stockholders last approved the Plan in 2002. However, the Committee believes that tax-deductibility is but one factor to be considered in fashioning an appropriate
compensation package for executives. As a result, the Committee reserves and will exercise its discretion in this area so as to serve the best interests of the Company and its stockholders. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">THE COMPENSATION COMMITTEE </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Jean-Luc B&eacute;lingard, Chairman
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Wendy E. Lane </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Andrew G. Wallace </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">15 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>COMMON STOCK
PERFORMANCE </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Company&#146;s common stock
is traded on the New York Stock Exchange, Inc. (the &#147;NYSE&#148;). The graph below shows the cumulative total return assuming an investment of $100 on December 30, 1997 in each of the Company&#146;s common stock, the Standard &amp; Poor&#146;s
(the &#147;S&amp;P&#148;) Composite-500 Stock Index, the S&amp;P 400 Health Care Index (the &#147;New Peer Group&#148;), and the peer group reported in the Company&#146;s prior proxy statement (the &#147;Old Peer Group&#148;) and that all dividends
were reinvested. The Old Peer Group was based on the weighted average cumulative total return (based on stock market capitalization) of the stock of six publicly traded medical service and medical supply companies and one clinical laboratory company
which is a direct competitor of the Company: Allergan, Inc., Quest Diagnostics, Incorporated, C.R. Bard Inc., Magellan Health Services Inc., Fisher Scientific International Inc., Thermo Electron Corporation, and Bausch &amp; Lomb Inc. Following the
implementation of the new Executive Compensation Plan, in 2002, the Company changed the peer group used to compare the performance of the Company and of the Executive Officers. This New Peer Group includes other organizations in the health care
services industries that engage in diagnostics and genomic research and better aligns with the Company&#146;s strategic focus. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>COMPARISON OF FIVE YEAR CUMULATIVE TOTAL RETURN </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>12/1997</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>12/1998</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>12/1999</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>12/2000</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>12/2001</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>12/2002</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="52%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Laboratory Corporation of America Holdings</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">100</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">79</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">211</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1,006</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">924</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">531</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="52%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">S&amp;P 500</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">100</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">129</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">156</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">141</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">125</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">97</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="52%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Old Peer Group</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">100</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">106</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">133</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">216</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">199</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">167</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="52%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">New Peer Group</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">100</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">129</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">132</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">203</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">192</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">152</FONT></P></TD></TR>
</TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>

<IMG SRC="g22611g47g81.jpg" ALT="LOGO"> </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">16 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL HOLDERS AND MANAGEMENT </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">The following table sets forth as of March 31, 2003, the total number of shares of Common Stock beneficially owned, and the percent so owned, by (i) each director of the Company who is a beneficial owner of any shares of Common
Stock, (ii) each person known to the Company to be the beneficial owner of more than 5% of the outstanding Common Stock, (iii) the officers named in the &#147;Summary Compensation Table&#148; set forth above, and (iv) all current directors and
Executive Officers as a group. The number of shares owned are those &#147;beneficially owned,&#148; as determined under the rules of the Commission, and such information is not necessarily indicative of beneficial ownership for any other purpose.
Under such rules, beneficial ownership includes any shares as to which a person has sole or shared voting power or investment power and any shares of Common Stock which the person has the right to acquire within 60 days through the exercise of any
option, warrant or right, through conversion of any security, or pursuant to the automatic termination of power of attorney or revocation of trust, discretionary account or similar arrangement. Except as otherwise indicated below, the persons named
in the table have sole voting and investment power with respect to the shares beneficially owned by them as set forth opposite their respective names. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD VALIGN="bottom" WIDTH="62%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Beneficial Owner</B></FONT></P><HR WIDTH="95" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Amount and Nature of Beneficial Ownership of Common Stock</B></FONT></P><HR SIZE="1" NOSHADE
COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Percent of Class</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="62%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Wellington Management Company, LLC</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">16,892,500</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">11.3%</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="62%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">75 State Street</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Boston, Massachusetts 02109</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="62%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Chieftain Capital Management, Inc.</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">13,531,687</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">9.0%</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="62%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">12 East 49</FONT><FONT FACE="Times New Roman" SIZE="1"
COLOR="#000000"><SUP>th</SUP></FONT><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"> Street</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">New York,
New York 10017</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="62%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Thomas P. Mac Mahon</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1,244,117</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3,4)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="62%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Jean-Luc B&eacute;lingard</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">20,253</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="62%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Wendy E. Lane</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">20,693</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="62%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Robert E. Mittelstaedt, Jr.</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">13,931</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="62%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">James B. Powell</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">16,549</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(5)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="62%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Andrew G. Wallace</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">17,010</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="62%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Wesley R. Elingburg</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">349,255</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3,4)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="62%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Richard L. Novak</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">504,301</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3,4)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="62%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Bradford T. Smith</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">335,171</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3,4)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="62%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Myla P. Lai-Goldman</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">184,074</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3,4,6)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="62%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">All directors and Executive Officers</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">as a group (11 persons)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2,865,483</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" WIDTH="15%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1.9%</FONT></P></TD></TR>
</TABLE><HR WIDTH="10%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left">
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">*</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Less than 1% </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">As reported on Schedule 13G filed with the Commission on February 12, 2003, on behalf of Wellington Management Company, LLC (&#147;WMC&#148;). WMC is a registered
investment advisor with shared voting power for 11,590,835 of the above listed shares. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">As reported on Schedule 13G filed with the Commission on February 14, 2003, on behalf of Chieftain Capital Management, Inc. (&#147;CCM&#148;). CCM is a registered
investment advisor with shared voting power for 13,531,687 of the above listed shares. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(3)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Beneficial ownership by officers of the Company includes shares of Common Stock, which such officers have the right to acquire upon the exercise of options which
either are vested or which may vest within 60 days of March 31, 2003. The number of shares of Common Stock included in the table as beneficially owned which are subject to such options is as follows: Mr. Mac Mahon&#151;627,001; Mr.
Elingburg&#151;156,578; Mr. Novak&#151;252,667; Mr. Smith&#151;132,666; Dr. Lai-Goldman&#151;90,667; all directors and Executive Officers as a group&#151;1,352,895. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">17 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(4)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Includes shares of Restricted Common Stock. The number of shares of Restricted Common Stock included in the table is as follows: Mr. Mac Mahon&#151;486,800; Mr.
Elingburg&#151;171,200; Mr. Novak&#151;219,000; and Mr. Smith&#151;171,200; Dr. Lai-Goldman&#151;77,000; all directors and Executive Officers as a group&#151;1,202,200. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(5)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Includes 700 shares of common stock held by Allemanni LLC. Dr. Powell is the sole manager of Allemanni LLC. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(6)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Includes 2,000 shares of common stock held by Dr. Lai-Goldman&#146;s daughter. Dr. Lai-Goldman disclaims beneficial ownership of the 2,000 shares of common stock
held in her daughter&#146;s name. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Section 16(a)
Beneficial Ownership Reporting Compliance </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Section 16(a) of the Securities Exchange Act of 1934, as amended, (the &#147;Exchange Act&#148;) requires the Company&#146;s Executive Officers, directors and persons who own more than 10% of the Company&#146;s equity securities to
file reports on ownership and changes in ownership with the Commission and the securities exchanges on which its equity securities are registered. Additionally, Commission regulations require that the Company identify in its proxy statements any
individuals for whom one of the referenced reports was not filed on a timely basis during the most recent fiscal year or prior fiscal years. To the Company&#146;s knowledge, based solely on a review of reports furnished to it, all Section 16(a)
filing requirements applicable to its Executive Officers, directors and more than 10% beneficial owners were complied with, with two exceptions: i) James B. Powell inadvertently reported late his October 9, 2002, October 31, 2002, and December 29,
2002 acquisitions of an aggregate of 1,200 shares of Common Stock on Forms 4 (statement of changes of beneficial ownership of securities) filed with the Commission on November 5, 2002 and January 6, 2003 because Dr. Powell was belatedly notified
that the shares had been acquired on his behalf by a financial advisor having discretion over certain of his accounts, and ii) Jean-Luc B&eacute;lingard, Wendy E. Lane, Robert E. Mittelstaedt, James B. Powell, David B. Skinner, and Andrew G. Wallace
inadvertently reported late the September 3, 2002 issuance of the stock portion of the non-employee director retainer of 39 shares of Common Stock on Forms 5 (annual statement of changes of beneficial ownership of securities) filed on their behalf
by the Company with the Commission on February 14, 2003 because of inadvertent oversight and advice from the Company&#146;s then outside counsel during the transition to the new Sarbanes-Oxley filing rules. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>ITEM TWO:&nbsp;&nbsp;&nbsp;&nbsp;AMENDMENT TO THE 2000 STOCK
INCENTIVE PLAN </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">On October 16, 2002, the
Board of Directors adopted an amendment to the Laboratory Corporation of America Holdings 2000 Stock Incentive Plan (the &#147;Plan&#148;) to increase the fair market value of the shares of stock subject to options to be awarded on an annual basis
to non-employee directors from $65,000 to $77,000 as part of a new director&#146;s compensation plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The summary description herein of the principal features of the Plan, as amended by the Stock Plan Amendment, is qualified by reference to
the Plan and the Stock Plan Amendment. The Plan was originally effective following approval at the annual meeting of stockholders on May 2, 2000 and subsequently amended following approval at the annual meeting of stockholders on May 15, 2002. As of
March 31, 2003, 12,950,043 shares had been issued under this Plan and under the Laboratory Corporation of America Holdings Amended and Restated 1999 Stock Incentive Plan and the Laboratory Corporation of America Holdings 1994 Stock Option Plan (the
&#147;Prior Plans&#148;), and 6,729,957 shares were available from this Plan and Prior Plans for future issuance. A total of 19.68 million shares, including those available from the Prior Plans, were authorized for issuance under the Plan. A copy of
the Plan, as proposed to be amended, is attached hereto as Annex V. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">The purpose of the Plan is to attract and retain the best available employees and directors for the Company and to encourage the highest level of performance by such persons, thereby enhancing the value of the Company for
the benefit of its stockholders. The Plan is also intended to motivate such persons to contribute to the Company&#146;s future growth and profitability, to reward the performance of employees and increase the proprietary </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">18 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">and vested interest of all such persons in the growth and performance of the Company in a manner that provides them with a means to increase
their holdings of Common Stock and aligns their interests with the interests of the stockholders of the Company. Potentially all employees (approximately 24,000), officers and directors of the Company are eligible to participate in the Plan. As of
March 31, 2003, there were 234 participants under the Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">The exercise price of incentive stock options (&#147;ISOs&#148;) within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;) and non-qualified stock options (&#147;NSOs&#148;)
(&#147;Option Price&#148;) may not be less than 100% of the fair market value of the shares of Common Stock on the date of grant, except that, in the case of an ISO granted to an individual who, at the time the ISO is granted, owns shares possessing
more than 10% of the total combined voting power of all classes of Common Stock, the Option Price may not be less than 110% of the fair market value. The Option Price of, and the number of shares covered by, each option will not change during the
life of the option, except for adjustments to reflect stock dividends, splits, other recapitalizations or reclassifications or changes affecting the number or kind of outstanding shares. Stock appreciation rights, restricted stock, and performance
awards may also be granted under the Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Except as otherwise provided in an award agreement, in the case of an NSO, no award may be transferred by an optionee except by will or the laws of descent and distribution. Options may be exercised in whole or in installments and
must be exercised within a fixed period, which period may not exceed 10 years from the date of the option grant in the case of ISOs. In the case of ISOs granted to any holder on the date of the grant of more than 10% of the total combined voting
power of all classes of stock of the Company, the options must be exercised within five years from the date of grant of the option. Options may expire before the end of the option period due to termination of service with the Company. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The exercise costs related to shares of Common Stock purchased
upon the exercise of an option are to be paid for in cash, by using the cashless exercise method, through the delivery of other shares of Common Stock held for at least six months with a value equal to the total option price, or by a combination of
cash and such shares. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The shares of Common Stock
to be delivered under the Plan will be made available from the authorized but unissued shares of Common Stock or from treasury shares and have been registered by the Company with the Commission on Form S-8 and will be freely tradable, subject to
applicable restrictions under Section 16 of the Exchange Act. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">The annual per participant limitation for grants of options and stock appreciation rights is 600,000 shares. This limit, and the other per participant limitations, are subject to adjustment in the event of changes in the
Company&#146;s capitalization. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Plan is
administered by the Compensation Committee of the Board of Directors. Subject to the provisions of the Plan, the Committee shall be authorized to interpret the Plan, to establish, amend, and rescind any rules and regulations relating to it and to
make all other determinations necessary or advisable for its administration; provided, however, that the Committee shall have no discretion with respect to the selection of directors to receive shares of Common Stock, as these are pre-determined, or
the timing or pricing of grants of shares of Common Stock. The determinations of the Committee in the administration of the Plan, as described herein, shall be final and conclusive. The Secretary of the Company is authorized to implement the Plan in
accordance with its terms and to take such actions of a ministerial nature as shall be necessary to effectuate the intent and purpose thereof. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">In the event of a stock split, stock dividend, subdivision or combination of the shares of Common Stock or other change in corporate
structure affecting the shares of Common Stock, the number of shares of Common Stock authorized by the Plan shall be increased or decreased proportionately, as the case may be. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">19 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">No award may
be granted under the Plan after May 4, 2010. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The
Plan may be amended by the Board as it shall deem advisable or to conform to any change in any law or regulation applicable thereto; provided, that amendments will be submitted to stockholders for approval to the extent required by applicable law or
as otherwise determined to be appropriate by the Committee. The Board also has the authority to terminate the Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">In 2002, the Compensation Committee granted NSOs to purchase an aggregate of 2,186,818 shares of Common Stock and 966,408 shares of
restricted stock under the Plan to Executive Officers, non-employee directors, and non-executive employees of the Company. No ISO&#146;s, stock appreciation rights (&#147;SARs&#148;), or performance awards were granted in 2002. There has been no
decision with respect to the number or terms of options that may be granted following stockholder approval of the Stock Plan Amendment or the number or identity of future optionees under the Plan. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>2002 Stock Incentive Plan Benefits </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD VALIGN="bottom" WIDTH="66%"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Name and Position</B></FONT></P><HR WIDTH="133" SIZE="1" NOSHADE ALIGN="left" COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Dollar Value ($)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Number of Options(1)(#)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>Number of Restricted Shares(1)(#)</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="66%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Thomas P. Mac Mahon</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">President and Chief Executive Officer</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">491,400</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">338,400</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="66%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Richard L. Novak</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Executive Vice President and Chief Operating Officer</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">230,800</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">159,000</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="66%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Wesley R. Elingburg</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Executive Vice President, Chief Financial Officer, and Treasurer</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">178,800</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">123,200</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="66%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Bradford T. Smith</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Executive Vice President, Chief Legal Officer, and Secretary</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">178,800</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">123,200</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="66%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Myla P. Lai-Goldman</FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Executive Vice President, Chief Scientific Officer, and Medical Director</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">85,800</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">59,000</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="66%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">All current Executive Officers as a group</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1,251,400</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">861,800</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="66%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">All current non-employee directors as a group</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">8,118</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">0</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="66%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">All current non-executive officer employees as a group</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD ALIGN="right" COLSPAN="1" VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2</FONT></P></TD>
<TD COLSPAN="1" NOWRAP VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">)</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="12%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">927,300</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right" WIDTH="11%"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">104,608</FONT></P></TD></TR>
</TABLE><HR WIDTH="10%" SIZE="1" NOSHADE COLOR="#000000" ALIGN="left">
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(1)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Options granted to Executive Officers in 2002 have an exercise price of $39.34 per share or $43.53 per share (see &#147;Stock Options Transactions in 2002&#148;).
All options granted to non-executive officer employees in 2002 have an exercise price of $43.53 per share. Options granted to non-employee directors in 2002 have an exercise price of $48.02 per share. All options granted in 2002 have a ten-year
term, vest in equal one-third increments on the first, second, and third anniversaries of their grant date and are subject to earlier termination as described above. The dollar value of each of the options granted is not determinable due to
fluctuating market prices. At March 31, 2003, the Company&#146;s Common Stock had a closing price of $29.65 per share. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(2)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Amounts for the executive officers include option and restricted stock awards from special grants in 2002 (see &#147;Special Grants in 2002&#148; in the
&#147;Compensation Committee Report on Executive Compensation&#148; section above). </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>Federal Income Tax Consequences.</I>&nbsp;&nbsp;&nbsp;&nbsp;The following summary generally describes the federal income tax
consequences to optionees and the Company and is based on current laws and regulations. The summary is general in nature and is not intended to cover all tax consequences that could apply to a particular individual or the Company. Additionally, the
summary does not cover any state or local tax consequences of participation in the Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">Generally, when an optionee exercises an NSO, the difference between the option price and any higher fair market value of the shares of Common Stock on the date of exercise will be ordinary income to
the optionee and </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">20 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">will be generally allowed as a deduction for federal income tax purposes to the Company. Any gain or loss realized by an optionee on
disposition of the Common Stock acquired upon exercise of an NSO will generally be capital gain or loss to such optionee, long-term or short-term depending on the holding period, and will not result in any additional tax consequences to the Company.
The optionee&#146;s basis in the shares of Common Stock is determined generally at the time of exercise. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">When an optionee exercises an ISO while employed by the Company or a subsidiary or within three months (one year for disability and
without limit for death) after termination of employment, no ordinary income will be recognized by the optionee at that time, but the excess (if any) of the fair market value of the shares of Common Stock acquired upon such exercise over the Option
Price will be an adjustment to taxable income for purposes of the federal alternative minimum tax applicable to individuals. If the shares of Common Stock acquired upon exercise of the ISO are not disposed of prior to the expiration of one year
after the date of acquisition and two years after the date of grant of the option, the excess (if any) of the sales proceeds over the aggregate Option Price of such shares of Common Stock will be long-term capital gain, but the Company will not be
entitled to any tax deduction with respect to such gain. Generally, if the shares of Common Stock are disposed of prior to the expiration of such periods (a &#147;Disqualifying Disposition&#148;), the excess of the fair market value of such shares
at the time of exercise over the aggregate Option Price (but not more than the gain on the disposition if the disposition is a transaction on which a loss, if realized, would be recognized) will be ordinary income at the time of such Disqualifying
Disposition (and the employer will generally be entitled to a federal income tax deduction in a like amount). Any gain realized by the optionee as the result of a Disqualifying Disposition that exceeds the amount treated as ownership income will be
capital in nature, long-term or short-term depending on the holding period. If an ISO is exercised more than three months (one year for disability and without limit for death) after termination of employment, the tax consequences are the same as
described above for NSOs. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Certain additional
special rules apply if the exercise price for an option is paid in shares of Common Stock previously owned by the optionee rather than in cash. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">ACCORDINGLY, EACH OPTIONEE SHOULD CONSULT HIS OR HER TAX ADVISOR TO DETERMINE THE PARTICULAR TAX CONSEQUENCES TO HIM OR HER OF INCENTIVE
PLAN AWARDS, AS WELL AS THE USE OF SHARES FOR EXERCISE, INCLUDING THE APPLICATION AND EFFECT OF FEDERAL, STATE, LOCAL, OR FOREIGN INCOME TAX AND OTHER LAWS. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">When a participant exercises &#147;SARs&#148;, the amount of cash and the fair market value of property received (including Shares),
unless the property is subject to transfer restrictions or forfeiture, will be ordinary income to the participant and will generally be allowed as a deduction for federal income tax purposes to the Company or a subsidiary. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">In the absence of an election by a participant under Section
83(b) of the Code, the grant of restricted shares will not result in taxable income to the participant or a deduction to the Company or its subsidiary or affiliate in the year of the grant. The value of such restricted shares will be taxed to a
participant in the year in which the restrictions lapse. Alternatively, a participant may elect to treat as income in the year of grant the fair market value of the restricted shares on the date of grant, provided the participant makes an election
under Section 83(b) of the Code within thirty days after the date of such grant. If such an election were made, a participant would not be allowed to deduct at a later date the amount included as taxable income if he/she should forfeit the
restricted shares to the Company or its subsidiary or affiliate. Generally, the amount of ordinary income recognized by a participant is deductible by the Company or its subsidiary or affiliate in the year the income is recognized by the
participant. If the participant does not make an election under Section 83(b) of the Code, dividends paid on the shares prior to the lapse of restrictions on such shares will be taxable to the participant as additional compensation in the year
received free of restrictions, and the Company or its subsidiary or affiliate will generally be allowed a corresponding deduction. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">In general, the grant of performance awards will not result in taxable income to the participant or a deduction to the Company or its
subsidiary or affiliate in the year of the grant. The value of the award will be </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">21 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">taxed to a participant in the year in which the award is settled, and the Company will generally receive a deduction in the same amount.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>The Board of Directors of the Company
recommends that stockholders vote &#147;FOR&#148; approval and adoption of the Stock Plan Amendment. </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>ITEM THREE:&nbsp;&nbsp;&nbsp;&nbsp;AMENDMENT TO THE MANAGEMENT INCENTIVE BONUS PLAN </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Board of Directors has adopted and recommends that the stockholders approve the Management Incentive Bonus Plan (the &#147;Incentive
Plan&#148;), formerly known as the Annual Bonus Incentive Plan, as proposed to be amended and attached hereto as Annex VI for the plan year beginning 2003. The summary description herein of the principal features thereof is qualified by reference to
the Incentive Plan documents. If approved by stockholders, the Incentive Plan will provide incentives for senior executives and other key employees whose performance in fulfilling the responsibilities of their positions can have a major impact on
the profitability and future growth of the Company and its subsidiaries. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">The Incentive Plan must be administered by a committee (for the purposes of this section, the &#147;Committee&#148;) of two or more &#147;outside&#148; directors designated by the Board of Directors to the extent necessary
to comply with Code Section 162(m). The Board of Directors has appointed the Compensation Committee as the Committee to administer the Incentive Plan. The Committee will have full authority to interpret the Incentive Plan and to adopt such rules and
regulations deemed necessary by the Committee to effect the purposes of the Incentive Plan. The Committee, however, may not exercise any such authority if such action would have the effect of increasing the amount of an award under the Incentive
Plan to any officer defined as a &#147;covered employee&#148; (each a &#147;Covered Employee&#148;) under Section 162(m), if such action would be impermissible under Section 162(m). The Covered Employees generally include executive officers listed
in the compensation tables of the Company&#146;s proxy statement for the annual meeting following the year in which such compensation is paid. The Committee has the sole discretion to select officers or other employees of the Company or the
Company&#146;s subsidiaries who will be eligible to earn awards under the Incentive Plan for that award year. The Committee also has the authority to determine the amount of such awards and any conditions under which they may be earned. The
Executive Committee of the Company shall be authorized to implement the Incentive Plan in accordance with its terms and to take such ministerial actions as shall be necessary to effectuate the intent and purpose thereof. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Target awards, expressed as a percentage of base salary, will
be based upon the achievement of specified levels of the Performance Measures (as defined in the Incentive Plan) and will be paid in the form of cash. The Performance Measures are earnings before interest, income taxes, depreciation and
amortization, return on capital, return on equity, net income, earnings per share, days sales outstanding, revenue growth, expense control, individual performance, which may be determined on a corporate, regional or subregional basis, as applicable,
or any combination of the foregoing; provided, however, individual performance may not be used as a Performance Measure for a Covered Employee. Such awards are nontransferable and nonassignable other than by will or by the laws of descent and
distribution or pursuant to a qualified domestic relations order prior to the payment of an award. Subject to the discretion of the Committee to reduce such amount, the amount payable with respect to any award to any Covered Employee under the
Incentive Plan will not exceed $2,500,000. Payments to a Covered Employee are contingent upon the Committee&#146;s certifying the achievement of performance measures for the applicable performance period. Where special factors are present, the
Committee, at its sole discretion, may adjust the performance measures used to determine payments under the Incentive Plan, except that such adjustments shall be disregarded for purposes of calculating the amount that may be paid to a Covered
Employee under the Incentive Plan to the extent required by Section 162(m). The Committee may reduce or eliminate an award amount to a Covered Employee. In the event of a &#147;change in control&#148; (as defined in the Incentive Plan), all Target
Awards (also as defined in the Incentive Plan) shall become payable in full. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">Under the Incentive Plan, and as designated by the Committee, any employee of the Company or the Company&#146;s subsidiaries may participate in the Plan and receive award(s) thereunder. This includes
the Chief Executive Officer and all of the other executive officers and approximately 350 other key employees. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">22 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Acting by a
majority vote, the Board of Directors may terminate or amend, in whole or in part, the Incentive Plan. Upon such whole or partial termination of the Incentive Plan the Committee may, in its sole discretion, direct the payment to participants of any
awards not already paid out prior to the respective dates upon which payments would otherwise be made, in a lump sum or installments. The Board of Directors may delegate to the Committee any or all of its authority relating to amending or
terminating the Incentive Plan. However, any amendment to the Incentive Plan that would affect any Covered Employee must be approved by the Company&#146;s stockholders if required by Section 162(m). </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Discussion of Federal Income Tax Consequences </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Section 162(m) limits the corporate income tax deduction for
publicly held companies to $1,000,000 in any tax year for compensation paid to each of the Chief Executive Officer and the four highest paid executive officers apart from the Chief Executive Officer. This rule applies to all deductible compensation,
including the deduction arising from the payment of annual bonuses. Various forms of compensation are exempted from this deduction limitation, including payments that are (i) subject to the attainment of pre-established objective performance goals,
(ii) established and administered by a committee of outside directors, and (iii) approved by the stockholders. The Board of Directors believes, but can give no assurance, that payments made under the Annual Plan will qualify for exemption from the
operation of Section 162(m) and, therefore, will qualify as deductible compensation by the Company. Awards are taxable to the recipient when paid as compensation income. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>The Board of Directors of the Company recommends that the stockholders vote FOR approval and adoption of
the Incentive Plan Amendment. </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>ITEM
FOUR:&nbsp;&nbsp;&nbsp;&nbsp;RATIFICATION OF INDEPENDENT ACCOUNTANTS </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">Upon the recommendation of the Audit Committee, the Board of Directors has appointed PricewaterhouseCoopers LLP (&#147;PricewaterhouseCoopers&#148;) to audit the accounts of the Company for the year ending December 31, 2003.
For the year ended December 31, 2002, the Company&#146;s accounts were audited by PricewaterhouseCoopers. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">PricewaterhouseCoopers&#146;s report on the financial statements of the Company for the year ended December 31, 2002 did not contain an
adverse opinion or a disclaimer of opinion and was not qualified or modified as to uncertainty, audit scope, or accounting principles. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">To the knowledge of management and the Audit Committee, in connection with the audit of the Company&#146;s financial statements for the
year ended December 31, 2002, there were no disagreements with PricewaterhouseCoopers on any matters of accounting principles or practices, financial statement disclosure, or auditing scope and procedure which, if not resolved to the satisfaction of
PricewaterhouseCoopers, would have caused PricewaterhouseCoopers to make reference to the matter in its reports. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Representatives of PricewaterhouseCoopers will be present at the Annual Meeting with the opportunity to make a statement if they desire to
do so and will be available to respond to appropriate questions. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Stockholder ratification of the appointment of PricewaterhouseCoopers as the Company&#146;s independent accountants is not required by the Company&#146;s By-Laws or otherwise. The Board of Directors has elected to seek such
ratification as a matter of good corporate practice. Should the stockholders fail to ratify the appointment of PricewaterhouseCoopers as the Company&#146;s independent accountants for the year ending December 31, 2003, the Board of Directors will
consider whether to retain that firm for such year. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">23 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Principal Accountant Fees
and Services </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Aggregate fees for
professional services rendered for the Company by PricewaterhouseCoopers as of or for the years ended December 31, 2002 and 2001, were: </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">

<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>2002</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1" COLOR="#000000"><B>2001</B></FONT></P><HR SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="79%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Audit</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">606,540</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">$</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">469,272</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="79%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Audit Related</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">79,689</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">20,458</FONT></P></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="79%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Tax</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">12,000</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">26,600</FONT></P></TD></TR>
<TR>
<TD VALIGN="top" WIDTH="79%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">All Other</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">18,085</FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">117,456</FONT></P></TD></TR>
<TR>
<TD><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><HR SIZE="1" NOSHADE ALIGN="right" COLOR="#000000"></TD>
<TD><HR SIZE="1" NOSHADE COLOR="#000000"></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD><HR SIZE="1" NOSHADE ALIGN="right" COLOR="#000000"></TD>
<TD><HR SIZE="1" NOSHADE COLOR="#000000"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" WIDTH="79%"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:6%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Total</B></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>$</B></FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>716,314</B></FONT></P></TD>
<TD VALIGN="bottom" WIDTH="3%"><FONT FACE="Times New Roman" SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>$</B></FONT></P></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>633,786</B></FONT></P></TD></TR>
</TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The
<I>Audit</I> fees for the years ended December 31, 2002 and 2001, respectively, were for professional services rendered (including reimbursement for out-of-pocket expenses) for the audits of the consolidated financial statements of the Company
($540,000 and $389,895, respectively) and the issuance of comfort letters, consents, income tax provision procedures, and assistance with review of documents filed with the SEC ($66,540 and $79,377, respectively). </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The <I>Audit Related</I> fees for the years ended December 31,
2002 and 2001, respectively, were primarily for assurance and related services related to due diligence related to mergers and acquisitions and accounting consultations in connection with acquisitions. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>Tax </I>fees for the years ended December 31, 2002 and
2001, respectively, were for services related to tax compliance, tax planning and tax advice. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>All Other </I>fees for the year ended December 31, 2002 were for assistance with the development of investment policies. For the year ended December 31, 2001 such fees were related to valuation
assistance related to acquisitions and healthcare advisory services. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">No fees were paid for <I>Financial Information Systems Design and Implementation</I> for the year ended December 31, 2002. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee has considered the other services rendered and believes that they are compatible with PricewaterhouseCoopers remaining
independent. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>The Board of Directors of the
Company recommends that stockholders vote &#147;FOR&#148; the ratification of the appointment of PricewaterhouseCoopers as the Company&#146;s independent accountants for 2003. </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Beneficial Ownership by Roche </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">In 1995, the Company and affiliates of Roche entered into the
Stockholder Agreement. The Stockholder Agreement contains certain provisions relating to (i) the governance of the Company, including, but not limited to, the composition of the Board of Directors, (ii) the issuance, sale, and transfer of the
Company&#146;s Equity Securities (as defined in the Stockholder Agreement) by the Company and Roche, and (iii) registration rights granted by the Company to Roche with respect to the Company&#146;s Equity Securities. A copy of the Stockholder
Agreement was included as an exhibit to the Company&#146;s report on Form 8-K filed with the Commission on May 12, 1995. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">On February 21, 2002, Roche registered to sell 7,000,000 shares with a 700,000 over-allotment option pursuant to a Registration Statement
on Form S-3 filed with the Commission. At that time, Roche owned </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">24 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">10,705,074 shares of Common Stock (approximately 15.13% of the Common Stock outstanding). On March 12, 2002, Roche sold the 7,000,000 shares
of Common Stock and on March 18, 2002, an additional 700,000 shares of Common Stock were sold to cover over-allotments of shares, leaving Roche with 3,005,074 shares of the Company&#146;s outstanding Common Stock, or approximately 4.22% at March 29,
2002. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Prior to March 12, 2002, Roche had the
right to designate one director for nomination to the Board of Directors. Because Roche&#146;s ownership fell below 10% on March 12, 2002, Roche&#146;s rights under the Stockholder Agreement terminated with respect to (i) changing the total number
of members of the Board of Directors, (ii) designating a replacement director upon the death, resignation or retirement of a director selected by Roche, (iii) causing the Board of Directors to create vacancies on the Board for Roche&#146;s
designated directors, (iv) voting and solicitation of votes, (v) directors serving on Board committees, (vi) vacancies on Board committees and the management committee and (vii) action taken to conform the Company&#146;s Certificate of Incorporation
and By-laws to the Stockholder Agreement. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">Roche&#146;s right to (i) have its shares included in a registration statement which the Company prepares and (ii) have the Company furnish it with certain financial information, terminated when Roche&#146;s ownership fell below 20%.
If Roche ceases to own any Registrable Securities (as defined under the Stockholder Agreement), then (i) all of its registration rights and (ii) covenants of the Company in its favor with respect to transfers made by Roche pursuant to Rule 144A
under the Securities Act of 1933 under the Stockholder Agreement would terminate. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000"><B>Certain Transactions with Roche </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">The Company purchases certain items, primarily laboratory testing supplies from various affiliates of Roche. Total purchases from these affiliates, which are recorded in cost of sales, were $55.2 million in 2002. In addition, the
Company made royalty payments to Roche for diagnostic technology in the amount of approximately $4.7 million in 2002. The Company provides certain diagnostic testing and support services to Roche in connection with Roche&#146;s clinical
pharmaceutical trials, with an aggregate value of approximately $1.4 million in 2002. The amount owed to Roche and its affiliates at December 31, 2002 was $3.3 million. The amount owed from Roche and its affiliates at December 31, 2002 was $600,000.
Each of these arrangements was entered into in the ordinary course of business, on an arm&#146;s-length basis, and on terms which the Company believes are no less favorable to it than those obtainable from unaffiliated third parties. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>AUDIT COMMITTEE&#146;S REPORT </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee of the Board of Directors, comprised
entirely of non-management directors, held nine meetings during 2002. The members meet the independence and experience requirements of the current listing requirements of the New York Stock Exchange. The charter of the Audit Committee was amended on
September 18, 2002 and is attached hereto as Annex IV. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">The Audit Committee met with the independent public accountants, management, and internal auditors to assure that all were carrying out their respective responsibilities. The Audit Committee reviewed the performance and fees of the
independent public accountants prior to recommending their appointment, and met with them to discuss the scope and results of their audit work, including the adequacy of internal controls and the quality of financial reporting. The Audit Committee
discussed with the independent public accountants their judgments regarding the quality and acceptability of the Company&#146;s accounting principles, the clarity of its disclosures and the degree of aggressiveness or conservatism of its accounting
principles and underlying estimates, and other communications required by Statement of Accounting Standards No. 61, Communications with Audit Committees, as currently in effect. The Audit Committee discussed with and received a letter from the
independent public accountants confirming their independence, as required by Independence Standards Board Standard No. 1. Both the independent public accountants and the internal auditors had full access to the Audit </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">25 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Committee, including regular meetings without management present. Additionally, the Audit Committee reviewed and discussed the audited
financial statements with management and recommended to the Board of Directors that these financial statements be included in the Company&#146;s Form 10-K for filing with the Commission. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">As part of its duties, the Audit Committee also considered whether the provision of services other than audit
services during fiscal year 2002 by PricewaterhouseCoopers LLP, the Company&#146;s independent public accountants, is compatible with maintaining the accountant&#146;s independence. See &#147;Item Four: Ratification of Independent Accountants.&#148;
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Management is responsible for the Company&#146;s
financial reporting process, including its system of internal controls, and for the preparation of consolidated financial statements in accordance with generally accepted accounting principles. The Company&#146;s independent auditors are responsible
for auditing those financial statements. The Audit Committee&#146;s responsibility is to monitor and review these processes. It is not the Audit Committee&#146;s responsibility to conduct auditing or accounting reviews or procedures. Therefore, the
Audit Committee has relied, without independent verification, on (a) management&#146;s representation that the financial statements have been prepared with integrity and objectivity and in conformity with accounting principles generally accepted in
the United States and (b) the representations of the independent auditors appearing in the auditor&#146;s report on the Company&#146;s financial statements. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">THE AUDIT COMMITTEE </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Wendy E. Lane, Chairman </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">Robert E. Mittelstaedt, Jr. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">James B. Powell </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>STOCKHOLDER PROPOSALS </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Under the rules and regulations of the Commission as currently
in effect, any holder of at least $2,000 in market value, or 1% of Common Stock, who desires to have a proposal presented in the Company&#146;s proxy material for use in connection with the annual meeting of stockholders to be held in 2004 must
transmit that proposal (along with his name, address, the number of shares of Common Stock that he holds of record or beneficially, the dates upon which the securities were acquired and documentary support for a claim of beneficial ownership) in
writing as set forth below. Such holder must continue to hold his Common Stock through the date of the meeting. Proposals of stockholders intended to be presented at the next annual meeting must be received by Bradford T. Smith, Secretary,
Laboratory Corporation of America Holdings, 358 South Main Street, Burlington, North Carolina 27215, no later than December 16, 2003. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Regarding stockholder proposals intended to be presented at the 2004 Annual Meeting but not included in the Company&#146;s proxy
statement, stockholders must give the Company notice not later than March 1, 2004 of their proposals in order to be considered timely under applicable Commission rules. Notice shall be given in the form and manner described in the paragraph above.
The persons named as proxies in the enclosed proxy card may vote in their discretion on any proposals for which timely notice is not received in the manner described above. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Holders of Common Stock who want to have proposals submitted for consideration at future meetings of
stockholders should consult the applicable rules and regulations of the Commission with respect to such proposals, including the permissible number and length of proposals and other matters governed by such rules and regulations. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">26 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>HOUSEHOLDING
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">As permitted by the Exchange Act, we have
adopted a procedure approved by the Commission called &#147;householding.&#148; Under this procedure, stockholders of record who have the same address and last name and do not participate in electronic delivery of proxy materials will receive only
one copy of this proxy statement and annual report unless one or more of these stockholders provides notification of their desire to receive individual copies. This procedure will reduce our printing costs and postage fees. Stockholders who
participate in householding will continue to receive separate proxy cards. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">If you and other stockholders of record with whom you share an address currently receive multiple copies of annual reports and/or proxy statements, or if you hold stock in more than one account and in
either case, you wish to receive only a single copy of the annual report or proxy statement for your household, please contact our transfer agent (in writing: American Stock Transfer and Trust Company, Shareholder Services, 6201 Fifteenth Avenue,
Brooklyn, NY 11219; by telephone: 800-937-5449) with the names in which all accounts are registered. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">If you participate in householding and wish to receive a separate copy of the 2002 annual report or this Proxy Statement, or if you wish
to receive separate copies of future annual reports or proxy statements, please contact American Stock Transfer and Trust Company at the above address or phone number. We will deliver the requested documents to you promptly upon your request.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Beneficial stockholders can request information
about householding from their banks, brokers or other holders of record. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">You may also obtain an on-line version of the proxy statement at www.labcorp.com. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>ADDITIONAL INFORMATION </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Company will make available a copy of the Annual Report on Form 10-K for the year ended December 31, 2002 and any quarterly reports on
Form 10-Q filed thereafter, without charge, upon written request to the Secretary, Laboratory Corporation of America Holdings, 358 South Main Street, Burlington, North Carolina 27215. Each such request must set forth a good faith representation
that, as of the Record Date (April 11, 2003), the person making the request was a beneficial owner of Common Stock entitled to vote. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">In order to ensure timely delivery of such document(s) prior to the annual meeting, any request(s) should be submitted promptly to the
Company. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>OTHER BUSINESS </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Company knows of no other matters which may come before
the Annual Meeting. However, if any such matters properly come before the Annual Meeting, the individuals named in the proxies will vote on such matters in accordance with their best judgment. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">By Order of the Board of Directors
</FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">

<IMG SRC="g22611g61o27.jpg" ALT="LOGO"> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Bradford T. Smith </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><I>Secretary </I></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">April 14, 2003 </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">27 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>ANNEX I
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>AUDIT COMMITTEE CHARTER </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Purpose </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee is appointed by the Board to be directly responsible for the selection, appointment,
compensation and oversight of the work of any registered public accounting firm employed by the Company and to assist in Board oversight of (1) the integrity of the financial statements of the Company; (2) the compliance by the Company with legal
and regulatory requirements; (3) the qualifications and independence of the Company&#146;s independent auditors and (4) the performance of the Company&#146;s internal audit functions and independent auditors. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Committee Membership </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall consist of no fewer than three
members of the Board all of whom shall meet the independence, experience and expertise requirements of the New York Stock Exchange and applicable rules and regulations. At all times at least one member of the Audit Committee shall be a
&#147;financial expert&#148; within the meaning of Section 407 of the Sarbanes-Oxley Act of 2002 and applicable rules and regulations of the Securities and Exchange Commission. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The members of the Audit Committee shall be appointed by the Board on the recommendation of the Nominating
and Corporate Governance Committee. Audit Committee members may be removed and replaced by the Board. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Committee Powers, Authority, Duties and Responsibilities </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall have the sole authority to select and appoint the independent auditors to be retained by the Company, approve the compensation of the
independent auditors, and be directly responsible, and have the sole authority, for the discharge or replacement of the independent auditors. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall approve in advance the provision by the independent auditors of all services whether or not related to the audit. The Company shall provide
for appropriate funding, as determined by the Audit Committee, for payment of compensation to the independent auditors retained by the Company for the purpose of rendering or issuing an audit report. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall review the annual audited financial statements with management and the independent auditors, including major issues regarding accounting
and auditing principles and practices, the Company&#146;s disclosures under &#147;Management&#146;s Discussion and Analysis of Results of Operations and Financial Condition,&#148; the adequacy of internal controls that could significantly affect the
Company&#146;s financial statements, any material correcting adjustments that have been identified by the independent auditor, whether or not made, any material off-balance sheet transactions, arrangements, obligations and other relationships of the
Company with unconsolidated entities and other matters related to the conduct of the audit which are to be communicated to the Audit Committee under Statement on Auditing Standards No. 61, Communications with Audit Committees.
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall review analyses and reports prepared by management and the independent auditors of significant financial reporting issues and judgments and
critical accounting policies and practices in connection with the preparation of the company&#146;s financial statements and the ramifications of the use of alternative disclosures and treatments, the treatment preferred by the independent auditors,
and other material written communications between the independent auditors and management, including any management letter or schedule of unadjusted differences. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">I-1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall review with management and the independent auditors the Company&#146;s quarterly financial statements and the Company&#146;s disclosures
under &#147;Management&#146;s Discussion and Analysis of Results of Operations and Financial Condition.&#148; The Audit Committee shall also discuss earnings press releases, as well as financial information and earnings guidance provided to analysts
and rating agencies. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall (a) review policies and procedures with respect to Company transactions in which officers or directors have an interest, including when
their review is requested by management or the independent auditors, (b) review policies and procedures with regard to officers&#146; expense accounts and perquisites, including their use of corporate assets and (c) consider the results of any
review of these areas by the internal audit staff or independent auditors. The Audit Committee shall review all related party transactions and similar matters. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">7.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall meet periodically with management, internal audit staff and the independent auditors to review the Company&#146;s major financial risk
exposures and the steps management has taken to monitor and control such exposures. The Audit Committee shall also review and evaluate the Company&#146;s processes for identifying and assessing key financial statement risk areas and for formulating
and implementing steps to address such risk areas. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">8.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall review major changes to the Company&#146;s auditing and accounting principles and practices as suggested by the independent auditor,
internal auditors or management. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">9.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall receive periodic reports, at least annually, from the independent auditor regarding the auditors&#146; independence, the auditors&#146;
internal quality-control procedures; any material issues raised by the most recent internal quality-control review, or peer review, of the firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding
five years, respecting one or more independent audits carried out by the firm, and any steps taken to deal with any such issues; and all relationships between the independent auditors and the Company, discuss such reports with the auditor, and take
appropriate action on any disclosed relationship to satisfy itself of the auditor&#146;s independence. The Audit Committee will also establish clear hiring policies for employees or former employees of the independent auditor.
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">10.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall evaluate the performance of the independent auditor and, if so determined by the Audit Committee, have the exclusive authority to terminate
and replace the independent auditors (subject, if deemed appropriate, to shareholder ratification). </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">11.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall review the appointment and replacement of the senior internal auditing executive. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">12.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall review the significant reports to management prepared by the internal auditing department and management&#146;s responses thereto
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">13.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall meet with the independent auditor prior to the audit to review the planning and staffing of the annual audit and other examinations of the
Company&#146;s quarterly, annual and other financial information. The Audit Committee shall also review with internal audit staff and the independent auditors the coordination of audit efforts to assure completeness of coverage, reduction of
redundant efforts and the effective use of internal and external audit resources. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">14.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall obtain from the independent auditor assurance that Section 10A of the Securities Exchange Act of 1934 has not been implicated.
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">I-2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">15.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall obtain reports from management, the Company&#146;s senior internal auditing executive and the independent auditor that the Company&#146;s
subsidiary/foreign affiliated entities are in conformity with applicable legal requirements and the Company&#146;s Code of Conduct. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">16.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall review with the independent auditor any problems or difficulties the auditor may have encountered and any management letter provided by the
auditor and the Company&#146;s response to any such problems or difficulties and to any management letter. Such review should include: </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Any difficulties encountered in the course of the audit work, including any restrictions on the scope of activities or access to required information.
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Any changes required in the planned scope of the internal audit. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c)</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The internal audit department responsibilities, budget and staffing, the independent auditor&#146;s assessment of the adequacy of the Company&#146;s internal control
structure and procedures of the Company for financial reporting. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">17.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall prepare the report required by the rules of the Securities and Exchange Commission to be included in the Company&#146;s annual proxy
statement and shall receive the information to be provided by the independent auditors for inclusion in the proxy statement, including information regarding fees relating to the audit. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">18.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall meet with the Chief Executive and Chief Financial Officers of the Company and review with them the content of the certifications made by
them as to the accuracy and completeness of the Company&#146;s SEC filings. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">19.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall advise the Board with respect to the Company&#146;s accounting policies and procedures regarding compliance with applicable laws and
regulations and with the Company&#146;s Code of Conduct. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">20.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall review with the Company&#146;s Chief Legal Officer legal and regulatory matters that may have a material impact on the financial
statements, the Company&#146;s compliance policies and any material reports or inquiries received from external counsel, regulators or governmental agencies. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">21.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall establish procedures for the receipt, retention and treatment of complaints received by the Company regarding accounting, internal
accounting controls or auditing matters and the confidential, anonymous submission by employees of the Company of concerns regarding questionable accounting or auditing matters. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">22.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall meet at least annually with the chief financial officer and the members of management, the senior internal audit executive and the
independent auditors, in separate executive sessions. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">23.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee may form and delegate authority to subcommittees if determined to be necessary or advisable. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">24.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall make reports to the Board at the next regularly scheduled meeting following the meeting of the Audit Committee accompanied by any
recommendation to the Board. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">25.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall review and reassess the adequacy of this Charter annually and recommend any proposed changes to the Board for approval.
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">I-3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">26.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall annually review its own performance. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">27.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall have the authority to engage, and obtain advice and assistance from outside legal, accounting and other advisers, and the Company shall
provide appropriate funding therefor as determined by the Audit Committee. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">28.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Audit Committee shall have such other authority and responsibilities as may be assigned to it from time to time by the Board. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">While the Audit Committee has the responsibilities and powers
set forth in this Charter, it is not the duty of the Audit Committee to plan or conduct audits or to determine that the Company&#146;s financial statements are complete and accurate and are in accordance with generally accepted accounting
principles. This is the responsibility of management and the independent auditor. Nor is it the duty of the Audit Committee to conduct investigations, to resolve disagreements, if any, between management and the independent auditor or to assure
compliance with laws and regulations and the Company&#146;s Code of Conduct. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">I-4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>ANNEX II
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>COMPENSATION COMMITTEE CHARTER
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Purpose </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Compensation Committee is appointed by the Board to
discharge the Board&#146;s responsibilities relating to compensation of the Company&#146;s Chief Executive Officer (&#147;CEO&#148;) and other executive officers, and to consider, recommend, administer and implement the Company&#146;s
incentive-compensation plans and equity-based plans. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">The Compensation Committee is also responsible for preparing a report on executive compensation for inclusion in the Company&#146;s annual meeting proxy statement, in accordance with applicable rules and regulations. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Committee Membership </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Compensation Committee shall consist of no fewer than
three members of the Board. The members of the Compensation Committee shall meet the independence requirements of the New York Stock Exchange and any other legal requirements relevant to the proper administration of the Company&#146;s executive
compensation program, including requirements under the federal securities laws and the Internal Revenue Code of 1986. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The members of the Compensation Committee shall be appointed by the Board on the recommendation of the Nominating and Corporate Governance
Committee. Compensation Committee members may be removed and replaced by the Board, but all replacements shall be made on the recommendation of the Nominating and Corporate Governance Committee. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Committee Powers, Authority, Duties and Responsibilities </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Compensation Committee shall have the sole authority to retain and terminate any compensation consultant to be used to assist in the evaluation of CEO or other
executive officer compensation, including the sole authority to approve the consultant&#146;s fees and other retention terms. The Compensation Committee shall also have authority to obtain advice and assistance from internal or outside legal,
accounting or other advisors. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Compensation Committee shall annually review and approve corporate goals and objectives relevant to CEO compensation, evaluate the CEO&#146;s performance in
light of those goals and objectives, and set the CEO&#146;s compensation level based on this evaluation. In determining the long-term incentive component of CEO compensation, the Compensation Committee shall consider the Company&#146;s performance
and relative stockholder return, the value of similar incentive awards to CEOs at comparable companies and the awards given to the CEO in past years, and may consider such other factors as it deems necessary or advisable. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Compensation Committee shall annually and at the time of any new executive hire review and approve, for the CEO, his compensation and related employment
agreements. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Compensation Committee shall annually and at the time of any new executive hire review and recommend to the Board for its approval, his compensation and related
employment agreements. To the extent appropriate or necessary to comply with any federal securities or tax law requirements, such as Rule 16b-3 of the Securities Exchange Act of 1934, or Section 162 (m) of the Internal Revenue Code of 1986, the
Board may delegate exclusive authority to the Compensation Committee to approve or ratify elements of compensation of executive officers. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">II-1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Compensation Committee shall consider, recommend, administer and implement the Company&#146;s incentive compensation plans and equity-based plans in which
directors, the CEO, other executive officers and other employees of the Company and its subsidiaries may be participants, including, but not limited to, (a) approving option grants and restricted stock or other awards, (b) interpreting the plans,
(c) determining rules and regulations relating to the plans, (d) modifying or canceling existing grants or awards and (e) imposing limitations, restrictions and conditions upon any grant or award as the Compensation Committee deems necessary or
advisable. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Compensation Committee shall annually assess the desirability of proposing and make recommendations to the Board with respect to any new incentive-compensation
plans and equity-based plans and any increase in shares reserved for issuance under existing equity plans. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">7.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Compensation Committee shall prepare a report on executive compensation for inclusion in the Company&#146;s annual meeting proxy statement, in accordance with
applicable rules and regulations. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">8.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Compensation Committee may form and delegate authority to subcommittees if determined to be necessary or advisable. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">9.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Compensation Committee shall make reports to the Board at the next regularly scheduled meeting following the meeting of the Compensation Committee.
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">10.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Compensation Committee shall review and reassess the adequacy of this Charter annually and recommend any proposed changes to the Board for approval.
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">11.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Compensation Committee shall annually review its own performance. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">12.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Compensation Committee shall have such other authority and responsibilities as may be assigned to it from time to time by the Board. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">II-2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>ANNEX III
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>ETHICS AND QUALITY ASSURANCE COMMITTEE
CHARTER </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Purpose </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Ethics and Quality Assurance Committee is appointed by
the Board to assist the Board in ensuring that the Company adopts and implements procedures that require the Company&#146;s employees to act in accordance with high ethical standards and to deliver high quality services. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Committee Membership </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Ethics and Quality Assurance Committee shall consist of
no fewer than three members of the Board. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The
members of the Ethics and Quality Assurance Committee shall be appointed by the Board on the recommendation of the Nominating and Corporate Governance Committee. Ethics and Quality Assurance Committee members may be removed and replaced by the
Board. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Committee Powers, Authority, Duties and
Responsibilities </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Ethics and Quality Assurance Committee shall have the authority to engage and obtain advice and assistance from internal or outside legal, accounting or other
advisors and the Company shall provide appropriate funding therefore as determined by the Ethics and Quality Assurance Committee. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Ethics and Quality Assurance Committee shall annually review and reassess the adequacy of the Company&#146;s Code of Business Practices, Corporate Integrity
Program and other compliance programs and policies and shall recommend any proposed changes to the Board for approval. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Ethics and Quality Assurance Committee shall receive copies of all complaints and allegations relating to the Company&#146;s operations received by the Company,
through its anonymous complaint procedure or otherwise, and management shall consult with members of the Ethics and Quality Assurance Committee regarding the resolution of all such complaints and allegations. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Ethics and Quality Assurance Committee shall be responsible for reviewing the Company&#146;s processes for assuring excellent performance and meeting quality
performance benchmarks. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Ethics and Quality Assurance Committee may form and delegate authority to subcommittees if determined to be necessary or advisable. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Ethics and Quality Assurance Committee shall make reports to the Board at its next regularly scheduled meeting following the meeting of the Ethics and Quality
Assurance Committee accompanied by any recommendation to the Board. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">7.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Ethics and Quality Assurance Committee shall review and reassess the adequacy of this Charter annually and recommend any proposed changes to the Board for
approval. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">8.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Ethics and Quality Assurance Committee shall annually review its own performance. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">9.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Ethics and Quality Assurance Committee shall have such other authority and responsibilities as may be assigned to it from time to time by the Board.
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">III-1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>ANNEX IV
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>NOMINATING AND CORPORATE GOVERNANCE
COMMITTEE CHARTER </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Purpose </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Nominating and Corporate Governance Committee is
appointed by the Board (1) to assist the Board by identifying individuals qualified to become Board members, and by recommending to the Board the director nominees for the next annual meeting of stockholders; (2) to develop and recommend to the
Board a set of corporate governance principles applicable to the Company; (3) to lead the Board in its annual review of the Board&#146;s performance; and (4) to recommend to the Board director nominees for each Board committee. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>Committee Membership </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Nominating and Corporate Governance Committee shall
consist of no fewer than three members of the Board all of whom shall meet the independence requirements of the New York Stock Exchange. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The members of the Nominating and Corporate Governance Committee shall be appointed by the Board. Nominating and Corporate Governance
Committee members may be removed and replaced by the Board. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000"><B>Committee Powers, Authority, Duties and Responsibilities </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Nominating and Corporate Governance Committee shall have the sole authority to retain and terminate any search firm to be used to identify director candidates,
including the sole authority to approve the search firm&#146;s fees and other retention terms. The Nominating and Corporate Governance Committee shall also have the authority to obtain advice and assistance from internal or outside legal, accounting
or other advisors. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Nominating and Corporate Governance Committee shall establish criteria for the selection of new directors, evaluate the qualifications of potential candidates
for director, including any nominees submitted by stockholders under and in accordance with the provisions of the Company&#146;s Bylaws, and recommend to the Board the nominees for election at the next annual meeting or any special meeting of
stockholders and any person to be considered to fill a Board vacancy or a newly created directorship resulting from any increase in the authorized number of directors. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">3.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Nominating and Corporate Governance Committee shall oversee the orientation and training of newly elected directors and continuing education for all Board
members. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">4.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Nominating and Corporate Governance Committee shall annually recommend to the Board director nominees for each Board committee, taking into account the listing
standards of the New York Stock Exchange and applicable laws, rules and regulations, including, with respect to the Compensation Committee, whether Compensation Committee members meet the definitions of (a) a &#147;non-employee director&#148; within
the meaning of Rule 16b-3 promulgated under the Securities Exchange Act of 1934, as amended, and (b) an &#147;outside director&#148; within the meaning of Section 162(m) of the Internal Revenue Code of 1986, as amended. The Nominating and Corporate
Governance Committee shall also advise the Board on removal of any Board committee members. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Nominating and Corporate Governance Committee shall receive comments from all directors and report annually to the Board on an assessment of the Board&#146;s
performance, to be discussed with the Board following the end of each fiscal year. The Nominating and Corporate Governance Committee together with the Compensation Committee shall also establish and oversee an annual performance evaluation of
management. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">IV-1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Nominating and Corporate Governance Committee shall review and reassess the adequacy of the corporate governance principles of the Company annually and recommend
any proposed changes to the Board for approval, including any changes in director fees and qualifications, the size of the Board, director responsibilities for preparation for and attendance at Board meetings and management succession planning.
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">7.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Nominating and Corporate Governance Committee shall be responsible for ensuring that executive sessions of the Board are held regularly
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">8.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Nominating and Corporate Governance Committee may form and delegate authority to subcommittees if determined to be necessary or advisable.
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">9.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Nominating and Corporate Governance Committee shall make reports to the Board at its next regularly scheduled meeting following the meeting of the Nominating and
Corporate Governance Committee accompanied by any recommendation to the Board. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">10.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Nominating and Corporate Governance Committee shall review and reassess the adequacy of this Charter annually and recommend any proposed changes to the Board for
approval. </FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">11.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Nominating and Corporate Governance Committee shall annually review its own performance. </FONT></TD></TR></TABLE><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">12.</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Nominating and Corporate Governance Committee shall have such other authority and responsibilities as may be assigned to it from time to time by the Board.
</FONT></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">IV-2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>ANNEX V
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>LABORATORY CORPORATION OF AMERICA HOLDINGS
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>2000 STOCK INCENTIVE PLAN
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>As Amended and Restated Effective October 16, 2002 </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">1.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Purpose; Restrictions on Amount Available under this Plan.</I></B>
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">This 2000 Stock Incentive Plan, as amended and
restated effective October 16, 2002, (this &#147;<B>Plan</B>&#148;) is intended to encourage stock ownership by employees, consultants, and non-employee directors of Laboratory Corporation of America Holdings (the &#147;<B>Company</B>&#148;) and
employees and consultants of Affiliate Corporations (as defined in Section 2(a) hereof), so that they may acquire or increase their proprietary interest in the Company, and to encourage such employees, consultants and non-employee directors to
remain in the employ and/or service of the Company and to put forth maximum efforts for the success of the business of the Company. It is further intended that options granted by the Committee pursuant to Section 6 of this Plan shall constitute
&#147;incentive stock options&#148; (&#147;<B>Incentive Stock Options</B>&#148;) within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended, and the regulations issued thereunder (the &#147;<B>Code</B>&#148;), and options
granted by the Committee pursuant to Sections 7 and 8 of this Plan shall constitute &#147;nonqualified stock options&#148; (&#147;<B>Nonqualified Stock Options</B>&#148;). Grants under this Plan may consist of Incentive Stock Options, Nonqualified
Stock Options (collectively, &#147;<B>Options</B>&#148;), stock appreciation rights (&#147;<B>Rights</B>&#148;), which Rights may be either granted in conjunction with Options (&#147;<B>Related Rights</B>&#148;) or unaccompanied by Options
(&#147;<B>Free Standing Rights</B>&#148;), restricted stock awards (&#147;<B>Restricted Shares</B>&#148;), or performance awards (&#147;<B>Performance Awards</B>&#148;), as hereinafter set forth. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">2.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Definitions.</I></B>
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">As used in this Plan, the following words and
phrases shall have the meanings indicated: </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(a)&nbsp;&nbsp;&nbsp;&nbsp;&#148;<B>Affiliate Corporation</B>&#148; or &#147;<B>Affiliate</B>&#148; shall mean any corporation, directly or indirectly, through one or more intermediaries, controlling, controlled by, or under common
control with the Company. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(b)&nbsp;&nbsp;&nbsp;&nbsp;&#148;<B>Award</B>&#148; shall mean an Option, a Right, Restricted Share, or Performance Award granted hereunder. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c)&nbsp;&nbsp;&nbsp;&nbsp;&#148;<B>Award Agreement</B>&#148; shall have the meaning set forth in Section 3 hereof.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(d)&nbsp;&nbsp;&nbsp;&nbsp;&#148;<B>Change in Control</B>&#148; shall mean an event of a nature that: </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(i) any &#147;person&#148; (as the term is defined in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as
amended, &#147;the Exchange Act&#148;) who is not now presently but becomes the &#147;beneficial owner&#148; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing 30% or more of the
Company&#146;s outstanding securities except for any securities purchased by any tax-qualified employee benefit plan of the Company; or </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(ii) individuals who constitute the Board of Directors on the Effective Date (the &#147;Incumbent Board&#148;) cease for
any reason to constitute at least a majority thereof, provided that any person becoming a director subsequent to the date hereof whose election was approved by a vote of at least three-quarters of the directors comprising the Incumbent Board, or
whose nomination for election by the Company&#146;s stockholders was approved by the Incumbent Board, shall be for purposes of this clause (ii), considered as though he or she were a member of the Incumbent Board; or </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(iii) a plan of reorganization, merger,
consolidation, sale of all or substantially all the assets of the Company or similar transaction occurs in which the Company is not the resulting entity; or </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">V-1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(iv) a proxy statement soliciting proxies from shareholders of the
Company, by someone other than the current management of the Company, seeking stockholder approval of a plan of reorganization, merger or consolidation of the Company or similar transaction with one or more corporations, as a result of which the
outstanding shares of the class of securities not issued by the Company shall be distributed. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(e)&nbsp;&nbsp;&nbsp;&nbsp;&#148;<B>Common Stock</B>&#148; shall mean shares of the Company&#146;s common stock, par value
$0.10 per share. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(f)&nbsp;&nbsp;&nbsp;&nbsp;&#148;<B>Covered Officer</B>&#148; as of a particular date shall mean (i) any individual who, with respect to the previous taxable year of the Company, was a &#147;covered employee&#148; of the Company
within the meaning of Section 162(m) of the Internal Revenue Code; provided, however, that the term &#147;Covered Officer&#148; shall not include any such individual who is designated by the Committee, in its discretion, at the time of any Award or
at any subsequent time, as reasonably expected not to be such a &#147;covered employee&#148; with respect to the current taxable year of the Company and (ii) any individual who is designated by the Committee, in its discretion, at the time of any
Award or at any subsequent time, as reasonably expected to be such a &#147;covered employee&#148; with respect to the current taxable year of the Company or with respect to the taxable year of the Company in which any applicable Award will be paid.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(g)&nbsp;&nbsp;&nbsp;&nbsp;&#148;<B>Disability</B>&#148; shall mean a Participant&#146;s inability to engage in any substantial gainful activity by reason of medically determinable physical or mental impairment that can be expected
to result in death or that has lasted or can be expected to last for a continuous period of not less than twelve (12) months. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(h)&nbsp;&nbsp;&nbsp;&nbsp;&#148;<B>Exchange Act</B>&#148; shall mean the Securities Exchange Act of 1934, as amended.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(i)&nbsp;&nbsp;&nbsp;&nbsp;&#148;<B>Fair Market Value</B>&#148; per share as of a particular date shall mean (i) the closing sales price per share of Common Stock on a national securities exchange for the last preceding date on which
there was a sale of such Common Stock on such exchange, or (ii) if the shares of Common Stock are then traded on an over-the-counter market, the average of the closing bid and asked prices for the shares of Common Stock in such over-the-market for
the last preceding date on which there was a sale of such Common Stock in such market, or (iii) if the shares of Common Stock are not then listed on a national securities exchange or traded in an over-the-counter market, such value as the Committee
in its discretion may determine. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(j)&nbsp;&nbsp;&nbsp;&nbsp;&#148;<B>Parent Corporation</B>&#148; shall mean any corporation (other than the Company) in an unbroken chain of corporations ending with the Company if, at the time of granting an Award, each of such
corporations (other than the Company) owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(k)&nbsp;&nbsp;&nbsp;&nbsp;&#148;<B>Participant</B>&#148; shall have the meaning set forth in Section 4 hereof. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(l)&nbsp;&nbsp;&nbsp;&nbsp;&#148;<B>Prior Plans</B>&#148; shall mean the Laboratory Corporation of America Holdings
Amended and Restated 1999 Stock Incentive Plan and the Laboratory Corporation of America Holdings 1994 Stock Option Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(m)&nbsp;&nbsp;&nbsp;&nbsp;&#148;<B>Retirement</B>&#148; shall mean a Participant&#146;s termination of employment in
accordance with the provisions of the Company&#146;s Employee Retirement Plan at such Participant&#146;s Normal Retirement Date, as defined in such Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(n)&nbsp;&nbsp;&nbsp;&nbsp;&#148;<B>Subsidiary Corporation</B>&#148; shall mean any corporation (other than the Company)
in an unbroken chain of corporations beginning with the Company if, at the time of granting an option, each of such corporations other than the last corporation in the unbroken chain owns stock possessing fifty percent (50%) or more of the total
combined voting power of all classes of stock in one of the other corporations in such chain. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(o)&nbsp;&nbsp;&nbsp;&nbsp;&#148;<B>Ten Percent Stockholder</B>&#148; shall mean a Participant who, at the time an
Incentive Stock Option is granted, owns stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or of its Parent Corporation or Subsidiary Corporations. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">V-2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">3.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Administration.</I></B> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">This Plan shall be administered by a committee (the &#147;<B>Committee</B>&#148;) appointed by the Board of Directors of the Company (the &#147;<B>Board</B>&#148;), which shall be comprised of two or more persons, each of
whom shall qualify as a &#147;Non-Employee Director&#148; as described in Rule 16b-3(b)(3)(i) promulgated under the Exchange Act. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Committee shall have the authority in its discretion, subject to and not inconsistent with the express provisions of this Plan, to
administer this Plan and to exercise all the powers and authorities either specifically granted to it under this Plan or necessary or advisable in the administration of this Plan, including, without limitation, the authority to grant Awards; to
designate Participants, other than as set forth in Section 8 hereof; to determine the type or types of Awards to be granted to a Participant; to determine which Options shall constitute Incentive Stock Options and which Options shall constitute
Nonqualified Stock Options; to determine which Rights (if any) shall be granted in conjunction with Options; to determine the purchase price of the shares of Common Stock covered by each Option (the &#147;<B>Option Price</B>&#148;); to determine the
persons to whom, and the time or times at which, Awards shall be granted; to determine the number of shares to be covered by each Award; to interpret this Plan; to prescribe, amend and rescind rules and regulations relating to this Plan; to
determine the terms and provisions of the agreements (which need not be identical) entered into in connection with Awards granted under this Plan (each an &#147;<B>Award Agreement</B>&#148;); and to make all other determinations deemed necessary or
advisable for the administration of this Plan. The Committee may delegate to one or more of its members or to one or more agents such administrative duties as may be deemed advisable, and the Committee or any person to whom it has delegated duties
as aforesaid may employ one or more persons to render advice with respect to any responsibility the Committee or such person may have under this Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">No member of the Board of Directors or Committee shall be liable for any action taken or determination made in good faith with respect to
this Plan or any Award granted hereunder. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">4.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Eligibility.</I></B> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">Awards may be granted to key employees (including, without limitation, officers and directors who are employees) and non-employee directors of the Company or its present or future Affiliate Corporations. For purposes of the
foregoing, &#147;<B>employee</B>&#148; shall mean any employee, independent contractor, consultant, advisor, or similar individual who is providing or who has agreed to provide services to the Company or to any of its present or future Affiliate
Corporations. Notwithstanding any provision of this paragraph, Incentive Stock Options shall be granted only to individuals who, on the date of such grant, are employees of the Company or a Parent Corporation or a Subsidiary Corporation. In
determining the persons to whom Awards shall be granted and the number of shares to be covered by each Award, the Committee shall take into account the duties of the respective persons, their present and potential contributions to the success of the
Company and such other factors as the Committee shall deem relevant in connection with accomplishing the purpose of this Plan. A person to whom an Award has been granted hereunder is sometimes referred to herein as a &#147;<B>Participant</B>&#148;
or &#147;<B>Optionee</B>.&#148; </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">A Participant
shall be eligible to receive more than one grant of an Award during the term of this Plan, but only on the terms and subject to the restrictions hereinafter set forth. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">5.<B><I>&nbsp;&nbsp;&nbsp;&nbsp;Stock.</I></B> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The stock subject to Awards hereunder shall be shares of Common Stock. Such shares may, in whole or in part,
be authorized but unissued shares or shares that shall have been or that may be reacquired by the Company. The aggregate number of shares of Common Stock as to which Awards may be granted from time to time under this Plan shall not exceed 14.8
million, plus any shares which remain available for grants of awards under the Prior Plans, of which the number of shares of Common Stock as to which Restricted Shares and/or Performance Awards may be granted from time to time under this Plan shall
not exceed 6 million. No person may be granted Options or Rights under this Plan representing an aggregate of more than 600,000 shares of Common Stock in any year. The limitations established by the preceding three sentences shall be subject to
adjustment as provided in Sections 14 and 18 hereof. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">V-3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">To the extent
that (1) any Award granted under the Plan or the Prior Plans expires, is terminated or forfeited without being exercised, settled or with respect to Restricted Shares, vested, (2) any Option granted under the Plan or the Prior Plans is surrendered
on exercise of a Right for cash or the issuance of fewer shares of Common Stock than issuable under such surrendered Option, or (3) any Free Standing Right granted under the Plan or the Prior Plans expires or is terminated without being exercised,
the shares of Common Stock issuable thereunder, less such shares issued, shall become available for grants of Awards. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">6.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Incentive Stock Options.</I></B> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Options granted pursuant to this Section 6 are intended to constitute Incentive Stock Options and shall be
subject to the following special terms and conditions, in addition to the general terms and conditions specified in Sections 5 and 9 hereof: </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a)<I>&nbsp;&nbsp;&nbsp;&nbsp;Value of Shares.</I>&nbsp;&nbsp;&nbsp;&nbsp;The aggregate Fair Market Value (determined as
of the date the Incentive Stock Option is granted) of the shares of Common Stock with respect to which Options granted under this Plan and all other option plans of the Company, any Parent Corporation and any Subsidiary Corporation become
exercisable for the first time by a Participant during any calendar year shall not exceed $100,000. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b)<I>&nbsp;&nbsp;&nbsp;&nbsp;Ten Percent Stockholders.</I>&nbsp;&nbsp;&nbsp;&nbsp;In the case of an Incentive Stock
Option granted to a Ten Percent Stockholder, (i) the Option Price shall not be less than one hundred ten percent (110%) of the Fair Market Value of a share of Common Stock of the Company on the date of grant of such Incentive Stock Option, and (ii)
the exercise period shall not exceed five (5) years from the date of grant of such Incentive Stock Option. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">7.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Employee Nonqualified Stock Options.</I></B> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Options granted pursuant to this Section 7 are intended to constitute Nonqualified Stock Options and shall be
subject only to the general terms and conditions specified in Sections 5 and 9 hereof. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">8.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Director Nonqualified Stock Options.</I></B> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a)&nbsp;&nbsp;&nbsp;&nbsp;Each non-employee director shall be granted an Option to purchase that number of shares of
Common Stock having a Fair Market Value equal to $77,000 as of the date of each annual meeting of the stockholders of the Company (the &#147;<B>Annual Grant Amount</B>&#148;) following the meeting at which the Plan is approved at which such
individual is elected or reelected to the office of director (the &#147;<B>Meeting Grant Date</B>&#148;) with each such grant effective as of each Meeting Grant Date. In addition, notwithstanding the foregoing, (i) options will be granted to
directors elected at the meeting at which the Plan is approved for a number of shares having a Fair Market Value equal to $77,000 as of the Effective Date to be effective as of the Effective Date and (ii) with respect to any person who is elected or
nominated as and becomes a director other than in connection with an annual meeting of the stockholders of the Company, such director shall be granted an Option, to be effective as of the date of his or her election or appointment, in an amount
equal to the product of the Annual Grant Amount and a fraction the numerator which is the number of months from the date of such election or appointment until the expected date of the next annual meeting and the denominator of which is twelve.
Options granted pursuant to this Section 8 are intended to constitute Nonqualified Stock Options and shall be subject, to the extent applicable, to the general terms and conditions specified in Sections 5 and 9 hereof. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b)&nbsp;&nbsp;&nbsp;&nbsp;No fractional
shares shall be issued under this provision. Any fractional share that would otherwise be granted in connection with the Annual Grant Amount shall be rounded down to the nearest whole share, with the remainder being paid in cash. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c)&nbsp;&nbsp;&nbsp;&nbsp;With respect to the
Options granted pursuant to this Section 8, neither the Board nor the Committee shall have discretion with respect to the selection of directors to receive Options, the number of shares subject to such Options, the purchase price thereunder or the
timing of the grant of Options under this Section 8. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">V-4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(d)&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise provided in an award agreement, the Options granted pursuant to this Section 8 shall vest in equal one-third installments on each of the three anniversaries following the grant date.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">9.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Terms and
Conditions of Options.</I></B> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Each Option
granted pursuant to this Plan shall be evidenced by a written Award Agreement between the Company and the Participant, which agreement shall comply with and be subject to the following terms and conditions: </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a)<I>&nbsp;&nbsp;&nbsp;&nbsp;Number of
Shares</I>.&nbsp;&nbsp;&nbsp;&nbsp;Each Award Agreement shall state the number of shares of Common Stock to which the Option relates. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b)<I>&nbsp;&nbsp;&nbsp;&nbsp;Type of Option</I>.&nbsp;&nbsp;&nbsp;&nbsp;Each Award agreement shall specifically identify
the portion, if any, of the Option that constitutes an Incentive Stock Option and the portion, if any, which constitutes a Nonqualified Stock Option. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c)<I>&nbsp;&nbsp;&nbsp;&nbsp;Option Price</I>.&nbsp;&nbsp;&nbsp;&nbsp;Each Award Agreement shall state the Option Price
per share of Common Stock, which shall be not less than one hundred percent (100%) of the Fair Market Value of a share of Common Stock of the Company on the date of grant of the Option and which, in the case of Incentive Stock Options, shall be
further subject to the limitation described in Section 6(b) hereof. The Option Price shall be subject to adjustment as provided in Section 14 hereof. The date on which the Committee adopts a resolution expressly granting an Option shall be
considered the day on which such Option is granted. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">(d)<I>&nbsp;&nbsp;&nbsp;&nbsp;Medium And Time of Payment</I>.&nbsp;&nbsp;&nbsp;&nbsp;The Option Price shall be paid or satisfied in full, at the time of exercise, in cash or in shares of Common Stock owned by the Participant
for at least six months (which are not the subject of any pledge or other security interest) having a Fair Market Value equal to such Option Price or in a combination of cash and such shares. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(e)<I>&nbsp;&nbsp;&nbsp;&nbsp;Term and
Exercise of Options</I>.&nbsp;&nbsp;&nbsp;&nbsp;Options shall be exercisable over the exercise period as and at the times and upon the conditions that the Committee may determine, as reflected in the Award Agreement; provided, however, that the
Committee shall have the authority to accelerate the exercisability of any outstanding Option at such time and under such circumstances as it, in its sole discretion, deems appropriate. The exercise period shall be determined by the Committee;
provided, however, that in the case of any Incentive Stock Option, such exercise period shall not exceed ten (10) years from the date of grant of such Incentive Stock Option and such exercise period shall be further limited in circumstances
described in Section 6(b) hereof. The exercise period shall be subject to earlier termination as provided in Section 9(f) and 9(g) hereof. An Option may be exercised as to any or all full shares of Common Stock as to which the Option has become
exercisable, by giving written notice of such exercise to the Committee; provided, however, that an Option may not be exercised at any one time as to fewer than one hundred (100) shares (or such number of shares as to which the Option is then
exercisable if such number of shares is less than one hundred (100)). </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">(f<I>)&nbsp;&nbsp;&nbsp;&nbsp;Termination of Employment</I>.&nbsp;&nbsp;&nbsp;&nbsp;Except as provided in this Section 9(f) and in Section 9(g) hereof, an Option may not be exercised unless the
Participant is then in the employ or service of (1) the Company, (2) an Affiliate Corporation or (3) a corporation issuing or assuming the Option in a transaction to which Section 424 of the Code applies or a parent corporation or subsidiary
corporation of the corporation described in this Clause 3, and unless the Participant has remained continuously so employed since the date of grant of the Option. In the event that the employment or service of a Participant shall terminate (other
than by reason of death, Disability or Retirement), all Options of such Participant that are exercisable at the time of such termination may, unless earlier terminated in accordance with their terms, be exercised within three (3) months after such
termination. Nothing in this Plan or in any Option or Right granted pursuant hereto shall confer upon an individual any right to continue in the employ or service of the Company or any of its Affiliate Corporations or interfere in any way with the
right of the Company or any such Affiliate Corporation to terminate such employment or service at any time. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">V-5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(g)<I>&nbsp;&nbsp;&nbsp;&nbsp;Acceleration of Benefits upon Death, Disability or Retirement of Participant or a Change in Control</I>.&nbsp;&nbsp;&nbsp;&nbsp;If (i) a Participant shall die while employed by the Company or an
Affiliate Corporation thereof, (ii) a Participant shall die within three (3) months after the termination of such Participant&#146;s employment, (iii) the Participant&#146;s employment shall terminate by reason of Disability or Retirement, or (iv)
there is a Change in Control, then in any such case all Options theretofore granted to such Participant (whether or not then exercisable) may, unless earlier terminated or expired in accordance with their terms, be exercised by the Participant or by
the Participant&#146;s estate or by a person who acquired the right to exercise such Option by bequest or inheritance or otherwise by reason of the death or Disability of the Participant, at any time within one year after the date of death,
Disability or Retirement of the Participant or the Change in Control. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">(h)<I>&nbsp;&nbsp;&nbsp;&nbsp;Nontransferability of Options</I>.&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise provided in an Award Agreement, Options granted under this Plan shall not be transferable
otherwise than by will or by the laws of descent and distribution, and Options may be exercised, during the lifetime of the Participant, only by the Participant or by his guardian or legal representative. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(i)<I>&nbsp;&nbsp;&nbsp;&nbsp;Rights as a
Stockholder</I>.&nbsp;&nbsp;&nbsp;&nbsp;A Participant who is the holder of an Option or a transferee of an Option shall have no rights as a stockholder with respect to any shares covered by the Option until the date of the issuance of a stock
certificate to him or her for such shares. No adjustment shall be made for dividends (ordinary or extraordinary, whether in cash, securities or other property) or distribution of other rights for which the record date is prior to the date such stock
certificate is issued, except as provided in Section 14 hereof. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">(j)<I>&nbsp;&nbsp;&nbsp;&nbsp;Other Provisions</I>.&nbsp;&nbsp;&nbsp;&nbsp;The Award Agreements authorized under this Plan shall contain such other provisions, including, without limitation, (i) the
granting of Rights, (ii) the imposition of restrictions upon the exercise of an Award, and (iii) in the case of an Incentive Stock Option, the inclusion of any condition not inconsistent with such Option qualifying as an Incentive Stock Option, as
the Committee shall deem advisable. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">10.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Stock Appreciation Rights.</I></B> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a)<I>&nbsp;&nbsp;&nbsp;&nbsp;Grant and Exercise</I>.&nbsp;&nbsp;&nbsp;&nbsp;In the case of a Nonqualified Stock Option,
Related Rights may be granted either at or after the time of the grant of such Option. In the case of an Incentive Stock Option, Related Rights may be granted only at the time of the grant of the Incentive Stock Option. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">A Related Right or applicable portion thereof granted with
respect to a given Option shall terminate and no longer be exercisable upon the termination or exercise of the related Option, except that, unless otherwise provided by the Committee at the time of grant, a Related Right granted with respect to less
than the full number of shares covered by a related Option shall only be reduced if and to the extent that the number of shares covered by the exercise or termination of the related Option exceeds the number of shares not covered by the Right.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">A Related Right may be exercised by a
Participant, in accordance with paragraph (b) of this Section 10, by surrendering the applicable portion of the related Option. Upon such exercise and surrender, the Participant shall be entitled to receive an amount determined in the manner
prescribed in paragraph (b) of this Section 10. Options, which have been so surrendered, in whole or in part, shall no longer be exercisable to the extent the Related Rights have been exercised. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b)<I>&nbsp;&nbsp;&nbsp;&nbsp;Terms and
Conditions</I>.&nbsp;&nbsp;&nbsp;&nbsp;Rights shall be subject to such terms and conditions, not inconsistent with the provisions of this Plan, as shall be determined from time to time by the Committee and as evidenced by a written Award Agreement
between the Company and the Participant, including the following: </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">(i) Related Rights shall be exercisable only at such time or times and to the extent that the Options to which they relate shall be exercisable in accordance with the provisions of Section 6, 7, 9 and
this Section 10 of this Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">V-6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(ii) Upon the exercise of a Related Right, a Participant shall be entitled to receive up to, but not more than, an amount in cash or shares of Common Stock equal in value to the excess of the Fair Market Value of one (1) share of
Common Stock over the option price per share specified in the related Option multiplied by the number of shares in respect of which the Related Right shall have been exercised, with the Committee having the right to determine the form of payment.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(iii) Related Rights shall be
transferable only when and to the extent that the underlying Option would be transferable under paragraph (h) of Section 9 of this Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(iv) A Related Right granted in connection with an Incentive Stock Option may be exercised only if and when the market
price of the Common Stock subject to the Incentive Stock Option exceeds the exercise price of such Option. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(v) Free Standing Rights shall be exercisable at such time or times and subject to such terms and conditions as shall be
determined by the Committee at or after grant. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(vi) The term of each Free Standing Right shall be fixed by the Committee, but no Free Standing Right shall be exercisable more than ten (10) years after the date such right is granted. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(vii) Upon the exercise of a Free Standing
Right, a Participant shall be entitled to receive up to, but not more than, an amount in cash or shares of Common Stock equal in value to the excess of the Fair Market Value of one share of Common Stock over the price per share specified in the Free
Standing Right (which shall be no less than one hundred percent (100%) of the Fair Market Value of the Common Stock on the date of grant) multiplied by the number of shares in respect of which the Right is being exercised, with the Committee having
the right to determine the form of payment. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(viii) No Free Standing Right shall be transferable by the Participant otherwise than by will or by the laws of descent and distribution, and all such rights shall be exercisable, during the Participant&#146;s lifetime, only by the
Participant or his legal guardian or legal representative. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">(ix) In the event of the termination of employment of a recipient of a Free Standing Right, such right shall be exercisable to the same extent that an Option would have been exercisable in the event of
the termination of employment of a Participant. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">11.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Restricted Shares.</I></B> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">(a)<I>&nbsp;&nbsp;&nbsp;&nbsp;Grant</I>.&nbsp;&nbsp;&nbsp;&nbsp;Subject to the provisions of this Plan, the Committee shall have sole and complete authority to determine the Participants to whom
Restricted Shares shall be granted, the number of Restricted Shares to be granted to each Participant, the duration of the period during which, and the conditions under which, the Restricted Shares may be forfeited to the Company, and the other
terms and conditions of such Awards (including whether or not such Restricted Shares shall qualify as Performance Awards). </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b)<I>&nbsp;&nbsp;&nbsp;&nbsp;Transfer Restrictions</I>.&nbsp;&nbsp;&nbsp;&nbsp;Restricted Shares may not be sold,
assigned, transferred, pledged or otherwise encumbered, except as otherwise provided in an Award Agreement. Certificates issued in respect of Restricted Shares shall be registered in the name of the Participant and deposited by such Participant,
together with a stock power endorsed in blank, with the Company. Upon the lapse of the restrictions applicable to such Restricted Shares, the Company shall deliver such certificates to the Participant or the Participant&#146;s legal representative.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(c)<I>&nbsp;&nbsp;&nbsp;&nbsp;Dividends and Distributions</I>.&nbsp;&nbsp;&nbsp;&nbsp;Dividends and other distributions paid on or in respect of Restricted Shares, if any, may be paid directly to the Participant, or may be reinvested
in additional Restricted Shares, as determined by the Committee in its sole discretion. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(d)<I>&nbsp;&nbsp;&nbsp;&nbsp;Acceleration of Benefits upon Death, Disability or Retirement of Participant or a Change in
Control</I>.&nbsp;&nbsp;&nbsp;&nbsp;If (i) a Participant shall die while employed by the Company or an Affiliate Corporation thereof, (ii) the Participant&#146;s employment shall terminate by reason of Disability or Retirement, or (iii) there is a
Change in Control, then in any such case all Restricted Shares theretofore granted to such Participant shall become immediately vested and nonforfeitable. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">V-7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">12.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Performance Awards.</I></B> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">(a)<I>&nbsp;&nbsp;&nbsp;&nbsp;Grant</I>.&nbsp;&nbsp;&nbsp;&nbsp;Subject to the provisions of this Plan, the Committee shall have sole and complete authority to determine the Participants to whom
Performance Awards shall be granted, the number of shares of Common Stock subject to Performance Awards, the duration of the period during which, and the conditions under which, the Performance Awards may be forfeited to the Company, and the other
terms and conditions of such Awards. Performance Awards may be (i) denominated in cash or Shares, (ii) valued, as determined by the Committee, in accordance with the achievement of such performance goals during such performance periods as the
Committee shall establish, and (iii) payable at such time and in such form as the Committee shall determine. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b)<I>&nbsp;&nbsp;&nbsp;&nbsp;Terms and Conditions</I>.&nbsp;&nbsp;&nbsp;&nbsp;Subject to the terms of the Plan and any
applicable Award Agreement, the Committee shall determine the performance goals to be achieved during any performance period, the length of any performance period, the amount of any Performance Award and the amount and kind of any payment or
transfer to be made pursuant to any Performance Award. Unless otherwise provided in an Award Agreement, Performance Awards may not be sold, assigned, transferred, pledged or otherwise encumbered. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c)<I>&nbsp;&nbsp;&nbsp;&nbsp;Payment of
Performance Awards</I>.&nbsp;&nbsp;&nbsp;&nbsp;Performance Awards may be paid in a lump sum or in installments following the close of the performance period or, in accordance with procedures established by the Committee, on a deferred basis.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">13.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Provisions
Applicable to Covered Officers.</I></B> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">To the
extent the Committee determines, all performance-based Restricted Shares and Performance Awards granted to Covered Officers shall be subject to the terms and provisions of this Section 13. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a) Performance goals shall be limited to one or more of the following Company, subsidiary,
operating unit or division financial performance measures: </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">(i) earnings before interest, taxes, depreciation and/or amortization </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(ii) operating income or profit </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(iii) return on equity, assets, capital, capital employed, or investment </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(iv) after tax operating income </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(v) net income </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(vi) earnings or book value per share
</FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(vii) cash flow(s)
</FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(viii) total sales or revenues
or sales or revenues per employee </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(ix) stock price or total shareholder return </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">(x) dividends </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:8%; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">(xi) strategic business objectives, consisting of one or more objectives based on meeting specified cost targets, business expansion goals, and goals relating to acquisitions or divestitures or any
combination thereof. Each goal may be expressed on an absolute and/or relative basis, may be based on or otherwise employ comparisons based on internal targets, the past performance of the Company and/or the past or current performance of other
companies, and in the case of earnings-based measures, may use or employ comparisons relating to capital, shareholders&#146; equity and/or shares outstanding, or to assets or net assets. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b) The maximum annual number of shares in respect of which performance-based Restricted
Shares and Performance Awards may be granted to any Participant under the Plan is 400,000, subject to adjustment </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">V-8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1%">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">as provided in Section 14, and the maximum annual amount of any such Award settled per Participant in cash is $5 million.
</FONT></P></TD></TR></TABLE><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c) To the
extent necessary to comply with Section 162(m), no later than 90 days following the commencement of each performance period (or such other time as may be required or permitted by Section 162(m) of the Code), the Committee shall, in writing, (A)
select the performance goal or goals applicable to the performance period, (B) establish the various targets and bonus amounts which may be earned for such performance period and (C) specify the relationship between performance goals and targets and
the amounts to be earned by each Covered Officer for such performance period. Following the completion of each performance period, the Committee shall certify in writing whether the applicable performance targets have been achieved and the amounts,
if any, payable to Covered Officers for such performance period. In determining the amount earned for a given performance period, subject to any applicable Award Agreement, the Committee shall have the right to reduce (but not increase) the amount
payable at a given level of performance to take into account additional factors that the Committee may deem relevant to the assessment of individual or corporate performance for the performance period. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">14.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Effect of Certain
Changes.</I></B> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(a)&nbsp;&nbsp;&nbsp;&nbsp;If there is any change in the number of outstanding shares of Common Stock by reason of any stock dividend, stock split, recapitalization, combination, exchange of shares, merger, consolidation,
liquidation, split-up, spin-off or other similar change in capitalization, any distribution to shareholders, including a rights offering, other than cash dividends, or any like change, then the number of shares of Common Stock available for Awards,
the maximum number of shares of Common Stock that may be subject to Awards, the number of such shares of Common Stock covered by outstanding Awards, and the price per share of Options or the applicable market value of Rights, shall be
proportionately adjusted by the Committee to reflect such change or distribution; provided, however, that any fractional shares resulting from such adjustment shall be eliminated. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b)&nbsp;&nbsp;&nbsp;&nbsp;In the event of a change in the Common Stock as presently
constituted, which is limited to a change of all of its authorized shares with par value into the same number of shares with a different par value or without par value, the shares resulting from any such change shall be deemed to be Common Stock
within the meaning of this Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(c)&nbsp;&nbsp;&nbsp;&nbsp;To the extent that the foregoing adjustments relate to stock or securities of the Company, such adjustments shall be made by the Committee, whose determination in that respect shall be final, binding and
conclusive, provided that each Incentive Stock Option granted pursuant to this Plan shall not be adjusted in a manner that causes such option to fail to continue to qualify as an Incentive Stock Option within the meaning of Section 422 of Code.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">15.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Agreement by
Participant Regarding Withholding Taxes.</I></B> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">If the Committee shall so require, as a condition of grant, exercise, or settlement or otherwise, each Participant shall agree that: </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a) no later than the date a Participant recognizes taxable income in connection with an Award granted hereunder in
connection with the exercise or settlement of such Award or otherwise, the Participant will pay to the Company or make arrangements satisfactory to the Committee regarding payment of any federal, state or local taxes of any kind required by law to
be withheld upon the exercise or settlement of such Award (any such tax, a &#147;<B>Withholding Tax</B>&#148;); and </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b) the Company shall, to the extent permitted or required by law, have the right to deduct any Withholding Tax from any
payment of any kind otherwise due to the Participant. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">V-9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">16.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Gross-Up for Excise Tax.</I></B> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">An Award Agreement may provide that in the event that a Participant becomes entitled by reason of a Change of Control to the accelerated vesting of an Award, if such Participant will be subject to
excise tax (the &#147;<B>Excise Tax</B>&#148;) under Section 4999 of the Code, the Company shall pay to such Participant as additional compensation an amount (the &#147;<B>Gross-Up Payment</B>&#148;) which, after payment by such Participant of all
taxes (including any federal, state and local income tax and excise tax upon the payment provided for by this Section 16) allows Participant to retain an amount of the Gross-Up Payment equal to the Excise Tax. For purposes of determining whether a
Participant will be subject to the Excise Tax and the amount of such Excise Tax, (i) any other payments or benefits received or to be received by such Participant in connection with a Change in Control of the Company or the Participant&#146;s
termination of employment (whether pursuant to the terms of the Award Agreement or any other plan, arrangement or agreement with the Company, any entity whose actions result in a Change in Control of the Company or any entity affiliated with the
Company or such entity) shall be treated as &#147;<B>parachute payments</B>&#148; within the meaning of Section 280G(b)(2) of the Code, and all &#147;<B>excess parachute payments</B>&#148; within the meaning of Section 280G(b)(1) of the Code shall
be treated as subject to the Excise Tax, unless in the opinion of tax counsel selected by the Company&#146;s independent auditors and reasonably acceptable to the Participant such other payments or benefits (in whole or in part) do not constitute
parachute payments, including by reason of Section 280G(b)(4)(A) of the Code, or such excess parachute payments (in whole or in part) represent reasonable compensation for services actually rendered, within the meaning of Section 280G(b)(4)(B) of
the Code, or are otherwise not subject to the Excise Tax, (ii) the amount of payments or benefits treated as subject to the Excise Tax shall be equal to the lesser of (A) the total amount of payments or benefits conferred on such Participant by
reason of the Change of Control or (B) the amount of excess parachute payments within the meaning of Section 280G(b)(1) of the Code (after applying clause (i), above), and (iii) the value of any noncash benefits or any deferred payment or benefit
shall be determined by the Company&#146;s independent auditors in accordance with the principles of Sections 280G(d)(3) and (4) of the Code. For purposes of determining the amount of the Gross-Up Payment, the Participant shall be deemed to pay
federal income taxes at the highest marginal rate of federal income taxation in the calendar year in which the Gross-Up Payment is to be made and state and local income taxes at the highest marginal rate of taxation in the state and locality of the
Participant&#146;s residence on the date on which the Excise Tax is incurred, net of the maximum reduction in federal income taxes which could be obtained from deduction of such state and local taxes. In the event that the Excise Tax is subsequently
determined to be less than the amount taken into account hereunder, the Participant shall repay to the Company, at the time that the amount of such reduction in Excise Tax is finally determined, the portion of the Gross-Up Payment attributable to
such reduction (plus that portion of the Gross-Up Payment attributable to the Excise Tax and federal, state and local income tax deduction) plus interest on the amount of such repayment at the rate provided in Section 1274(b)(2)(B) of the Code. In
the event that the Excise Tax is determined to exceed the amount taken into account hereunder (including by reason of any payment the existence or amount of which cannot be determined at the time of the Gross-Up Payment), the Company shall make an
additional Gross-Up Payment in respect of such excess (plus any interest, penalties or additions payable by the Participant with respect to such excess) at the time that the amount of such excess finally is determined. The Participant and the
Company each shall reasonably cooperate with the other in connection with any administrative or judicial proceedings concerning the existence or amount of liability for Excise Tax. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">17.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Termination and Amendment.</I></B> </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Unless terminated by action of the Board of Directors or the
Committee, no Awards may be granted under this Plan after May 4, 2010. This Plan may be amended or terminated at any time by the Committee, except that no amendment may be made without shareholder approval if the Committee determines that such
approval is necessary to comply with any tax or regulatory requirement, including any approval requirement which is a prerequisite for exemptive relief from Section 16 of the Exchange Act, for which or with which the Committee determines that it is
desirable to qualify or comply. The Committee may amend the terms of any Award Agreement and any Award granted, retroactively or prospectively, but no amendment may adversely affect any vested Award without the holder&#146;s consent. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">V-10 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">18.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Effectiveness; Approval of Stockholders.</I></B>
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Except as otherwise provided herein, this
amended and restated Plan shall take effect as of May 14, 2003 (the &#147;<B>Effective Date</B>&#148;), subject to the approval of the holders of the majority of the voting shares of the Company at the Company&#146;s 2003 Annual Meeting of
Stockholders (the &#147;<B>2003 Annual Meeting</B>&#148;). If the amended and restated Plan is not approved by the stockholders, this Plan shall continue under its terms prior to amendment and restatement. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">19.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Effect of Headings.</I></B>
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The section and subsection headings contained
herein are for convenience only and shall not affect the construction hereof. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:6%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">20.&nbsp;&nbsp;&nbsp;&nbsp;<B><I>Governing Law</I></B> </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The validity, construction and effect of the Plan shall be determined in accordance with the laws of the State of Delaware. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">V-11 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>ANNEX VI
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>LABORATORY CORPORATION OF AMERICA HOLDINGS
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>MANAGEMENT INCENTIVE BONUS PLAN </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>As Amended and Restated Effective March 19, 2003 </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>SECTION 1.&nbsp;&nbsp;&nbsp;&nbsp;Purpose. </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The purpose of the Laboratory Corporation of America Holdings Management Incentive Bonus Plan (the &#147;Plan&#148;), formerly known as
the Annual Bonus Incentive Plan, is to promote the profitability of Laboratory Corporation of America Holdings (the &#147;Company&#148;) and its Subsidiaries by providing senior executives and other key employees with cash awards based on the
achievement of annual short-term goals. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>SECTION
2.&nbsp;&nbsp;&nbsp;&nbsp;Definitions. </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">For
the purposes of the Plan, the following terms shall have the meanings indicated: </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;<B>Award</B>&#148; shall mean the grant of an award by the Committee to a Participant. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;<B>Award Year</B>&#148; shall mean any fiscal year with respect to the Company&#146;s performance in which an Award is granted.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;<B>Base Salary</B>&#148; shall mean as to
any Award Year a Participant&#146;s annual salary rate. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&#147;<B>Board of Directors</B>&#148; shall mean the Board of Directors of the Company. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;<B>Change in Control</B>&#148; shall mean an event of a nature that: </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(i) any &#147;person&#148; (as the term is defined in Sections 13(d) and 14(d) of the
Securities Exchange Act of 1934, as amended, &#147;the Exchange Act&#148;) who is not now presently but becomes the &#147;beneficial owner&#148; (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company
representing 30% or more of the Company&#146;s outstanding securities except for any securities purchased by any tax-qualified employee benefit plan of the Company; or </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(ii) individuals who constitute the Board of Directors on the Effective Date (the
&#147;Incumbent Board&#148;) cease for any reason to constitute at least a majority thereof, provided that any person becoming a director subsequent to the date hereof whose election was approved by a vote of at least three-quarters of the directors
comprising the Incumbent Board, or whose nomination for election by the Company&#146;s stockholders was approved by the Incumbent Board, shall be for purposes of this clause (ii), considered as though he or she were a member of the Incumbent Board;
or </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(iii) a plan of
reorganization, merger, consolidation, sale of all or substantially all the assets of the Company or similar transaction occurs in which the Company is not the resulting entity; or </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(iv) a proxy statement soliciting proxies from shareholders of the Company, by someone other
than the current management of the Company, seeking stockholder approval of a plan of reorganization, merger or consolidation of the Company or similar transaction with one or more corporations, as a result of which the outstanding shares of the
class of securities not issued by the Company shall be distributed. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman"
SIZE="2" COLOR="#000000">&#147;<B>Committee</B>&#148; shall mean the Committee designated pursuant to Section 3. Until otherwise determined by the Board of Directors, the Compensation Committee designated by the Board of Directors shall be the
Committee under the Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;<B>Common
Equity</B>&#148; shall mean the common stockholders&#146; equity appearing on the Company&#146;s audited consolidated balance sheets as of the end of the fiscal year prior to the beginning of the Award Year in question. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">VI-1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;<B>Covered Officer</B>&#148; as of a particular date shall mean (i) any individual
who, with respect to the previous taxable year of the Company, was a &#147;covered employee&#148; of the Company within the meaning of Section 162(m) of the Internal Revenue Code; provided, however, that the term &#147;Covered Officer&#148; shall
not include any such individual who is designated by the Committee, in its discretion, at the time of any Award or at any subsequent time, as reasonably expected not to be such a &#147;covered employee&#148; with respect to the current taxable year
of the Company and (ii) any individual who is designated by the Committee, in its discretion, at the time of any Award or at any subsequent time, as reasonably expected to be such a &#147;covered employee&#148; with respect to the current taxable
year of the Company or with respect to the taxable year of the Company in which any applicable Award will be paid. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;<B>Days Sales Outstanding</B>&#148; (&#147;<B>DSO</B>&#148;) shall mean the quotient of the net accounts receivable amount divided
by the average daily sales based on a 360-day year. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&#147;<B>Disability</B>&#148; shall mean a Participant&#146;s inability to engage in any substantial gainful activity by reason of medically determinable physical or mental impairment that can be expected to result in death or that
has lasted or can be expected to last for a continuous period of not less than twelve (12) months. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;<B>Earnings Per Share</B>&#148; shall mean the Company&#146;s earnings per share of common stock as determined for purposes of the
Company&#146;s audited consolidated statement of operations for the Award Year. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;<B>EBITDA</B>&#148; shall mean earnings before interest expense, income tax, depreciation and amortization as determined in accordance with generally accepted accounting principles. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;<B>Exchange Act</B>&#148; shall mean the Securities
Exchange Act of 1934, as amended. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;<B>Long
Term Debt</B>&#148; shall mean the sum of total preferred stock plus total long-term debt of the Company, as determined for purposes of the Company&#146;s audited consolidated balance sheets for the Award Year in question. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;<B>Net Income</B>&#148; shall mean the consolidated net
income of the Company as determined for purposes of the Company&#146;s audited consolidated statement of operations for the Award Year; provided Net Income shall be increased or reduced by the after-tax earnings impact of each of the following items
if they occur during an Award Year: </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">(i) the cumulative effect of changes in accounting principles for the Award Year required by the Financial Accounting Standards Board, the Securities and Exchange Commission or any other governing body that sets accounting standards,
as determined for purposes of the Company&#146;s audited consolidated statements of operations or the notes thereto; </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(ii) the cumulative effect of changes in the tax law occurring during the Award Year as determined for purposes of the
Company&#146;s audited consolidated statements of operations or the notes thereto; </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(iii) extraordinary items, as defined under generally accepted accounting principles, during the Award Year as determined
for purposes of the Company&#146;s audited consolidated statements of operations; </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(iv) gain or loss from discontinued operations; and </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(v) nonrecurring items, as defined under generally accepted accounting principles, during the
Award Year as determined for purposes of the Company&#146;s audited consolidated statements of operations or the notes thereto. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;<B>Participant</B>&#148; shall mean a senior executive or other key employee of the Company selected by the Committee in accordance
with Section 4 or Section 6 who receives an Award. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&#147;<B>Performance Goals</B>&#148; shall mean the levels of Performance Measures required to be achieved by a Participant in order to earn an Award. Notwithstanding anything in the Plan to the contrary, no Performance Goal shall be
deemed achieved if its effect would be to compromise the quality of service provided by the Company or if it is accomplished in a manner which violates any policy of the Company, including without limitation, any legal or ethical compliance policy.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">VI-2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&#147;<B>Performance Measures</B>&#148; shall include without limitation, EBITDA, ROC, ROE, Net Income, Earnings Per Share, DSO, revenue growth, expense control, individual performance, which may be determined on a corporate,
regional or subregional basis, as applicable, or any combination of the foregoing; provided, however, individual performance may not be used as a Performance Measure for a Covered Officer. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;<B>Retirement</B>&#148; shall mean a Participant&#146;s
termination of employment in accordance with the provisions of the Company&#146;s Employee Retirement Plan at such Participant&#146;s Normal Retirement Date, as defined in such Plan. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;<B>ROC</B>&#148; shall mean the percentage equivalent to a fraction resulting from dividing (i) Net
Income by (ii) the sum of Common Equity plus Long Term Debt. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2"
COLOR="#000000">&#147;<B>ROE</B>&#148; shall mean the percentage equivalent to the fraction resulting from dividing (i) Net Income by (ii) Common Equity. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;<B>Section 162(m)</B>&#148; shall mean Section 162(m) of the Internal Revenue Code of 1986 and the rules and other authorities
thereunder promulgated by the Internal Revenue Service of the Department of the Treasury. </FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">&#148;<B>Subsidiary</B>&#148; shall mean any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company if, at the time of granting an option, each of such
corporations other than the last corporation in the unbroken chain owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain </FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">&#147;<B>Target Award</B>&#148; shall mean the amount,
expressed as a percentage of Base Salary, which will be earned by a Participant if target Performance Goals are achieved. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>SECTION 3.&nbsp;&nbsp;&nbsp;&nbsp;Administration. </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a) Subject to the authority and powers of the Board of Directors in relation to the Plan as hereinafter provided, the Plan shall be
administered by a Committee designated by the Board of Directors which, to the extent necessary to satisfy Section 162(m) shall consist of two or more members of the Board of Directors each of whom is an &#147;outside director&#148; within the
meaning of Section 162(m). The Committee shall have full authority to interpret the Plan and from time to time to adopt such rules and regulations for carrying out the Plan as it may deem best; provided, however, that the Committee may not exercise
any authority otherwise granted to it hereunder if such action would have the effect of increasing the amount of an Award which has been earned hereunder by any Covered Officer. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b) All determinations by the Committee shall be made by the affirmative vote of a majority of its members,
but any determination reduced to writing and signed by a majority of the members shall be fully as effective as if it had been made by a majority vote at a meeting duly called and held. All decisions by the Committee pursuant to the provisions of
the Plan and all orders or resolutions of the Board of Directors pursuant thereto shall be final, conclusive and binding on all persons, including the Participants, the Company and shareholders. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>SECTION 4.&nbsp;&nbsp;&nbsp;&nbsp;Eligibility for and Payment of Awards.
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a) Subject to the provisions of the Plan,
in each Award Year the Committee may select officers or employees (including officers or employees who are also directors) of the Company who will be eligible to earn Awards under the Plan with respect to such Award Year, and determine the amount of
such Participant&#146;s Target Awards and the conditions under which such Target Awards may be earned. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b) Awards that are earned with respect to any Award Year shall be paid in cash to Participants in such amounts and at such times as are
determined by the Committee. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c) Except as
otherwise determined by the Committee, no portion of any Target Award may be earned unless a Participant is employed by the Company at the time of payment. In the event the employment of a </FONT>
</P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">VI-3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">Participant is terminated by reason of death, Disability or Retirement prior to the payment of any Award, provided such Participant shall
have been actively employed by the Company for at least six months during the Award Year, the Committee may provide that such Participant shall receive a prorated payout of the Award, payable at the time such payment would have been made in the
absence of a termination of employment; payments to Participants with less than six months of active employment during the Award Year shall be made at the sole discretion of the Committee. In the event the employment of a Participant is terminated
for reasons other than death, Disability or Retirement prior to the payment of any Award, payments, if any, to Participants shall be made at the sole discretion of the Committee. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(d) Subject to Section 6, in the event of a Change in Control of the Company, Target Awards shall be payable
in full. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>SECTION 5.&nbsp;&nbsp;&nbsp;&nbsp;Awards.
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a) Subject to Section 6, the Target Award
and the applicable Performance Measures and Performance Goals for each Participant and their relative weightings shall be established by the Committee or its delegate before the beginning of the Award Year with respect to which the Award under the
Plan is to be earned or as soon as practicable thereafter. Subject to Section 6, the individual performance portion of an Award may be increased or decreased on a Participant-by-Participant basis based on the achievement of other financial or
non-financial goals as evaluated by the Committee (with the advice of the Chief Executive Officer) in its sole discretion. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b) Subject to Section 6, notwithstanding the foregoing, the Committee shall have the discretion to cancel, withhold, defer or reduce any
Award earned, and no participant shall have any contractual right under the Plan to the award of any amount hereunder. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>SECTION 6.&nbsp;&nbsp;&nbsp;&nbsp;Special Provisions Relating to Covered Officers. </B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT
SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a) The Target Award and the Performance Measures and Performance Goals for each Covered Officer and their
relative weightings shall be established by the Committee at such time as may be required by Section 162(m). </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b) The maximum Award opportunity for each Covered Officer in any Award Year is $2,500,000. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c) No Covered Officer shall receive any payment with respect
to an Award unless the members of the Committee shall have certified that the Performance Goals have been achieved. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(d) The Committee shall have the authority in its discretion to reduce an Award otherwise earned by any Covered Officer under the terms of
the Plan; however, the Committee shall have no discretion under this Plan to increase the amount of any Award earned in accordance with the provisions of the Plan or to take any action in administering the Plan that would have such effect.
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>SECTION 7.&nbsp;&nbsp;&nbsp;&nbsp;General Provisions.
</B></FONT></P><P STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(a) If Performance Goals for any year shall
have been affected by special factors (including material changes in accounting policies or practices, material acquisitions or dispositions of property, or other unusual items) which in the Committee&#146;s judgment should or should not be taken
into account, in whole or in part, in the equitable administration of the Plan, the Committee may, for any purpose of the Plan, adjust the Performance Goals and make payments accordingly under the Plan. </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(b) Notwithstanding the provisions of subparagraph (a) above,
any adjustments made in accordance with or for the purposes of subparagraph (a) shall be disregarded if and to the extent that such adjustments would not satisfy the requirements of Section 162(m). </FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">VI-4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(c) No portion
of any Award under the Plan may be assigned or transferred prior to the payment thereof. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT
FACE="Times New Roman" SIZE="2" COLOR="#000000">(d) All payments made pursuant to the Plan shall be subject to withholding in respect of income and other taxes required by law to be withheld, in accordance with procedures to be established by the
Committee. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(e) The selection of an individual
for participation in the Plan shall not give such Participant any right to be retained in the employ of the Company, and the right of the Company to dismiss or discharge any such Participant, or to terminate any arrangement pursuant to which any
such Participant provides services to the Company, is specifically reserved. The benefits provided for Participants under the Plan shall be in addition to, and shall in no way preclude, other forms of compensation to or in respect of such
Participants. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(f) The Board of Directors and the
Committee shall be entitled to rely on the advice of counsel and other experts, including the independent public accountants for the Company. No member of the Board of Directors or of the Committee or any officers of the Company shall be liable for
any act or failure to act under the Plan, except in circumstances involving bad faith on the part of such member or officer. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">(g) Nothing contained in the Plan shall prevent the Company or any affiliate of the Company from adopting or continuing in effect other
compensation arrangements, which arrangements may be either generally applicable or applicable only in specific cases. </FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P><P
STYLE="margin-top:0px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000"><B>SECTION 8.&nbsp;&nbsp;&nbsp;&nbsp;Amendment and Termination of the Plan; Compliance With Section 162(m). </B></FONT></P><P
STYLE="margin-top:0px;margin-bottom:-6px"><FONT SIZE="1">&nbsp;</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">The Board of Directors may at any time terminate, in whole or
in part, or from time to time amend the Plan. In the event of such termination, in whole or in part, of the Plan, the Committee may in its sole discretion direct the payment to Participants of any Awards not theretofore paid out prior to the
respective dates upon which payments would otherwise be made hereunder to such Participants, in a lump sum or installments as the Committee shall prescribe with respect to each such Participant. The Board may at any time and from time to time
delegate to the Committee any or all of its authority under this Section 8. Any amendment to the Plan that would affect any Covered Officer shall be approved by the Company&#146;s shareholders if required by and in accordance with Section 162(m).
</FONT></P><P STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2" COLOR="#000000">VI-5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">
 <DIV ALIGN="LEFT">
<PRE>


           STOCKHOLDERS' PROXY SOLICITED BY THE BOARD OF DIRECTORS OF
                   LABORATORY CORPORATION OF AMERICA HOLDINGS

To: Laboratory Corporation of America Holdings

         I appoint Bradford T. Smith and Wesley R. Elingburg, individually and
together, as my proxies, with power of substitution, to vote all of my
LABORATORY CORPORATION OF AMERICA HOLDINGS common stock at the Annual Meeting of
stockholders of LABORATORY CORPORATION OF AMERICA HOLDINGS to be held at The
Paramount Theater, 128 East Front Street, Burlington, NC, 27215 on Wednesday,
May 14, 2003 at 9:00 a.m., Eastern Daylight Time, and at any adjournment or
postponement of the meeting.

         My proxies will vote the shares represented by this proxy as directed
on the other side of this card, but in the absence of any instructions from me,
my proxies will vote "FOR" the election of all the nominees listed under Item 1
and "FOR" Item 2, Item 3, and Item 4. My proxies may vote according to their
discretion on any other matter which may properly come before the meeting. I may
revoke this proxy prior to its exercise.


                Please sign and date the other side of the card.


            (Please fill in the appropriate boxes on the other side.)
</PRE>
 </DIV>
<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">
 <DIV ALIGN="LEFT">
<PRE>

The Board of Directors recommends that you vote "FOR" all the nominees listed
under Item No. 1 and "FOR" Item No. 2, Item No. 3, and Item No. 4.

                                           FOR ALL         WITHHOLD AUTHORITY
1. Election of the                         NOMINEES         for all nominees
   members of the
   Company's Board of
   Directors.                                [_]                   [_]


For, except vote withheld from the following nominee(s).


---------------------------------------------------------

Nominees:
Thomas P. Mac Mahon, Jean-Luc Belingard, Wendy E. Lane, Robert E. Mittelstaedt,
Jr., James B. Powell, M.D., and Andrew G. Wallace, M.D.

                                                   FOR      AGAINST     ABSTAIN

2. Approval of the Stock Plan                      [_]        [_]         [_]
   Amendment to the Laboratory
   Corporation of America Holdings
   2000 Stock Incentive Plan

3. Approval of the Incentive Plan                  [_]        [_]         [_]
   Amendment to the Laboratory
   Corporation of America Holdings
   Management Incentive Bonus Plan

4. Ratification of the appointment                 [_]        [_]         [_]
   of PricewaterhouseCoopers LLP
   as Laboratory Corporation of
   America Holdings' independent
   accountants for 2003.

SHAREHOLDER NAME AND ADDRESS



Signature(s)                                               Date:
             -------------------------------------------         ---------------

NOTE: Please sign exactly as name(s) appear(s) above. If acting as an executor,
administrator, trustee, guardian, etc. you should so indicate signing. If the
shareholder is a corporation, please sign the full corporate name, by duly
authorized officer. If shares are held jointly, each shareholder should sign.

Date and promptly return the card in the envelope provided.

</PRE>
 </DIV> </BODY></HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g22611g40f84.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g22611g40f84.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0PR4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````4````1`````&`&<`-``P
M`&8`.``T`````0`````````````````````````!``````````````$0````
M4``````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````"98````!````<````"$`
M``%0```K4```"7H`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``A`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#N/K?]:\?ZJ]/ISLC'?DLNN%`:PAI!+;+=WN_XI4,+_&!C6TB[J&,.
MD^JP/Q*\R^MEMN[U-ECJ/YS&Q'>CL^V9'IT_I*MF]7OK7]D->"V]OZ<WEV'>
MZLW,HM;7:_[5;2V['V^G2+?2RK/T.%?Z63;_`#?J+S'ZS];Q>AY-F-CU/S^K
M6,:Y^?G-?94UK@WTWXV/G6YWVRW:W8S-LNLQMG]&]2M)3WGUM_QCX?U7ZC5@
M9&%9D/MH;D!S'M`&YUE>SW?\2NNK?O8U\1N`,?%>*_XZ?_%3B=_U"O\`\^Y*
M]AO%IZ58*+FXUQH/IY#P'-K=L]ESVN]KFU.]Z2FR;*VN#'.`<>&DB5SOUR^N
MV-]4VXCLC%LR1F&P-]-S6[?3V?2W_O>JO&^NX'U:Q\;(NIZW=UOJ]MH.]E3Z
MZP)/VBW)NR=[LAUCOYI]-G^?O5SZQYN3F?47ZM695CKK&69M?J/<7.+6OKV;
MG/GZ#/T;/^#24^X],ZA5U#IV'G-'I_;:*\AE3B"X"QC;=O\`*V;UR/UV_P`9
M/[`SQT;I>+]MZF0TOWSZ;'6:TU>G7^EOM>T[MC/3^G7[UY?]8NEYW1JNA=1.
M=9=D9F%3DTODM=0&AOV:JFS=N:VBKTMFU:_6,@Y?^-;!RB(-^5TNTCL-]>$_
M_OR2GKOJA_C-ZAU+KC>@]>P68>7:7,8]@=5ML:#9Z-^/DN?8S>UNUOZ3^=].
MOT?TB]"<]C(WN#9T$F%Q>3TC_%^?K>,V[.#>O?::W"GUX/K#8*J_2_E^S]&O
M-.DXMOURSNM9_6,FY]^)@9&;20X:/80^FC](VS;B,]1_Z&KTO^#V)*?H%)?/
MV!U'-R?\7_6,&ZYUF/A9.&['8XSL]4Y`M;7/T:_T+'>G]#>M[_%[]7.HY6!7
M]9+\P_8NF,S*\7!()TLIM9>]CMVVG==?^Y^D]/\`XM)3[$YS6M+G$-:.2=`G
M7SGT'H5O5.@]<RQEOHKZ973>['`)9:Z;@SU/</=2SUO2]G^&7IG^)C/R,GZN
MY.-?8ZQN+D[:=Q)VL<QA])D_1K:\/=M_EI*?_]#I/\9_5V]+Z'CNNQVY>'DY
M==.7C.<]A?6`_(_1W4/KMIM;9CLV/_S]ZY5O3^F=<Z53B4SG='>XOQ;VNKJO
MP+7;KLAEWVJ^QS-M%%C\O&>_[#F?TK$MKO\`37;?7OZL/^LO3<?$#W-KQ\@9
M%K:PTVO:VNUGHX_K/JH]6UUFW??:RJM<STKZK_6*@/PL;I%/2NE^E-U5XIS'
MY+F-_F\NRO.Q_MEM]C[/2]5F'AX?^!]*S](DIK?XT/JA]8^N=?QLOI>&<JAF
M'74ZQKJVC>++WN;%MC7?1L8E7B?XW.KLMZ5U4"C!RJ+:K+",=K0?3>:6N=B_
MIFLMN;74_9_I%WO4W=8%%]73ZK/5(W4/#JMH_1%K:G>L_?\`TAO_`*E4)^L'
M86&L-9](4"TPWW?1+Z?M#K-_J_\`:?T_LOH?]J4E/DO3OJI]?OV)U3HM/2Q7
MCVV5V7NM`9:]]3PUE6+:Y[:[J_\`#;_YC97^CN_2?IKG4/J3];<CZI](Z:SI
MK_M.%?EFYF^K1MIILJ?N]7:[?^D;_P!;7I>/_P`XFE@N-@:+;GVEPI/Z*;+,
M:JOTM[]_\U2_V?S'_#?I$1_[:+Z;7,L)=2USQ4^MHK?^E=D5>E;[;K-ME%>+
MO]2KU*?4M]'_`+4)3Y-U?ZI?XP.J7])Z3F8.YN)BUTX^0P?HF5D;XR\G5C+L
M;^CV,_X#]`R_U/5OVOKQ]1^OX?U@H^L70*3F5TC'<VIHW65V8K:Z:MU/M]:M
M[**OYG_A/T;/S^]:[ZP^HQK]Y!>XW;&T@-J+[6T>@Y[O=D;68S[]_P"C]"S)
M_P`/]F4F_P#.$/>-7'T'N87>D*OM!,U5?H_UCT6-_P#5B2GSOZL?57ZT=;^N
MC/K+U["^PTUW?:;0X&HFRL?J]=%%GJ6^VUE3G>I_@_\`#>JLS_FM]=OJGG=0
MQ\#IYZA1U#&MPAD5,=:TU6Q^E`J<U]&0S;_A_P!'_P`:O6IZX*[70]P+6>FT
MBGU1!K]6(=Z'VA];KOI_J_JL9^8H-JZZ!CRYY+;KG9#MU?\`-VV/KQV,;MVN
M^R4VLR?=_P!Q_1_36VI*?-L7_%W]9,7ZD9U)Q]_4NI9&.\8;7,W,JH-L/ML<
M]M6]_K?S;7^QGI_X3U*Z^N^IG2.I='^HF3A=2H./DM&2XUDM=HYIVNFMSVK9
MQQ]9H+,@M(]-VUXV!Q?#7,#MOM;[_P!'[?\`!?\`"HM+.IY&0ZC-K><*VJUE
M^\U`%Q]%M?H_9W>OL?OR_I_X.NK_``B2GP[ZLL^L]O1NMXW0\<95&0RBO/8U
MN^\,+K?3?C5SN?Q97=L9;_.?]=K]5_Q6_5SJ'0?J_8WJ5?HY.9<;Q23+F5[6
M5UMM_<M]KW[/_1OJ5K;Z']5.@?5]USND8OV8Y`:+CZEEFX,W;/Y^RW;MWN^B
MM=)3_]'U5)?*J22GZJ27RJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^JDE\JI
M)*?JI)?*J22G_]DX0DE-!"$``````%4````!`0````\`00!D`&\`8@!E`"``
M4`!H`&\`=`!O`',`:`!O`'`````3`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S
M`&@`;P!P`"``-@`N`#`````!`#A"24T$!@``````!P`(``$``0$`_^X`#D%D
M;V)E`&1``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$!`0$!
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`4`$0`P$1``(1`0,1`?_=``0`(O_$`(0```(#`0$!
M`0$!```````````*"`D+!P4&!`(#`0$`````````````````````$```!@("
M``0#!`4)!0D````"`P0%!@<!"``)$1(3"B$4%187>#DQ(K6X&B.4U5:7M]<X
M6#*VF!E9,],D)3=W&*C8$0$`````````````````````_]H`#`,!``(1`Q$`
M/P!_C@'`.`<`X!P#@'`.`<`X!P#@'`.`<`X!P/RK5R)L1J7!R6)6]`C),4+%
MRU04D1I4Y0<B-/4J3QEDD$EAQXB$(6`XQ^G/`C$];T:21MY61R1;BZL,,A;U
M`4B]B>M@ZD:WE"J$$`@IEC6NEQ"Y,H$$P.<`&`(LX%CX?''`D7')/&I@T))!
M$I"QREA7E@.0O<<=D#VT+2C``-`:D<FQ0J1J2QEF!%@0!BQD(L9_1G'`]S@'
M`.`<`X!P#@'`.`<`X!P#@?_0?XX".?NCNX3L8ZZ-N]?*OTVV(^YV"SC7`F>R
MAC^Z2B["^J2P5G3V/"=?J=IUE.'A%XL[*F)]!.H)3?R7G]/SB&(0+,I/=!=\
M2]4F0H=W%"U<M4$I$:-)J_J`I5*U2DP)*=,F3DZ]C./4'G#P```8R(0LXQC&
M<YX#@/6&D]PO8,$3;=]IV_4XUDUK96L$O341&-1M6739VQF<DE,N2$/<59=7
M)-(ZZ;WK!OH@:"&QPFRX03$Q;>WFF)U0@N4@VTU\[R'4!9&F+J=2-40N]<I-
MOZEVRUQMJHMBY!52#Z@F0%5@;/V8,93H9'GT%QAB=N5X4(QX+*>VUQ2JVTP(
M_>XVW,V3T-ZTI/L#JC9'W56ZW7!4T61RW['P*<^BPR9U7IGM#]!LB+3",F?.
MDDA#ZHD0CB_#Q+&#.<YX&?'_`!1W>O\`ZYO_`*S:>?\`Y]X&@Y[<G<S9/?+K
M2C&P.UUD?>K;KC<%LQ99+?L?`H-ZS#&75`F9$/T&MXM#XR7\D2<(/JA1!.,\
M?$P8\XQG@7O<`X!P#@'`1#]T!W,=DW7;OU45*:=;'_<_64HU`@-I/L:^Y^A;
M`^>G;W=%_P`3<WWZS:573:0)OF8_"6M/\J2K+1@^5\X"@F&&C,"H#KV]QYW.
M7COUH]2EI;D_:BLK@V_UIJVQ8U_\>=5&3[102P+HA43ES%]9CM&M$@:/J\?=
MU"?YI"K2K$_J><DTLP(1X#4[X!P(/=CN\];]<.F]S[<682)U05NPE$1.()U`
M$[A8%D2182PU_!T!F<&&DA?)*N(PM4EEG9;FLM4M$6,M,/'`Q]]]>U#>'LBG
MS[,=G;PEC[&G)T`X,-*1UW=X[1,$3I##\M*&(U>F<3(^2H:TYWI?5%@5KVLP
M'`U:U09^OP*\.!,?3#?[;CK^LYHM356ZYI6;FA>$#J_1-"].1M;6(G0BQ@3%
M9E?Y6`C4W8U:;(BA%K"!G)_'!J8TA064<6&R!UF[U0GLATGH[;J%(R60RQHZ
M<DG4.+4X4F0.T8LN41RPX@,0C!*A(6V3-QYC:<>$HY:SGI%>2P84!QP)X\`X
M!P#@'`.`<`X!P#@'`.!__]%_C@9_/NE]&]GNP/METUH/5:KGJQYPZ:A(U+NM
M(!E##X%'OOLM`M9,;%ERD&&:'15OQXXRH5&8,4GY`E2%J%AQ"<T.A:CTCT0^
MWQ?CVG:G;^C[8[5&J,!=OMC)*GNN^:TUSF9WS)"5FB$4I>O)>9`7AK6D!$I4
MO*IMG"Q'C!A'TA&O]$05^7MN.W[/7*_60I]VS;]?/4V=$R1FJ_6W3CLYI>M&
M$HPW"1DC$*K:M5#6ASZ`3`)P'J,+GEP'@(UBM6I$(T07V=?_`%3[U4?>VL6T
MNQ_?AMS;U(KI,VN#!KY>#KM)3RZZ9$^M3B5%*UEE:[*W22^(%SBH%E2:PND9
M&['!2^F%*6+/JEAUWW>7Y-LT_$!1/[<=.!E"\#5Z]H;^3;"_Q`7M^W&O@,_<
M"LCM5[4]>NIG77%Y7<4Z2N22AT416G:>BZA,FEUJ3,E'\Z>@2+5@#DD=B["D
M$!0\O*@LTEO(&6`!2E8H2(U((3W7[S+LZG4@4'4]6^LE%1$IP6'-325"I-9<
MJ$VFF&?)H))*I;+"F1V4(R,AP)0@8F?!IF,B],(18+"'-8K[POM^C[XC=7D_
M6*<MR<6<J(U):46(6AP`+'AY5"J&S:*2`D0/TAR2M+QC/^U@6/AP&_>CWW&U
M4]L4E<=>[)K4G7[;)ABJV7)(XAD93[6EMQ]E^1+?W"MG%T^1DC=)F?YH2M7'
M%9*TTAK+$K(7K"R5F$@*P>]6_--H/\`%6?O%;5<!='K@G\-JCL/T+M*QI"WQ
M&O:UW/U<G\[E;L,PMJC$-AMX0:12B0N9A19IH&]E9&X]2=D(1"P65G.,9S\.
M`SONI[S+<>96J]H=&ZSJVF:.9G98GB[S:D3.L.VINVDY$G3/,I+,?D\,B9+D
M`.%(&I"D5'HA#],;BJQCQX$QNG_W<EJVYL-`-;.Q^+5>BCEM21MA,'V)K9C<
M869$9O)W8M!&$-KQM0].\=/A;JY+B4&7EO`UX9<>F>N+/3Y4JTP=T][M;"UD
MU6TDI$E064CLB_+"LU:GPNP2H5"IVOT<:2XPWX%@:U&2.[!",,\,@(-]+&?B
M8'@9O_`U5-:]0Z7?/:@IJK>8)$3FF7===J[!GJ,,9"HTFXWJOIA<<>LPPQ5G
MYM5,HU*A(3B5(C<"`%$6F+$!*`LH(95?`TR_90390Z]>^SL`4.'S((=M^YR!
M$A,RJ,.;44VIZK4WD*&:,28IO5+X@H,+)*P'RGY/,%CQ-QG(>?VY^[=@FHEL
MS76O12KX?L+:-<O#A&+!N&R'!X^X^.3!H.^4=XM%V"(.K'*++4,;@6:D<%A;
MLRH251`@)C%H/$T(+EKO=\]QJM:L5)Y1KLV$*52A02VH:+;S$3>4<:,PM"C,
M<G]P<1I4@!8++RH4'GY`''G,&+Q%D)W:<^]/V=C$RC;)O+KY5EIU:,P"*136
MAFQYKVWVP@TTO(Y`6PR28OE=3!0C*P/&&TH$:`?Y@Y^;*R#/J`\9:>\\%5=:
M5U=B.K[[$[>AT7U`NC9NI%ZL2\48E2RMJMELW;&"3I$:AM?6HQ/(8T)K?&X0
MTCFVJB5*4[!"HD80`AW_`!M&_7^E'4#^;W/_`(H\"R='[P!;#NNF.WS:%%5P
M_;J6S:=G1&J*/@CG*H]6S+6D&0Q1*GN6R7%^=I/*/H:F6/#@WHT2(TH;ZK:E
M2<D]'\JJ4E!Z_4U[CK>;=*M>U"UKJ@VNA.=+M'+0VEJJ)P*%SB-LZ^80>.R^
M0M\=E:UVLB3O3C%U0H^40:$I0G6>F(0@GX%X9P%8/\;1OU_I1U`_F]S_`.*/
M`DJ^>\RND.B^9BAH^A2=W9C?T]@<>B[>3/CZIKBCHE7M4/J"T98R.$P.DDEE
MTNFDV=FMH1$.B-#@#.>H4>.$^$ZX*ZJQ]XQVOQ"9-;U8+3K9;<1),"6]0ESJ
MY=#\N"(9I0CQMDEA\F;G)G>`$@$%.>:6M2EB'D1J4_PP'`:*77'V`4OV9:GU
M_M;2/SS<RR<2U@F4)>323I%6=DL`$H9;`'\Y,$LA4J:35A)Z54`!8'!L5)58
M0%A/P6$)T\#_TG^.!71O!.;NDQ+KKIH1LCK12?80?#XU<$?B^PL37RE!.Z00
M/DOC"PH*9IR8^HF=-+?4R:[H&Z1Y9AA](]O+^J$*@@M*CT"[G;$M2P(`FF7M
MCIM<T1,02.V88CH-FE-J1;[8F'.#?(+`C)>IJF5,YDH&(T].I<RR?GQ>881C
M\<BX'Z-R.T7K_P"EJ"LU8FU;IAN[VNQCYEX<WNB-6*2H^K:`G!J`)+87(GZ`
M,!K]&RXRO*R86RIG53+UWB:8L.9"%2+!0+F]>G8MMWV0=]?7_;NU]LO$Z<2-
MB$_V.A2,1C-6-8M*]J?#,Q^N(*F.&TQUO`2224:HSZ[HX8(+,7JU:C&3A`X[
M[O+\FV:?B`HG]N.G`RA>!J]>T-_)MA?X@+V_;C7P&?N`F-[EKIF['^TS:*@9
M7K`UUH]4?4-!F1X":;6:WPYP0VM*K#EKE.CTC0M2*,FHUT1:(L'YD.<8,&0(
M&?\`LN!3YH1[0W<X&W-+JM_H96@]0VU\>':YFZOKP+/ED@:VJ*OSA&XLA^SJ
M9N?D[?*)LF;&]R/1*D:U.UJ%)J<\D\!8\!5S[C;5OKTU`WW;Z=Z[E;6DA#=3
M\:77#!(_8TAM2/UM<ALCEJ1RC*65RN02N0)W11$T;4O7M:AR5Y;E*K(0Y)P/
MY4@(\=#4T=X%W%=>3XR'J$ZQ=L?$86<8E5#1F":+(3N-=R`@1I81B&G4L,I4
MEG%>'E/*&(L6<8'G.`N.]ZM^:;0?X`*L_>*VJX"CT8CCO,))'HE'TAB]^E+X
MTQQD0E!&,U:[O:].V-J0H!0##!F*5BH``X"$0LY%\,9S\.`Q5W?^WQD'3]3F
MM]S(+V^_*.6H\"K*RS#8<5$"H;;Y,6-E28F,BP^.JE[A\F0,[QE()04G5I,-
MF/6R/*@."P6[`,98PF%B$`8!!&`8!9",`PYP((@B#G&0B#G'CC./CC/`<5]T
M;?+_`+#ZB=!5G2)8E<W:QM+I7;TA<RQ!,6*9M9D!U5638E:<1DM$(21[91`R
M`LDK)9_K8SXX\H0`G1P-J'ISCS!+NG#0&*2MC9Y/%I/I144>DL:D+8B>F"0L
M#U7B)M>6-\9G(A2W.S.[-RDQ.I3*"S"3R3!`&$019QD.L?\`*=ZLO^FGH!_P
M;ZZ_X<\"-'8O]PW5#U7[Y73J-2='ZN.R&GWC#.?1U80&GD!ELSS*"HJREK@C
M@L<94+S((_*IJA&B$I+,&,98"<""$?P#&A..-4&FGGFF'GGF#....&(PTXTP
M61F&FF#R(9AA@Q9R(6<YSG.?'/`=LZ<O;MZM;O\`37;^VES%33&Q5MH[Q-UJ
MFB:5/L<BE5%5`-ZBT;=3(TV8,:YNCD-F19R)?Q.)"W`FHO"=O"A6%C6#!(_@
M/1>W_P!@'V:^WN[W]<WAT5.2"A=<MFYU%B%CD-7EAC][ZEVV4>PMB$S(LM3+
MF4U.YN(0`\"C5SDK,P'U!&"$"+O`G3HIUU[D]EUEK*FU*JURLIUAS2C<9:^.
M3VU1F!UK''1S5X2+91+9(N0L[.2X.`E9J5`0(YQ<!E*1)$IXBSO*#?G7[TJ[
MP]6^D7>/8&V#)6K/'[1ZJMF(=$LPBPD,T6J'AHJ2SGI=A8F1(D^$24I%X>`Q
MB_6&+&,8S\<X!!K@,G=.OMXY?VQZ?[0;.MEX%U>YUC))%5E'P\,3#(DMAV[%
MH+&K"<$,T<,NR!9'(>M1S%I;"E2(A:I`I6G*?2-PB^45`MNH3J$:@](K(.2J
MDIQJ=2F4%#(4)U!`Q%'$'DFA"82<28'(1!%C`@BQG&<>/`?L]C]=+[E;OQKL
MM<#CHT6EIFZ8VU#&L$G;GTXV80:;."<OSB0$G/*`B/EG"\H#C`H"L>(P@\`!
MH#<#_]-_C@*\=K?4#?.^W;%J-M(R7RY:E:\ZOT5%/MAL)#Y8ACULAFQ5RSYW
M#!JD-&H]./R9<R.Q`3GMU+$U(2UY>,)W,>1H1!/RUW2:;>03:_3=.ZW7HRPO
M<7)CU:[XQN_-19#,KA>2AHVUQ>DC17]PR^U(BG>OEP%@(5-,?7*H[ZA)*Q@4
M^@B`&5;V5=7VV_5Y=RJJ]G(B8-M?E#@OK:YX[\^[5A<+,0<'*AXBDE5)DYH7
MA)D\&7)I7`3NS<,T`CB?1.3GGAV/H(_.2Z]OQ`,_[#?N`_Y[O+\FV:?B`HG]
MN.G`RA>!J]>T-_)MA?X@+V_;C7P&?N`J)[C/W!<GZOSXGJUJHU15]VSL2&AG
M4AFDM2%2*,4;`G58Z,T>7`C`%`$K]94D6M2I2A2.6<H6]$G*5*DJPI8G+R&?
M38?8AVK[\SY'7DKVJVWON6VN\$1AEIF'3B<X89<\OBT'RT>C-(5P:U0PQ0XK
M/($"1`S`P/TP!P#RE@P$.7[J=>NUG7H]53$]N*\3U5.;?KO[THY!3I+'Y')&
MJ'FR!VCB!3*@Q9P>6=B='!8RGCPWB5C7)08P%64G.\2L!VCI2_-PZY?Q?T?_
M`+[-?`N^]ZM^:;0?X`*L_>*VJX"X/7M_GZT>_%_K3_?/"N!H>>]6_*RH/\?]
M6?NZ[5<#,$X#5_?/&\%]4/MN)>2G7#RKTRL:-N*O`!C;4^&Z(:NNC*G$8$KR
M$+EF71>+`1#\3BR,Y"'^3'G@*H<#9(Z[[2=Z.]OWK5=<?;VUW?Z?ZSVBTF1J
M><*LM#F[U_1:N6-K>ZX1*$JW+:M6M("S_1-+-](0O(,(O#.`3T_C:-^O]*.H
M'\WN?_%'@2&O/N8O7N#]OMW$22[ZMJ:L55%2;1)DCI%5%S`"=W3SW:^M5[B:
M]?:Z320S)R,R+$X(]`10?*8/S8%GR^`(><#7X]KH`!G1+HX68$(P##LV`8!A
MP(`P"W"V#"((@BQG`@BQGPSC/PSC@9`_`;']NF!;GKX]R,86%5EN#UE2\"H8
M`F_)!6CI+;02`*@6,>AA4,@M3DG`OU\@";Y?A@?`4XX&FG[)Z(,J+KFV;GI"
M1."127=>21!T7!2)`*E++"*+HUY8$ARX!(5RA.B76"Y#**,,&42)08(L(1&F
MY&#$W;%^5EV6?@`W(_=UL;@8@W`U._9M_E'R/\7]R_[DU#P,P2V?_52R_P#W
M`F7^\;EP&_?9+_Y^MKOP@*/[YZNX&EWP/__4?XX"TO=/O!UQHMA*XZM>TJ"O
M"?6_9^FXW9D;O5OET@8V:KK03V?*HLR*I:5',HG&,MZ,V.IE">2^JL1MV1GD
MN*7#6H6G!"@'L0Z?M#]&)/$ET`ZAMW-UJ$LMK0.U:7[J_N5(I^S/!*QK3N@4
M<IBD6H65.T-6*4IWS*!0(]:T.R$03D:XXP*DA,$T:6["*;VOI6#=9>^/3=V:
MI-3G1*.)L-\7Y&K6V4G%.NIV%*"'2A1,@41$;(8@PPAU4)T<D1J')W:$0@IA
M%'MV30%!`ZM>@R^^J+N^Z^[(BBATN_268;,,9%>7HB3%JGB&F.C,^?281=Z1
MJ0I6V/R@W(\%H79,`+(_`\@T^4RH9K<F"_KW>7Y-LT_$!1/[<=.!E"\!F/JT
M]S%>O5MJ@UZH0/6>I;4CK3.IG.$\KETKF+*]&*)FJ2*U3><C9@FH<DHCDV<%
MC#Y1""+PSCQQXY"QG^-YVG_T/Z__`-H5B_\`<<"BOW!5K2R]NS^R;KEC8J9#
M;>U]T7M!J8LJ')4QL:*PM'M>9BZ-$2/<OUC8ZWRYZ<RPB+Q@`U85`A_RV3>!
MRSI&VSIO1OM)U*VAV"-7(Z=KB33U%.'=N95LB4QMOL2H+#J]%+LL;6B<GAT2
MPYXFB9T/)0IE"\1",?RI1BCTP""<?N;NR?6KLLWGK>>:F2=RGM/5)KU&JR+L
M!RB4JA();+E,UG4WD"AE8)NV,$K(86A'*$*$(U[:@/,7IE8@`,3?+G&!7]TM
MJTJ+MKZXSEBE.D)'N/0B0!JDXL@L:I?8+*A0I@C-$`(E"U<I+))!C/F,-,"`
M.,B%C&0O&]ZM^:;0?X`*L_>*VJX"FE=3N0U=8,$LV(JQ()774RC$[C"X&1!&
MBD,1>T,@9581!S@01)G)O*'C./CC(>`U'[B'W`=(=KNO.KM`Z\0&Q(LRQ:6)
M+ZNE38J!L;#&BSTL+?H1'X%%?I+VZER!OCR.:/IBQT-+3@48.2>@'&?F`A!2
MK@:$WN.-))1$O;^=7+T7&57VCT<BNM5<VB%,B"C*C+#.Z"8:ZF3^\IB!>@0<
MMN2-QU&:(6!#$M<_'(LB&+(@SV>`^5K?[C#2.L_;W..G\N?9T;N=&M6K9U2C
M%2YA$N>6Q^52F/3"%U[88+!^63P=+7K+'Y`@-<D1[LC>4^4AZ5&C.+"G.,!#
M7@/%=2^@LMM;VM_:R]9B*K,@V,D4HLFM0DD*BG*>173(B!V#'<M!R7!ASF$R
MUH))FI(E"#P-7)S2A9\#<^4$=>`^YTC=]>G>GO2#:]"7;9)<=V%UL3WR33%1
MF-TF"]7"DMAP?9[7Z:&O+8U.+868IM&;.*%S'DTL3(E*PO4@"G$$T0(1\![K
MH+US>8![=;O&V3>FTYM+V*UUVNB45,4)TX!/L,H75&U$94@1J"R/F#VW,XLE
M_;0A,.%@M2V'^4LOS9&<"(O`T^_94_E97Y^/^T_W==5>!?\`=L7Y6799^`#<
MC]W6QN!B#<!NGH4]PM2O5?HMM/KC;4$LB66"MG$OO/6]3&$3<ZQE]G$J@$(@
MWW=RY8YOZ(V%L:-]A:-WRK(1*RA)E+D+(1*@IDZL%(G%P6NS@N=7)08L<'-8
MI<%ZL[.,FJEJPX:E4H-SC&,9,//,$(7AC'QSP'W/8^5`]9>M_+\5-YA4=`UT
ME4#"ZC^;"4O>C5<YF<L;TW@7A">8TH264P_Q%DTK"TKPQ@)F<Y#00X'_U7^.
M!FB>]H_S]:H_A`3_`-\]H\""72+[B.\>LEU:Z(N\Z77EHR]*E*9?`2G<\VP*
M1R["\%DEHUX6N"03>VA.&-2KC65*9O4GC,4)#$*TTY0>#"^RFBMF6G4\J[(-
M*?<A[_PGKR>F/$\(0(Y_O9M8^U(E$<:9*F5>54]K+K421^!>?&'$A]8_K$9)
M)."\G^*<U3D+0^D.@MS:284=UVKVX3C>S4F_4Z<,*9]K:4V,KNU1S)=Z"*&O
ME42G:>;I;,:8_*`%XP4W#;%30^$#"I;R\&F95#"2_N!]$[^[%^NN2:UZU-T7
M=+/<[8JZ7I4DODJ:)LV6:)N:Y4[C&[JR3R0*`$J`^F7Y?$>?AC@(=_PAW<E_
M4J@/[=F+^C.`?PAW<E_4J@/[=F+^C.`?PAW<E_4J@/[=F+^C.!?GW1>VSO\`
MVYUXTTNO69-$U^X6O.HE'ZYWK3*Z2LC`U6XCJR#MK8VNL!FKKEKC(9Y%WHY<
M@,R\K$B!W9<)?35)3$!9"\%3:[]N)W0V-,T,+2Z.6!$3%*CTUDFL21U]"H8S
MI"U)2=6Y+I&\RTI*K3I`F^KZ*#"Q:H+"+*8@[./+P+G-G?9S;:0^D]66C6)_
MK6X+T/;;)>-MY/(+`S!H<V29R,@?W>Q&K$+ZT)U;I#8VB3NY67!242XN"L1J
MD\I*4<E1)0Y7J![7;N'UNVSU=V(<*\H9S04)L32=T+6U/>C`8H<$E6V5&9PI
M1$`$WEA&<K)8A%AQD0<9$+'QQ^G@7"^Y+Z*-_.SO>6JK[U7CU8.U>Q'5"#5"
M\*9K93;#74$R8+?O69N!"=L6(U!I[>%DG[<(!^!8"(P1@/#Q!GQ"EO6SVB_9
M:BV*H-9L;`*66Z])+JJQ3>Z-AO)L-?5=,D3EB-M!,RE(4!2TUV/A`%P$P21!
M-$=D.`9P+PSP(N;J^UM[4=:+=D$<IND'+:ZFU3TZ9KFU:B=HZN7N$<PK/,9T
M\[@SHYL\JATN(:1$?4`82*&?YL0P(EZL(,CP%A'2U[5[;66[$5CL-V)5XCHO
M7^JY8V3HFFI(]Q]\M"ZGN+.*5RCT<=XW'UKZAA5;JWI'_P"="=STSLM1D93)
MD6"EH7%.&BU=U+UKL74%DT1<<70S2KK:AK[`YS&7#`PDND>D*`Y`M`0I)$!4
MVN28)N#D:Q.,M4B5EEJ"!EG%@&$,UC?7V>F^=,S22/NC[A%=M*:4+EBV+1YR
ME\4K2\X\T"/":4U2=NFZZ+5[)E38E.\F%S6[%G.62!C"VI1C+3Y"H`?0-W)@
M&(`NO>_LY`(0<Y`U,)@,Y#G.,Y"86_B`,/CCX9#G.,X^.,\"VW0GV?W8#=LY
MCKUNR*+ZBTHC=&M9*6@$SB-C7C*V`0B5BIOA;+`7"80>,+%Z/`TPUC\Z$J6L
M\P)F6M;Y!D<#2WI2E*RUWIZN*%J"*-\.JJJ(6QP&$Q9$$1B9NCC`WE-R0I2>
M?DQ2YN"L!>3EJM0(U2N5&FGGC,.-&,0(2]N'M";<<+4FU\=7JR&R6$39V>Y4
MYZJS*1-$`D$'?754H<SV2G9:\A;("Y04Q2<,M"W/:YF.9BL%$X5+2\Y&0"X;
MK[?7N;9G):U+.ON\#E2!08F/-:@PY^;3#"L^`A(GECE3BT.2?.?]DY.>:4/'
MQ"+..!:#H7[0[L0ON<1AUW$1,.GM'!7$+)7E?+8C.KN?&$)9:C*&$PV&.$JC
MS&[.8L_+9/D:]`-M\1*!(5>2PI3PT%KOTECT=ZK+_P"OW4R(,<6;'#2"]-;*
M0BZI8G:FO+_-::F$*CBB2/F2`A$X2*5/N%KR['@$<J6JE"P_(S3#!"#.7_A#
MNY+^I5`?V[,7]&<!VWVVG7+LOUB:-6K0FU#7#VFPI=M?.;>9TT*EB29-0X:_
MU!14,;SU#FC(3E$.`GN`.(1D9#D02PEC\?`>/`+#^V+\K+LL_`!N1^[K8W`Q
M!N`PMH;T+W+V9]8,SVRU(4M;_L=4FV]I5+(JBD\D;XPALZLFNFM?IK&2X.^O
M8T4999XPR:;.WJ`=5B%"Y(U@<"5$&)"P*0YK4_MN.YRV)TUPDO2V95T2N5%%
M.4VMB10N#P6.(1*2TZEW='97(%*]P2HL&^H).U)')Q-+#G)"8[./#@:=_4)U
MKP[JKTE@6KS`\I9?,S')RL:ZY^C291I9S<$L2-:>2.C:080F5`CK*VLR%F:?
M7`%2)K;$XS\8/$9P+/>!_]9_C@9HGO:/\_6J/X0$_P#?/:/`4LU\USO/:VUH
MQ1^N=72ZW[5F"H*9BAT-;1+UPR_5)*4.CFJ,&0UQZ.MGKA&N='`]*VH"?$U2
M>47C(\!I+]5/5_L+T&ZIV9=4J2[';L[*7<VMZ,6C>K2HE;1T<DN"P*FMUD;K
M)AM30JDS40B+1O,L%D@HA":<A0-[QY2C3PF-=.AVSNZ^W_5KV4,UDW5`XE1,
MVC#_`')H;?:5)7S950@HY*U/TS@$.8CG&/YL%H6/(TCB8M<7DUU9BRAMSL82
M62D."]&R[KBM5S37J"R%OD"QWV4N!ZI2"J&9*W*&YIE3%05X;%JW"6'+G5N4
MH8^9":">$I9J,E>IRZJ490B`IS#U*<.F+WQE:E+<C='AK;5CPHRD:$J]P2(U
M+JJQDO&4S<0H.+-7*,9-#^H5@0OUL?#XXX'):8OZ!WD1,QQ/+DW+8-:5OU0Z
MLLCRS(WM4[TI8SS5\KD#8W-KR[FGQ%9)6,S*%69Z)IA!A?K$D&BR4$.K%R%@
M.$\`)?&<T<>\?KX"W-$,3'X%&'Y^L!"?G+9X$%"'_+>3]0.<_HQG@?XAE48&
MH;$@)&PC5/8E@&9,%X;Q*'<;>,92\+83A1DQ>)"86()V"L#R4(.<"\,XSP.6
MU)L74=UUSBUH5+&_[%_;2=U^8YO2I"T>A*:[G<AKN0-RC"A7DLDPR01H\23`
MAX$I2&$G!#Y30\#K2Y_8FPX*9R>FEO4""4,)"YQ1I#A`4?-Y($$I0<6/(3L(
M#_)GP\!>B9X>/D%X!Z`5"<2@U($\D2H@DA0<F":#*@E.J&H*3'FDX%ZA9*@Q
M&:$L6<8",10\8SG(1>`022;]PE1,VM&?4MOM],/VQCIJ@P[++2*[Q5#K=[5)
MWJMQ-1;2FL)1:R.'NMU,*B`MSZICI*-=+O3*+Q].4)7-0$WP/C*8X+F@MX:S
M'5L3E*W)L`X)!.#>E/#@9*E<B"=E2D3G`SC(1F!"$6,^.,\#\(Y?$R_0P9*(
MZ7E2<%.FP-[;0_,*!G)DP""/,IQZIPU"TDO`0^(LC-`'P\1!QD/04/+.D<6]
MG5.K:F=W8*D;4UJ%R4EQ<P(BLGK!-Z$PT*E8%(0'(S<EA%@L&/$7AC@?A6RR
M*MP'`QPDT?0%M)9!SJ-:\MR4#84J7&M:8UP$>I`%&6H<B!IP",\N!G@$7CQ'
MC..!R.4;%0=A?+AAK(B?+`L6FZ+8+_<ZYAAT5Q)Y?$9<=:*.)-$*52V412**
M9)(76I7!(5]2<VML3&JD0U:U.0IP<`.U&/+.4Z$,9KJVEO:I*-<F9S%R4#HH
M1%"$`U80WB-PK.2EC!G`C`@R#&<9QG/PX'\HWQE<52E"WO#6N7(BRSEB-&X)
M%2I(4<8<24:I3D'#.(+-.3&`"(6,8$(L6,?$.?`!:^,K:M;6UQ>&MO<'HPXE
MG0+7!(E6NQJ?!65!3:E/.+/7F$8/!D82@CR'SA\?#QQP./TUL'!KV>;H:H*G
M>#$U'VP[TS(WQP%'PM;Y,HZT,SE),1M.VR!S?PM;$O>,MQISHB:QJ%J4\24"
MA+@I2:'R55[<U5;^P&RNN,7*D2>;:N"KG[;/#N3'R8?*2;&8G%W+5UXYM\C<
MG)]2PIR9U3+(1*D2#Z8^)S$F<&"!D6`[WB:PW)>#L2V,Y*$[$,`3</S5DL3Z
MI*R>F9<#PJ\N7903CS@3>/K##\<!SC@>EA\9<N2EFP\->7=$C"XK&K#@DRY)
M&\><!"N4H?6^:(1B$+&,&C#@&<Y_3P/F\3E*?-F&'MC,Z/2)YC<Y?5<W:5\3
M4Q*-N,(>8$S_`&/?BQR8F7?:B3XG)BIOPB:5K>4G9%^'!6A/&W$N`>L=+XFG
M9@2)1*(Z1'S#AIRWTY[;2F8Q06H-2#(`YC4A1#.`K(&5D.!^;!@!!\/'&<<"
M(79K$Y5/>MOL&@L%C4@FDVFFD&U\3AT.B;,XR.52R52.AI\SQZ-1J/,Z98[O
ML@?7=82E1(DI)JE4I-`44`0Q!#D,>7_E.]IO_33W_P#^#?8K_#G@:+GM%->K
M]UKZV[M@NQ='W!0,V=MW[)EC7#KKK2:57*G**KJ&UK9T,E;X].F5B=UD?6.[
M$N2E+2R1)C%*,\H(\C),"$&G>`<`X'__UW^.`I=WI]%\_P"T[>RB[QF-U5_K
MCIO1NM!3%=EM21T1&2LDYNL:PY<[MD38W`:-@;RT;`XIC%;T^+D+:WE*/5`!
M<,DU-P*]H/V\]3/49%ISJ%UO::;<V"WJ&$49G^[M?QB,,MG65-$Z0QL52YIF
MMMP>0JI82TJ@C4M_K1]#$TRTTX;4U?)F!-/"FU%9/75L9;)*)%IYWV6U<MMR
M[(2RP[4Q:12^:S"1+<C&,9@Z:-5+5RU4;D8S!YP$`<9$+(0!SG`-XZ']:.C_
M`%D7%K#=\GL/<6F]J=AQ*ZNA>JUB[5EWL0Y*IDGP8N9I^W55!H_&7]MA:5(4
MO<5RA8IBK:Z)R,%JU:KY'U@M4W_F\+K.VNKZP[(E\7KZ`1+?>;*Y7.9N_M,4
MA\92N_6?V+1=I4R&3/RM`RLJ=SDS\A;DXU)Y83URTA.#(C3BP""N[LGO6@+6
M56$_5K-]5EZEDH'7B<1?8`MP2W-95F)F7::PU^:XUF51J<QYA@XJ8DU7&R&<
M2ML4OA[.G7MYSDVA)0)E1(>?K^=4:RY4#)5*>$I-M,=U&W<PF7R[<D!9ZRCL
MNE[G3J8.*GY8YYQ3KI4#FD:DSH?DN.J7X]$B(-R[F)0"#F"QI@#WJGB+U6@A
MJBS&/H[WVA.^+5%6T/WA)KU<X/0P\QC8(Q@)+>D]XN=RJ+"7)2Y,+ZPI4G2A
M4E\QBE<:8':=UPTA6EV0ZMHI$=6-=T-4;#]49#"C40L9E\6!7L6W1JZ:G*Z*
M;T4BA4=I37>G8Z^2H$D>D2!^;C2E,E+6%-N,'*5`>!J^#7"(D:[XN\VC(]KU
M$99W1UM:3'8Z:)I*]9=IG[=6N2:ZB<Y;'E)]DFNUU>N2:<HT+>[>B\*(\L4I
MTQ)B8\P'`['KCJNTWJQ2B*6K%5B*Q))TPZ2T?&K$F#(I!;59-5G#WQCKND3R
M"5,IDABED)&18TYD@@$@5F.B,O*H)OIE8X$N^LF>S78NL9EN-93`LB\QOUTA
M\:2Q9W2K43Y`H]04):JNF%>+TBW!0DZ=HVA1V<ZI`DDD)QIWP)I83/4RH/#C
M6N6VD'JB"Q_5!/'6&5[:MFZMC5@_ZP@?"F*PF.NI5N//9,X[6+8^8P.ST53J
M'7U:;9K3(3F\AH?5/RC-]11.RW_PX1KCZ6!FR:IHS#@H<[813=GL\DFVS6W#
M;RKF*IZ75AOS]/D=I)%:4F?*-=I;-GBHC8.)>`"`UK^QH4.<I4J4L`<(C<>U
M#JN/:!,]\Q>FH3%WOHONI80V3^,1]K9GNT)OC3\Z;C3I')N`E=KBGHG1QR8`
M`3)(]F*%V"L*!C5>(?>LC3E'`I5%MG&^/N^];E6?6&LU?;9XG3.U]'RR,UK3
MY'U*!N3B$<B<?L)M<WS9WE"IA4'E,R<2UP<QDIS1F##LD\::<K=*IF$J@&LD
M0E=E]F^PZU7L3M*Q*S*NKMRAL=O-/$Y3,6]*^P4JSWPV+JW!DB$?=I$RM@'%
MV,<4JD+@E3E*0C=4":NE>I&UPFLF"J[)>>A"&16(C:8XWQR9.['6;MO[!++C
ML6C*GU9<U,M?OPX@SO;($1GV>599V]<$LX*,'`E+9`(23L)L"P2IOC:C;]^[
M2]#)=01"=(W@NUUUK8&;20$UE56'N6$\PQ2D4J=):Z"6*6P0&,&0S!*9ZAJQ
M:!6'I:Z5NP06Z>OF2Q&!,\.?)E..SDFR9!'(LBCSM*DCW.'>0>E.'5L0I%CX
MG=WR+M2[RKS#0J%;<D._6,3DB`'K;OGUFCF>[K9/T4;-VBF5%TNCT(PK1$?>
M,^2YO+F^:6044O5`*4K9Y#-MQ*79V3M!HE30E4-:]W"6W'(S!!);19LB%5,N
M_,O5,#/"VHG>39F7R1U2L:5F^<9&A)'',YY6FIDJ<;@G3IL*3`&BR/'ZP\AS
M\1>(5STY&=HZD'K=?MU1^N6F&;4P7<.(O3)&#K6569"YEO,GEN^S"5=14H(!
M%TYU=SRMSJ^:AIO1*0JY,0VI4^"#2`)@YP^ZQU`QUCLGEBH6`M2MI]O?4SA'
MCVRMV1(O0V$>W;4.JYW:U:9H`L+GQCPVMZHU:6/ZIE622;DSU,`%P.HQ&,2<
M>P3OB=6=6!MWL6V?9=(9/6%;4+G.S.*)F<-VK3T6IV:NQ]OC"T[7!SI@=5',
M9[;!/`U];(6SE&#)1*UA8?;3VL$T+UOHF.5A`1,:<WI?WE5/C#"(TO(>WQWD
MJ?KZ=)N!&ECJ/ZR[VK.4A+F).=G(G1R>1^J,T1V1FX#UK4M+1ISDB6.TA']5
M&6M9!/Y1+GO9*X6I%9&E9=A1[7ROX@Z1.HJVA=BQZ$V9?DBIV2(VPMJ*4,8,
M-[8\"]5:M2Y0*0G_`-6S@YNG6=UZ*WY6L6R/&DFK*.5'.9IIKN7+FZD(0W2Q
M&^Y49RK*D#=(TJI.X%'^"@A84:6;@)@18P$[^`<`X!P#@?_0?XX!P#@'`.`<
M`X!P#@'`.!\_*V$R41I]CA+_`""*FO;6L;"Y)%%:5!)6,2LD1.'-B6KD+FC2
M.B3S><DPQ.<``\8SD&?T<#P:LK*&TS7,+JJOFL3/#(#'6V,Q]$<K5.*W*)M3
MA)^==W9>:H<WU^=#\#5.#@K-.6."TXU2H,,.-,&(/ON`<#EZNH8:MNA@OL\E
MPS84:J^7U"UJ`KQA:@0V;RN$3-]).;/)Z1S@8]U\W"*/R+`BRPF`QC.!Y\`Z
<AP#@'`.`<`X!P#@'`.`<`X!P#@'`.`<`X'__V3\_
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g22611g47g81.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g22611g47g81.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0\44&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@`````````````!1P```B(````&`&<`-``W
M`&<`.``Q`````0`````````````````````````!``````````````(B```!
M1P`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````#'<````!````<````$,`
M``%0``!7\```#%L`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"`!#`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#TK/%!]$W56V%KW.8ZD.)8X5V>YWI$.]S-]?\`QCZUGXM>'LI9CT96
M+6_(L-C+#<QSB*G[G?SG\V[8ST__``-:^0+#2\56"E\>VQPW!I_>+)9N_P`Y
M4F#(#\;ULEF2[UWP]C`P`>C9#(%EGT4E)/LF+`/ZQK_PE_\`Y-/]CQ9C]/\`
M]N7_`/DU:]W[P^[_`&I>Z?I#[O\`:DIJ?9,6"?UC3_A+_P#R:?['B_\`#Z_\
M)?\`^35KW?O#[O\`:E[OWA]W^U)35^QXLQ^GT_X2_P#\FF^R8L3^L?\`;E__
M`)-6_=^\/N_VH&79<R@BJ'76$,K@?G.]N\Z_0K_G7_R&)*<G=FV9.2*<6QF#
M2X,HRO7LN=<=I]9WV5M^/;0S%R6^E_A7Y/\`@E8H^RLI8,ZY[;C(<_=DT5N.
MNWTVY-I_,_X5:=5;::V550VNMH:QO@`-K1RGAQ!!(/R_VI*:&2.F8E;;<FRZ
MICG!@<;;XW'Z+='J=5&#=6VRIUSZWC<UXMO@CR]ZC?TK&%^/FX]5;<O"%C:(
M&QI9;M]>EP;[?TOIU_I-OZ)_\CU:[;=%XOK]1ACD.8X>YKA]*M^UQ][$E-2R
MFJJ[&=4;@?6VG=9:01LL_-L?L>M%5,N?4Q9(/Z<<?U+%;24__]#O\?).<.JU
MO:S.IJR#0W&ECA#:Z?5HL:^NO_"NM>YMWK?\9Z>Q-14RM^.T=-;A`9%GL;Z4
M._0V?I?T)_PW^?\`Z5+%+IZNZ^ZW&I^T17<]Q&QHJH:Y]/VCU*JZO7];9M9Z
M/_!I\=^.]V.:<]V:!D6`O<ZMQ:?1?-7Z*NO^:_=_[<24Z!:V!^KSY0S33XI]
MK=Q_0_/V_P!Z6D#]*?C[?_(I])_G#\/;_<DICM;!_5_'3VZ_BD6MD?H)\_;I
M^*EI!_2GX^W3_HI&-/TA'^;_`.124L&MD_H8\_;K^*JM8R[+W"N68GL],!NE
MKQ+W.UV_HZ'MV[?^Y%BL76BFI]NYUA8)%;8DG\UC=/SW>Q0Q:C5CL;9:/5/N
MM<V(+W$OL+?;]'>Y)20-;(_0>&OMT_%(-;!_01\FZ_BI:2/TA^'MU_Z*0C7]
M*3_F_P#D4E,2UL#]7GRAFFGQ5?(JLKL.5107N@"ZH;/TK1[1MW'VWU-_F_\`
M2?S-O^!LILZ0/TI^/M_\BGTG^</P]O\`<DIIOMIN&)=0!Z=EP+7MB'#99[M%
MH+&ZD,G$NQK<"AV9Z^4T6T>HRMM9++=V6'/'T=W](J9]/^>K_2^KZVGC/R7L
M)R:FTOG1K7^H(_K;*TE/_]'O.G[FY?7/LU338,IA%3H8USCC8CMSGL:_^<_?
MVO5@/SW6XQR::J7>N^&UV.>"/1LV.W&JK^U[4>[&PJ*,AWI>DVX^ID.I:0][
MM!ZCO1'J66>U4L9F&'8_V8Y&S[19N%QOF32_=M^T^_T]NWTMOZ/_`$*2G3FZ
M![6SW]Q_\BGFV?HMCXG_`,BHEM<#5_WO3[6%W+I^+H24O-T'VMGM[C_Y%(FW
MLUOGJ?\`R*H8/5,7.?Z=;+6$U-N.YP.CS]']%;8_^U_,_P"BM5FR_%99Z1>X
MVAI?Z32]S]O[QK9+]J2F%Q=?EUXYB*8OL:"8.KF8[7^W_2-?=_7QU8FZ/HMG
M^L?_`"*QND]3?D!MM]3<1^7:Z<>ZTB\$'96Q]=?J5;_L]37_`,\K_P"T.F2:
MZ[S<]LDLI<^YVAVN]M'J/]KOI)*;<W2/:V.^I_\`(I`W=VM\O<?_`"*P\KKI
M9DVT5U78GV<M9ZV758*K2]AL8_%>VUGJ54._1Y;O])Z=?^$6A5F4FMKGLR`7
M!NH9<X&1RW9ZGM_U>DIMS=`]K9[^X_\`D4\VS]%L?$_^169E]7QJ7TU,#P^U
MKWS?Z]#0RMOJ6?I'U._2ZM_0_P#&_P"C1*.J].?4QU^337:X'<&W%U>X#=9Z
M-MGH^LUG[_II*3Y1?ZF+O`'Z<1!G\RSR:K:S<W+PJ_L]GKM+1=)]^XDBNYQ:
MQDN>]_Z-_P"BK]ZN8V53DM<ZDDM:=I):YNH\/4:W<DI__]+U*[UC6[T2T6Q[
M2\$MG^4&EKEC=0P^LY.3@UV78PQQ;=ZVUEK7:TO;B[/3N;]";_7_`$U>_P#1
MK<639TRP.L]'"Q"'7/N:;'O,OLEMESV^D[WO:[Z*2E5X'6Z*131FX[6-)('H
M6%QDN>Z;LC,ROSG?N*EU[`^M&5T;,HPLC;F65!M#JK?1<'AS#O%C:6N8YS6O
MW?I6?];6S^S.G?\`<:K_`#`JV5TQA(9CX.*^LCW&PEA#@6ED"NJS_JDE.?@8
M8S;';++<=HK#GNQ[F;"7M9%6^NV[-_0[/T6VVK&6E5T6BETUW7@27%GK/#27
M1N<[8YCGN]OTGN_]&*6-TS&]!OVG"QJ[==S*6AS(!.R'.KJ=_-[?S$LCIU#6
ML.+AXSW;AO%@V`-@^YNRNWW;DE.1TCZJ586/7T[T&LZ=0YSV56EE^XBUSHL]
M2OW>LUK,CU/YVG?]G_P:WV8^QH:PAH'9NX#S]H>JF)TNIH<S(PL5C&0*?2EY
MVB?I^I77^;L1K>F88K<:<2AUGYH<T`'XN#7)*06]#J=E79E=KF79)8;MWZ5L
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M6_VJFL9[OI;4"S!MKR6OP\+$VUD.98YQ8\.(>Q_MKIL_-?\`OK0I-IJ8;@UM
MI:/4:PDM#H]X8YP:YS=W\E)3_]/M\/[/^U\[;^U=T8^WU_7^RSM/]!]3V?\`
MA[U?T>__`*XHT[9;_P`K<CZ>[G</I?VO[&S_`(-?.J22GZ,?LW/C]I[=H_F]
MVWD?1W?I/5_TW_7%/]%L;N_:<^[;_.;N6_3V>S_BO4_X3_A%\X))*?HZG9Z6
MO[4XK^GOW3ZE.WC_`-F/\%]G^T>K[/54^E1]K&S]I;-A_I<^E/MY]7]/ZG[O
M^"7S<DDI^B:?L_[>S/\`E3^A5_3]?[)&G]%_[O\`\WZO^%_GO^[*FS[-%&[]
MJ[O5$;O7\&?SVS]'Z/\`6_X1?.:22GZ6ZCZ?VK&C[=N^TLW_`&;?Z?\`-7?T
MF?T?V+;_`#OH_P#:O[-_A%7?]E]6W_E/9/NC[1LF*?YK_#_N?S7_`'8_X9?.
M*22GZ,?LV#;^U-VT3MW;OI?G;_T?^;_@U?ZQZ/V*[U?M6W8-WV+U?5C<W^9^
MR_I/4_XO])Z:^9$DE/TEF_9OM3]_V^-KMWH>OM^@S_0_V?1]/_#>M_PJ$_9%
M<?M/=L=]'=/TG_SN[]%O_P!'_P`&OG)))3__V0`X0DE-!"$``````%4````!
M`0````\`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'`````3`$$`9`!O
M`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P`"``-@`N`#`````!`#A"24T$!@``
M````!P`(``$``0$`_^X`#D%D;V)E`&1``````?_;`(0``0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#
M`P,#`P,#`P$!`0$!`0$!`0$!`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@!1P(B`P$1``(1`0,1
M`?_=``0`1?_$`(8``0`"`P`#`0$````````````'"`8)"@,$!0L"`0$`````
M````````````````$``!!`("``0#!P(&`0(""`<&`P0%!P$"``@1$A0)(A,C
M(205%UF9V18WMG=XN#D*&#$V,AE!,S0E958X6&,U9M97E]@1`0``````````
M``````````#_V@`,`P$``A$#$0`_`._C@.!$]]+-6]&7.N],RBN6:%3V*L[L
M((9N)`T`VJ8?,;N#,08-&SQV^*!=+7+Z/121545=H)ZZZ;9SC7(<D0E:.U:>
MV/W0#9RPH>(EZ$[1]?H*#[44QV'L2.I3LFN4=UYQK+$L5$RQJ^P&6(^$_P`3
MP:"JL^3-W\4I$2[I=?9=/=(-QWNV=H*57Z:=C8@+["P<#9%#6OTV;FJ`G:SX
M)F1)Y;%N5&4#,81KPL]":R\&?U#.O9!%FXW=QS^/U46RGOEMG9(-7_?VT.R[
M$T[JRG6TJ.G?N(,.YL,UZ9B(C(2,W,D/2IY[9<&1-GPD'-EGT(1T5)6BH:R+
MF01148:V*T:8=*IR3=DEH&SWVL"2'F;J[/L:9+)0SZM,NOGMZ20C,:SKXF&/
M_(R:K&V/_(31O,.UW&F]B20)'5O*%^FNWJ%)F1R[?>,D[>;;!8GMQV=[H]8J
M"[+]AF_6/K$7`_7RI;@N35/?N):D:6$0?50B0FF^^PQ_X2*PS,BD8*"SMF.Q
M/;-]7.WR,/\`.G@XX&$CW9'W9R*`@R!G[;W43+.=AXR9:Y6]S@V;JY;2;)!Z
MA\U#'MW.,(J?*7QYM/F;^7/V>;;P\<A]C\^?=P_3>Z@?N>FW\=/`?GS[N'Z;
MW4#]STV_CIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z
M@?N>FW\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#
M]STV_CIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N
M>FW\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]ST
MV_CIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N>FW
M\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_C
MIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N>FW\=/
M`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_CIX#
M\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N>FW\=/`?G
MS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_CIX#\^?
M=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N>FW\=/`?GS[N
M'Z;W4#]STV_CIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_
M3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;
MW4#]STV_CIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z
M@?N>FW\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#
M]STV_CIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N
M>FW\=/`?GS[N'Z;W4#]STV_CIX$/]A>[?NF==Z"O#L`8^W!U0T$:+I^R[B*M
MHGW*#2>E=1NL@N:-9S:,@M_;_'])J0Q&0BN46F7[+#E3P3RX1\WS-0V^B$YN
M3B8N2J-M6>Y".PDYNTT4RMHUWEHUL_V;:K;:)Y5U0RX\N-LZZYVQCQ\,?^G`
MR+@.`X#@.`X'_]#OXX#@.!Z;&.CXM'=M&L6<<W5>2,BHW8MD6B*DA+R#F6EG
MVZ3?1-/=Y*2CU9RX5SCSKN%MU-\[;[;9R'QXL/%H0@*"N*@(M@3&RD.H63[=
MHEK+S^!Z.Q$P*$E(9QERX9PS#SZ-4,[?)0V66WTUQNLMMN&2<!P*`>[%_P`6
M7N6?Z`.Y'^W6QN!;^IO[5UI_E^&_X<C>!('`<!P'`<!P'`<!P'`<!P'`<!P'
M`<!P'`<!P'`<!P'`<!P'`<!P'`<"B78?W!:>ZZ=@*<ZTS0K:5@6E;S56?_!:
MO%6Q,Y"036"LR:2.R",6EXV=G(53:III-1`?:3+]IHSW5<())[M_4!.-8=CJ
M^MNV.PE-"S4L;&'6<D"1:Q\D(XZ@8M:3/@YL=0"HNY>J:N9Z+5@'B>^7>J*;
M??;?'R=U=/CX%0'GNU=5H_1JH];V8VP:N)!EU[TW'![9;M;(QO90;ZD+Q_7]
MLF7[N)5PK>9V-QZ.Q#H.(KQA$QF=-]H;U3]L&?#'N/T$<$@/6H/%6,6WJ:$U
MQB[OK_%PHTULVOW'7P\=UG<LQ9;J;+XFM1$9#S9MHR:R"A"HV)]G+?8?VEM%
MM-LA?W@.`X#@.`X#@.`X#@.`X#@.`X#@4`]V+_BR]RS_`$`=R/\`;K8W`M_4
MW]JZT_R_#?\`#D;P)`X#@.`X#@.!_]'OXX#@.`X#@.`X%`/=B_XLO<L_T`=R
M/]NMC<"W]3?VKK3_`"_#?\.1O`D#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.
M`X#@.`X#@.`X#@.`X#@?F0=Z?^V?[EH_W7NN$ZV2]5UU0-66X4@0379%50Z7
MO"X=K\H?P'XT?D<Q\PG3E#7\,V7=(1#Z,38H+ZH(;?-2V=*ATIO5#+WTJR]O
M#M+U\L'K=59H(HUI;Q.3!E@/'':KIJ?_`-#WI!7=!Q$B&/$ITPK4X*9H.;:B
MTJZ@FKQ6`3VF6L@S>J(L0VDMZ:[?4K<_?KL%5HE29Q,=D['ZHR55"4@>%6SM
MN+5K%5[3EEJ':#P0#(R"D%*X:RTVPW8R\IJV>II(;).\:YU6"D$K[--N2"O3
MW9"SJS:[>VA,%<_T\<[;%B^;.=%_;RGNP#V/OIG^`IZ@K=M4-&QP/ZB%6)-E
MI&;?$&J*&6C6)4#""OV-#LK/[QMJ7E>O$]9/:M.==&A//QI0ZG>I)9MW7..T
M@0?]5BO43R1D)0+"UBJQ3[=TJ';3$^.14GJHR:[+1J0=+/`<!P'`<!P'`<!P
M'`<!P'`<!P'`H![L7_%E[EG^@#N1_MUL;@6_J;^U=:?Y?AO^'(W@2!P'`<!P
M'`<#_]+OXX#@1?=TB]AZ7MZ7C;`BZFD8NKS^1C[4G&#65A:T>L126<M;`EXM
M[]RDHL-72UD7#=;Z2R3;;3?X<YX',6%=ANQ`9[?W<0/([5OH,[3=8^PM`Q]@
M&#.\,W/7!W'V;W/F:\5+:2LXM4E;4BJ]L"`9R+%]`2*,`YCE8=!1HW39/U-G
M@;<^Z-N.)[M#TLZQQ%NRP)6UAV#?,?V,G*NLO<&.A^?#>JYG:U/5P0%PQ,,2
MFO-B=KJ\-$$_F--Y1H(ZZJY6C573=R'.,%>Y![BLG[>\YW;=V$?.>Z8=;M,U
M-7M#;[.$@RU*E(/:A#>P"9I(T.KC([)35F&Q7,V9^-:1OK==X'$:S71C$'#+
M(="7MRV$9O[X[(U+FVSJZZA%.M7MX6^'FQ\7S%A2FUG7S75PJ6R@R+YM[(ND
MHTC@:Z$BG$,DKJRC5B119H@W:O44L!\/W6;UM%?VZ/<E%%>F'95G`K=*NX@\
MI9C@IZ>;!#6(4HRQ8W<Z78-.U[JQ]A5!GG\0V12'U)O+3&==8_9UX-LA>KKC
M8=I$?7.")2>@"JO2N$KV&V&:ZFCJL)N9-<QX7'NXO1I/"15."4'M//M<-4_7
M/4L(;9PHMG1/QS@)$#C^T9X(+2(GH8B!2R$1E%!NOI`[KF<DC55G$8?1Z#`@
M'2&0&87:7DL^BTV?N4-45,?,5SJE\7`!Q_:,\$%I$3T,1`I9"(RB@W7T@=US
M.21JJSB,/H]!@0#I#(#,+M+R6?1:;/W*&J*F/F*YU2^+@`X_M&>""TB)Z&(@
M4LA$910;KZ0.ZYG)(U59Q&'T>@P(!TAD!F%VEY+/HM-G[E#5%3'S%<ZI?%P`
M<?VC/!!:1$]#$0*60B,HH-U]('=<SDD:JLXC#Z/08$`Z0R`S"[2\EGT6FS]R
MAJBICYBN=4OBX`./[1G@@M(B>AB(%+(1&44&Z^D#NN9R2-56<1A]'H,"`=(9
M`9A=I>2SZ+39^Y0U14Q\Q7.J7Q<`'']HSP06D1/0Q$"ED(C**#=?2!W7,Y)&
MJK.(P^CT&!`.D,@,PNTO)9]%IL_<H:HJ8^8KG5+XN`#C^T9X(+2(GH8B!2R$
M1E%!NOI`[KF<DC55G$8?1Z#`@'2&0&87:7DL^BTV?N4-45,?,5SJE\7`!Q_:
M,\$%I$3T,1`I9"(RB@W7T@=US.21JJSB,/H]!@0#I#(#,+M+R6?1:;/W*&J*
MF/F*YU2^+@`X_M&>""TB)Z&(@4LA$910;KZ0.ZYG)(U59Q&'T>@P(!TAD!F%
MVEY+/HM-G[E#5%3'S%<ZI?%P`<?VC/!!:1$]#$0*60B,HH-U]('=<SDD:JLX
MC#Z/08$`Z0R`S"[2\EGT6FS]RAJBICYBN=4OBX`./[1G@@M(B>AB(%+(1&44
M&Z^D#NN9R2-56<1A]'H,"`=(9`9A=I>2SZ+39^Y0U14Q\Q7.J7Q<`'']HSP0
M6D1/0Q$"ED(C**#=?2!W7,Y)&JK.(P^CT&!`.D,@,PNTO)9]%IL_<H:HJ8^8
MKG5+XN`#C^T9X(+2(GH8B!2R$1E%!NOI`[KF<DC55G$8?1Z#`@'2&0&87:7D
ML^BTV?N4-45,?,5SJE\7`!Q_:,\$%I$3T,1`I9"(RB@W7T@=US.21JJSB,/H
M]!@0#I#(#,+M+R6?1:;/W*&J*F/F*YU2^+@`X_M&>""TB)Z&(@4LA$910;KZ
M0.ZYG)(U59Q&'T>@P(!TAD!F%VEY+/HM-G[E#5%3'S%<ZI?%P`<?VC/!!:1$
M]#$0*60B,HH-U]('=<SDD:JLXC#Z/08$`Z0R`S"[2\EGT6FS]RAJBICYBN=4
MOBX`./[1G@@M(B>AB(%+(1&44&Z^D#NN9R2-56<1A]'H,"`=(9`9A=I>2SZ+
M39^Y0U14Q\Q7.J7Q<`'']HSP06D1/0Q$"ED(C**#=?2!W7,Y)&JK.(P^CT&!
M`.D,@,PNTO)9]%IL_<H:HJ8^8KG5+XN`#C^T9X(+2(GH8B!2R$1E%!NOI`[K
MF<DC55G$8?1Z#`@'2&0&87:7DL^BTV?N4-45,?,5SJE\7`!Q_:,\$%I$3T,1
M`I9"(RB@W7T@=US.21JJSB,/H]!@0#I#(#,+M+R6?1:;/W*&J*F/F*YU2^+@
M`X_M&>""TB)Z&(@4LA$910;KZ0.ZYG)(U59Q&'T>@P(!TAD!F%VEY+/HM-G[
ME#5%3'S%<ZI?%P`<?VC/!!:1$]#$0*60B,HH-U]('=<SDD:JLXC#Z/08$`Z0
MR`S"[2\EGT6FS]RAJBICYBN=4OBX`./[1G@@M(B>AB(%+(1&44&Z^D#NN9R2
M-56<1A]'H,"`=(9`9A=I>2SZ+39^Y0U14Q\Q7.J7Q<`'']HSP06D1/0Q$"ED
M(C**#=?2!W7,Y)&JK.(P^CT&!`.D,@,PNTO)9]%IL_<H:HJ8^8KG5+XN`#C^
MT9X(+2(GH8B!2R$1E%!NOI`[KF<DC55G$8?1Z#`@'2&0&87:7DL^BTV?N4-4
M5,?,5SJE\7`!Q_:,\$%I$3T,1`I9"(RB@W7T@=US.21JJSB,/H]!@0#I#(#,
M+M+R6?1:;/W*&J*F/F*YU2^+@`X_M&>""TB)Z&(@4LA$910;KZ0.ZYG)(U59
MQ&'T>@P(!TAD!F%VEY+/HM-G[E#5%3'S%<ZI?%P`<?VC/!!:1$]#$0*60B,H
MH-U]('=<SDD:JLXC#Z/08$`Z0R`S"[2\EGT6FS]RAJBICYBN=4OBX`./[1G@
M@M(B>AB(%+(1&44&Z^D#NN9R2-56<1A]'H,"`=(9`9A=I>2SZ+39^Y0U14Q\
MQ7.J7Q<`'']HSP06D1/0Q$"ED(C**#=?2!W7,Y)&JK.(P^CT&!`.D,@,PNTO
M)9]%IL_<H:HJ8^8KG5+XN!7#L1W)*NN'4"]^RMGTA-5^45Q"JL:UK&8*PTSE
M+7LHGWC!>H0F'7`)Z4;X?6+:A%&P#=OE9-S\YQY\8QIX;<#F;%_^IKURO`>8
M7MVF2[;C/97\'V++[`A"Z*%<C/9:[7D=L8'Q0*S2P\:[5C%V/84B\:8;KRZ6
MC5ME/;3TF?,XV#>I$^V'T=/J;BV1K[6=75T34@(M1&G(N+D*VA[I?PH<'H1X
MNQ@>P]5%,>:0CY_E'#'#R2(TG'JO,Z<*^.VRV0PL/Z,]G1(',2GKKVG]P7JP
M6#Z,K@)HB[;UI7OM6Y4U90NCN(@V2W8G%GFHVQ<R*>D>T\E@PF6N-=LJ;X0S
MKMJ'TJLLKWU@N&<O;7ZV],.Q$=#RFT6DQ@[2G>J%SD\1\AMN@4-H%&1[<4LJ
M\QONIJNS6)X+7973P3\B><*<#+I7W8)*JHPO6[4>W_WMZVOQF->.8^76J)+L
M/4Y%((Q:KEC'XN+JE*7:*A[66ED\,M)`AUB6#;YNBSI5NG\SY83!U2]S'K[W
M#""B<J`NJDAL&&UEM(*EA_L/1Y791(_CXC9\SBGD%`&3IZ#R4G))[,L(SJ+!
M5OOKE5771'X^!;,./[1G@@M(B>AB(%+(1&44&Z^D#NN9R2-56<1A]'H,"`=(
M9`9A=I>2SZ+39^Y0U14Q\Q7.J7Q<`'']HSP06D1/0Q$"ED(C**#=?2!W7,Y)
M&JK.(P^CT&!`.D,@,PNTO)9]%IL_<H:HJ8^8KG5+XN`#C^T9X(+2(GH8B!2R
M$1E%!NOI`[KF<DC55G$8?1Z#`@'2&0&87:7DL^BTV?N4-45,?,5SJE\7`!Q_
M:,\$%I$3T,1`I9"(RB@W7T@=US.21JJSB,/H]!@0#I#(#,+M+R6?1:;/W*&J
M*F/F*YU2^+@`X_M&>""TB)Z&(@4LA$910;KZ0.ZYG)(U59Q&'T>@P(!TAD!F
M%VEY+/HM-G[E#5%3'S%<ZI?%P,1?7Y.A-'V[=UW5:XH^*J,3+S:2CC.R:R<L
MWHT'BZY*^EW1A#$;T2&8_?#55#=:2=-]&_R\JJYU2^+@5``_=HHDEHXDN,T$
MC^IY:)3M9:&J(Q'YM:T9AG3=?"]DG4Y,BD-!OYBO@\>'#B$<2,[/MV$-&-9I
M@Y=.DD7B&VX2957N(UA9IT14IM"*#O8EN/F!%7E0+%8U.-;C;!0U`D,TQK>X
M()P\I0BG(O\`J5FC)1[:?7?P^JN5WR*"":F^@2CUZ[4:=C:WMDZ#*^64EJJ/
MK'JI<1C[!KTFWGK*J_3T1.'-"N`FW8E'R3$JUWB%MW#O5NW=I[Y44QIKMM@)
M0#C^T9X(+2(GH8B!2R$1E%!NOI`[KF<DC55G$8?1Z#`@'2&0&87:7DL^BTV?
MN4-45,?,5SJE\7`!Q_:,\$%I$3T,1`I9"(RB@W7T@=US.21JJSB,/H]!@0#I
M#(#,+M+R6?1:;/W*&J*F/F*YU2^+@`X_M&>""TB)Z&(@4LA$910;KZ0.ZYG)
M(U59Q&'T>@P(!TAD!F%VEY+/HM-G[E#5%3'S%<ZI?%P`<?VC/!!:1$]#$0*6
M0B,HH-U]('=<SDD:JLXC#Z/08$`Z0R`S"[2\EGT6FS]RAJBICYBN=4OBX`./
M[1G@@M(B>AB(%+(1&44&Z^D#NN9R2-56<1A]'H,"`=(9`9A=I>2SZ+39^Y0U
M14Q\Q7.J7Q<`'']HSP06D1/0Q$"ED(C**#=?2!W7,Y)&JK.(P^CT&!`.D,@,
MPNTO)9]%IL_<H:HJ8^8KG5+XN!1CW$#`^,_::]SQ]8-135/2;7HEW):,H.;+
M0DO<2;'_`,:S];$JD^!IF:CVR.7"NZ/REE-%O,EG;R^7.N<AL-J;^U=:?Y?A
MO^'(W@2!P'`<!P'`<#__T^_C@.!Z[MHU?M7+%\V;O6+UNLT>,W:*;EJ[:N4]
MD7#9RW6UW17;KH[YTWTWQG7;7.<9QG&>!!#3JAU?95V\J)#KK2&:JD2R1.WU
M;.*L"7@([,Y68=S[XH<";R$7@E9Q27?*K:.<H952SMC">=====<!X5NIO6IY
M,V?.R](5J1O;E=5X[LE$J%(DJB"?>IAG0/K5)Q`D+:2@VK4*'\;HQZ3=NDFW
MRNKOKCSJ[[;!(J=3U8D;,++2K2OT[&BH/09BS],-'-#:-&TTE4$QY@5:QN)U
MG!IH+J::M$U]6^--]L8T\,YX'F`:OK2J8M["5=78+6T+)26\S(Q`")0`=%OY
M=1HTCU)5ZP'8^.:.I+=A'H(974TV5RB@GIG;RZ:XP%.O=B_XLO<L_P!`'<C_
M`&ZV-P+?U-_:NM/\OPW_``Y&\"0.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X
M#@.`X#@.`X#@.`X#@:D.P*>>VWN2=;^L+;=1[471N+AN^78;5%)16.D[OF'!
M$"=**XE7>B'R4W$-(LRRPE&FROGU=#<(XRGC&4M\AMOX#@.`X#@5:O[H_P!.
M>U*.VG8WJ_1-SN\:ZX:SI_6(E/ED2IIX?+<P!DZB\E8X^2Q]FCA@];+ZZYSC
M&^,9SC(51_\`E5C%>*^LZE]Q.]?4;=HGYH<1$.PDI?-,Q[K&WGQC2E^WT7V$
M"F$6IOG.%&<2G$I^3/E3RGC77RAX_P"E_>2IA#P'[4Z0=YX-G]YPPM0"LOI7
M;C]'3?Q5C=SVL9/L74\I(*M],816P%P*'S]]LJ8U3\,:AY-O<<N"L%$VG:WV
MU.Z]2IZ^=5X?46-AW=VI4&26N/GR.KSK<1D5X-6;?.JFV_XC7\<KJEIY\Z>&
MV.!,%.>Z'[>]\S:HG7';FEU3Q!PFU<5@;D^E2VXV<J;:Z:(NJCME`)LMLIE3
M?77.%(K7PVVUUSX9VQC(7QWWT3TV44VUTTTUVWWWWVQKIIIKC.VVVVVV<8UU
MUQCQSG/V8QP-(=H>\Q[3G8:1M'H^%=F.N'8"Y+$'R:J6E&'3XP'Z<NB7)&CT
M;<U)^>#T'>4_(N#KYJL4VU9RKW99TY2TTTWSOKC(4C%/;([I+T3L,CD]=8`=
M#3R^J7Z6RIO:-)EDCUJZS=EJ\K&`O0-[0RAL+VS(VQ6?]<5RVDPV-@F\X>:H
MQ+)HZ*(ML^<K,PM\KU![6/K`KRDQ&LX6H:0ZST=-=<^J?9K4\#YTE!<$E7L1
M6SNRD_58Z[@2N7M&PD8/4;A6#*6A\P;"5DYAP_5?O]&\6%S_`&Z.L=M=5`6[
M@*RWE1;0D]V&.#.JXBFZ_F:[&H:NY&*&XJ$;IP4Q9]GJQ;79O"::-8WU7S(U
M%+R*+NL[XWT#8;P'`<!P'`<"@'NQ?\67N6?Z`.Y'^W6QN!;^IO[5UI_E^&_X
M<C>!('`<!P'`<!P/_]3OXX#@.`X#@.`X%`/=B_XLO<L_T`=R/]NMC<"W]3?V
MKK3_`"_#?\.1O`D#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X
M#@.!A-E6('5#71Y:]B3;4:`:S#28_-B%[G.K.#$P^&>D!#+.<XQG;*,?$QZJ
MNV,8SMG&OAC&<\#7M[4M<&*%!EG:VX()Y`W[[@-F3/;BR8>8T0VFP<0-(V+A
M.NU-N5M/,N@WI[KN/C40HTWV\4);604VUU676SL&S_@.`X#@.`X#@.`X$-W)
MUVH#L5`Y%K_I"H[N&_EJ):0=LUR(6'%HZJ__`!Y;,RR(ED&JF<_;C=/&N^NV
M,9QG&<8SP-7MY^RQ0^](6Z%],#KL7TS+2NJ[!%A89HGM!=0=0K\AG`Z9A!MF
M7T9,DAG4"(QI(/M$W6T8/LG^C3=7""R:GDVU#\N"&]I'W%X?MC4G5,TZVVI1
MMM6C;D=5X$46A"20!73LLT]?*;RHS;4CJU""AG&1$$]DFZT'(OUGR3+;##5R
MOE-+</VMXQJX8QL>R>/UI5VT8M&KJ3<)HHN)%PW;II+OUTF^NB"2SQ73*FVN
MF,::[;9QC&,>'`][@.`X#@.`X#@.!0#W8O\`BR]RS_0!W(_VZV-P+?U-_:NM
M/\OPW_#D;P)`X#@.`X#@.!__U>_C@.`X&`VL]*XVKK)D0.5$8(X8`)B]#)P_
M66;@<,5M1Z17'94V<-\ZKH",=+IHK26^F<;ZL]%,X^W&.!S'5EWT[GIUW^`W
M);W:FLIFG;AO"&[_`!DVZPU/<Q_U5B6H1V:7J0R!)NJJ2/*SM;J\16&#-$G4
M^S$GRPZ\&7;60D&#!79%`(CS[R/?:'Z,%GN%%:4;#%E76=1]*SG354`'-A(P
MR<>V/6':@C/,OMX-G=D492MN6ZE+,XY&>3CXD6A=V"[9VXV6?X#>)T0O"[":
M]>PO7VVK64O6/K3KYT8OD:M&2&`$7G%)CLX+W4R.PO9O6`R("#P7B)BCD9R'
M4V99DTFY+N@X<.4D6JG`C'W6>Q,VX]NGW)0W;K/V6;M5NE7<09R<.!6OM0A!
MNI1EBQ62M=^G9RDQJ*I)[>LV6U8[.<-,9VPAG?Z?`OKU^MB1)>OL05KT]<`L
MX$*_A?3!Y1""K0O-?PD)CI)/^BV4<92L6^_&=\>E9^K>,?.Z^%3Y>GQ\#.@Z
MW9(M""TR<TO<P:Z%D915N#F,&)L3<MS&Q&)5-$2811K,P[Q:44SZ-KAT^9XW
M=X\N^=-/J<`'6[)%H06F3FE[F#70LC**MP<Q@Q-B;EN8V(Q*IHB3"*-9F'>+
M2BF?1M<.GS/&[O'EWSII]3@`ZW9(M""TR<TO<P:Z%D915N#F,&)L3<MS&Q&)
M5-$2811K,P[Q:44SZ-KAT^9XW=X\N^=-/J<`'6[)%H06F3FE[F#70LC**MP<
MQ@Q-B;EN8V(Q*IHB3"*-9F'>+2BF?1M<.GS/&[O'EWSII]3@`ZW9(M""TR<T
MO<P:Z%D915N#F,&)L3<MS&Q&)5-$2811K,P[Q:44SZ-KAT^9XW=X\N^=-/J<
M`'6[)%H06F3FE[F#70LC**MP<Q@Q-B;EN8V(Q*IHB3"*-9F'>+2BF?1M<.GS
M/&[O'EWSII]3@`ZW9(M""TR<TO<P:Z%D915N#F,&)L3<MS&Q&)5-$2811K,P
M[Q:44SZ-KAT^9XW=X\N^=-/J<`'6[)%H06F3FE[F#70LC**MP<Q@Q-B;EN8V
M(Q*IHB3"*-9F'>+2BF?1M<.GS/&[O'EWSII]3@`ZW9(M""TR<TO<P:Z%D915
MN#F,&)L3<MS&Q&)5-$2811K,P[Q:44SZ-KAT^9XW=X\N^=-/J<`'6[)%H06F
M3FE[F#70LC**MP<Q@Q-B;EN8V(Q*IHB3"*-9F'>+2BF?1M<.GS/&[O'EWSII
M]3@`ZW9(M""TR<TO<P:Z%D915N#F,&)L3<MS&Q&)5-$2811K,P[Q:44SZ-KA
MT^9XW=X\N^=-/J<`'6[)%H06F3FE[F#70LC**MP<Q@Q-B;EN8V(Q*IHB3"*-
M9F'>+2BF?1M<.GS/&[O'EWSII]3@`ZW9(M""TR<TO<P:Z%D915N#F,&)L3<M
MS&Q&)5-$2811K,P[Q:44SZ-KAT^9XW=X\N^=-/J<`'6[)%H06F3FE[F#70LC
M**MP<Q@Q-B;EN8V(Q*IHB3"*-9F'>+2BF?1M<.GS/&[O'EWSII]3@`ZW9(M"
M"TR<TO<P:Z%D915N#F,&)L3<MS&Q&)5-$2811K,P[Q:44SZ-KAT^9XW=X\N^
M=-/J<`'6[)%H06F3FE[F#70LC**MP<Q@Q-B;EN8V(Q*IHB3"*-9F'>+2BF?1
MM<.GS/&[O'EWSII]3@`ZW9(M""TR<TO<P:Z%D915N#F,&)L3<MS&Q&)5-$28
M11K,P[Q:44SZ-KAT^9XW=X\N^=-/J<`'6[)%H06F3FE[F#70LC**MP<Q@Q-B
M;EN8V(Q*IHB3"*-9F'>+2BF?1M<.GS/&[O'EWSII]3@`ZW9(M""TR<TO<P:Z
M%D915N#F,&)L3<MS&Q&)5-$2811K,P[Q:44SZ-KAT^9XW=X\N^=-/J<`'6[)
M%H06F3FE[F#70LC**MP<Q@Q-B;EN8V(Q*IHB3"*-9F'>+2BF?1M<.GS/&[O'
MEWSII]3@`ZW9(M""TR<TO<P:Z%D915N#F,&)L3<MS&Q&)5-$2811K,P[Q:44
MSZ-KAT^9XW=X\N^=-/J<`'6[)%H06F3FE[F#70LC**MP<Q@Q-B;EN8V(Q*IH
MB3"*-9F'>+2BF?1M<.GS/&[O'EWSII]3@`ZW9(M""TR<TO<P:Z%D915N#F,&
M)L3<MS&Q&)5-$2811K,P[Q:44SZ-KAT^9XW=X\N^=-/J<`'6[)%H06F3FE[F
M#70LC**MP<Q@Q-B;EN8V(Q*IHB3"*-9F'>+2BF?1M<.GS/&[O'EWSII]3@`Z
MW9(M""TR<TO<P:Z%D915N#F,&)L3<MS&Q&)5-$2811K,P[Q:44SZ-KAT^9XW
M=X\N^=-/J<`'6[)%H06F3FE[F#70LC**MP<Q@Q-B;EN8V(Q*IHB3"*-9F'>+
M2BF?1M<.GS/&[O'EWSII]3@`ZW9(M""TR<TO<P:Z%D915N#F,&)L3<MS&Q&)
M5-$2811K,P[Q:44SZ-KAT^9XW=X\N^=-/J<`'6[)%H06F3FE[F#70LC**MP<
MQ@Q-B;EN8V(Q*IHB3"*-9F'>+2BF?1M<.GS/&[O'EWSII]3@`ZW9(M""TR<T
MO<P:Z%D915N#F,&)L3<MS&Q&)5-$2811K,P[Q:44SZ-KAT^9XW=X\N^=-/J<
M#4AW]N.9[;+4'T$BZ9NH73OTVF;>[-@I/#C$>;2_27JQ@:LBS8"(;C1_*((:
M]B[-?"E9LO5/6:+Y&=E4M]TTT=U,!MM"[;D"D&*B]6E;D"EA-O);M`0N@1&/
M-"O6+A]9-%N(1T0:S,,[4DM_N;35R^9Z[.\>7?*>GU.!_0=;LD6A!:9.:7N8
M-="R,HJW!S&#$V)N6YC8C$JFB),(HUF8=XM**9]&UPZ?,\;N\>7?.FGU.`#K
M=DBT(+3)S2]S!KH61E%6X.8P8FQ-RW,;$8E4T1)A%&LS#O%I13/HVN'3YGC=
MWCR[YTT^IP`=;LD6A!:9.:7N8-="R,HJW!S&#$V)N6YC8C$JFB),(HUF8=XM
M**9]&UPZ?,\;N\>7?.FGU.`#K=DBT(+3)S2]S!KH61E%6X.8P8FQ-RW,;$8E
M4T1)A%&LS#O%I13/HVN'3YGC=WCR[YTT^IP`=;LD6A!:9.:7N8-="R,HJW!S
M&#$V)N6YC8C$JFB),(HUF8=XM**9]&UPZ?,\;N\>7?.FGU.`#K=DBT(+3)S2
M]S!KH61E%6X.8P8FQ-RW,;$8E4T1)A%&LS#O%I13/HVN'3YGC=WCR[YTT^IP
M`=;LD6A!:9.:7N8-="R,HJW!S&#$V)N6YC8C$JFB),(HUF8=XM**9]&UPZ?,
M\;N\>7?.FGU.`#K=DBT(+3)S2]S!KH61E%6X.8P8FQ-RW,;$8E4T1)A%&LS#
MO%I13/HVN'3YGC=WCR[YTT^IP`=;LD6A!:9.:7N8-="R,HJW!S&#$V)N6YC8
MC$JFB),(HUF8=XM**9]&UPZ?,\;N\>7?.FGU.`#K=DBT(+3)S2]S!KH61E%6
MX.8P8FQ-RW,;$8E4T1)A%&LS#O%I13/HVN'3YGC=WCR[YTT^IP`=;LD6A!:9
M.:7N8-="R,HJW!S&#$V)N6YC8C$JFB),(HUF8=XM**9]&UPZ?,\;N\>7?.FG
MU.!`-V`M<=Y^L%LUY>'7^](`9].I)1HU)MAL1NIL7!S=N7A1_1\X-FTPD.60
M,$[-NN/2>9!GNWEV^N%/H9W\X5,Z&=X;E8;D/3KO*&6!&=OZM!RDXJ,@FQ4:
M$)KOK1`8NY:,[0KT6CRR5$HB\(A+5FP-Q+29SHRE72,FV4UBG^F&8;,0ZW9(
MM""TR<TO<P:Z%D915N#F,&)L3<MS&Q&)5-$2811K,P[Q:44SZ-KAT^9XW=X\
MN^=-/J<`'6[)%H06F3FE[F#70LC**MP<Q@Q-B;EN8V(Q*IHB3"*-9F'>+2BF
M?1M<.GS/&[O'EWSII]3@`ZW9(M""TR<TO<P:Z%D915N#F,&)L3<MS&Q&)5-$
M2811K,P[Q:44SZ-KAT^9XW=X\N^=-/J<`'6[)%H06F3FE[F#70LC**MP<Q@Q
M-B;EN8V(Q*IHB3"*-9F'>+2BF?1M<.GS/&[O'EWSII]3@`ZW9(M""TR<TO<P
M:Z%D915N#F,&)L3<MS&Q&)5-$2811K,P[Q:44SZ-KAT^9XW=X\N^=-/J<`'6
M[)%H06F3FE[F#70LC**MP<Q@Q-B;EN8V(Q*IHB3"*-9F'>+2BF?1M<.GS/&[
MO'EWSII]3@`ZW9(M""TR<TO<P:Z%D915N#F,&)L3<MS&Q&)5-$2811K,P[Q:
M44SZ-KAT^9XW=X\N^=-/J<`'6[)%H06F3FE[F#70LC**MP<Q@Q-B;EN8V(Q*
MIHB3"*-9F'>+2BF?1M<.GS/&[O'EWSII]3@48]Q"QWUE^TU[GDL_K"SJL48=
M$NY,?I#VE$CL1,2.F.M9^Y_$H]`;*2MJK&YV7REYU%DU/FI[X\GAC&V0V&U-
M_:NM/\OPW_#D;P)`X#@.`X#@.!__UN_C@.`X'Q20<'S$=GA$M@XDF%2J%E!P
MF&YZ/:RT$0#\XQ7C)F#FHI\DNRDXF6CG2B#ENMINDLBIMIOKG7.<<"J@[T`Z
M?C`5,5U'4>,KA).;*GYF.3#R>G(RP9W$Q+SL<TLQO+2[S2SA4=D9Q?>+A"#\
M2AXW/DRW;)[)Z;:A(\IU9Z\3EH;7-,5$&R=CJ;)KN)]['[.$'LFB%R-:MR*0
M'U%MAJ1+FM;2[H<1F5V:DJD/N%(W1QJRWV0R'VJ=Z^TU0#"9C:?`8<);D*D!
MM-*,5)!^_D&PD-188'12\K,O9*4_I\+#X5I%0L;JMB/AXUNFV9HH(:XTX%9/
M=B_XLO<L_P!`'<C_`&ZV-P+?U-_:NM/\OPW_``Y&\"0.`X#@.`X#@.`X#@.`
MX#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X&H_VX<)=F+<[7^Y=)Z:OH:^C+7KMU
M->+_`#%\Q_37K).D`Q#D<)N[:M74<QOR]7A>9[::Z8U=Q#B%VWV4^2GG4-N'
M`<!P'`<!P'`<!P'`<!P'`I]W3Z?C/<&L(P>R42U57+61,SL_K;V"$VZ:QS0E
MSP3=PB/G,"BHNT0G85T@Y5CY^`=J?AI%!NG+!UKY%<;IA&O1?N*3W=L>==NR
M8U#U1WKZVIPL7?\`5\8ZRH,F4)*I92#^R-'N'"RKF?HBX-&RCEAYMU7P](8<
M0TEX.VNJK@-A?`<!P'`<!P'`H![L7_%E[EG^@#N1_MUL;@6_J;^U=:?Y?AO^
M'(W@2!P'`<!P'`<#_]?OXX#@.`X#@.`X%`/=B_XLO<L_T`=R/]NMC<"W]3?V
MKK3_`"_#?\.1O`D#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X
M#@:T/=1M`R@^NL1UQIR9_!NPW>VQ(#I]3<DWW3WD`]*SF<FXN:XDVNN^7OHZ
M-H&%)RG*Z22N-'T<T1VQC9QIXA>VI:M":/JRMZ8K6&1':\J<%%*X!X)#PRE$
M"87!L1V`C\;8UT^9LVBXY+7;?./-OMC.V?MSG@2%P'`<!P'`<!P'`<!P'`<!
MP'`U\=ZNGA1>J0%?O7(KBZC[R];/QN8Z[VK)M7KP6((Z9U:*FO7ZZX:.?Q^Y
M;1=QMHQ%G)H;[;.H5[JWEX[*;UIKA4)"Z5=PQGN%6LU,[BLM4MV545/:M[+=
M>"UZR>G-"W)!HHJS(=-.V&-6!$.RC1=*3'2!EC,<0P;IN\;YUSNJBB%Q>`X#
M@.`X#@4`]V+_`(LO<L_T`=R/]NMC<"W]3?VKK3_+\-_PY&\"0.`X#@.`X#@?
M_]#OXX#@.!AMBR!K$5\=RM;#T:76+&!I/(`(I,RND%$$YJRA'SD5'I6;4\=(
M>-FIU)!LNZV^QNDKLIG_`.'@<S+[WH^Q(GU8>6L;.PE>R`GL*<U7V1J@9ZV&
MT;V5ZS8A*T[*6-'P#_KX1W@Y96C$M']5P2[PF'YZ08Q8+F<>N=5MH5]-HAEE
MJ>]-?E1=?[7[J2X]1QE2-!6M5G7X]KD!Q,3"I\2&700`[7S]MUA<#<M?Q*PD
MK:-NP,+!-MXUZBZ%&CQXHOL[=-LM@VG]*^REX6-;EV]>^P&]>SAU5%'=.[[U
M,JU&ID-'G;'M4/VXC*A.1^<*C%WOL"G=&3663_UFNSJ$DF"2Z>SMLY<N0@CW
M6>U]7.O;H]R6OTA;LKK/..E7<0.3?N.F'<-F$:RZU&6+":/%[,=T4A7#45P\
MV\^TZK*Z0FC3Q=;.\-<96X%]>OUX!9?U]AS>)A;@:0P%7\+^.,BCKW?H.7OO
MP,)CI=[_`$97QI6@^>V/\]KCR,_Z=C93\1=?=FGSG'TN!G0?>X0<A!98$+!W
M,R@0M&37F&!AUR["UX;O-(B(Q-N]1.LS^KQFQSY95GGR-4X**D5'SO[JWU5=
M?1X`/O<(.0@LL"%@[F90(6C)KS#`PZY=A:\-WFD1$8FW>HG69_5XS8Y\LJSS
MY&J<%%2*CYW]U;ZJNOH\`'WN$'(066!"P=S,H$+1DUYA@8=<NPM>&[S2(B,3
M;O43K,_J\9L<^659Y\C5."BI%1\[^ZM]577T>`#[W"#D(++`A8.YF4"%HR:\
MPP,.N786O#=YI$1&)MWJ)UF?U>,V.?+*L\^1JG!14BH^=_=6^JKKZ/`!][A!
MR$%E@0L'<S*!"T9->88&'7+L+7AN\TB(C$V[U$ZS/ZO&;'/EE6>?(U3@HJ14
M?._NK?55U]'@`^]P@Y""RP(6#N9E`A:,FO,,##KEV%KPW>:1$1B;=ZB=9G]7
MC-CGRRK//D:IP45(J/G?W5OJJZ^CP`?>X0<A!98$+!W,R@0M&37F&!AUR["U
MX;O-(B(Q-N]1.LS^KQFQSY95GGR-4X**D5'SO[JWU5=?1X`/O<(.0@LL"%@[
MF90(6C)KS#`PZY=A:\-WFD1$8FW>HG69_5XS8Y\LJSSY&J<%%2*CYW]U;ZJN
MOH\`'WN$'(066!"P=S,H$+1DUYA@8=<NPM>&[S2(B,3;O43K,_J\9L<^659Y
M\C5."BI%1\[^ZM]577T>`#[W"#D(++`A8.YF4"%HR:\PP,.N786O#=YI$1&)
MMWJ)UF?U>,V.?+*L\^1JG!14BH^=_=6^JKKZ/`!][A!R$%E@0L'<S*!"T9->
M88&'7+L+7AN\TB(C$V[U$ZS/ZO&;'/EE6>?(U3@HJ14?._NK?55U]'@`^]P@
MY""RP(6#N9E`A:,FO,,##KEV%KPW>:1$1B;=ZB=9G]7C-CGRRK//D:IP45(J
M/G?W5OJJZ^CP`?>X0<A!98$+!W,R@0M&37F&!AUR["UX;O-(B(Q-N]1.LS^K
MQFQSY95GGR-4X**D5'SO[JWU5=?1X`/O<(.0@LL"%@[F90(6C)KS#`PZY=A:
M\-WFD1$8FW>HG69_5XS8Y\LJSSY&J<%%2*CYW]U;ZJNOH\`'WN$'(066!"P=
MS,H$+1DUYA@8=<NPM>&[S2(B,3;O43K,_J\9L<^659Y\C5."BI%1\[^ZM]57
M7T>`#[W"#D(++`A8.YF4"%HR:\PP,.N786O#=YI$1&)MWJ)UF?U>,V.?+*L\
M^1JG!14BH^=_=6^JKKZ/`!][A!R$%E@0L'<S*!"T9->88&'7+L+7AN\TB(C$
MV[U$ZS/ZO&;'/EE6>?(U3@HJ14?._NK?55U]'@`^]P@Y""RP(6#N9E`A:,FO
M,,##KEV%KPW>:1$1B;=ZB=9G]7C-CGRRK//D:IP45(J/G?W5OJJZ^CP`?>X0
M<A!98$+!W,R@0M&37F&!AUR["UX;O-(B(Q-N]1.LS^KQFQSY95GGR-4X**D5
M'SO[JWU5=?1X`/O<(.0@LL"%@[F90(6C)KS#`PZY=A:\-WFD1$8FW>HG69_5
MXS8Y\LJSSY&J<%%2*CYW]U;ZJNOH\`'WN$'(066!"P=S,H$+1DUYA@8=<NPM
M>&[S2(B,3;O43K,_J\9L<^659Y\C5."BI%1\[^ZM]577T>`#[W"#D(++`A8.
MYF4"%HR:\PP,.N786O#=YI$1&)MWJ)UF?U>,V.?+*L\^1JG!14BH^=_=6^JK
MKZ/`!][A!R$%E@0L'<S*!"T9->88&'7+L+7AN\TB(C$V[U$ZS/ZO&;'/EE6>
M?(U3@HJ14?._NK?55U]'@`^]P@Y""RP(6#N9E`A:,FO,,##KEV%KPW>:1$1B
M;=ZB=9G]7C-CGRRK//D:IP45(J/G?W5OJJZ^CP`?>X0<A!98$+!W,R@0M&37
MF&!AUR["UX;O-(B(Q-N]1.LS^KQFQSY95GGR-4X**D5'SO[JWU5=?1X`/O<(
M.0@LL"%@[F90(6C)KS#`PZY=A:\-WFD1$8FW>HG69_5XS8Y\LJSSY&J<%%2*
MCYW]U;ZJNOH\`'WN$'(066!"P=S,H$+1DUYA@8=<NPM>&[S2(B,3;O43K,_J
M\9L<^659Y\C5."BI%1\[^ZM]577T>`#[W"#D(++`A8.YF4"%HR:\PP,.N786
MO#=YI$1&)MWJ)UF?U>,V.?+*L\^1JG!14BH^=_=6^JKKZ/`U74#9HYW/[\]@
MNZ^D=8CKKO[>5;D?56BF$I45N0YA-WZ7LHFQ.Z1K$U%/!T7:SHL"(*"%:_81
MJ$`K*NY!";;-T5=ED,*AM1#[W"#D(++`A8.YF4"%HR:\PP,.N786O#=YI$1&
M)MWJ)UF?U>,V.?+*L\^1JG!14BH^=_=6^JKKZ/`!][A!R$%E@0L'<S*!"T9-
M>88&'7+L+7AN\TB(C$V[U$ZS/ZO&;'/EE6>?(U3@HJ14?._NK?55U]'@`^]P
M@Y""RP(6#N9E`A:,FO,,##KEV%KPW>:1$1B;=ZB=9G]7C-CGRRK//D:IP45(
MJ/G?W5OJJZ^CP`?>X0<A!98$+!W,R@0M&37F&!AUR["UX;O-(B(Q-N]1.LS^
MKQFQSY95GGR-4X**D5'SO[JWU5=?1X`/O<(.0@LL"%@[F90(6C)KS#`PZY=A
M:\-WFD1$8FW>HG69_5XS8Y\LJSSY&J<%%2*CYW]U;ZJNOH\`'WN$'(066!"P
M=S,H$+1DUYA@8=<NPM>&[S2(B,3;O43K,_J\9L<^659Y\C5."BI%1\[^ZM]5
M77T>`#[W"#D(++`A8.YF4"%HR:\PP,.N786O#=YI$1&)MWJ)UF?U>,V.?+*L
M\^1JG!14BH^=_=6^JKKZ/`!][A!R$%E@0L'<S*!"T9->88&'7+L+7AN\TB(C
M$V[U$ZS/ZO&;'/EE6>?(U3@HJ14?._NK?55U]'@`^]P@Y""RP(6#N9E`A:,F
MO,,##KEV%KPW>:1$1B;=ZB=9G]7C-CGRRK//D:IP45(J/G?W5OJJZ^CP`?>X
M0<A!98$+!W,R@0M&37F&!AUR["UX;O-(B(Q-N]1.LS^KQFQSY95GGR-4X**D
M5'SO[JWU5=?1X`/O<(.0@LL"%@[F90(6C)KS#`PZY=A:\-WFD1$8FW>HG69_
M5XS8Y\LJSSY&J<%%2*CYW]U;ZJNOH\`'WN$'(066!"P=S,H$+1DUYA@8=<NP
MM>&[S2(B,3;O43K,_J\9L<^659Y\C5."BI%1\[^ZM]577T>`#[W"#D(++`A8
M.YF4"%HR:\PP,.N786O#=YI$1&)MWJ)UF?U>,V.?+*L\^1JG!14BH^=_=6^J
MKKZ/`!][A!R$%E@0L'<S*!"T9->88&'7+L+7AN\TB(C$V[U$ZS/ZO&;'/EE6
M>?(U3@HJ14?._NK?55U]'@`^]P@Y""RP(6#N9E`A:,FO,,##KEV%KPW>:1$1
MB;=ZB=9G]7C-CGRRK//D:IP45(J/G?W5OJJZ^CP`?>X0<A!98$+!W,R@0M&3
M7F&!AUR["UX;O-(B(Q-N]1.LS^KQFQSY95GGR-4X**D5'SO[JWU5=?1X&L+L
MR*$A#.N_<XZ"B%IH=G:)%U!&XZ3L&C+VI3?O3UZ&=%3"3HAR'VQ78@1O+0'\
M/5WM<&,9#R:S&>W4AU,N&+YVW2"[O5OO50?<&A)KL332EFO@T26)H8Y@9VE;
M<@K#%#D$:;*6%6VH"]"]28V.@F606BG3,9;S>KF60V:LMW2N=,;A,`?>X0<A
M!98$+!W,R@0M&37F&!AUR["UX;O-(B(Q-N]1.LS^KQFQSY95GGR-4X**D5'S
MO[JWU5=?1X`/O<(.0@LL"%@[F90(6C)KS#`PZY=A:\-WFD1$8FW>HG69_5XS
M8Y\LJSSY&J<%%2*CYW]U;ZJNOH\`'WN$'(066!"P=S,H$+1DUYA@8=<NPM>&
M[S2(B,3;O43K,_J\9L<^659Y\C5."BI%1\[^ZM]577T>`#[W"#D(++`A8.YF
M4"%HR:\PP,.N786O#=YI$1&)MWJ)UF?U>,V.?+*L\^1JG!14BH^=_=6^JKKZ
M/`!][A!R$%E@0L'<S*!"T9->88&'7+L+7AN\TB(C$V[U$ZS/ZO&;'/EE6>?(
MU3@HJ14?._NK?55U]'@47]Q"VQ6X/::]SR;$XJSHAE&=$NY,4Y1M*D[EHZ75
M=8ZUG[OYL>/W6!5_/R\;\ISKCUC1LLS^;C=/YOS--]-0V&U-_:NM/\OPW_#D
M;P)`X#@.`X#@.!__T>_C@0Z/]A^OY84R@,*WG3I*:P9LO6LV'C]FA4R4P]C-
M1^7+'0!*#\=-N9:/-FPJ/OY-2*61T?Z1[%PXREA%%3?4)BX&+FX8.6,%E]>F
M+!25$3L7GPPIBT9"3B%9(<*(EW"3C!*5A7D=,QBCR,?*IZN&CA!RCG;SI*:;
MXUVP%%A+VP>L@AMF99+W,]LC2SB6TV=S2E[6Q)VRQF"!I;4$G#)F$F6/7+D5
MBA&[R2.TCG&BS5PM*.)1QHK,K*2&P?4A/;`Z2#J8_$Q--HI`XTQ!VS*JWA68
MS-6/9"M>OO\`XJ`I-/@TW/24.2%0]UW31%='[_5PLNQ:-%G&5GC-JY1";Z`Z
MITUUIV*'-811%B8,8FNQP@)#$U+#XE>"E1"NH55XCI-E\O+OFHR#CN5M&;1+
M;33=V]>/E_G/WSQRN$'>[%_Q9>Y9_H`[D?[=;&X%OZF_M76G^7X;_AR-X$@<
M!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`J!WU[-J]0>IEPWG$
M0O\`5A]!P;$6ID#3TV6=6/?-DS<;7='5VS;)[Z+N%#*TRB*8J>3[46RJJVV=
M4T]]M0]SHQUHQU#ZJ4]0[V:_JLQ&1]S.VP<[X3RXL6[C^7D3^Z[$<J:-&6RB
MAO:1-+2.GG3QNFBXT3S_`/!C@6SX#@.`X#@.`X#@.`X#@.`X#@.`X#@:=NT]
M661T>N@M]QKJD'31R"&6L>\]Q3JJ(H[.I2W`X7A_PUEVGI*'W6W02[(TX.--
M=92'9I)9L4<;^CWS^+,XU7<-H]3VO7%ZUH#7'4)A"V!6-E#,48`QF/.,N8@A
M'9IKH[CY!KOOHDNCMLGOY54%M$G#9;7=)9--73?34)"X#@.`X%`/=B_XLO<L
M_P!`'<C_`&ZV-P+?U-_:NM/\OPW_``Y&\"0.`X#@.`X#@?_2[^.!P_\`3/J-
M88[:/6GL&][&S=-^WF9^X?4+&M*BD.C]3]9[V[.637BQPWZOW#9$K%DR,E8(
M?9[\@:H.S6,;O9XS8K(R<M#LDDW<C%!W`<!P'`<!P*`>[%_Q9>Y9_H`[D?[=
M;&X%OZF_M76G^7X;_AR-X$@<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!
MP'`<!P'`U'VXHGV[]SZEZ";YVDJ=]NH9B^WUXI:_+4B93M%:T:2@W40"DL?.
M2<*/J^!]"X^72QJHF@\4'7&WAMLGP-N'`<!P'`<!P'`<!P'`<!P'`<!P'`<!
MP'`T?V+&27M!6X5=A0F/?/?;#O0V=E7:>MH=HN]VZ.7$9RC-*4[5UM$-$WLB
MMUVL.9<XWL8;8HX3%Y!78E8)X:J2S?4-V49)QLW&Q\S#2#&7AY=BTDXF6C';
M=_&R<:_;INV,A'OFBBK5ZQ>M5=%$E4]]DU$]L;:YSC.,\#WN`X#@4`]V+_BR
M]RS_`$`=R/\`;K8W`M_4W]JZT_R_#?\`#D;P)`X#@.`X#@.!_]/MH[/%79T0
M"P^0ZIU17]P'#ZV*^A#0?L4Z4`(J#J*7E=VEA&T5*IMW'XD0"<?LFY089QYG
M2>%?EZJJZIH*AQO=#^EUOW9W"HGW)ZB]MOJ`C4TGV;C954TK_N99-G05)IJV
MYJ*W4<`'7:4)V%>P5@#*'XIE=DW5=14`\3V=Q;'91JTQP.['@8;8I'.!]?'9
M<,!\E89*+!I.1CP!#/&T?+G,Y"0CZ3B0^*?O==V;&2)G[5-D@LMC*22J^NVV
M,ZXSP-*])>Y_V4O3J797:`/KKJ)B%I;\WB:[-BR\K5!7-*#]29,G196-JUJ\
MI>=ML%N\4AQM!\LVF8N,92,4YU>YUCU=]6&`Q6QO>E-Z.JD\[%W3U\B1JG^O
MMA5[UZ[*#424R\E9HO?13TK%>VA8Z"<.H9@PFP$+*+!@`75L[9-9-^N[=S&=
MVR+#5B\#83T][861=5AVW25U@(F$6Q5-3]7;Q?Y`)V2GP]P%]JANP7L".ZNY
MANVD%"BOC2HB:&?.==<-)9HV92:*;3+U2/9!5[W4^[73.4]M_P!QVOXOMMUF
ME#R4Z3=O`N,"(R]ZND#"0,)"B[!@6(LQ&692M-NB)U-K:--&6B&SC9QMA/R>
M;[.!?+KUV,HT[ZSC=M!MG"I+6H6$PK(H-(A]L\@H=U`!\%(S*+EVDEG&VT<R
M?(J*>3&^,:[X_P#7/CC@2(+]AJ4-:])K7%;''9RN@U:2;E!<R6<;1,*M#QK&
M8DTWJF[?1779E&2:"V_AIGPT5UX`7[#4H:UZ36N*V..SE=!JTDW*"YDLXVB8
M5:'C6,Q)IO5-V^BNNS*,DT%M_#3/AHKKP`OV&I0UKTFM<5L<=G*Z#5I)N4%S
M)9QM$PJT/&L9B33>J;M]%==F49)H+;^&F?#177@!?L-2AK7I-:XK8X[.5T&K
M23<H+F2SC:)A5H>-8S$FF]4W;Z*Z[,HR306W\-,^&BNO`"_8:E#6O2:UQ6QQ
MV<KH-6DFY07,EG&T3"K0\:QF)--ZINWT5UV91DF@MOX:9\-%=>`%^PU*&M>D
MUKBMCCLY70:M)-R@N9+.-HF%6AXUC,2:;U3=OHKKLRC)-!;?PTSX:*Z\`+]A
MJ4-:])K7%;''9RN@U:2;E!<R6<;1,*M#QK&8DTWJF[?1779E&2:"V_AIGPT5
MUX`7[#4H:UZ36N*V..SE=!JTDW*"YDLXVB85:'C6,Q)IO5-V^BNNS*,DT%M_
M#3/AHKKP`OV&I0UKTFM<5L<=G*Z#5I)N4%S)9QM$PJT/&L9B33>J;M]%==F4
M9)H+;^&F?#177@!?L-2AK7I-:XK8X[.5T&K23<H+F2SC:)A5H>-8S$FF]4W;
MZ*Z[,HR306W\-,^&BNO`"_8:E#6O2:UQ6QQV<KH-6DFY07,EG&T3"K0\:QF)
M--ZINWT5UV91DF@MOX:9\-%=>`%^PU*&M>DUKBMCCLY70:M)-R@N9+.-HF%6
MAXUC,2:;U3=OHKKLRC)-!;?PTSX:*Z\`+]AJ4-:])K7%;''9RN@U:2;E!<R6
M<;1,*M#QK&8DTWJF[?1779E&2:"V_AIGPT5UX`7[#4H:UZ36N*V..SE=!JTD
MW*"YDLXVB85:'C6,Q)IO5-V^BNNS*,DT%M_#3/AHKKP`OV&I0UKTFM<5L<=G
M*Z#5I)N4%S)9QM$PJT/&L9B33>J;M]%==F49)H+;^&F?#177@!?L-2AK7I-:
MXK8X[.5T&K23<H+F2SC:)A5H>-8S$FF]4W;Z*Z[,HR306W\-,^&BNO`"_8:E
M#6O2:UQ6QQV<KH-6DFY07,EG&T3"K0\:QF)--ZINWT5UV91DF@MOX:9\-%=>
M`%^PU*&M>DUKBMCCLY70:M)-R@N9+.-HF%6AXUC,2:;U3=OHKKLRC)-!;?PT
MSX:*Z\`+]AJ4-:])K7%;''9RN@U:2;E!<R6<;1,*M#QK&8DTWJF[?1779E&2
M:"V_AIGPT5UX`7[#4H:UZ36N*V..SE=!JTDW*"YDLXVB85:'C6,Q)IO5-V^B
MNNS*,DT%M_#3/AHKKP`OV&I0UKTFM<5L<=G*Z#5I)N4%S)9QM$PJT/&L9B33
M>J;M]%==F49)H+;^&F?#177@!?L-2AK7I-:XK8X[.5T&K23<H+F2SC:)A5H>
M-8S$FF]4W;Z*Z[,HR306W\-,^&BNO`"_8:E#6O2:UQ6QQV<KH-6DFY07,EG&
MT3"K0\:QF)--ZINWT5UV91DF@MOX:9\-%=>`%^PU*&M>DUKBMCCLY70:M)-R
M@N9+.-HF%6AXUC,2:;U3=OHKKLRC)-!;?PTSX:*Z\`+]AJ4-:])K7%;''9RN
M@U:2;E!<R6<;1,*M#QK&8DTWJF[?1779E&2:"V_AIGPT5UX`7[#4H:UZ36N*
MV..SE=!JTDW*"YDLXVB85:'C6,Q)IO5-V^BNNS*,DT%M_#3/AHKKP,1E^WG7
M>*H2UNS.EF0<M3%*CY<1V&8Q&ZKAI"LP@;1*Y]OY%]&VZT@C#.4=TTL?_6;+
MIZXSX[<"B'M-$`JTZ>6#V^LXF@T+8[.6@==J>U4IL[>O,5@2F$1`O@REI5Z\
M1V>H-^NU`MA04]-IYVZ*D8LHGCQ6WSL&QT7[#4H:UZ36N*V..SE=!JTDW*"Y
MDLXVB85:'C6,Q)IO5-V^BNNS*,DT%M_#3/AHKKP`OV&I0UKTFM<5L<=G*Z#5
MI)N4%S)9QM$PJT/&L9B33>J;M]%==F49)H+;^&F?#177@!?L-2AK7I-:XK8X
M[.5T&K23<H+F2SC:)A5H>-8S$FF]4W;Z*Z[,HR306W\-,^&BNO`"_8:E#6O2
M:UQ6QQV<KH-6DFY07,EG&T3"K0\:QF)--ZINWT5UV91DF@MOX:9\-%=>`%^P
MU*&M>DUKBMCCLY70:M)-R@N9+.-HF%6AXUC,2:;U3=OHKKLRC)-!;?PTSX:*
MZ\`+]AJ4-:])K7%;''9RN@U:2;E!<R6<;1,*M#QK&8DTWJF[?1779E&2:"V_
MAIGPT5UX`7[#4H:UZ36N*V..SE=!JTDW*"YDLXVB85:'C6,Q)IO5-V^BNNS*
M,DT%M_#3/AHKKP`OV&I0UKTFM<5L<=G*Z#5I)N4%S)9QM$PJT/&L9B33>J;M
M]%==F49)H+;^&F?#177@!?L-2AK7I-:XK8X[.5T&K23<H+F2SC:)A5H>-8S$
MFF]4W;Z*Z[,HR306W\-,^&BNO`"_8:E#6O2:UQ6QQV<KH-6DFY07,EG&T3"K
M0\:QF)--ZINWT5UV91DF@MOX:9\-%=>`%^PU*&M>DUKBMCCLY70:M)-R@N9+
M.-HF%6AXUC,2:;U3=OHKKLRC)-!;?PTSX:*Z\`+]AJ4-:])K7%;''9RN@U:2
M;E!<R6<;1,*M#QK&8DTWJF[?1779E&2:"V_AIGPT5UX`7[#4H:UZ36N*V..S
ME=!JTDW*"YDLXVB85:'C6,Q)IO5-V^BNNS*,DT%M_#3/AHKKP`OV&I0UKTFM
M<5L<=G*Z#5I)N4%S)9QM$PJT/&L9B33>J;M]%==F49)H+;^&F?#177@!?L-2
MAK7I-:XK8X[.5T&K23<H+F2SC:)A5H>-8S$FF]4W;Z*Z[,HR306W\-,^&BNO
M`"_8:E#6O2:UQ6QQV<KH-6DFY07,EG&T3"K0\:QF)--ZINWT5UV91DF@MOX:
M9\-%=>`%^PU*&M>DUKBMCCLY70:M)-R@N9+.-HF%6AXUC,2:;U3=OHKKLRC)
M-!;?PTSX:*Z\`+]AJ4-:])K7%;''9RN@U:2;E!<R6<;1,*M#QK&8DTWJF[?1
M779E&2:"V_AIGPT5UX`7[#4H:UZ36N*V..SE=!JTDW*"YDLXVB85:'C6,Q)I
MO5-V^BNNS*,DT%M_#3/AHKKP/1BKSH&T*K-SV.-@\SJ*#;SL(?3"R7XD+H,V
MT*U>D45.M7K/9)VS_`IA+9RCNDHFH@OY=L9QG..!I;H3L75WME3Z(-I9[$R]
MHVQ#I\)=?+O5?R4LPZ%W-+:Z$6>I=FRCEJ\F5>OQCF8U7KTD?*Y2&7;C0:>J
M8;J1*W`W9"_8:E#6O2:UQ6QQV<KH-6DFY07,EG&T3"K0\:QF)--ZINWT5UV9
M1DF@MOX:9\-%=>`%^PU*&M>DUKBMCCLY70:M)-R@N9+.-HF%6AXUC,2:;U3=
MOHKKLRC)-!;?PTSX:*Z\`+]AJ4-:])K7%;''9RN@U:2;E!<R6<;1,*M#QK&8
MDTWJF[?1779E&2:"V_AIGPT5UX%&/<8N>K;A]H_W-BZLC:%,QMET>[D"[N8A
MU5E6:!!GK@9+XBM]E44=\.OE3;3;P\/#P7U^W_U\`V&U-_:NM/\`+\-_PY&\
M"0.`X#@.`X#@?__4[+>^G<!/H_UVG+M:4Q:G8PQW)!,#K6B*5@W1!95IV`:R
MR<9"#8\Q9LI)PFF@WPX?O5]&SE1!@R6W3075QHBH'/'[2_MYDUOTI0U_H]^?
M<QI[\I>S4,2W3T,[&[QH?5`K<U?W?#6F?U-,4IAO`24`.EQ4_P!)0=US(JY:
M;2S%VLV<+Z*,]PZY^!BYN+('067A+J7(!]J8B\^+.9X3E-X,JA$"&)=Q*TN-
M32::RD.01J;O*S)UKIOENYTT4QC.=?#@:^`/VPJM'0GL(,G%JVQ:1)VDL@,-
M+OL68;5:)D9V+U[<DS;(]6$Q#`-;C8+L+D+4BDX(G<I1*,G+Q<R^2:N(Q#6*
M;Q0>]</M;];;V,[*F+)?V%-UG<MG-KLMCKOK)"36F#RX6?7Q3K*C8,P@@%ZV
M*C)*UBA&Y79MB)"*7F(./D=FOJ4W.[H)NZT]0`OK3,&Y9'GEF6L?6`'TU71!
M8-KO0MV4*5[0(W-#E6!Z60,(`8;:/@MBJ;DEEUF:KYY+3KY=5?*>Z**`1G[L
M7_%E[EG^@#N1_MUL;@6_J;^U=:?Y?AO^'(W@2!P'`<!P'`<!P'`<!P'`<!P'
M`<!P'`<!P'`<!P'`<!P'`U&>XRE_Y/7/U,]M:-V3>#=S&&O9WMNUU^\)(]1.
MKY.+D>P5.-M6^_RX^_K\?"@QOKNLCJ\A$IM+P5TU4TX&W/@.`X#@.`X#@.`X
M#@.`X#@.`X#@.`X#@.`X$>VQ5%<7K6AS3EO!\+8%8V4,RH><AA"WRYB"$=FF
MN[20CW6FFZ2Z.VR>_F271W2<-EM=%45$U=--]0U>=7;6L;I%=0E[=':TOFC<
M&--9-K[=_:LL6PXD+>$1F+WE'O5FZ)1NUU:L^QM-C+7_`.ZI9VJG^8@XV]8G
MC$JSD4-@W"\!P*`>[%_Q9>Y9_H`[D?[=;&X%OZF_M76G^7X;_AR-X$@<!P'`
M<!P'`__5["?<0Z2*]^Z*A:,3O.T.NFC*T!&PU[2I:3V@;4B4A-G/:88!9'JL
MG@>D)9>4T17=;:+XPRV73^7ME3&<!J,J3_KFPM!W)5MX17N:=^['=@G8.F;K
M(:_ONVFAG5=IS0`:@CG1L=C[9C!JSQ(]A!)DPB'RZZJK-ZTC]O*JFV31R'3%
MP'`<!P'`H![L7_%E[EG^@#N1_MUL;@6_J;^U=:?Y?AO^'(W@2!P'`<!P'`<!
MP'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P/&LLDW2577530003W6666WU32123U
MSNHJJIOG71--/37.=MLYQC&,>.>!J2]L;5;L46=H_<PG=-G"/;@^;5SUHV=:
M8WV@^D/6J2)@BFG,/E95RLQ8W6=2)98JV$]M$G:).RSX;:((;8#;CP'`<!P'
M`<!P'`<!P'`<!P'`<!P'`<!P'`<!P*[]I^KU2]Q*3*Z*N6)>/!DB]#)P\_!O
M=H8VKHY'W6DJ$VA6Y,AIN]$[$`2!!&0B9%'QRBX2QJIHJANJBH%0.E/9ZV1^
MS)WV_>[LFS7[<5B-O2RL;?;1ND&(]X.O$5(-XAA?(>Q:LT(0:M`=5>-6%A!Z
M"RJD++;ZO6GS8I\V43#:/P*`>[%_Q9>Y9_H`[D?[=;&X%OZF_M76G^7X;_AR
M-X$@<!P'`<!P'`__UNT;N;?ER]<J>2/:%ZKG7<6QWID."L93-?E$2%2SAG,X
M?*R1,_+2",DQZ`A1]LQSLLL^^0AMNHFEA7511/7<.-&FH;W5#[M]T('^P=.]
MT(SI)079OK<`4($2G8WJP=1@-:@+9$7+6%)=A5:/@<$E^-ZSK\4FTHF/5BV+
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M8;:M,)9<9<9^7C3S_9P+QT7;-6$M&"Q6.677\^+!]?CO]6DL(9#DK`"WX0'Q
MTE*_U',L9)>.A/PR.QZAQZE1+Y*/Q[^&OV\#/!^WJF+1J>,Q6T*[)@\63>K$
MY6/FHU-#0XE&L,2LBK/3L;)N8N(381>?4K[.%4\)-_J;>&GV\`/V]4Q:-3QF
M*VA79,'BR;U8G*Q\U&IH:'$HUAB5D59Z=C9-S%Q";"+SZE?9PJGA)O\`4V\-
M/MX`?MZIBT:GC,5M"NR8/%DWJQ.5CYJ-30T.)1K#$K(JST[&R;F+B$V$7GU*
M^SA5/"3?ZFWAI]O`#]O5,6C4\9BMH5V3!XLF]6)RL?-1J:&AQ*-88E9%6>G8
MV3<Q<0FPB\^I7V<*IX2;_4V\-/MX`?MZIBT:GC,5M"NR8/%DWJQ.5CYJ-30T
M.)1K#$K(JST[&R;F+B$V$7GU*^SA5/"3?ZFWAI]O`#]O5,6C4\9BMH5V3!XL
MF]6)RL?-1J:&AQ*-88E9%6>G8V3<Q<0FPB\^I7V<*IX2;_4V\-/MX`?MZIBT
M:GC,5M"NR8/%DWJQ.5CYJ-30T.)1K#$K(JST[&R;F+B$V$7GU*^SA5/"3?ZF
MWAI]O`#]O5,6C4\9BMH5V3!XLF]6)RL?-1J:&AQ*-88E9%6>G8V3<Q<0FPB\
M^I7V<*IX2;_4V\-/MX`?MZIBT:GC,5M"NR8/%DWJQ.5CYJ-30T.)1K#$K(JS
MT[&R;F+B$V$7GU*^SA5/"3?ZFWAI]O`#]O5,6C4\9BMH5V3!XLF]6)RL?-1J
M:&AQ*-88E9%6>G8V3<Q<0FPB\^I7V<*IX2;_`%-O#3[>`'[>J8M&IXS%;0KL
MF#Q9-ZL3E8^:C4T-#B4:PQ*R*L].QLFYBXA-A%Y]2OLX53PDW^IMX:?;P`_;
MU3%HU/&8K:%=DP>+)O5B<K'S4:FAH<2C6&)615GIV-DW,7$)L(O/J5]G"J>$
MF_U-O#3[>`'[>J8M&IXS%;0KLF#Q9-ZL3E8^:C4T-#B4:PQ*R*L].QLFYBXA
M-A%Y]2OLX53PDW^IMX:?;P`_;U3%HU/&8K:%=DP>+)O5B<K'S4:FAH<2C6&)
M615GIV-DW,7$)L(O/J5]G"J>$F_U-O#3[>`'[>J8M&IXS%;0KLF#Q9-ZL3E8
M^:C4T-#B4:PQ*R*L].QLFYBXA-A%Y]2OLX53PDW^IMX:?;P`_;U3%HU/&8K:
M%=DP>+)O5B<K'S4:FAH<2C6&)615GIV-DW,7$)L(O/J5]G"J>$F_U-O#3[>`
M'[>J8M&IXS%;0KLF#Q9-ZL3E8^:C4T-#B4:PQ*R*L].QLFYBXA-A%Y]2OLX5
M3PDW^IMX:?;P`_;U3%HU/&8K:%=DP>+)O5B<K'S4:FAH<2C6&)615GIV-DW,
M7$)L(O/J5]G"J>$F_P!3;PT^W@!^WJF+1J>,Q6T*[)@\63>K$Y6/FHU-#0XE
M&L,2LBK/3L;)N8N(381>?4K[.%4\)-_J;>&GV\`/V]4Q:-3QF*VA79,'BR;U
M8G*Q\U&IH:'$HUAB5D59Z=C9-S%Q";"+SZE?9PJGA)O]3;PT^W@!^WJF+1J>
M,Q6T*[)@\63>K$Y6/FHU-#0XE&L,2LBK/3L;)N8N(381>?4K[.%4\)-_J;>&
MGV\`/V]4Q:-3QF*VA79,'BR;U8G*Q\U&IH:'$HUAB5D59Z=C9-S%Q";"+SZE
M?9PJGA)O]3;PT^W@!^WJF+1J>,Q6T*[)@\63>K$Y6/FHU-#0XE&L,2LBK/3L
M;)N8N(381>?4K[.%4\)-_J;>&GV\`/V]4Q:-3QF*VA79,'BR;U8G*Q\U&IH:
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M)@\63>K$Y6/FHU-#0XE&L,2LBK/3L;)N8N(381>?4K[.%4\)-_J;>&GV\`/V
M]4Q:-3QF*VA79,'BR;U8G*Q\U&IH:'$HUAB5D59Z=C9-S%Q";"+SZE?9PJGA
M)O\`4V\-/MX`?MZIBT:GC,5M"NR8/%DWJQ.5CYJ-30T.)1K#$K(JST[&R;F+
MB$V$7GU*^SA5/"3?ZFWAI]O`#]O5,6C4\9BMH5V3!XLF]6)RL?-1J:&AQ*-8
M8E9%6>G8V3<Q<0FPB\^I7V<*IX2;_4V\-/MX`?MZIBT:GC,5M"NR8/%DWJQ.
M5CYJ-30T.)1K#$K(JST[&R;F+B$V$7GU*^SA5/"3?ZFWAI]O`#]O5,6C4\9B
MMH5V3!XLF]6)RL?-1J:&AQ*-88E9%6>G8V3<Q<0FPB\^I7V<*IX2;_4V\-/M
MX`?MZIBT:GC,5M"NR8/%DWJQ.5CYJ-30T.)1K#$K(JST[&R;F+B$V$7GU*^S
MA5/"3?ZFWAI]O`#]O5,6C4\9BMH5V3!XLF]6)RL?-1J:&AQ*-88E9%6>G8V3
M<Q<0FPB\^I7V<*IX2;_4V\-/MX`?MZIBT:GC,5M"NR8/%DWJQ.5CYJ-30T.)
M1K#$K(JST[&R;F+B$V$7GU*^SA5/"3?ZFWAI]O`#]O5,6C4\9BMH5V3!XLF]
M6)RL?-1J:&AQ*-88E9%6>G8V3<Q<0FPB\^I7V<*IX2;_`%-O#3[>`'[>J8M&
MIXS%;0KLF#Q9-ZL3E8^:C4T-#B4:PQ*R*L].QLFYBXA-A%Y]2OLX53PDW^IM
MX:?;P`_;U3%HU/&8K:%=DP>+)O5B<K'S4:FAH<2C6&)615GIV-DW,7$)L(O/
MJ5]G"J>$F_U-O#3[>`'[>J8M&IXS%;0KLF#Q9-ZL3E8^:C4T-#B4:PQ*R*L]
M.QLFYBXA-A%Y]2OLX53PDW^IMX:?;P`_;U3%HU/&8K:%=DP>+)O5B<K'S4:F
MAH<2C6&)615GIV-DW,7$)L(O/J5]G"J>$F_U-O#3[>`'[>J8M&IXS%;0KLF#
MQ9-ZL3E8^:C4T-#B4:PQ*R*L].QLFYBXA-A%Y]2OLX53PDW^IMX:?;P`_;U3
M%HU/&8K:%=DP>+)O5B<K'S4:FAH<2C6&)615GIV-DW,7$)L(O/J5]G"J>$F_
MU-O#3[>`'[>J8M&IXS%;0KLF#Q9-ZL3E8^:C4T-#B4:PQ*R*L].QLFYBXA-A
M%Y]2OLX53PDW^IMX:?;P`_;U3%HU/&8K:%=DP>+)O5B<K'S4:FAH<2C6&)61
M5GIV-DW,7$)L(O/J5]G"J>$F_P!3;PT^W@!^WJF+1J>,Q6T*[)@\63>K$Y6/
MFHU-#0XE&L,2LBK/3L;)N8N(381>?4K[.%4\)-_J;>&GV\`/V]4Q:-3QF*VA
M79,'BR;U8G*Q\U&IH:'$HUAB5D59Z=C9-S%Q";"+SZE?9PJGA)O]3;PT^W@!
M^WJF+1J>,Q6T*[)@\63>K$Y6/FHU-#0XE&L,2LBK/3L;)N8N(381>?4K[.%4
M\)-_J;>&GV\`/V]4Q:-3QF*VA79,'BR;U8G*Q\U&IH:'$HUAB5D59Z=C9-S%
MQ";"+SZE?9PJGA)O]3;PT^W@!^WJF+1J>,Q6T*[)@\63>K$Y6/FHU-#0XE&L
M,2LBK/3L;)N8N(381>?4K[.%4\)-_J;>&GV\"G';6E^OW>^D]IT2O@/#+`Z_
MDFUJT=VUK,F#2>7ZP6X*1>TDD9[2FDFN/.A=>"4W;%0_*+:1DZ..5V[K&F-D
MG"(8/[?'N+B_9X,M,`N>>JL'[6=3?DP_:8<#3V()*N4C-(U21@^PE7&_S&\=
M,T/9T&UWE&CE7?5P/K>HBY/Y3IGMLH'T/<KLBN[,]J+W-Y:N#T+L"+8=#.Y,
M<^D@@I@RN/92&.MU@N<L7;R!?/V[9YANOHI\K?;7?R;Z[>'AG&>!?.IO[5UI
M_E^&_P"'(W@2!P'`<!P'`<#_U^_C@<#O3JZYR0]PB@N@8CV4J$&]O*JNYT9;
M=8VI6O1NR:LDNY-Y`\W(9$P@ZN5S"ZU9)%I9,#[=@Z,8UW'-35PUSAOJYP[:
MMU@[XN!BYO!2I2%EXS!%$H#S9&+S\%#FL&@R<S0?*R\2[CX\HB&TDBXCG$H/
MNW&CMOHNGNCNJCKC?7.N<XR&FJM_:%(*_M:<[/Q%XUZ/]H)/L5:-WZOH*A'6
M_764;V8-7!7I"D8TGBV8@J(38L#;435D9M,Q:.='$##L_%TR8+:R(8(,^P33
M(_0Z/3QW<A-/].YB6KP]L6KY(/9I6*<6S7_4&$Z?ZDNEL,29M'P(:0CX;`%#
MN"T&W"R9-%>9O(HQ[A5AP-C/4WJ%/=?3"S[3L:VV]RVQ9]?]?Z@D2B*K_-90
MK6L.M$$:QM:QR@TJ:6`Y?F#V9LTCE9N6S(I(/G4EJFV8LF[=-+@1;[K]=5\G
M[8GN4S*8(&Z3&G0[N/)Z2V@Q":R6DEKU]L9WK(:OM6.'6K[5UCYF%<;_`#,*
M?%X^/V\"Z-,B8K&4X"Q,:,C\?%S%?BOXO&LH:.:1\IZL6CFSO\19H-DV[[U3
M?Z:GS==O/I\.?''V<#/H\0$XB-?PT4+CL9#RNJ^DG$Q\)&LHV1T<M_2.=7[%
MLV3:O-7#7Z>^%--L;I_#GQQ]G`1X@)Q$:_AHH7'8R'E=5]).)CX2-91LCHY;
M^D<ZOV+9LFU>:N&OT]\*:;8W3^'/CC[.`CQ`3B(U_#10N.QD/*ZKZ2<3'PD:
MRC9'1RW](YU?L6S9-J\U<-?I[X4TVQNG\.?''V<!'B`G$1K^&BA<=C(>5U7T
MDXF/A(UE&R.CEOZ1SJ_8MFR;5YJX:_3WPIIMC=/X<^./LX"/$!.(C7\-%"X[
M&0\KJOI)Q,?"1K*-D='+?TCG5^Q;-DVKS5PU^GOA33;&Z?PY\<?9P$>("<1&
MOX:*%QV,AY75?23B8^$C64;(Z.6_I'.K]BV;)M7FKAK]/?"FFV-T_ASXX^S@
M(\0$XB-?PT4+CL9#RNJ^DG$Q\)&LHV1T<M_2.=7[%LV3:O-7#7Z>^%--L;I_
M#GQQ]G`1X@)Q$:_AHH7'8R'E=5]).)CX2-91LCHY;^D<ZOV+9LFU>:N&OT]\
M*:;8W3^'/CC[.`CQ`3B(U_#10N.QD/*ZKZ2<3'PD:RC9'1RW](YU?L6S9-J\
MU<-?I[X4TVQNG\.?''V<!'B`G$1K^&BA<=C(>5U7TDXF/A(UE&R.CEOZ1SJ_
M8MFR;5YJX:_3WPIIMC=/X<^./LX"/$!.(C7\-%"X[&0\KJOI)Q,?"1K*-D='
M+?TCG5^Q;-DVKS5PU^GOA33;&Z?PY\<?9P$>("<1&OX:*%QV,AY75?23B8^$
MC64;(Z.6_I'.K]BV;)M7FKAK]/?"FFV-T_ASXX^S@(\0$XB-?PT4+CL9#RNJ
M^DG$Q\)&LHV1T<M_2.=7[%LV3:O-7#7Z>^%--L;I_#GQQ]G`1X@)Q$:_AHH7
M'8R'E=5]).)CX2-91LCHY;^D<ZOV+9LFU>:N&OT]\*:;8W3^'/CC[.`CQ`3B
M(U_#10N.QD/*ZKZ2<3'PD:RC9'1RW](YU?L6S9-J\U<-?I[X4TVQNG\.?''V
M<!'B`G$1K^&BA<=C(>5U7TDXF/A(UE&R.CEOZ1SJ_8MFR;5YJX:_3WPIIMC=
M/X<^./LX"/$!.(C7\-%"X[&0\KJOI)Q,?"1K*-D='+?TCG5^Q;-DVKS5PU^G
MOA33;&Z?PY\<?9P$>("<1&OX:*%QV,AY75?23B8^$C64;(Z.6_I'.K]BV;)M
M7FKAK]/?"FFV-T_ASXX^S@(\0$XB-?PT4+CL9#RNJ^DG$Q\)&LHV1T<M_2.=
M7[%LV3:O-7#7Z>^%--L;I_#GQQ]G`1X@)Q$:_AHH7'8R'E=5]).)CX2-91LC
MHY;^D<ZOV+9LFU>:N&OT]\*:;8W3^'/CC[.`CQ`3B(U_#10N.QD/*ZKZ2<3'
MPD:RC9'1RW](YU?L6S9-J\U<-?I[X4TVQNG\.?''V<!'B`G$1K^&BA<=C(>5
MU7TDXF/A(UE&R.CEOZ1SJ_8MFR;5YJX:_3WPIIMC=/X<^./LX"/$!.(C7\-%
M"X[&0\KJOI)Q,?"1K*-D='+?TCG5^Q;-DVKS5PU^GOA33;&Z?PY\<?9P$>("
M<1&OX:*%QV,AY75?23B8^$C64;(Z.6_I'.K]BV;)M7FKAK]/?"FFV-T_ASXX
M^S@(\0$XB-?PT4+CL9#RNJ^DG$Q\)&LHV1T<M_2.=7[%LV3:O-7#7Z>^%--L
M;I_#GQQ]G`U'=9@P.[/^X;VC[+M18?Q2/4&'F^@G7R-9PL0W&)^U)=6!,>\U
MF(Q>K#1)V\_&V(K6^CS'PXP)3+;7.VBZV-@VXQX@)Q$:_AHH7'8R'E=5]).)
MCX2-91LCHY;^D<ZOV+9LFU>:N&OT]\*:;8W3^'/CC[.`CQ`3B(U_#10N.QD/
M*ZKZ2<3'PD:RC9'1RW](YU?L6S9-J\U<-?I[X4TVQNG\.?''V<!'B`G$1K^&
MBA<=C(>5U7TDXF/A(UE&R.CEOZ1SJ_8MFR;5YJX:_3WPIIMC=/X<^./LX"/$
M!.(C7\-%"X[&0\KJOI)Q,?"1K*-D='+?TCG5^Q;-DVKS5PU^GOA33;&Z?PY\
M<?9P$>("<1&OX:*%QV,AY75?23B8^$C64;(Z.6_I'.K]BV;)M7FKAK]/?"FF
MV-T_ASXX^S@(\0$XB-?PT4+CL9#RNJ^DG$Q\)&LHV1T<M_2.=7[%LV3:O-7#
M7Z>^%--L;I_#GQQ]G`1X@)Q$:_AHH7'8R'E=5]).)CX2-91LCHY;^D<ZOV+9
MLFU>:N&OT]\*:;8W3^'/CC[.`CQ`3B(U_#10N.QD/*ZKZ2<3'PD:RC9'1RW]
M(YU?L6S9-J\U<-?I[X4TVQNG\.?''V<!'B`G$1K^&BA<=C(>5U7TDXF/A(UE
M&R.CEOZ1SJ_8MFR;5YJX:_3WPIIMC=/X<^./LX"/$!.(C7\-%"X[&0\KJOI)
MQ,?"1K*-D='+?TCG5^Q;-DVKS5PU^GOA33;&Z?PY\<?9P$>("<1&OX:*%QV,
MAY75?23B8^$C64;(Z.6_I'.K]BV;)M7FKAK]/?"FFV-T_ASXX^S@(\0$XB-?
MPT4+CL9#RNJ^DG$Q\)&LHV1T<M_2.=7[%LV3:O-7#7Z>^%--L;I_#GQQ]G`1
MX@)Q$:_AHH7'8R'E=5]).)CX2-91LCHY;^D<ZOV+9LFU>:N&OT]\*:;8W3^'
M/CC[.`CQ`3B(U_#10N.QD/*ZKZ2<3'PD:RC9'1RW](YU?L6S9-J\U<-?I[X4
MTVQNG\.?''V<!'B`G$1K^&BA<=C(>5U7TDXF/A(UE&R.CEOZ1SJ_8MFR;5YJ
MX:_3WPIIMC=/X<^./LX"/$!.(C7\-%"X[&0\KJOI)Q,?"1K*-D='+?TCG5^Q
M;-DVKS5PU^GOA33;&Z?PY\<?9P$>("<1&OX:*%QV,AY75?23B8^$C64;(Z.6
M_I'.K]BV;)M7FKAK]/?"FFV-T_ASXX^S@(\0$XB-?PT4+CL9#RNJ^DG$Q\)&
MLHV1T<M_2.=7[%LV3:O-7#7Z>^%--L;I_#GQQ]G`1X@)Q$:_AHH7'8R'E=5]
M).)CX2-91LCHY;^D<ZOV+9LFU>:N&OT]\*:;8W3^'/CC[.`CQ`3B(U_#10N.
MQD/*ZKZ2<3'PD:RC9'1RW](YU?L6S9-J\U<-?I[X4TVQNG\.?''V<!'B`G$1
MK^&BA<=C(>5U7TDXF/A(UE&R.CEOZ1SJ_8MFR;5YJX:_3WPIIMC=/X<^./LX
M"/$!.(C7\-%"X[&0\KJOI)Q,?"1K*-D='+?TCG5^Q;-DVKS5PU^GOA33;&Z?
MPY\<?9P$>("<1&OX:*%QV,AY75?23B8^$C64;(Z.6_I'.K]BV;)M7FKAK]/?
M"FFV-T_ASXX^S@(\0$XB-?PT4+CL9#RNJ^DG$Q\)&LHV1T<M_2.=7[%LV3:O
M-7#7Z>^%--L;I_#GQQ]G`1X@)Q$:_AHH7'8R'E=5]).)CX2-91LCHY;^D<ZO
MV+9LFU>:N&OT]\*:;8W3^'/CC[.!KX[I]#T[48"5X=5TP6E^Z%"(STA3!LH.
M,6@'90].-DL''6?L)$13/38LH*Z6K)%G)XRFL^@'NC>8C?!TTRDX"J%[=FZT
M[-^RY[HDJ,5UK1ELUUTJ[I5QV9ZZ2;",C3*BKR@^LYUL2!9'K%LV#,BB7#=9
M%Z/D39/\/)(!PU?M<XT5RDD&YBIO[5UI_E^&_P"'(W@9XBLDX2270537073T
M6161WU42624UQNFJDIIG;11-33;&==L9SC.,^..!Y.`X#@.`X'__T.Z*\+24
MI*ICFV-*UM*W]0.%VGW5<TH.1QA:A)'MG+?223"A.2G!Q,GEHV/55>?AZ#KU
M[Q%ONDR1<N]T&RP<1O0V[V=P=HNEL\"+^_:64B=795TS"]3K?8&K[HU2`\BL
MXG@Z71O1"(0WM&F.OY?'1$G`L'\;$M]HZ*;Y7=*Y:8T<AWD<!P'`<!P*`>[%
M_P`67N6?Z`.Y'^W6QN!;^IO[5UI_E^&_X<C>!('`<!P'`<!P'`<!P'`<!P'`
M<!P'`<!P'`<!P'`<!P*8>X)V4FNJ74ZT;2"(M,DN.1;PE6]=@K;TBBIWV/N&
M>CJTHP3T:O%D4W3-_9!/'J2&,9SE&+1=+YQG1+;@9=TLZSPW3SJS2G7&(E5B
M1S6P:V:%YF[V<;R%A69.NG93:ME2N[M59SM+6-9,Y*S;G&^^WE6?[:X\-<8Q
M@+0\!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P.#7_M]]B33J/95
M+_\`C?\`B52GW=3K5?E$]K["@FK!2+OKK\V6$1V'JLNAIF*DX&5FA=$NF,-I
MU'1`BAX^7RU;.TVSG.G`C?V,/=>[9^X-U=[Q])NW/8HE'F`%3M:3%6=O603%
MNIZH8DFM,4J]R,6U_3FXDT,*Q5>D#!>37>N&#Q`31G\.Y5-KHBLQ"X$3-+6G
MT/Z_ZQY35`'<]"RAG*A'1!64)+'HOW*U&8SU^&Y&:Z^)(%%?60,-Y1[).HC1
MC#*2T>+&DM/INT7S!/+K(;<@%E6T?[JEUE]<6%7I50Q;U>[0B/:0BKN[K#2)
MJ0N.N[BJ^4)M^TTTJ7O1L,)FS,GFHRO<(N!J8$QR'E=6.JT=K\R/"UOLSD,@
M3^U9T)E)N<>$)-GK)5C0OD9636EIW)>R&V;<E;$CMVNXD/ZD:2^BJ;[1UMZI
M-SC?57&-\9QP-F?`<!P/_]'K']T],H;T56Q,PB^XL[6X+?H<9W[!="RBR!GL
MY.U'$!UAIZ0@8E4IF#V`1#LO:#L9;DS&,>;.]1E1^[0U37:I.FX<\?35/O,1
MW4(>X!V_.?</J+L/VO[UU"*]3^D"*5\/J+J7I#M;0@%V9GLN#*C4J!!K-Y3T
MG-Z,5296'DE)J+8SVGSG,ANMH':;P,3/3<:K,&,[(,WZD6'U\)D1N5R:+%_*
M*QPT*0[R>G7Z49%-GLI(J-(M@JIJ@V16<+9U\B>FV^<:Y#6=K[OO7=A00OV!
M+`FS@V!L>R8JLJ<'YZ6HUD]NB7(G]B(C[BMCA[<S*F9?5Q&59-N7+=<H:N4-
MV6$4]%]G<;L^#,"GW4>N]=S<LTM07MJK1(,GANO;;M,RB0'\N*5NXBZZK=I=
MJ%L:5'+'(9G\QH"I=F:LBZA8^9%D)258QVLPH\<:HX"?.LO<`$[//#2!A@FS
M:N-P,=JDXG*_MN)%(LKS7=XC4@3U18#/`29'D#N.F*,#+LTTE'Z4FRDH1\V>
MM&RB.,;A&/NQ?\67N6?Z`.Y'^W6QN!;^IO[5UI_E^&_X<C>!('`<!P'`<!P'
M`<!P'`<!P'`<!P'`<!P'`<!P'`<!P-1A]KOVZ]U2N*OPFH_I+VRP=IV"L;3?
M+C:&G>YO8$>FA/K^+NVBVFK%](4Q0S@C+%-L?,W9O"Z#6U\-_MU#;GP'`<!P
M'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<#2K[^W2GK?VW]M/M087E7S
M<H,^J_6SLGV`H<O;2$A#$8!8P/39,5,W#"1C7#?9Z/SCX79)RT6ZPNQD$FZ6
M5$_G(-U4@F?VL/;"Z=^VS2&D;U:KMX/3=QP8056H>%$_(%AT=23*$W7AVTK-
M2&VJ#*#'\S;OT,<P;LV*&[E97Y65UUE5`V;QT='Q$>QB8EBSBXN+9MHZ-C8Y
MLBRCXZ/9(Z-F;%BS;:)-VC-HW2U3223UUT3TUQKKC&,8QP/<X#@.`X#@?__2
M[1^Y=U=BJ)J)J6=6>ILEW1N&4,H,9AZ486V,T6W<1;YI+24X42]IFL`0!XM&
MC\?$;9QF1U;HO'*J+5-;#E=!)4-*%'>]1[AUQR/4HM,/:;%:`ZR]F>P58T_K
MV+?=^Z-O3#!H<EVXDJE$T^(0($?JS3B3T^0DX7\$F6=M55&SC7=)-0.F#@8J
M=1I1,A!C$`\]&BQK*BI#&B!/,P>I/$#A0^B'C4?GI4:V>QNI#&Q$LJBX78Y<
M-\.TD]DOF:>?S8#1S47MCWE65:=D:W8`?39U57:2RK'DB/JZ6[6.14%2\01;
MV@T;V%2\'N/NQYA-$^Q5"+2`LR@!B+VC1]NEJ];R2[E_J&(GGL<2A]3I_P!-
MINZ6;_JE;MB5Q<UAF#EI))WVN;5YT<#>G']+1<?JV6$]A\BFZN&C9684D]'K
M;=%_#>A7T=IRC8-C/3;JS;%0V1<-Z7L2@,M:5JU+U;HE>+K'>>=B*`=U4@[-
M;0A@J_)(@>D$B:R"RXY^4=QB;++6":;,X]-Y);-U'ZX5O]UGISUA:>W3[DMD
M-J7#43IMTJ[B&Z!-HV=XDDBQ&C+%GDIW7?+S*?KM)C7#C&?+Y?F8_P#3P^S@
M7JZW];.OE:]<H*L0*DJK%*\L&OXG\P`N&!1MJ-GW]3!S&*(OZYBM8[+0P_&X
MA7+-U^(ZN?GL_!#?Q2QC3`2,']<NO5>!!968!1%,@U<'R,FW.J_#ZO"!D(-&
M\W$8@)E`L%(6#90)&C+P.,,G6KQNMJX:8^2IC9/X>`#^N77JO`@LK,`HBF0:
MN#Y&3;G5?A]7A`R$&C>;B,0$R@6"D+!LH$C1EX'&&3K5XW6U<-,?)4QLG\/`
M!_7+KU7@065F`413(-7!\C)MSJOP^KP@9"#1O-Q&("90+!2%@V4"1HR\#C#)
MUJ\;K:N&F/DJ8V3^'@`_KEUZKP(+*S`*(ID&K@^1DVYU7X?5X0,A!HWFXC$!
M,H%@I"P;*!(T9>!QADZU>-UM7#3'R5,;)_#P`?URZ]5X$%E9@%$4R#5P?(R;
M<ZK\/J\(&0@T;S<1B`F4"P4A8-E`D:,O`XPR=:O&ZVKAICY*F-D_AX`/ZY=>
MJ\""RLP"B*9!JX/D9-N=5^'U>$#(0:-YN(Q`3*!8*0L&R@2-&7@<89.M7C=;
M5PTQ\E3&R?P\`']<NO5>!!968!1%,@U<'R,FW.J_#ZO"!D(-&\W$8@)E`L%(
M6#90)&C+P.,,G6KQNMJX:8^2IC9/X>`#^N77JO`@LK,`HBF0:N#Y&3;G5?A]
M7A`R$&C>;B,0$R@6"D+!LH$C1EX'&&3K5XW6U<-,?)4QLG\/`!_7+KU7@065
MF`413(-7!\C)MSJOP^KP@9"#1O-Q&("90+!2%@V4"1HR\#C#)UJ\;K:N&F/D
MJ8V3^'@`_KEUZKP(+*S`*(ID&K@^1DVYU7X?5X0,A!HWFXC$!,H%@I"P;*!(
MT9>!QADZU>-UM7#3'R5,;)_#P`?URZ]5X$%E9@%$4R#5P?(R;<ZK\/J\(&0@
MT;S<1B`F4"P4A8-E`D:,O`XPR=:O&ZVKAICY*F-D_AX`/ZY=>J\""RLP"B*9
M!JX/D9-N=5^'U>$#(0:-YN(Q`3*!8*0L&R@2-&7@<89.M7C=;5PTQ\E3&R?P
M\`']<NO5>!!968!1%,@U<'R,FW.J_#ZO"!D(-&\W$8@)E`L%(6#90)&C+P.,
M,G6KQNMJX:8^2IC9/X>`#^N77JO`@LK,`HBF0:N#Y&3;G5?A]7A`R$&C>;B,
M0$R@6"D+!LH$C1EX'&&3K5XW6U<-,?)4QLG\/`!_7+KU7@065F`413(-7!\C
M)MSJOP^KP@9"#1O-Q&("90+!2%@V4"1HR\#C#)UJ\;K:N&F/DJ8V3^'@`_KE
MUZKP(+*S`*(ID&K@^1DVYU7X?5X0,A!HWFXC$!,H%@I"P;*!(T9>!QADZU>-
MUM7#3'R5,;)_#P`?URZ]5X$%E9@%$4R#5P?(R;<ZK\/J\(&0@T;S<1B`F4"P
M4A8-E`D:,O`XPR=:O&ZVKAICY*F-D_AX`/ZY=>J\""RLP"B*9!JX/D9-N=5^
M'U>$#(0:-YN(Q`3*!8*0L&R@2-&7@<89.M7C=;5PTQ\E3&R?P\`']<NO5>!!
M968!1%,@U<'R,FW.J_#ZO"!D(-&\W$8@)E`L%(6#90)&C+P.,,G6KQNMJX:8
M^2IC9/X>`#^N77JO`@LK,`HBF0:N#Y&3;G5?A]7A`R$&C>;B,0$R@6"D+!LH
M$C1EX'&&3K5XW6U<-,?)4QLG\/`!_7+KU7@065F`413(-7!\C)MSJOP^KP@9
M"#1O-Q&("90+!2%@V4"1HR\#C#)UJ\;K:N&F/DJ8V3^'@`_KEUZKP(+*S`*(
MID&K@^1DVYU7X?5X0,A!HWFXC$!,H%@I"P;*!(T9>!QADZU>-UM7#3'R5,;)
M_#P`?URZ]5X$%E9@%$4R#5P?(R;<ZK\/J\(&0@T;S<1B`F4"P4A8-E`D:,O`
MXPR=:O&ZVKAICY*F-D_AX$0V?`=/^D_5?L2;R%-4O6'784K.P[$ND,#ZQ!1@
M/-!N(#'FA-'3HA$0K""+I`G'F.(K1HY;K[R.%$VGE4QOJGD*U^U9TY@Z5Z/)
MQ-J4]6XM8/;^0-^Q'9NIXL)&V()$SG835644HER)(0S6"=!]15D^C`7##=NH
MS6;0ZGP[:+;>8+Y!_7+KU7@065F`413(-7!\C)MSJOP^KP@9"#1O-Q&("90+
M!2%@V4"1HR\#C#)UJ\;K:N&F/DJ8V3^'@`_KEUZKP(+*S`*(ID&K@^1DVYU7
MX?5X0,A!HWFXC$!,H%@I"P;*!(T9>!QADZU>-UM7#3'R5,;)_#P`?URZ]5X$
M%E9@%$4R#5P?(R;<ZK\/J\(&0@T;S<1B`F4"P4A8-E`D:,O`XPR=:O&ZVKAI
MCY*F-D_AX`/ZY=>J\""RLP"B*9!JX/D9-N=5^'U>$#(0:-YN(Q`3*!8*0L&R
M@2-&7@<89.M7C=;5PTQ\E3&R?P\`']<NO5>!!968!1%,@U<'R,FW.J_#ZO"!
MD(-&\W$8@)E`L%(6#90)&C+P.,,G6KQNMJX:8^2IC9/X>`#^N77JO`@LK,`H
MBF0:N#Y&3;G5?A]7A`R$&C>;B,0$R@6"D+!LH$C1EX'&&3K5XW6U<-,?)4QL
MG\/`!_7+KU7@065F`413(-7!\C)MSJOP^KP@9"#1O-Q&("90+!2%@V4"1HR\
M#C#)UJ\;K:N&F/DJ8V3^'@`_KEUZKP(+*S`*(ID&K@^1DVYU7X?5X0,A!HWF
MXC$!,H%@I"P;*!(T9>!QADZU>-UM7#3'R5,;)_#P`?URZ]5X$%E9@%$4R#5P
M?(R;<ZK\/J\(&0@T;S<1B`F4"P4A8-E`D:,O`XPR=:O&ZVKAICY*F-D_AX`/
MZY=>J\""RLP"B*9!JX/D9-N=5^'U>$#(0:-YN(Q`3*!8*0L&R@2-&7@<89.M
M7C=;5PTQ\E3&R?P\`']<NO5>!!968!1%,@U<'R,FW.J_#ZO"!D(-&\W$8@)E
M`L%(6#90)&C+P.,,G6KQNMJX:8^2IC9/X>`#^N77JO`@LK,`HBF0:N#Y&3;G
M5?A]7A`R$&C>;B,0$R@6"D+!LH$C1EX'&&3K5XW6U<-,?)4QLG\/`!_7+KU7
M@065F`413(-7!\C)MSJOP^KP@9"#1O-Q&("90+!2%@V4"1HR\#C#)UJ\;K:N
M&F/DJ8V3^'@`_KEUZKP(+*S`*(ID&K@^1DVYU7X?5X0,A!HWFXC$!,H%@I"P
M;*!(T9>!QADZU>-UM7#3'R5,;)_#P`?URZ]5X$%E9@%$4R#5P?(R;<ZK\/J\
M(&0@T;S<1B`F4"P4A8-E`D:,O`XPR=:O&ZVKAICY*F-D_AX`/ZY=>J\""RLP
M"B*9!JX/D9-N=5^'U>$#(0:-YN(Q`3*!8*0L&R@2-&7@<89.M7C=;5PTQ\E3
M&R?P\`']<NO5>!!968!1%,@U<'R,FW.J_#ZO"!D(-&\W$8@)E`L%(6#90)&C
M+P.,,G6KQNMJX:8^2IC9/X>`#^N77JO`@LK,`HBF0:N#Y&3;G5?A]7A`R$&C
M>;B,0$R@6"D+!LH$C1EX'&&3K5XW6U<-,?)4QLG\/`!_7+KU7@065F`413(-
M7!\C)MSJOP^KP@9"#1O-Q&("90+!2%@V4"1HR\#C#)UJ\;K:N&F/DJ8V3^'@
M`_KEUZKP(+*S`*(ID&K@^1DVYU7X?5X0,A!HWFXC$!,H%@I"P;*!(T9>!QAD
MZU>-UM7#3'R5,;)_#P`?URZ]5X$%E9@%$4R#5P?(R;<ZK\/J\(&0@T;S<1B`
MF4"P4A8-E`D:,O`XPR=:O&ZVKAICY*F-D_AX`/ZY=>J\""RLP"B*9!JX/D9-
MN=5^'U>$#(0:-YN(Q`3*!8*0L&R@2-&7@<89.M7C=;5PTQ\E3&R?P\`']<NO
M5>!!968!1%,@U<'R,FW.J_#ZO"!D(-&\W$8@)E`L%(6#90)&C+P.,,G6KQNM
MJX:8^2IC9/X>`#^N77JO`@LK,`HBF0:N#Y&3;G5?A]7A`R$&C>;B,0$R@6"D
M+!LH$C1EX'&&3K5XW6U<-,?)4QLG\/`!_7+KU7@065F`413(-7!\C)MSJOP^
MKP@9"#1O-Q&("90+!2%@V4"1HR\#C#)UJ\;K:N&F/DJ8V3^'@`_KEUZKP(+*
MS`*(ID&K@^1DVYU7X?5X0,A!HWFXC$!,H%@I"P;*!(T9>!QADZU>-UM7#3'R
M5,;)_#P`?URZ]5X$%E9@%$4R#5P?(R;<ZK\/J\(&0@T;S<1B`F4"P4A8-E`D
M:,O`XPR=:O&ZVKAICY*F-D_AX%%_<0I.FJ.]IKW/!^E*DK&GX"7Z)=R9F5A*
MM`A6OXB3E\]:S]EF5D(T3BHED]DLLFJ2/SU--E?E)Z:>;RZXQ@-AM3?VKK3_
M`"_#?\.1O`D#@.`X#@.`X'__T^_C@?G?]$YGHTS]WH>E8GJQ6<E[@Q'W3")%
M2DJPH7MR.!?6BNRMC8S*^Y0MA+B)6P,+VGU^EWL1/;%D5!Y''BC?3,0QC]'2
MCUF'Z('`<!P'`<"@'NQ?\67N6?Z`.Y'^W6QN!;^IO[5UI_E^&_X<C>!('`<!
MP'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<#4=WYREVB[-]0_;D8;ZOQ,@GD>
MZW;YDG\Q1%#K?UM+H1Y5H).IZNF6N6M\=G=H%IHCYU<NH47G<92VT2VX&W'@
M.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@4`]V+_BR]RS_0!W
M(_VZV-P+?U-_:NM/\OPW_#D;P)`X#@.`X#@.!__4[^.!Q%]6HCW4[,L3I<[[
M%=@IL6ZL4KW#I6NAGI.`7+6=B]J&Q>+&(//0TIW,:))B1Y,5O%"@X1%"X>NK
M)E0,P9HOI*'2CX5R]8AVZ<#X9.2CX6-D)B63$>/"HG!RQ*2S\LY39Q4&/P3!
MQ*3,Q)O%LZI-8^,CFJBZRFV<:Z)Z9VS]F.!3B`]QGJ9.4-;_`&5='9(%U%14
M/+$EC3MG5=9U7R,>-1\H0PT;/PPX?"(]/E4>628N\9Q.L8W=N'4HEO%Y3TED
M7#%$/L37N`]3ANP,UP1VA_3\L@I$Q\L0S0F:1M:C9//5`_[`0@(4VLZ'TZW&
M[`E*3BUB=*%>2B,AB*R@INGKL\8Z.0D#KWVLI/M"Q(7E13Y`^7%FXA)3<(8@
M!]61.T'K%'DRZN"S47L<:%IYP)GXJMA[%R";?9NM\M=MOLF^9O6K<(+]V+_B
MR]RS_0!W(_VZV-P+?U-_:NM/\OPW_#D;P)`X#@.`X#@.`X#@.`X#@.`X#@.`
MX#@.`X#@.`X'KNW;5@U<OGSENR8LFZSMX\=K)MFK1JV3V6<.7+A;;1%!N@CI
MG????.-==<9SG.,8X&J#VN6#R\/_`")]R8G0>:R7>JP&3BCF\DS<,G`WTDI+
M\8!NKS)JS?MDGS!.SF+F:L=QKY\IJJFNOPXRGC.0VS\!P'`<!P'`<!P'`<!P
M'`<!P'`<!P'`<!P'`<!P'`<!P'`<"@'NQ?\`%E[EG^@#N1_MUL;@6_J;^U=:
M?Y?AO^'(W@2!P'`<!P'`<#__U>T7NIW<Z[>WW1S_`+%]H2R4"ZIC20>$W<Y#
MBI&9/4YLI<+-89MK""T=*2VZ;A9#;&RF$LII^'CMG'`X/N@_9GK"2>X9U[HR
MH_<4KN>ZZ&?<.A[!%*EJ?H&1TK==YV=6\L3H5$^OVQ"(6%PO0@R\(T=C$L;2
M+F;+L([8W:?,43TT#]'3@8/9L5/SM;6%!BD2#SQ3,@Y9%#<%9K=Z[K::GY&!
M?M(>)L)K&M7TBY!Y&1631EDVZ"RV[#=7&FF^V<:Y#FX@O:&[?$?6KL120Y;F
M>ME+JSU^S75WI_/D<?V*KT1F3>`N<&CXI<L+!>/F0&J4&A?'/!>*:O)YM!R/
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M_''I1V$OTX+V/XX$QT0]_HRP32RR`]KCY#7/G9_T[)1?X<Z^\M/DN/J\#.@^
MB`@&""ROX6<N9[`FB,FA,/S#L;V%L,W9Z2\1B$=["=F']H$UC@*R3/'G:J04
MK'*,7?WIOLDZ^MP`?1`0#!!97\+.7,]@31&30F'YAV-["V&;L])>(Q".]A.S
M#^T":QP%9)GCSM5(*5CE&+O[TWV2=?6X`/H@(!@@LK^%G+F>P)HC)H3#\P[&
M]A;#-V>DO$8A'>PG9A_:!-8X"LDSQYVJD%*QRC%W]Z;[).OK<`'T0$`P065_
M"SES/8$T1DT)A^8=C>PMAF[/27B,0CO83LP_M`FL<!629X\[52"E8Y1B[^]-
M]DG7UN`#Z("`8(+*_A9RYGL":(R:$P_,.QO86PS=GI+Q&(1WL)V8?V@36.`K
M),\>=JI!2L<HQ=_>F^R3KZW`!]$!`,$%E?PLY<SV!-$9-"8?F'8WL+89NSTE
MXC$([V$[,/[0)K'`5DF>/.U4@I6.48N_O3?9)U];@`^B`@&""ROX6<N9[`FB
M,FA,/S#L;V%L,W9Z2\1B$=["=F']H$UC@*R3/'G:J04K'*,7?WIOLDZ^MP`?
M1`0#!!97\+.7,]@31&30F'YAV-["V&;L])>(Q".]A.S#^T":QP%9)GCSM5(*
M5CE&+O[TWV2=?6X`/H@(!@@LK^%G+F>P)HC)H3#\P[&]A;#-V>DO$8A'>PG9
MA_:!-8X"LDSQYVJD%*QRC%W]Z;[).OK<`'T0$`P065_"SES/8$T1DT)A^8=C
M>PMAF[/27B,0CO83LP_M`FL<!629X\[52"E8Y1B[^]-]DG7UN`#Z("`8(+*_
MA9RYGL":(R:$P_,.QO86PS=GI+Q&(1WL)V8?V@36.`K),\>=JI!2L<HQ=_>F
M^R3KZW`!]$!`,$%E?PLY<SV!-$9-"8?F'8WL+89NSTEXC$([V$[,/[0)K'`5
MDF>/.U4@I6.48N_O3?9)U];@`^B`@&""ROX6<N9[`FB,FA,/S#L;V%L,W9Z2
M\1B$=["=F']H$UC@*R3/'G:J04K'*,7?WIOLDZ^MP`?1`0#!!97\+.7,]@31
M&30F'YAV-["V&;L])>(Q".]A.S#^T":QP%9)GCSM5(*5CE&+O[TWV2=?6X`/
MH@(!@@LK^%G+F>P)HC)H3#\P[&]A;#-V>DO$8A'>PG9A_:!-8X"LDSQYVJD%
M*QRC%W]Z;[).OK<`'T0$`P065_"SES/8$T1DT)A^8=C>PMAF[/27B,0CO83L
MP_M`FL<!629X\[52"E8Y1B[^]-]DG7UN`#Z("`8(+*_A9RYGL":(R:$P_,.Q
MO86PS=GI+Q&(1WL)V8?V@36.`K),\>=JI!2L<HQ=_>F^R3KZW`!]$!`,$%E?
MPLY<SV!-$9-"8?F'8WL+89NSTEXC$([V$[,/[0)K'`5DF>/.U4@I6.48N_O3
M?9)U];@`^B`@&""ROX6<N9[`FB,FA,/S#L;V%L,W9Z2\1B$=["=F']H$UC@*
MR3/'G:J04K'*,7?WIOLDZ^MP`?1`0#!!97\+.7,]@31&30F'YAV-["V&;L])
M>(Q".]A.S#^T":QP%9)GCSM5(*5CE&+O[TWV2=?6X`/H@(!@@LK^%G+F>P)H
MC)H3#\P[&]A;#-V>DO$8A'>PG9A_:!-8X"LDSQYVJD%*QRC%W]Z;[).OK<`'
MT0$`P065_"SES/8$T1DT)A^8=C>PMAF[/27B,0CO83LP_M`FL<!629X\[52"
ME8Y1B[^]-]DG7UN!K&]PH1T"Z/`O;]H(ON#2S_<EMQ*AU)\TO&X;M-*_H5*`
MW).W5IPI)>)X?S8_%B/7^!D8YFDS>M$$B4AC=DM/4K^;8-CM4=8JGI*I'E&U
MMFTH>MG`[J),(N5[`7Z8SHF-(#+80CX:NSHULPA/:R8PD"S23C=1V3C/PQ9/
M5PU^2XQ\W@?<#Z("`8(+*_A9RYGL":(R:$P_,.QO86PS=GI+Q&(1WL)V8?V@
M36.`K),\>=JI!2L<HQ=_>F^R3KZW`!]$!`,$%E?PLY<SV!-$9-"8?F'8WL+8
M9NSTEXC$([V$[,/[0)K'`5DF>/.U4@I6.48N_O3?9)U];@`^B`@&""ROX6<N
M9[`FB,FA,/S#L;V%L,W9Z2\1B$=["=F']H$UC@*R3/'G:J04K'*,7?WIOLDZ
M^MP`?1`0#!!97\+.7,]@31&30F'YAV-["V&;L])>(Q".]A.S#^T":QP%9)GC
MSM5(*5CE&+O[TWV2=?6X`/H@(!@@LK^%G+F>P)HC)H3#\P[&]A;#-V>DO$8A
M'>PG9A_:!-8X"LDSQYVJD%*QRC%W]Z;[).OK<`'T0$`P065_"SES/8$T1DT)
MA^8=C>PMAF[/27B,0CO83LP_M`FL<!629X\[52"E8Y1B[^]-]DG7UN`#Z("`
M8(+*_A9RYGL":(R:$P_,.QO86PS=GI+Q&(1WL)V8?V@36.`K),\>=JI!2L<H
MQ=_>F^R3KZW`!]$!`,$%E?PLY<SV!-$9-"8?F'8WL+89NSTEXC$([V$[,/[0
M)K'`5DF>/.U4@I6.48N_O3?9)U];@`^B`@&""ROX6<N9[`FB,FA,/S#L;V%L
M,W9Z2\1B$=["=F']H$UC@*R3/'G:J04K'*,7?WIOLDZ^MP`?1`0#!!97\+.7
M,]@31&30F'YAV-["V&;L])>(Q".]A.S#^T":QP%9)GCSM5(*5CE&+O[TWV2=
M?6X`/H@(!@@LK^%G+F>P)HC)H3#\P[&]A;#-V>DO$8A'>PG9A_:!-8X"LDSQ
MYVJD%*QRC%W]Z;[).OK<`'T0$`P065_"SES/8$T1DT)A^8=C>PMAF[/27B,0
MCO83LP_M`FL<!629X\[52"E8Y1B[^]-]DG7UN`#Z("`8(+*_A9RYGL":(R:$
MP_,.QO86PS=GI+Q&(1WL)V8?V@36.`K),\>=JI!2L<HQ=_>F^R3KZW`!]$!`
M,$%E?PLY<SV!-$9-"8?F'8WL+89NSTEXC$([V$[,/[0)K'`5DF>/.U4@I6.4
M8N_O3?9)U];@`^B`@&""ROX6<N9[`FB,FA,/S#L;V%L,W9Z2\1B$=["=F']H
M$UC@*R3/'G:J04K'*,7?WIOLDZ^MP`?1`0#!!97\+.7,]@31&30F'YAV-["V
M&;L])>(Q".]A.S#^T":QP%9)GCSM5(*5CE&+O[TWV2=?6X`/H@(!@@LK^%G+
MF>P)HC)H3#\P[&]A;#-V>DO$8A'>PG9A_:!-8X"LDSQYVJD%*QRC%W]Z;[).
MOK<`'T0$`P065_"SES/8$T1DT)A^8=C>PMAF[/27B,0CO83LP_M`FL<!629X
M\[52"E8Y1B[^]-]DG7UN`#Z("`8(+*_A9RYGL":(R:$P_,.QO86PS=GI+Q&(
M1WL)V8?V@36.`K),\>=JI!2L<HQ=_>F^R3KZW`!]$!`,$%E?PLY<SV!-$9-"
M8?F'8WL+89NSTEXC$([V$[,/[0)K'`5DF>/.U4@I6.48N_O3?9)U];@`^B`@
M&""ROX6<N9[`FB,FA,/S#L;V%L,W9Z2\1B$=["=F']H$UC@*R3/'G:J04K'*
M,7?WIOLDZ^MP`?1`0#!!97\+.7,]@31&30F'YAV-["V&;L])>(Q".]A.S#^T
M":QP%9)GCSM5(*5CE&+O[TWV2=?6X`/H@(!@@LK^%G+F>P)HC)H3#\P[&]A;
M#-V>DO$8A'>PG9A_:!-8X"LDSQYVJD%*QRC%W]Z;[).OK<`'T0$`P065_"SE
MS/8$T1DT)A^8=C>PMAF[/27B,0CO83LP_M`FL<!629X\[52"E8Y1B[^]-]DG
M7UN`#Z("`8(+*_A9RYGL":(R:$P_,.QO86PS=GI+Q&(1WL)V8?V@36.`K),\
M>=JI!2L<HQ=_>F^R3KZW`!]$!`,$%E?PLY<SV!-$9-"8?F'8WL+89NSTEXC$
M([V$[,/[0)K'`5DF>/.U4@I6.48N_O3?9)U];@`^B`@&""ROX6<N9[`FB,FA
M,/S#L;V%L,W9Z2\1B$=["=F']H$UC@*R3/'G:J04K'*,7?WIOLDZ^MP`?1`0
M#!!97\+.7,]@31&30F'YAV-["V&;L])>(Q".]A.S#^T":QP%9)GCSM5(*5CE
M&+O[TWV2=?6X%%_<0J05I_VFO<\A!.5LZ792?1+N3*N5K2NRY;QETG6>M9^T
M^5'D%UGM@3\1&_*;:Y]&T<HL_FYW4^5\S???8-AM3?VKK3_+\-_PY&\"0.`X
M#@.`X#@?_];OF?PT/*N(AW)Q4;).A^2VF8%R_8M7CB$F-HV1AMI6(6<)**1L
MEM#S#MIE='.BN6SI9+S>17?78.!?J5=9*0]S>J]10-X>\I9W0D/[>UFOUZKV
MR/;SI>N^ND6X8V\DQJR=).Z;.X2`RFJJ'YJ6PHCO_1K)Y.MOE,-O097RJD'?
MUP'`<!P'`H![L7_%E[EG^@#N1_MUL;@6_J;^U=:?Y?AO^'(W@2!P'`<!P'`<
M!P'`<!P'`<!P'`<!P'`<!P'`<!P-1W5#=3MAW\[7]T7V-GM6]<-9CV]NJ6ZN
MZF[%X^$9^**NZ5J12'JG<:IL5W3$Q`2B^;^17=M7BNF?#5;?&P;<>`X#@.`X
M#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X%`/=B_XLO<L_T`=R/]NM
MC<"W]3?VKK3_`"_#?\.1O`D#@.`X#@.`X'__U^PWW"^]8K[=]&0W8(WJ^U+?
M$U;,%Z]F0RD8&.*[6<?U?&D.L4\#!27FAJ-(WC>=CFNKENK(L_)'[N%]-MU$
M=$50XKNI-F=%G/9#IN&U(/\`_85BK`?]Q^LTE%M.W3\5$.E']32O8H+)BZ1-
M0*&.B]G%1[]X[D'L,Q0;K*X(%&?F<^?SN>!^AYP/5?/F48R>24D\:Q\='M7#
MY^_?.$FC)BR:);N'3QXZ<;IH-FK9!/;=13?;73337.<YQC'`IQK[C'13-:R-
MP;=KJ21K:))G(@_*W)Q%-6*,ZV1FGV4-4'*J3]=BY@AQ_+MGJ:.[%W`LU95!
M92-TV=8"5=^T_6Y,^B:NVO&K_P"O9Z+:3$,.ZF,+NXDF4@(2MAQNK1UH[VCE
M9"4KN!?D31GA;U;H?8.9))+=BW67T#[U/W[2M_Q,I.TK9P;9L3"NHUI*OA":
M:RR3':;A(XG'W*V$-OF8C287EVDI%.\8RUE(QVB[:*+-U4U=@J][L7_%E[EG
M^@#N1_MUL;@6_J;^U=:?Y?AO^'(W@2!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<
M!P'`<"CGN+]D"?K%U1/"ZLFK>6OVP)`8H;K&-N,94U).R-XSK.N:@:JH892'
MJ(N$*)Q.9D]<I;:ZQ$8[WVSC77.<!*O4/K<)]0NLM)=:@M=:0AZB`888=S[S
M.^TH9E6=-Y,[L*>54W44<DUBG$A(SLHMG/BM(2*V_P!GF\.!8[@.`X#@.`X#
M@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.!0#W8O^++W+/]`'<C_;K8W`
MM_4W]JZT_P`OPW_#D;P)`X#@.`X#@.!__]#OL<QT>]6CG+QBS=N(AYO(Q+AR
MV176BY!6/?1*CZ.55TW49/%(N4<MME4LZ[Y;N%4\Y\BF^,AX96&B)UJDRFXJ
M-F62$E#3*+258M9%JC+CLNQ(!^52;NTEDDY*"GXQL^9KXQA5J\;I+)[:J)Z;
M8#Z7`CFX834EJ2TAS<`C;8T(*Y-X3:K9F7:C\196LJ,R;#8`E9Y\@Z90D:98
M7_#EW:R2B39)SLIOKMKKG&0YY:-ZX]HA'J_VIZQEE+]V6U06M-6A2G5XHCI'
MJ+)=OZ8K@N(KTDB02.K:*+AG=R.G7+MW$H1!').Y6:6E)N3<;/-H;:-F5`@2
MXO;![^6?UBN+IY*#\"A<-]WE3?8>3[8!$P*A]0`>17VOJTZNGD#`1K"5CCX;
MDFEW5.O!143&0^K/^DRM%PALFU;R+=L&X;H)3UP0EZ]A[^L>G9:@1^QNNW0V
MBQNKR*6")*:0*^M(C=+FRR)+6O2`C'-1E.5NAF,QKG*J*\AJ*J.4TOPY2.66
M#`/=9HJT4/;H]R4K5[G]E7D"CTJ[B$*E9N!;IYJ$.HA.C+%DMP5=^TZH-;'U
M%5V>/P_99(@3F\-,YVUD-77@YP%Z.M]/3`=UQ@@M_>5V'SXKK^)^2?F\N#+G
M0E^,AK%BC_2+H:K\8'(_\!SOA=CZB,=>1?7&ROSL>.N0D8.J*2$@@M#7-T7,
M9.BE&42;G!C.";XW$LR41B*36$G\4%0T.S6BU,>L:Y=,7F-'>?-OC?3Z?`!U
M120D$%H:YNBYC)T4HRB3<X,9P3?&XEF2B,12:PD_B@J&AV:T6ICUC7+IB\QH
M[SYM\;Z?3X`.J*2$@@M#7-T7,9.BE&42;G!C.";XW$LR41B*36$G\4%0T.S6
MBU,>L:Y=,7F-'>?-OC?3Z?`!U120D$%H:YNBYC)T4HRB3<X,9P3?&XEF2B,1
M2:PD_B@J&AV:T6ICUC7+IB\QH[SYM\;Z?3X`.J*2$@@M#7-T7,9.BE&42;G!
MC.";XW$LR41B*36$G\4%0T.S6BU,>L:Y=,7F-'>?-OC?3Z?`!U120D$%H:YN
MBYC)T4HRB3<X,9P3?&XEF2B,12:PD_B@J&AV:T6ICUC7+IB\QH[SYM\;Z?3X
M`.J*2$@@M#7-T7,9.BE&42;G!C.";XW$LR41B*36$G\4%0T.S6BU,>L:Y=,7
MF-'>?-OC?3Z?`!U120D$%H:YNBYC)T4HRB3<X,9P3?&XEF2B,12:PD_B@J&A
MV:T6ICUC7+IB\QH[SYM\;Z?3X`.J*2$@@M#7-T7,9.BE&42;G!C.";XW$LR4
M1B*36$G\4%0T.S6BU,>L:Y=,7F-'>?-OC?3Z?`!U120D$%H:YNBYC)T4HRB3
M<X,9P3?&XEF2B,12:PD_B@J&AV:T6ICUC7+IB\QH[SYM\;Z?3X`.J*2$@@M#
M7-T7,9.BE&42;G!C.";XW$LR41B*36$G\4%0T.S6BU,>L:Y=,7F-'>?-OC?3
MZ?`!U120D$%H:YNBYC)T4HRB3<X,9P3?&XEF2B,12:PD_B@J&AV:T6ICUC7+
MIB\QH[SYM\;Z?3X`.J*2$@@M#7-T7,9.BE&42;G!C.";XW$LR41B*36$G\4%
M0T.S6BU,>L:Y=,7F-'>?-OC?3Z?`!U120D$%H:YNBYC)T4HRB3<X,9P3?&XE
MF2B,12:PD_B@J&AV:T6ICUC7+IB\QH[SYM\;Z?3X`.J*2$@@M#7-T7,9.BE&
M42;G!C.";XW$LR41B*36$G\4%0T.S6BU,>L:Y=,7F-'>?-OC?3Z?`!U120D$
M%H:YNBYC)T4HRB3<X,9P3?&XEF2B,12:PD_B@J&AV:T6ICUC7+IB\QH[SYM\
M;Z?3X`.J*2$@@M#7-T7,9.BE&42;G!C.";XW$LR41B*36$G\4%0T.S6BU,>L
M:Y=,7F-'>?-OC?3Z?`!U120D$%H:YNBYC)T4HRB3<X,9P3?&XEF2B,12:PD_
MB@J&AV:T6ICUC7+IB\QH[SYM\;Z?3X`.J*2$@@M#7-T7,9.BE&42;G!C.";X
MW$LR41B*36$G\4%0T.S6BU,>L:Y=,7F-'>?-OC?3Z?`!U120D$%H:YNBYC)T
M4HRB3<X,9P3?&XEF2B,12:PD_B@J&AV:T6ICUC7+IB\QH[SYM\;Z?3X`.J*2
M$@@M#7-T7,9.BE&42;G!C.";XW$LR41B*36$G\4%0T.S6BU,>L:Y=,7F-'>?
M-OC?3Z?`U&15/R/9+W)'57.+JMZPJ>]MP!D326,#*=#Y<H8]X>UU<2`B!H#C
MB,#HP=;R76[K4[DIYGZN-<J-)FQF;C;&_ITM=0VYAU120D$%H:YNBYC)T4HR
MB3<X,9P3?&XEF2B,12:PD_B@J&AV:T6ICUC7+IB\QH[SYM\;Z?3X`.J*2$@@
MM#7-T7,9.BE&42;G!C.";XW$LR41B*36$G\4%0T.S6BU,>L:Y=,7F-'>?-OC
M?3Z?`!U120D$%H:YNBYC)T4HRB3<X,9P3?&XEF2B,12:PD_B@J&AV:T6ICUC
M7+IB\QH[SYM\;Z?3X`.J*2$@@M#7-T7,9.BE&42;G!C.";XW$LR41B*36$G\
M4%0T.S6BU,>L:Y=,7F-'>?-OC?3Z?`!U120D$%H:YNBYC)T4HRB3<X,9P3?&
MXEF2B,12:PD_B@J&AV:T6ICUC7+IB\QH[SYM\;Z?3X`.J*2$@@M#7-T7,9.B
ME&42;G!C.";XW$LR41B*36$G\4%0T.S6BU,>L:Y=,7F-'>?-OC?3Z?`!U120
MD$%H:YNBYC)T4HRB3<X,9P3?&XEF2B,12:PD_B@J&AV:T6ICUC7+IB\QH[SY
MM\;Z?3X`.J*2$@@M#7-T7,9.BE&42;G!C.";XW$LR41B*36$G\4%0T.S6BU,
M>L:Y=,7F-'>?-OC?3Z?`!U120D$%H:YNBYC)T4HRB3<X,9P3?&XEF2B,12:P
MD_B@J&AV:T6ICUC7+IB\QH[SYM\;Z?3X`.J*2$@@M#7-T7,9.BE&42;G!C."
M;XW$LR41B*36$G\4%0T.S6BU,>L:Y=,7F-'>?-OC?3Z?`!U120D$%H:YNBYC
M)T4HRB3<X,9P3?&XEF2B,12:PD_B@J&AV:T6ICUC7+IB\QH[SYM\;Z?3X`.J
M*2$@@M#7-T7,9.BE&42;G!C.";XW$LR41B*36$G\4%0T.S6BU,>L:Y=,7F-'
M>?-OC?3Z?`!U120D$%H:YNBYC)T4HRB3<X,9P3?&XEF2B,12:PD_B@J&AV:T
M6ICUC7+IB\QH[SYM\;Z?3X`.J*2$@@M#7-T7,9.BE&42;G!C.";XW$LR41B*
M36$G\4%0T.S6BU,>L:Y=,7F-'>?-OC?3Z?`!U120D$%H:YNBYC)T4HRB3<X,
M9P3?&XEF2B,12:PD_B@J&AV:T6ICUC7+IB\QH[SYM\;Z?3X`.J*2$@@M#7-T
M7,9.BE&42;G!C.";XW$LR41B*36$G\4%0T.S6BU,>L:Y=,7F-'>?-OC?3Z?`
M!U120D$%H:YNBYC)T4HRB3<X,9P3?&XEF2B,12:PD_B@J&AV:T6ICUC7+IB\
MQH[SYM\;Z?3X`.J*2$@@M#7-T7,9.BE&42;G!C.";XW$LR41B*36$G\4%0T.
MS6BU,>L:Y=,7F-'>?-OC?3Z?`!U120D$%H:YNBYC)T4HRB3<X,9P3?&XEF2B
M,12:PD_B@J&AV:T6ICUC7+IB\QH[SYM\;Z?3X`.J*2$@@M#7-T7,9.BE&42;
MG!C.";XW$LR41B*36$G\4%0T.S6BU,>L:Y=,7F-'>?-OC?3Z?`!U120D$%H:
MYNBYC)T4HRB3<X,9P3?&XEF2B,12:PD_B@J&AV:T6ICUC7+IB\QH[SYM\;Z?
M3X`.J*2$@@M#7-T7,9.BE&42;G!C.";XW$LR41B*36$G\4%0T.S6BU,>L:Y=
M,7F-'>?-OC?3Z?`!U120D$%H:YNBYC)T4HRB3<X,9P3?&XEF2B,12:PD_B@J
M&AV:T6ICUC7+IB\QH[SYM\;Z?3X`.J*2$@@M#7-T7,9.BE&42;G!C.";XW$L
MR41B*36$G\4%0T.S6BU,>L:Y=,7F-'>?-OC?3Z?`!U120D$%H:YNBYC)T4HR
MB3<X,9P3?&XEF2B,12:PD_B@J&AV:T6ICUC7+IB\QH[SYM\;Z?3X`.J*2$@@
MM#7-T7,9.BE&42;G!C.";XW$LR41B*36$G\4%0T.S6BU,>L:Y=,7F-'>?-OC
M?3Z?`!U120D$%H:YNBYC)T4HRB3<X,9P3?&XEF2B,12:PD_B@J&AV:T6ICUC
M7+IB\QH[SYM\;Z?3X`.J*2$@@M#7-T7,9.BE&42;G!C.";XW$LR41B*36$G\
M4%0T.S6BU,>L:Y=,7F-'>?-OC?3Z?`!U120D$%H:YNBYC)T4HRB3<X,9P3?&
MXEF2B,12:PD_B@J&AV:T6ICUC7+IB\QH[SYM\;Z?3X`.J*2$@@M#7-T7,9.B
ME&42;G!C.";XW$LR41B*36$G\4%0T.S6BU,>L:Y=,7F-'>?-OC?3Z?`HQ[B%
M</JT]IKW/(E_9]G6FH_Z)=R9#28M*6'9>8CM,]:S]M^&QZXV+"C5*-QLAE7R
M*(J*?-4WSY_#.-<!L-J;^U=:?Y?AO^'(W@2!P'`<!P'`<#__T>_C@.`X#@.`
MX#@4`]V+_BR]RS_0!W(_VZV-P+?U-_:NM/\`+\-_PY&\"0.`X#@.`X#@.`X#
M@.`X#@.`X#@.`X#@.`X$(=EK]!NK'7ZX^QME+J(A%+UV46%/(M]M?Q"41'8M
MP]:#T,GMC;+H@)I#1&/CF^N-MW+YTDEIKMMOC&0T_=9[Z5]O$(ZQ=?KQJRTK
M=[U^X`MV+[MW[`UCJ$:2NEE/XC%H6J/P+&QK`#%#22JR'>0@1!P$'L\?8@AU
M';;353#-%^&P$6[U,B#L;-=;Y/KAV'#Y][5]RVW2Q431-;M!SL$*T"="-<69
MJ#M$;*6)PZ00)[!@<Q.#-@,MI>/EVSM);5+?[`^2,>XS4Y=2'16_(8!M90([
M_EU9AU4Y6CPM%^%2-K"LR:C"MIM]C;_[L1W@!YW\S$-^.;:.T\)YQ\O;Y^`V
M"\!P'`<!P'`<!P-(ON-=G>QO6SMEU?EG%C%%;=)B*<K86/3*J!"O+1G1"UB5
MY=F%&G8FM9Z`E[,VHBQH"#B6\41"R[-(><PTZXD<Y5_"UFP?38GO<X2*N^F,
M]K5+>":PZL*D;(M=U12D4+T7W+B61T9&-04UH,B\!/&P6+5SF!>/69IN52$.
MH^8:+R[MRK(-&X09</N4WL!V'1+"43.&=!T[TDZJ=ONZ]I5I"4TO8T\Z[/'1
M#5(@RC1JT&6T;M6`Y)5Y/3A7@0B%YQ9-5NVC7+%9MNU?!T-<!P'`<!P'`<",
M[GM\`Z_5%9MZ6M-_TU6=/@959)]/X9/9+>($0R%>$$\^1C8QN[DI)PA&L%,I
MMVZ2JZZG@FGIMOMC&0J=$>XS2KFJ0"V"4-ND'C+&[(T]U8@H6>KEV^D$K,O8
MF`!FN'[V:&7L\#Z`,FXLR*W6G4Y95@@MLNPSMF5;JL-0QNQ?=5ZDU*4F\-8<
MR;#@B$3UQ`FUM[B*DI6Y5;G7\!VLZX*6#5(-_)FLU9P>&H.5]&FT(BTF'+!\
MRBG3Y\P>MFX6>H7LB%W^M:<'#P1@"V%1QXRK:XJML-G`LS>O2V7!`^SQ]I*[
MB9&8",M'DE>GT1+,7T3+2+%9!Y\O*NKE%P@B%@^`X#@.`X#@4`]V+_BR]RS_
M`$`=R/\`;K8W`M_4W]JZT_R_#?\`#D;P)`X#@.`X#@.!_]+OXX#@.`X$1L+_
M`**E!-Z>Q]S56[!XXD?AT@8I'XKD79%D9).(=^-NY[,KB+;SC:4:J(;-=E<+
M?,USC&N?LX&9?UT$8+&X'_6(K_7+N%_J1J&?U#$?U8Y'<K*-\3[<=]9^,+0N
M7".^GJM4<H>?7.OF\<9QP/Z$C<+/HU>9!"\7-8AK(.8ES*B4_$D<:WE66$MG
MD8N^AW;QJE(--5],JH[;843QOKYL8\<<"E'NQ?\`%E[EG^@#N1_MUL;@6_J;
M^U=:?Y?AO^'(W@2!P'`<!P'`<!P'`<!P-:GNL=R[-Z+=7DKMK0$CR7*M@18B
M;'9%$%)$#T*'R0D;32=OV&/!S7:;DPO!F.PXPY5]7&,XM4F2DGCO1HR735#,
M(/MG9,I<?7*MFP'59G$7ST,O#M9'$%4VY_64?-632Y3U*'7`"!DST;'@Z<K,
MJQV<34ABI1YK^(Z-M%E&K)'XE@I)+^YSV1KVX5NN%VU[UKK,SDNSX/U^8=AV
MY^<SO6(->F_4"T.V*0F9OB:'KB9>VI%:5]%CV6*;^/2=:FD5):ZI^&(YT&S;
MI7V3:]P>J%!]FV@U_1WYSUQ`F3X4TETR%L.S+M+=K/P\<1(M(](CAV$VT<)L
MI'5NWP_::IN/E)?,^7J%H.`X#@.`X#@?EX?]@[WY^Y%C]X;FZL4C9T&"]6.M
MMR!#`<%H`5!BUG9UDT46#ATRL,]F"L<(-2^+:6L.IN&,+_[:78,&NKEH]WRL
MNN'2-UH1['?]AGVU>J=T644U/6DNWF++$CV>_*N?0-JRNZNHBX:^$NW/5\[%
M;!$9P=,TG9-!2:T)NHG&I$4.EN@X19-7;"1#=E777+MR-=F;3ODVN&@SB-(A
M^;$JX8[52>L3P0`HN/WTKBL7!6YL^2%60FY*MOZF,WD4/,IDFG\)>+E",8QD
M8R"$P3VX[9!NIGME]:T+6KN1?^WY9E.',L6K"9*V9V='TL$%@%#QT=$:3RRP
MN\((XN5<N5%7#[1NNAIIIJIKMG;4-P?`<!P'`<#QK+)-TE5UU4T$$$]UEEEM
M]4TD4D]<[J*JJ;YUT333TUSG;;.<8QC'CG@5B*>ZO5,0N&'Z\25[5](=@2`9
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M.-7<-/IT?ILYKTATKDBB3>$C"(C!P`^1&Y..CBUNXAVCQ-L\9Z8\GS<!=;'N
M!=&M3JX*R<=O.N4<?]?(6:)+R%)BX06%EZD'1J5BH(CGK"0EIME@5A1Z;G63
M-^Z>9209N7B*2VVFZNF-@R2*[J]-YV#!R>$[:=9I@:LYU+L:V(8J^:LD(.PG
ML`Y:LIYF#RS0J68%CJ$>/D$7:;!1QNV56TU4QKMOKC(2^QM"LY21)8B,L0%D
M98+V=Z&,6Q+H!W(B>[!31)]J2LF\@HY@MF2JFNJV'6J64]ML8V\,YQP,T;N&
M[QN@[:+HNFKI%)PV<MU=%V[ANOIJJBN@LEMLFLBLGMC;7;7.==M<XSC/AP/-
MP'`].1?(Q<>^DG.CQ5O',W+YPG'1TA+R"B+1'=PKHQB8EL]E)1YNFGG"3=LB
MLX7W\-$]-M]L:Y#4I9_NP=";,Z[2+BL.R=*%Q?<`V'"5?5$9#14:E!>5766%
MU5BE8&W7>%&)VWGKB;+@N>A22%T'G4G"MX]ZJ]9ZI(^&X5HK#VO^S0!U?@Z9
M')6L!R'@>_\`U3[:UW04[;]C$E:4%6_6JW*GM>?JNM3]Q6D]-_A]J$=9.G;2
M(0AHV!%-YO;5HFKJCNFN$G7%[/X->'8NP[+,PP5WHQWKV(/&G7%"^[TR(7UV
M&[)4I(4,;6T?HXB$!CK:M^7$Y+,U,!D.0R3J8E\S^KUL];;MWP7!Z$=,ICJA
M&7J66$=R%D71V4MAO9UBD#\L.SQ*!B1D&%JOK&MHHXLV4E3PTCP4##FVBTO)
M9:*R<HZ>.46,<T4;QS4+_P#`<!P'`<!P*`>[%_Q9>Y9_H`[D?[=;&X%OZF_M
M76G^7X;_`(<C>!('`<!P'`<!P/_3[^.`X#@13>\1%$%'W+`3HV7&4'-U38<1
M,B``Y79'A5%20C,,I$;"7C9Y'N6A=.-%MVL:JFX0W3>*I[:J:9QC;`<M].58
MX".L'8BH;#ZA&':`88V0:4#U-O,LZ'6G.6`V#3(@O<7+SKL93,.#-]3<HZ_!
MR_RVA'%C0]M/J$^@LDI&_*FWC(,`N?I[VK*^O-U]?.MU1]EQB^[#['U';?5"
MZ#P0G!&4#>KX=[3HIUJ'-[*MG.K(,KP_9SHD3"DF%2L@QGVLF6X7S'?+=+KI
MANA]MBOR2.O'LA:T34-@TG1YAUI]NVK`T.LFOR>J)W:UZ)K2W8JV%D0,PBX>
M;V8C068`HOB9PAEG(+#JC9JLNC'ZJ[!\[W6:\[/)^W3[DLPY[*!K@%TZ5=Q)
M-<)TZ^-$))<3UHRQ72HMJ88M!11%\K#XRTQ)>@VVU4S\_P"1G/T^!>GK>`VY
M!=<H(?-+[E#PTGJ_B?Z=L#6N@,65!OQ`.8M(?\(%XQBXA9C^GW.=76OXGZSU
M*VN=5?%+/R\!(P<`6C`A!:.D]\D1T63:,HF-V#(`E<P<D%*O(C#&/78#XZ/1
MXS-;1$ECUNFK]LOJLIGY:N-DOAX`.`+1@0@M'2>^2(Z+)M&43&[!D`2N8.2"
ME7D1AC'KL!\='H\9FMHB2QZW35^V7U64S\M7&R7P\`'`%HP(06CI/?)$=%DV
MC*)C=@R`)7,')!2KR(PQCUV`^.CT>,S6T1)8];IJ_;+ZK*9^6KC9+X>`#@"T
M8$(+1TGODB.BR;1E$QNP9`$KF#D@I5Y$88QZ[`?'1Z/&9K:(DL>MTU?ME]5E
M,_+5QLE\/`!P!:,"$%HZ3WR1'19-HRB8W8,@"5S!R04J\B,,8]=@/CH]'C,U
MM$26/6Z:OVR^JRF?EJXV2^'@`X`M&!""T=)[Y(CHLFT91,;L&0!*Y@Y(*5>1
M&&,>NP'QT>CQF:VB)+'K=-7[9?593/RU<;)?#P`<`6C`A!:.D]\D1T63:,HF
M-V#(`E<P<D%*O(C#&/78#XZ/1XS-;1$ECUNFK]LOJLIGY:N-DOAX`.`+1@0@
MM'2>^2(Z+)M&43&[!D`2N8.2"E7D1AC'KL!\='H\9FMHB2QZW35^V7U64S\M
M7&R7P\`'`%HP(06CI/?)$=%DVC*)C=@R`)7,')!2KR(PQCUV`^.CT>,S6T1)
M8];IJ_;+ZK*9^6KC9+X>`#@"T8$(+1TGODB.BR;1E$QNP9`$KF#D@I5Y$88Q
MZ[`?'1Z/&9K:(DL>MTU?ME]5E,_+5QLE\/`UW=_08?%.IT_%=G^[UZ#3@DG"
M:#"#>N*B$"0Q('\A5IA,25<)4<!5B2QEKQ[04$I<E436B\.(Y.'4?;O6C5FL
MI@(+ZZ=?>N-($_4,(!?<"O>/-@CHIV:'.JT9+5548V)M^N)'+T2^NJPS3<MZ
MW;IY+PBR`,(F'#:7G(=9FY;ZMU(W#%=\W5"O%'P/4=GUZ[!=<6?NF]^[`FCX
MP&*\<1Y'UVW'NP4&27*+VS;3.6K.DU^E478EE2%]Q$80&3BQV$%,2\BQ&EI*
M+(6235^Z5#<YTW"AJ-ZA@$%0U^HGM02]4CT?UO/QL"KX?B0&MTPEA!`#<8&(
M<<C(=\B+(-4EM6TRT4=:N$]FSS3QTW3P$X!P!:,"$%HZ3WR1'19-HRB8W8,@
M"5S!R04J\B,,8]=@/CH]'C,UM$26/6Z:OVR^JRF?EJXV2^'@`X`M&!""T=)[
MY(CHLFT91,;L&0!*Y@Y(*5>1&&,>NP'QT>CQF:VB)+'K=-7[9?593/RU<;)?
M#P`<`6C`A!:.D]\D1T63:,HF-V#(`E<P<D%*O(C#&/78#XZ/1XS-;1$ECUNF
MK]LOJLIGY:N-DOAX%:K?[$59TEJHAQV[[WC8V1F*<BVKDK.(.L8*PTY&0CM8
MB)95I408._B5L3C";SZELP:PLLY=N,_(V243^#@4M"NS7N27H(%0CU&I*QGS
M(DVDVPQW:]Q@.%NJ`D)M7L*JC&$E:=50D+D+\MAJS<:)OV297`!+5\LOJDHZ
M]-C.V`D*6]JPZ[#B<FR]P7O#?':>6EAMY$ZUJ$(L.M'4R%E7#-75C+N^OU5/
M6[^WOPB3WT<^DL(D*XEYNAKKNQ31WW1R%&KZ_P"J9[<79&2D"P^?V$%V`J.L
MAB+GNOD+4E#BC"-@AQD."?J*I$*Y4KMRZ'6[!/.%V[%DN]TUQHZW6\NNVH9\
MH1&OM+3/3SVSZ4FP\&H&P&:8G4M\72+QHH)9*R36R=)FF1`X@('^@XZ_VY`Q
M8%,?L:Z2[L]F"7#1%'=)M(K(A9>1[)=S:YJ'W085I%DG9&[>L)P)@77M"N1`
M:(#F<3M2F*F+1HPD`D>!@F*F7`,_L_:=E(1!F_5V8Q;AJ@Z?;;)YV"FE2>[4
M<Z"-,UP==C8<J(;?JN4NRW>YZ_5>U(^H>J(R6WL<]6ZEK.7K09K]EN,VH[N>
MO)Z*F)&RY`:'!Z6&I'U>SM/9LPV#H`#@"T8$(+1TGODB.BR;1E$QNP9`$KF#
MD@I5Y$88QZ[`?'1Z/&9K:(DL>MTU?ME]5E,_+5QLE\/`^?""QX!UL=-K#[&2
M1#*.6,NO&6L3"-8"7Y=HKP^&;21UC8F#B0]^C!R&,OL9DT54U-\_+5\R7P\"
MI"?<.D*RB0^M2OO"^NNQ>R2TZPH<\K"GF5LJL<I3'Y:.9]HWZZ5L7`*`R"V"
MDMB2EB/",1'N6SG2073;ME_E!K(F/>^$`\"[-UF/6VQ,>Q0M+)"E*R-[&?7Z
M(EBR4DWSL6G"@/IWHL.]QKP7%:VT;:$#90BK=ODDW<(LD/!/911`)Q(G_N_P
MU7];+1"K>*.RSZTP^&FR^J:.ZW]=:I6@94@&U9Q,A*K?[?FE+3017B#!^Q]/
M"*UAN9H223E)[KC.^C-$(@ZL^VMWO/ANQ:N]Q=T%WK05LE#@]D&7:;M*<=T;
MK!"L>")N$K'(37+*AZ3ZB!X_!E$QM)2D,E&S;"5PILBZV=:MVNVH7;F_:^M<
MG@)(.6]RKMO5`)'B;`(K$#ZG!G5KJD/5T,CPY_3H5$IRM64.VL*7BP5KC76*
M8)3L?%LFZ>J"+5/3SYW#D1O3_IJ=Z[2N>T['B^VO7)W''!\4D[*1L<OOTVL>
M8;3$P[>HSMC&$V`S$B46%/:*X>3C_9QMH[E5UU$M4TMM$]`Z*0.NA+J;U0HS
MV=;<M/M"37$\KJLW.YUT\/;)@B+K*W.I.UE0LY!;*T-@OL&0UBWLNFB=PA':
MX(<#T"SQ'R2+>#39)JA7^J1;KW5CTM&RSNE[Z$C=T5-4J4]?'=R]E>PZ*]T,
M[JL]"I*;=U55)5<4A45DB)'93'762C+"CHE1O%O-EY5NUCM5'"`3]81N(W4]
MK@AF>ZONMCQ)8M@,NJB%B40D"5-6/7"\U;SL'K\P`KOK49CWE<$=F(7I`RT-
M)NFT44ZM8]LQ=O'#6'5BY)8-F'6WHQ8E$0EH,SKO;VN[43E@"LB+04MV.<5*
M6Q-;Z/6^N$Y<8$H6LQZ'?R2<@FFLMI)>L:.]$M$E4,Z8^T*M/_9W,9IC'Z$7
MN/=FR=Z/SDI,B+(KZ[^VN8@PKO.2:,Y,;Q0,:=("1HWE'LXAH\R\3<I*>J23
M6VUW63U5X$H2_M8#TM5EH03^QJS)[_N7Y\):/:X_Z+='"2SK,K:6GHXI**PL
M\:AZ-$JYL(7)R6':/W6LC%J>=XT07VUW72U4X%1$/87W3:T?!.>R]7O`OK^4
M2T_68DA[?7584:`J!<3M"P_TKU_7<:%R`=,%TPR277<8W>,5%T],NF+M/35+
M@9/8_LQW!(&-[F5-=V8.NY#LP-D@_="ICUX-B=V1KFA(T,"TDAE*9[7];(P/
M*)0EAV#G5_',D7.NJ*Z"NZ[=SNEJ&4=?_:*OD$%8`+O3W'+TLJ&K"+*=:.DZ
M1*.W?7`Q$"$Q(VY5-/;2(Y3O9>278T7UFV2"S6$+FCM!HGILU35Q'[[,^!4H
MG]O[WLZ4`.X=B(^ZJ,VI+VH$V84-59P*[+,9"B'7JT[#U7ZXAD)=1\(1+IC(
M0RC2.B]1Q?"3!VI'-L89Y2:)APP]:)KWDZ:[UL^\CCKOW+TO8KE'S0_N)UU/
M6T*%&A:P9CI23(RUC]5;T"!8@>Q"/A(3NH;+2.[=1WGR*K.5=MP_0GGR+W6`
MSKK0=Z!_9-GV7EY:0%!>^JDI:KNE=H239>8R1,R:<J^]C*Y>E-8S,@TEDXR&
MA4$8.4?+D+]MG,%(-MG#5$(*H?OC[H$B_NOK/8@Z5:]FS#:#6Z]E=T=-%ZQ%
M*3@Y9S,1Y"0]A)WK5;7:T%CQV#C463J'G7#=&%=RZN4G>^&2FF4PRYW[L9GU
MKG0&D>SO8?J82/C</'E[@[5L[X<!@=09@6Z2$6]S2L>_Z4#]*]A@\)04B931
MW(%D5(*R<BI&/8]OANGLZ";^J?N)VC</7CLH8#X]8':>9`"`?@`\JZJW?[9W
M80FPS.XDA9MR*-AZ_O0!K\;4KIQ!)R[^/-MH]VY1D$M6R;_1!\BS"S%8]FS=
M!E7=8FD1WCG3+L>'Q1&%W+)=1Q*6$*#=',5(Q\%!6@4T6Q+Z>'R`6DH[#]]F
M27?1C7+I'5VZPWVSC4,;K_OU0<32-WDMA=N;D9(`\Q#BLE;-]],K6ZU2==SU
MB,)Z'"=1L.L?KY6<?8J:$X+/G6%D(^5:)KI81>;ZIJ):;A*M7=H:%=,ANGWG
MN2TS8EW]B0UH;]?&TL3]>A.WI<2-1M[N&EE=4U'Z0D@>1.ZD6ZDF:JT0[2=9
M;+)[^=)+?34)LI9^X+Z^.XP=[=Q-]SSC9^PCK-%V%-2#BNG\E"8;Q6N(BOX[
M^DW[J->8S())2:"OS]O@4QLC\/`S@.`+1@0@M'2>^2(Z+)M&43&[!D`2N8.2
M"E7D1AC'KL!\='H\9FMHB2QZW35^V7U64S\M7&R7P\#5E[H%K"-&>WSWCZ[7
MQVF9G%X]@.@'N!D%(P1L.AH#.&$36O64B5-H(40#8"#'9B0@D9Y!]ELKOF47
M;JKJ(Z*(-%]D0DRY+ZI6Y^BW8BKZV[>0=+EE/A=4TQ;-T#ZDV^B>O=CG,6!;
M1,6>ST#)#&8R'P@1-6Q6O&SD>]'8IV[46?1;EOE=`-7W5_L!`2O3GV]9<IFI
M:C)X']QVBJ/<M8_M4;$U(6]E*IQ1\53-5.90B@(PXJ8@5D$7*HO*LI!$,,DI
MA@CJFNSV5R&6439![??<2SJ[[0%,2>XO2_>]%=F`0*'UH5C=_M\TQTRLB%S3
M\>SGQ:PFL.-TKV-KN'AWT^1P\.'S!*L9Q^Z\M*,EFJ+`-K_M4"^L9TX$K!;/
M3Y6$["F5C=C`.'L4[/["G!&GK;+I&>H02TG+-(RDO2UAZ*U&\.T7#O[97=VM
MA)#*VR6@;'>`X#@?_]3OXX#@.`X#@.`X%`/=B_XLO<L_T`=R/]NMC<"`>I/N
M/;7+V7M+IL*TA/+H=8`&DX@Q)U"\>CCC2;,:Q/2UF1N:RGL0WDJ6:T`V49%3
MS:6=*+21!&;.&K=H[W<-0_F+]V-D5U+3IV#=?"">/+1K/N7>\K4SZPX*)DPF
MDND)_P#EO9Q`^*FD'-C[LS*2N9@HX<BU\L(E_)2NZ:TRV;LUG>P9517NL5AV
M".:@R$@<TE0'8"XC7KI3MY2LZW;.26[P:BE^PCV!E0'$1OH,",\&#Y$PB))Q
M-;2+Z='5V_X7HV<,7KD-JO`<!P'`<!P'`@&[.UG63K8W]1V![!4S3&V\#*$[
M1C9=DB(=,2D#"Z*;R<E!P<Y+,YF>1:Y2VTSAD@OOLKX)ZXSOG&N0UU=YI>A?
M<KZK$57]9)KK_P!S9YDW?GZ,16'9(<@K?J)\M55DQ]87+4DT)2SEV-V7!65,
M0S3"$PXB&+N`?2[9=1?.V8YX`%Z[=QX*^/;DL&ZX[\]IKKCTX[@5)?MH-2\"
MS_4]B7W.=<)4&8(I2B%?2)8HPB.OKAE.S'X!&HN7<FS<Z(;X5?89A72/ZN=W
M+DES[L)=75QO3_=1A=`+:=!VU4W;2M9:,$)$<KFX:>"`"7_J.G21A`]<*]JB
MQR!F5I+P1M/EL\>R3]C%LD_D)1`;<^CO6-MTTZE4/UC1*G!TYJ(#90$X:N66
M(O):6/73R?,R1O$X</,P\?-EDN]<M6>5U]F;91-'*JN=,J;!96=GH(6A90C)
MYJ)'!Z#8N).:GIV19Q$+$1K-/99W(2DI(+-V,>Q:HZYW4554T3TUQG.V<8X&
MF&S??GZ3MS1S475266[NW%I)1<#I'TR75V*4C%3L](*Q4`S*^U%N%0-0K768
MDD=T$$(67()=PICRMV"VWCC`0SV/OF]H&5&8OW)O<YZP>U0&GK.3FQKKAU7*
M82?[&&PHP<MD7+:5[37J/IR"+A!YNFV4V`ZYAG>SA11!I+*[:8WR%J1&K/;'
M]MP/$NRT+6I5,D5PZPC-GV42J7LIW=[16;O/C*I$SD22QH`,O._]HF9@V6[M
M3Y^S2&0^Q/5-#'RDL!=97M.*/>M.W:$,J_L78`JYC\2,!6L)05E#'8$H14+<
M![;6+H^TX.O#YAZQWGUZ*DHTCD-X3PD_F>AVU7V#^J;[$DERUH<6"EU@[)55
M+BBTPT@:PN^`K8!L&QW<9`-YAI_2#="T"`<9,9N0<?A;9S-R40EAZGOLKE-K
MC5SL'Y)'O#=M^VSGW-^YKB5+^P/7>07N*15<TBI>3B36K7=2(A]L##A]5YO.
M5XX=--,XV5S#O7;#"F^V$EE<8\^P=*/M+!!_?7M-T;:5K5IW=[B5HPO*VB'L
M+!`5Z]4(L+0"*"DS25%DBUQVVMNN#^-DGJ=OS*J[T,EFZCB-B=&SM5!9.,=-
M0VW=@/=G]L.A`DSOT8[W]A-[7[K7)4!"2U'T^(^EO86_J:/:[J838O0Q<4AQ
MVUZQ2&XH1'X<9)]G,H8,'DCC&L4]6WW<O.!`IXUF[HZVV!V3ZP^UU[A$_5A7
M316)N8TO/J+$K.[O3+CLR:=E$D[HZXK,R^Y8,!(>RUF&9#+SHS)!9#^'$$E^
M$,7#)TQ32"8NI?8+W\O<FC*V(K/$(?VM`"GK<>/.RT>RIVY`B\KQJ]_(0,Q"
M"M2U[VFZHVW$IR`L.P\DW=34"4N=):1?));-FJ?E1R&8Q73OJ)[DG9OLH^#>
MZ7N01PA=03I*VWUUM#K[?XE7DP)X-X2><0X^0>Y#UL-16%%8X^U9N8P=`F\#
MF%132T;IZ(-DMT0NSTM7]JSK,>&W1*C+J)#BUS.8G*P.ZHNFSKWN9W*R%<LS
M?^H`QE!6JO,5B'0<?&N9C5S'CK2)B)!#&,;I+XU0\`M$Q[,^V)U!L?7JBPNG
MI5U:LOY(Q\BB4"ZFZ-F5\D.&:(:P9!FKH63=R4VG+(_AK-%'=RX36QE%/;7.
M<\"REJ=DNNM%O8B-NV_*5IR1GVKE]!,+4M,&KU[-,F:NC=V\B&I;.Q"\DU:K
MJZZ**(Z[Z:;[8QMG&<XX&=OK``XN$@B63-A&.'"G9AH,S[XDAFD(1;RD<O,1
MFL%*N'J;&7VD8EJJZ0PW44RLV3V4T\=-<[8#((V3C9EBWDX>08RL:[UVW:R$
M:[;OF+G313=+?9N[:J*H+:ZJZ;:YSKMG&-L9Q_ZXX'$9:?\`W4JQK&SK&K5?
MV_CR87KT[+P=:61["C[-*45$R"0@%)%)IO4SC=JF]WC\JZIY4WSIC;RYVV\/
M'(;6YD#M;WC:X]N?O?4`=5_7UH]4K>Y!BV530J:]I>NS)E(VVE:0=!$0>*0[
M"YJSMN,4'&3H:>R<#%8=LE%GK:015U]($M%'1SO/==B25NW5GI]$V(.7=0=W
M`,R%&=TE#F7B.LUZ-3ZI^O$J[(*S%FM=5BUKTC+TY*88,9V5D#<@TF]VV(]I
MI`Y#S(^V1;,_&!0_8&E(/)77N>_[_P`E>0V;VA%V12%UEO:-[=1N!TL(H!3"
M%,`]U3L3$5ZA.RTS!NG2+B3D7D2LFX_"U`WC<!P'`<!P'`<"LW=`'%+.ZC]E
M:U/(*TB4&L6D;)`S.#I%O(/K=D1,P%9,=(TJYC(MN]D)@NTAY);=DQ2;/-GR
MNN&_IG.%,H*!S9U:&7`OTH`X8HZY$AJTK+WB^@-KUU<U9]/K5$[(N2N*TO3K
MI+VG?-@T7``;TD"2BK*T#Y`9F"./AX6#G(Z#\K!MIKG=)0)ULSJ:91W=DHF"
M<+GKZZC`%U=U.XO96=%J#NIY:1R.]@>L7Y,QO22/2'6Z_P#Y2HOB1=@X1B!A
M"99;#PJQC)Q)ANW8I2@;&_:A'@*'KOL03@-1VM23>\.RI/V#)ZTL+K5;'5L<
MKPJ/P<!'<UW78+<H+6I.0(C8L`Q3HE((Z)P-S!C)RJ\<Y5QE9%L&Q]O6E<-&
MA0P:``2U8G#':,-&3<5@D&A?&[-'C#:/*&R;#5&?8[,9!PCE)WJLGE)=33P\
MN^V,AKV>>R_[7^SEP\&NGU=U4\=**+*/*#ECSKH[T75ROG=PU<T.75TLR<>#
MCPPHCLGOKJFEKC.-44<:!8RU^I$58M55A48??7:/K]#5''Q$.*DU)75+-+`D
M(B"&4Q*,CSPSLR/LV6LWY<2GC=5R1;2;UV_^^N%U7F,+X"&:IZ07=6MP!)\2
M^X/V![`@PCL]PM7]_P!-=,)\DDT58>3;QZ#>YZWZV579$-K'$$IN^\47&WG1
MQZ;7Y>-U%=PJMV%]M:VBEW9H/5-&>SJ9=8CLL&CII1=U=(#$1(-"44A=VD,^
M+;,JRT7@P6RD9(RDSZ"3W"D'S%M.N-,953U41=!)]/=*2$5AUKSMGJE08]V:
MZ_@"H-UD!NGG:OL<-U61@P#7<A!5T$O8@N':>`:UD)99^XAM=%X8A9QC)9)9
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MU]=<*K)MLN%/EZ[9SC3YFWAX>;/B'L<!P'`<#__5[^.`X#@.!Z[9VU>I[+,W
M+=VCHX=M-U6RR:Z>CI@Z68OFVVZ6V^NKAD^;*(K:9SYDU4]M-L8VUSC`>QP'
M`TP^\/W=Z7A?1;W(^NACV[ZP"?8-YT@[.";2B26_:I@KE=%1[UN+70*--JPE
M"QJ;+D!HV(X]2)9:L<N9%-^WV;Z*872SL$5]0.KU>]F.SU>>XG7'=2D.S`Y2
M5=QU85A.5#J$'9,$%LB)]AG)A0-M677)J\A9BMPB![20[Y(<U3C9=^K!#*\A
MNFK#(O)4)4'_`&E9\3J6K1$9[+,X:T*UK?N;1:MFMJ544A"JC^\!M'V79HM,
M5ZXMM538L#[`@HV3%Y7>:6CV*C+&CN*?X55\P9SU^]IZO.NQC4C$1LB6>]>.
MOEY%?9:D*5DQSYT^-7,94#(=>I*0*K/5)7"!J&Q`X5D<I$QV1]C(L)F:\^9)
M9JT;M,!M3EIF'@&*DG.RL;"QJ.R>BTA+/FL<Q2W64U21U4=O%44--E5=L:ZX
MSMC.VV<8Q]O`@2U>XG4:BI%Q#W?VFZY4W+M&*$FZB[5N^LJ\D6T:Z227;2#A
MB7$\0Y18N$%]-TU=M<)[Z;ZYQG.,XX%59/WG?:ICWKF.9=].N!B_:?-RNSK`
M^96XXUT2QIXK:)5?H7[K-]]U-=$U-,;)JJ[83TSMOG&O`^@3>Z]U.@R.7#Q^
M$[=VL50,AF-E(BE^@'>2TD$5TVJ3QULW)1+KV_#9%-BBX2^?Z626W2V4QC.O
MCC;RA-4%VV=%W7HHOX-ZK]O9MZ/32$*PH.=J6'J/L*8Y5DAUBK*"X3?!O54!
MB%:-"#9ZHXDIF-QLVCW>J>%'*6C=0*ZY[K=["#;Y@)[/_8ME'N$W*C"0NGLW
MTAK3*F-E-$HW\0B`>^+H(8KSYSON\UW9[*-D]<91T=;;>3`>3\ZO=X)]OE#?
M0/II7"?S/FZ2-O\`N&V!*+*-TDOEK,UX*J.C9>DS>.7:GG05TDW27ITL_-U3
M44QHF'!O_P!NM?MVX[&]05.W49UPB2+\CS3429]<9RSB*%_"L'6FTFL125FC
MPN^_$-WVVNB"39I\O5+3.^ZFVV^-$PR+_J"A-V']U=WQ^@[RC>O9SM3-7.E;
M"DJHAKDTT@D3Z4TD(=H)$!$-123Y\NL@HF]557PAA'.OR%,*9SJ'8P34U[U4
M)3<E5)?[IW1*`+2YK*QD-?TITI(16YXQ9Z];[:.!)JW[00],J24-J[2:M]E0
MYYX:*Z95U56VU5X%:K/[CP_M@]524)N3WE:4NKNS@@<.K=DKR#23L)M"(0FD
M\P)8>NNL/5RR*PM>E5%]Y&,^8YF)[:'C'J"V<Y;I;Z:MPU,>W_V2[QL2P&O"
M-[6]8*EI[M?'DE7TEV`[/6![BO="^[+C(<W%QR>4KOJLM[F?;BBQ68&3MHDS
M1=$LS$3S37*R2J6C5=TCP)5G?:BZ^R7:;LC?D9V#+.U]WU+(%AM>"7:[V9^X
MG;2+F+B>V<M"6M+4(!5R9=;.JQW'R1D[:Z-!\4'#)\T;1[E]H_69Z.%4`VN=
M<H\B@2.JK>[#=+%NU!':R(]"5>05G[/==]/+,ZS9"B=S7^KFZI:\NV1Z6#L+
M^`8:/(=)JDSPP@6FRB65=E-&R8-YK_L"/W]W-H*3K5/\M-9%O5<Z9]'Z"&X3
ML(XCS1F,.D@O,)[QAF5`[&3B=5IYBN514-HZC&VFJN$'BJ;7@63*YGWN23KY
MUB&:\"^F5=]C"!\UV[7W%9!.3D`=746U+)J)?Z5E08:RE4CF2F`Y1E,H?.L!
MBBS=I;1V^5L+9>H!'=>T=_V!XXH-9.PN\O0J:'(2>T<U8.L^M1DY1/8%J9>3
M#"V7+%\&2H(M+`&GSE<P#R6W:RV^6Z:RB&F'>P6.(*#]UXL<"$PC[BW7"J7*
M,'HUL`0`/;]=%@I)SR4E)[ZR@3,V-VMDRH=9N(95FDLWD%)?Q=HJK)[)IJZ-
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M<FLZQ["%*U56)&5F%`)P.10"NSKE\<Q1[9STYW'6>LPP;Q3%2)<3VSAQ$KLM
M'`;TAN;;$H[`$;/9KNT((6+FVN[&2CYEENVE6*#]#9G+Q+AW%2K79)?&4W+9
M55NOIX;I[[:;8SD/M<!P/ER<'"S7HOQF'BY;\.>)2,?^)Q[1_P"@D$/'Y+YE
MZI%7TKQ'QSY5=/+OKX_9G@8:<4]4EG.(]W956US83J)17;Q;DX"!DL<1K=SO
MHJY0CUIZ,D%&:+A1/7;?5/.NN^VN,YQG.,<#';5ZW]>+V!XFL;OH6E[DK6!<
M1SN#KVU:N![#!X9U#M-V$0YB1,N@I>`CG$6P4V0;;HM]-D$=LZ:9UUSG'`^$
M]ZD]6W]`.>J2G7:E6G6-VU49+=?8BM1&"IO#-4JR<K-D*YA8F/$VJ*YIG,LI
MJDUTPI([;.-O%7;;?(?G$VQ_T\_="(;3LN?`)#J!"`<Y8!E+A,+^:YA&?A`C
M)$4D]&XO\.:U*LVC_P`/AED4OD)[[Z)>3RZ[9QC&>!O<6ZV)=)!SVGNI'9.N
MHV-LIK3,)4A%?R7=WN_UOHLZ+1B:M`CC^O`>>T$;5M6(Y93A[M'N8=8UCG']
M2.)S1BS9*X1>NV0;=KW.1WL98W<4*O";['4FPZ&F57"U7O.FG;B^*D-[QG.R
MU?!9.#0$T/5[,U>.F]A$!5(0\(.0$RA,Q[66?J()N5$7CG=4,-'K;M6^>JWM
M5@#TDNBD?_*RX"^ESZSJX[&.)'L"#2U-];>VEK12#HY+:K+(ZW4R];K:JV()
M1]F,64=+IN$6ZGS,^G#:",]?#`+Z_P`_2@]VF[%/2V1:SVD!V*/'U46)=8D^
MF7&7;5VS5)JI<5S.(PBN<Z-D)0>>ZX;[Y3SMXZI;IA_?7NE[IJ2%+XZV^X%M
M]J)0@<,E1X@M*NNN((Z!$6K1V@NU@V-`TU4D7*IR+AQHNMM+)/\`?79#35+*
M6F5,*!B/7:F>W59ETN_OKNFU[,`S@==QT&,O.M=>U"31A$O+1CUN1R9F`$.(
MV9191J#MEJQ3A&2>^CE-3=3*B.=E@]<?K_OO%W\L3S_9_K46]:9$J*7.]/I]
M0SL4M<;"'.DFL&0D1=K?MI/#TX50Z^S)"1E'@<BT?(IN%$H]LHJEJ@'L6NT]
MP+>VXY:C2'IRVH?S#>TO&VN'76^MOR:+Z8+THZ:$#J.#?,NUUVS&J*L/!%3;
M&%M%,:YSN'W.Q\QW=B'HBIU$KSJK8$<HUF]#QKV/N6W*?>LGOS8O(XX$7]94
M1>*$FUPAJ]U>HO&S3?.^Z&R2OAHIHH%2_=L.>S`7[3G;0D!*[`9:TU>GU[:W
M#O%7B3`433L(IUOL9]8EE5$8?E++$5F3U=SS5+8?BG4>(KS>F=557\2IIY.!
M^/'_`.6':;_]RM__`/\`N2Q?_P"X^!^SH$=NC:(,JPI5_P!*^YLM"2D36,"W
M[*1`[1A!0C[8@%QEVZ)WLO']@'5JQ`[![2JF)%U)BC-715HXPFFMG"?S0S[L
M1WEI_JZ9PXA:8/VC>-9<;:D^Y]4G3GM+V"K&&;/I*:B6D20G5#U)8\-#E"SZ
M$SC,6KMA^FDZ:KJ):(.$U<AE_8WN-UDZBQ0M.]E;A%Z;A#1Q*-AV8,M)5I%.
ME(1LS>3&SR0;QKII#-XMH_2576>[MTDD\YVVVQKIOG4,D3[/=<-J=&>PRU\T
M^PH<R9Q;\5N.7L43A:TGVDWLII#JQ9I+RK(?=?B:B6^J&NJ_F4WTVUQC.<9Q
M@)&";``[+@DBFN#81L`9764;H$0220Q7!+.$M$E%4$I>">OX]19--;3;;7"F
M=L8WUSG'AG'`R[@.`X#@<Y__`&&NE/0#L?U;O:[.T,VQ4[$=:^EW9TQZNC\K
M?,R#:L"^/KLI+8*6A*N;%L3&%\E-G`K&H+9W8NMI+#!!HI\S1+1/`?+H+HOT
M)Z9]#NR49[<W9:!ZT&]^`-&,#BT->PQQ:@N#V3.3C`5K]\0H1)^^G*F8FI(:
M+#TB00[B'DHUB]V=I.T5(Y!9`(CH'L;.$'5SVQG^AE<U6DT'[FM0]?;5'9?L
MV56>`'3!OU_?$)*T#CUW+,I"T*-FGZ<-*HPT]HX_I`D</X3*#;:,1;H!+Q:8
MQ@-W7[/$=^]YH<VZL6C2][6G)V]1_9[L<!.^EH?0%N==P$OZ[&-4P_8RQNO`
MQ*6#$2^1U@<!@Z'6FN1:3R++5&0=_-;AL-]IF7CI;JK(;0EY.KN&4;NN-X#(
MR]QJ]@"NEJO*BI0\I^@CFWG92<298;5O4Q9":22;J9EE8==UF+U>.D6*2Z@;
M->`X#@?_UN_C@.`X$3WUJSWHVY]9">.!5AM4]BZOBBLFSUY9(VSR(3&',]7S
M.,;NY%V<0Z.=G$2FW2574?II:Z:;;9QC(<F]<Q<N*^VCW/JAA%CLN]IOLSU]
M9A_9N@'IJ#`O:3"_=67;3A++US&KX'(>VA\1;/52]BRDY]LM"NX=R[WT4:I:
MMPSOW`?_`"<6.>[B_7#\P-_<<=]TXE]T[?"'XLZ*U^EN_ME06B"@JJR^>R2H
M16UD#31PHAC2,VLU1GASM^+[,N!L[]J_\&WN;L\XI720QU54H#V^41+=!-TF
M+9[)LZRM=MV*0TPOKKIK9;,%3K5(Q3\,.DIC7&K_`!B1P[QP/SD?^S3N3[^^
M%WEV,&\"UF_Q*@M<I#3R0?17X/IU8H[0:5]1*,8YW^)+C6K11\G\KY2+[99-
M+=1+713<-VG_`%GNLONJ71[?]ZD71WW'`?J?5'_DO;`;*T^6=9@FTEI:V%:)
MHY?>U65H//3G(RX3B)F$;MF**CB-07AOGJLW6CAPW5#:':'LW_\`8Q-!%[$M
M_>Q4>ETB0+2>YC$69>M'H1T"YCWR+\69#-4A6[#;U\JX0=(R":K1:+T;90;I
M;:+9RF&3`?M@>\_4!O:,N^(`&_:[N^BIRESNM33W8.W%CY<N92NT1=R<2)IV
M$Z=%)!#S2YQ\HE;?TQB'<);M,QBCG$:IL@J%/17V9.\HS1\\/''MQU98G8=,
MTGB\&N]$L]IZXG.\!D!2'X2GCR$[&='&0;'`']6[[R^'L;`2DT@ONKG19/77
M1%4+WP@_[BSVQC>^>S'MM=QV-A.JSR$577%#-?8[M>MTBF"IEG70R;&MFR#4
M9[`L7D$6HZDD6FK(O(R+D?%)I'YB,9@M0^I7-I]TH3K/-5=9<3[Z59V8R,)P
MVKH\K^@^I1P_4T7"6D5%U,8/Z[ZH$X_!U^D684DG&[(27=X<;JJHRB^FVC/@
M2D(=S'[>>/K3[`'GNRU*>3-<S037U8J]*N]RG6E.<UJ>.!8Z=>IPWMWK$S&P
MOZKT5(W,A';2<>E)[*N6^N[;*$=P(]$.V5`[]=YZN+9]U;MO7=G-30E/04\E
M'?8<!FI)T\!X>!B*R/SBW^A`&]B1>/(8_9XM!MH1:69JJNG'COMKN@D$N5[W
M=Z)EY+:MEGWO"4F+7!/U^5!@A5;7W)R$'H&!77K-N`,)F7#[(AP%T`6(RGD]
MI!5RVCUI)E*94?II;.=<IZAF-9I=<K$ZZRE537NU0I$<X*BNQZ_)J@]W\PFY
MXL1F`:'@H\8,;=C)6!L5E6J4E%:KZM8='?\`#=W"[YHIATMOXAS9?]HVQZ[$
M16FDC611N"YNS4\XG7,I47?KL=9U0UE2]-ZUDT^4'5"4O]JG&"ZT"/939)_F
M%>1J#J/>O_1.I!?Y[4,4_P"NK;]1653/9&CZ#]J8%LWL;J`[5O;MZF_:5U4E
M+376NP2C$G#O>S$J1$,U-_U%!DXJQ14VKP%66EDFNRFJ,3G=;+@.B=K[`R]\
M@46*]TV_5!B`4\X*9WK/U*Z65#'T?3`41$^&Y#+*%W8XE#2ON)K_`%0:-&ZD
MXY$B`52D_2)/%66RN-6J8;:>K'3(,ZT5,=#8)U7Z<U(:2;&?;PZ-61\Y(Q)X
MN_9-)!NM<]B%`,TLHK=3!4Q1VDW;W,PZ4;H)*YW553TTU"S82IV`T`RC4X@*
M5C+!:-9!*OXH))35^!K;HPVN(%$HD9</AYN*:YF\?+<>B9.LI,\8V3QNI]/@
M>0.<]A5`@M5L"$IEE9":,ID%8AQ0;R80\<:Q&-H74MEIH0B)Z.15GO'1UEFR
M=;)M/C3QNI]/@`YSV%4""U6P(2F65D)HRF05B'%!O)A#QQK$8VA=2V6FA"(G
MHY%6>\='66;)ULFT^-/&ZGT^`#G/850(+5;`A*9960FC*9!6(<4&\F$/'&L1
MC:%U+9::$(B>CD59[QT=99LG6R;3XT\;J?3X`.<]A5`@M5L"$IEE9":,ID%8
MAQ0;R80\<:Q&-H74MEIH0B)Z.15GO'1UEFR=;)M/C3QNI]/@`YSV%4""U6P(
M2F65D)HRF05B'%!O)A#QQK$8VA=2V6FA"(GHY%6>\='66;)ULFT^-/&ZGT^`
M#G/850(+5;`A*9960FC*9!6(<4&\F$/'&L1C:%U+9::$(B>CD59[QT=99LG6
MR;3XT\;J?3X$$VKV<)^K]%E5E]I5ZG%BI=Y.0=40=9[VY8S$V*6@&1&D4.[Q
M$572A^\D,LQ&5?O\1D4\U90D<Y>J;:I(+;:!3:\T5N[`*&U"<]AX2E[?L^L3
MJSJH#JH:3TU5UKTX'E=0$Q;FZXWL1UTEXT4?#QB,QC779S'(3$+J[7QNTD&J
MLG$N0JM2UIT17U;'EBBW8>SZQLOKYU3$_;RI&M*TH_L!83L0'=ZMESR@K,BJ
MJM;H;,]EK5G-HNO)`G:$S&$,P>3'H-Y(*-GS)N[UU"T=#=8+1OCK&?6C$=L6
M1!,=SH.3LLMLRJ<UG,!/:,6.^NH34M;[%BY?U?8.*HBQP0$X]JTP,0C=Z@WR
MLI):R+W;P2#8_30Q<0!2_P#0K\1I,8F@(3:A]-C`,5'<J`-(07%&D.%11-,$
M`E&$<>S:NV2;=?9JT>*:,M,;Z?,5\=.!DP<Y["J!!:K8$)3+*R$T93(*Q#B@
MWDPAXXUB,;0NI;+30A$3T<BK/>.CK+-DZV3:?&GC=3Z?`!SGL*H$%JM@0E,L
MK(31E,@K$.*#>3"'CC6(QM"ZELM-"$1/1R*L]XZ.LLV3K9-I\:>-U/I\`'.>
MPJ@06JV!"4RRLA-&4R"L0XH-Y,(>.-8C&T+J6RTT(1$]'(JSWCHZRS9.MDVG
MQIXW4^GP`<Y["J!!:K8$)3+*R$T93(*Q#B@WDPAXXUB,;0NI;+30A$3T<BK/
M>.CK+-DZV3:?&GC=3Z?`!SGL*H$%JM@0E,LK(31E,@K$.*#>3"'CC6(QM"ZE
MLM-"$1/1R*L]XZ.LLV3K9-I\:>-U/I\`'.>PJ@06JV!"4RRLA-&4R"L0XH-Y
M,(>.-8C&T+J6RTT(1$]'(JSWCHZRS9.MDVGQIXW4^GP`<Y["J!!:K8$)3+*R
M$T93(*Q#B@WDPAXXUB,;0NI;+30A$3T<BK/>.CK+-DZV3:?&GC=3Z?`HIV)Z
M*V=W/'<Y[%FS&`S$+(J:476!HK-T%::(Z)64R$]#M\?T^X/Z\FER.RW"<G,"
M6[9^M$-D-<9W=-F*[(/<!.A+R5G>X-I=DAJH;V..SI,"&[>F+(:AMI];8`LI
MVN6H/5,E'L9_KP,&T"M&HM-6[APX5(7*;?Q<);Y<;;8R&%TI[;$E5=/=>Q`=
M>C-+DG3^ZK*[!TF/4A(@^`&S;*/*CM*I=U^PDD3=:49IS&[B5RS\)ON.L8]\
MC%+H+876=LVFR`;$PYSV%4""U6P(2F65D)HRF05B'%!O)A#QQK$8VA=2V6FA
M"(GHY%6>\='66;)ULFT^-/&ZGT^`#G/850(+5;`A*9960FC*9!6(<4&\F$/'
M&L1C:%U+9::$(B>CD59[QT=99LG6R;3XT\;J?3X`.<]A5`@M5L"$IEE9":,I
MD%8AQ0;R80\<:Q&-H74MEIH0B)Z.15GO'1UEFR=;)M/C3QNI]/@`YSV%4""U
M6P(2F65D)HRF05B'%!O)A#QQK$8VA=2V6FA"(GHY%6>\='66;)ULFT^-/&ZG
MT^`#G/850(+5;`A*9960FC*9!6(<4&\F$/'&L1C:%U+9::$(B>CD59[QT=99
MLG6R;3XT\;J?3X`.<]A5`@M5L"$IEE9":,ID%8AQ0;R80\<:Q&-H74MEIH0B
M)Z.15GO'1UEFR=;)M/C3QNI]/@8?)!-IVY15RUEV%`Z)(5K&"3D!R"PA*=R]
M9F8J8!SP??#A_)2HI!D3&)G]I%PSD/0M7&^D>IG9/S*_!@-0$C[*'M>591MO
MVIV)Z!]`J]6K@1,370ACYVT5*LA!P7%G$TK.6&13\?$34+$L'3-7=^HT9.]D
MF.GG3U45^GP+M4_WV$'E`_UB93E7@4V^N<)ZIU&,_P!-]B!Z,S=UBL@2&IJN
MC:#/Z?&;'&DR6?L2`TWD$XA>-:QLDBNHYUV^9KH'W!+OP+Z'EA]=[//:3&NS
M<&/V9/!<1&MKX94;.Z5<*M)PU8+WP;5(,UU/3E<+O-%BV*'9*7EAV.\RKMLE
MOIOIJ$E]5NR)GV:IHYL""9!:\]'R$E#`JN!#L?705-R7])14[!+R"UZTU6!C
M(C[E[,H:KR<'&2;#".=]$EE'22R"821H*6I8E7&<!?=<=<RDE4]8Y#1+1T1F
M]72<@RC=7`VJ9Y,P5J_9?+(\?64:Q[O=!MC"B7F5^#@1J"];T6O6RVJ'*^MO
M3D7%SF),HM&E*O@73.@3-`G&M(]RVL>#S70UC5&??Z8;R:C>+>*Y8Z:[Z_,4
MUUTP&)=/.G(]U#`K=1J+KOUDH<Y.?D+QPY2D[87Y83CH:B9C<)1)=)T<CW0O
M'L)XA>Z*)0T;LFBS<;;IZ;J>">`Q'JCT=GNMJY_8<;+GJ%DR`Z2PH77,_P!]
M>]'8KKRJ\E&T3(-)\A$NQAH7(0I,X(8C1!:38QCIXSC%%=6V<9542R`"ZH]L
MF=D&-\&?;VYH\L7(I\E&.M0W:@26]29O"\&ZT'Q,H1.>JVMPAPBTGGFV%-!R
M91>:MM$U-EW"FFJ>`&U.^Z":S,X<"W<*F:*=-6+=L+TA$4I$735,VXCXY5;+
MTCL$JA:]MD=?$4UG1!QNTWD6S!EKLHBV56WQKH'!/_W%E[F<=XNL.UUQ=8Q4
M_KU20UBD:MGRH@AU(?\`-ZR<X5D')8-C+U&2];E7'RTTE$OE8TSY_-G.N`M[
M_P!(O\*_K_W)?QW\/_!/ROZ_?C/XMZ;\*_"OQJY/Q#\3]9]T_#_2>?YWS?I_
M+\?-\/CP.[X<+^IB]<U*\&BB@5JL>ZQ`W2#IG-@*@<[4PW:MX:`KA?9SF,</
ML(((Z)-8_.5_'37'E\<>'`^M$3G6)T7EU8P,Q0[@]*)Q[+'E>Q$A7RQ>1$L=
MKJ^D9,N$V:VTS+SC#1GA9=9XW4<)82QOMG'E\<!,D/!PH\RUC8"'BX./U446
MU80\>TC&6JJN<955U:LD4$,**9QX[;>7QS_]/`^IP'`<#__7[^.`X#@.!Z[9
MHU9)[(LVS=HCNX=N]TFR*:">[I^Z6?/G.VB6NFNSAZ^<J++;YQYE%5-M]LYV
MVSG(>QP'`UL>[6$!;WVR_<J(W@@+NR'3H1V]=Z3SF`B5YG1TPZYV!JQ<ZRBK
M3=]JX9:MD\([XW\R>$]?+G'EQX!=&CH""'JDKII`0L3!M7(2(OG#:'CF<8W7
M>K#,2DJ\619(H)JNE4T--=E-L9WVUTUQG/AC'`E;@.`X#@.`X#@?'FQZ`)6J
M;$C@X<@8I.-':3.;C&4JU2=)IJHZ.4V[]!='1QHBOOIC?&,;8UWVQX^&<\""
M23IWU&,L.,%_5CKB58>/MY-W@DI"LIS#J24W544D'&),8=?/?**+[[;*[>*F
M<[[9SG[<\#F^][O_`*QM==](RL#OH)!=7NH=S`BQ#&F`XC6,?4]6W#!DCJ.?
M)31;,TT"2LTU-A-VR7PU=*PLIZYN^W14W;X13VV#5\)_]>\D]K/H#=Q]V)[*
MUXZ[&V3:@"N,Q8<'%MD=4W<'6@!=4HSJR[G1:-ALF\$[-WGW#K$T]C&&@X70
MPVM&^ID<(IN`W:8E[#GK)]MDIJ2M9:@KRG_:3]Q:!$Z>GBHKF6E>6<HAU9==
M<1=PF<ICTFFU?2\03KC*DM&Q<P^A(]WHHEIB/<(M0UV_@UH.YWJ^%TO84O0'
M0VQ*)]N`9]S.TIJ"(I`:'NT,17/<4I-H"_LN"FO9*,,K%-8:NA:]'TA)QS]?
M\4@&)(JHFLY9+AU2^WN9'-@=+>O!?9%8BM/&4P`H;RH$#!4C6H4P19RDG'1$
MV(UW,[JS`(,FL(T;3;&'>;J.XUM(Z-UM]U$]MLA<G@.`X#@.`X&N#W4.NY'V
M>ZH3]8#%+1=V26\A-3K*-1L5W5=F`1%&UA8Z-=VC19@BK'Q[6U!*U'T%CY$@
M_CX]V/.95)51?.VK%V$9U!1?<@4L;V\""\L_G<645UT[0`-Z7`@5!R/SB^VI
M>GGM:,77J4A*;.)"''JKVCR&?;0+'#Y_N@_39Y]4Z29!"VU+=[JH?]N+YZ[4
M/):6/VXDNN&V]/6KVPASB3I6P1.!L\=[$WW7]HG+6Q(2-1FZ](A@9!AI-NO$
M1KH;P_<136.64A%`VE]2`-[5O6>D:S>U3"T;FO:]@0F/J2`.U;08`<"+-_P,
M;@E+%7B81<UED1]BUWD)+=MKN[?[K;[;*YSE7<+$\!P'`<!P'`<!P'`<!P'`
M<!P'`<!P'`AGL2&.;%HBW@%K78+;NQI7I2+.*JLQ^O%@-CQT[$N8V5!RJ4;Q
M\LK&Q)1&.5F6[CTR^J&5L;[:9UUSC@:':UZ2=W!CJ$)U([&S(L$P7W'>FO8R
MA:=L"R00DM>F.N?72[J7N2RP0KM"?(8A@3[2D[7T\F$1Z\F0/VK-Y'I2$SJB
MKNE$!;V]*P[&V=V0)IXEZ&`=R477=?WK752"Q)?59C(J=15U`C_2YBLH"%Q(
M@6?'%XR*28<S:RBK>,B!V3E7[Y99Q*+LVP6,]N_K+)]6:UML-:BCRJ*I,+WG
M+'H'KL\-53S'6NJYBMJM'WU4,9=&;(QZ,BY&VA<I+FT/!OG4'!(E.L>SWRFV
MX%_^`X#@.`X#@:Q/>"JRL2WVUO<.,RJN`,F,!;H)V[6&"L@$!^:)1Q6-H2QY
M6.5@9V2CG,I$*,)3/J4-FZJ>4G'U-?#?[>!]:SNL'7J8Z$GE=XIV6'1:WZ*#
MQ.Q%.KE=CK&XGL/)Q\.W4(1^*@AUVL9RP=L_5EM8U9A+^N306;X8/OG[,UPY
MQ1?I_P!NCCI>E&!U:1,G:A[UFN'V\:JAG_3JT`\>NBI+\I'IS%P?<L\+7DT)
M0?6.VJ9<5SN-SQ!,YT8'$>#)2T!%.%E(EHZ#H$H7J:,!?>?^J(ZI&8_#];>K
MC,;0N;:N6HP\[#]B^UIV[,.PMBRI=B+;.+`+!N'IN#7>2?J7>4WY_+(;[X5R
MMK@-K?`<!P'`_]#OXX#@.`X#@.`X%`/=B_XLO<L_T`=R/]NMC<"W]3?VKK3_
M`"_#?\.1O`D#@.`X#@.`X#@.`X&-D)>,BBPTV(YEG$+F!(U$!E-WMOKM,DSV
M/DY5I#,_+IOYGB\?#.E=<9\,>1';[>!KN]V7MK8?3'JEO;@)7$*;Q[P^AQ"Q
MRLN%YXWK^D:_DADPF5[;L80&MF\I,A+<L'X@>=*Y=,6<4H0IR;Q?5FR7UW"(
M3_O)W!"L]<CR-`>I]C5+?$@P_`&5168=6:7'H6,=<"?L/:EI5J614+&@RP7B
M.!I./'=G.B_KG#F*UW5RM)(H8#+?;<]QF1[ID)*&D"U.3LNUZQ]3NV,80T20
M.I\8&AWM6QLSPI`]T=SA&YCK7J*9JYRD]<JK,,SD?(M7NL5&?&WX&V;@.`X#
M@.`X#@8WN7C*9>V`=YEGJ8O!M\7M1[.V_P"(+C,9)QT*_F=-/)\O+-K*2S9#
M;/F\?.MK]G_T\#).`X#@.`X#@.`X#@.!C<&7C)+)F4+`S+.3E*])&H@:,FVV
M^RPZ3/1`5/FL-(8VTUQH\7#CB)D-<:YVQZ=^EGQ\<YQ@,DX#@.`X#@.`X#@.
M`X&-B!>,GPS#&0;,LR$7(6>LA"S4?MONRD66^^Z>KAOLIHGOLGMNGG'VXQ_Z
M<#).`X#@.`X#@.`X#@4`]V+_`(LO<L_T`=R/]NMC<"W]3?VKK3_+\-_PY&\"
M0.`X#@.`X#@?_]'OXX#@.`X#@<DON.=D[]ZU>XS?A175P6)<LS/=<+?A>LE5
M4Q:DJWE.N79@9ZC0!^%4_=76:5G50*Z:WL:6B$S=M)LHM8F9N2C/JL;1L:T5
M0#:=[:)Y/2EZ=E:Z@+BL6[Z&'.M7MT6<$&%C6477"^2MBZ*OMI[;+>-/C:9(
M)I-J2`P>!$ZT-JY](S<D*CU%)+63SKD/-[HLKW4GO;^]P\49T#UH5#)SJ!VP
M&T2-'MO9G]::B4M39[%9(4@9WTQ9#BA0C".,N]8=0G19[N]?39E-$\^KP&1A
MMO\`NY#8@*CN_MQ]1%MX$;@X7=9;W.#%NJKM%QC5CLJJ@A[>;]!!13*'CMIH
MNMIKG/AC??&/-D,D_/GW</TWNH'[GIM_'3P'Y\^[A^F]U`_<]-OXZ>`_/GW<
M/TWNH'[GIM_'3P'Y\^[A^F]U`_<]-OXZ>`_/GW</TWNH'[GIM_'3P'Y\^[A^
MF]U`_<]-OXZ>`_/GW</TWNH'[GIM_'3P'Y\^[A^F]U`_<]-OXZ>`_/GW</TW
MNH'[GIM_'3P*N]E+M]TUU.]6MB#V^>J4,LS[1"3L<2C_`'(#&;TG"/2N;42:
MPDDJKT#A\P,:X8+.5MW^FKW9-1#1/TVV%<J)!_?;F!]V_M=4+RJO_#:A*>V7
MD'$A@DKSW/Y5UO(INA@E%'4"6CI9[9TZ/EHFNS)U'66+A'3*<FT9.TE4UFJ>
MW`Q^HZ<]PFD7]$.P#VY.N#%EUPI"PZ,JN!D/=5))2$AXRU24"*CT\<MWGMF[
MNGED3DE7;)/#W*VK)FS7>-FK-%%VMIL&4=?`SW).NDO:Q@->W-U@+;.O,DBB
M:W+7-O<^D=C0V<#4:K"AT,X0#/;""PT>$PJ)<+I1<1#1$;'(+/'CS9'=^_?N
MG(67_/GW</TWNH'[GIM_'3P'Y\^[A^F]U`_<]-OXZ>`_/GW</TWNH'[GIM_'
M3P'Y\^[A^F]U`_<]-OXZ>`_/GW</TWNH'[GIM_'3P'Y\^[A^F]U`_<]-OXZ>
M`_/GW</TWNH'[GIM_'3P*NO[M]TW/=,5?[^WSU2T+=.KI^T;#>ON0&.\0N.*
MVQ6BSZ;5)_\`P#U7;R3232;H:,,1V^JR2VZN7.F4L)*!:+\^?=P_3>Z@?N>F
MW\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_
MCIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N>FW\=
M/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_CIX
M%7J`NWW36UK]WUH3V^>J4K)R':$3=F#!][D!C$-1DBTZ6]0F#6$AI!/H'*;E
M,:N),HN2V?J(1NZ;R079>FVU9ZNW06A_/GW</TWNH'[GIM_'3P'Y\^[A^F]U
M`_<]-OXZ>`_/GW</TWNH'[GIM_'3P'Y\^[A^F]U`_<]-OXZ>`_/GW</TWNH'
M[GIM_'3P'Y\^[A^F]U`_<]-OXZ>`_/GW</TWNH'[GIM_'3P'Y\^[A^F]U`_<
M]-OXZ>`_/GW</TWNH'[GIM_'3P'Y\^[A^F]U`_<]-OXZ>!5WI5=ONFL.JM'L
MQ'V^>J1(-MPEJG#SLQ[D!B,2<FSP\>YU<O(!#H&1)12VV^<XREJ^<XQC'CY_
MM\,!:+\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N>FW
M\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_C
MIX#\^?=P_3>Z@?N>FW\=/`?GS[N'Z;W4#]STV_CIX#\^?=P_3>Z@?N>FW\=/
M`IU[B-I^Z@:>W[WH#BWV_NJPF*EG3KLV-$Q3`^XT6&,Z-#\[2AM%S)!"B+[H
M:&,BJ6AHYTHY;1JTQ%)/ED]4=WC77?*^@;UJ_B7T`!A,%)IZHR4*(C<3((Z*
M)K:)/HZ&9,W:>JR6VR2NNBZ.V,;:YSKMC'CC/AP,NX#@.`X#@.!__]+OXX#@
M.`X#@8;M78%L=I6AL&C.;'1'5Q%(ZS"Q_P#5>@NY>-Y!>`Q._(_$?PE5ZT35
MRA\SY?GTQGPX'O"P:(`\>O$!0J-A\4YD'DLYC!:#C!^/<2LAMKN_DUV42U:-
ME9!]OIC*RVVN5%<XQG;.?#@>G80$)VJ`G%7GL5^/`MD!Y,!&D'ZZ2B_QD3,(
M5Z/$<5^)PSR.F([\1AY%9'Y[1P@Y1\_G24TWQKM@,PX#@.`X#@.`X#@.`X&'
ME@")G#D.=E,3^*.``P9'PDIZZ29?A)9'14S",Y;R1SQIH_\`DQA`\2^0YPLV
MV^=YMD\[Z:;:AF'`<!P'`<!P'`<!P'`P]0!$UC]E:"D3YCJ/#Y,!9SGKI+'R
M1.8FHDAD8G\,U>8AU/43$&U6^?LWV<Z?*\FJFNFV^NP9AP'`<!P'`<!P'`<!
MP,/&0(3#YJPB$<BOPZ8M4P9'IZ\]=)._QXLC@$'J]G*^G?/'36+^2"UO"L?D
M,M&[;;T7SMD\N%EU50S#@.`X#@.`X#@.`X#@8>``(G5P:/5\"Q/X&("D?I%0
M$1ZZ2D_0,$U%%=$/7S#R0DW7ANKMGS++*;_;_P"O`S#@.`X#@.`X#@.`X&'V
M$!"=J@)Q5Y[%?CP+9`>3`1I!^NDHO\9$S"%>CQ'%?B<,\CIB._$8>161^>T<
M(.4?/YTE--\:[8#,.`X#@.`X#@.!_]/OXX#@.`X#@4B]Q&_+,ZP]5#"[JGR&
M[%0H:TM#JM#@>EB.(?0-B7.!5C/(M6\,5";B/FFT>9[.6;I15VW260QJHU6U
MW^$(KMV]NSU-]Q:KCR,TH9YU7,D;JG[&!(VOC52T*5Z_U%0DN:K]ES.W%3M.
M!RBO>K",%W,1J+:--&!*TPW<.7;1TYV"%JW[G=R72O7R8,`$')G/8#VU.Z?=
MZ!H<9!"8>M:/LFI++ZJR5)TZY(W)X11KUP^K'M$R'9-JG#(N\DD8JZPYW37U
M:HA2.O\`W?NP9B?#52/"NMX\4E6'5,DMOMHVZ^V$H+]9G_8;JYVALZ6J6QZK
M=G"#Z$((*[NO\/#IR,N];:,(XKQ&R*2<HFW?*A9#K=W&[V=AFWML7(Z,J(#P
MSO&W&BR9Z]PM(&,C/C%1!-!/[`NFV4;D(;8:.M!\KLIG&QPNVP*K;,V!C"8<
MN'*F7+G4-\W`<!P'`<!P*-73?UKU_P!W.G5##NH*]K3L(!=GYDF9RL%-HF;0
MII`9"9L<WC#-L2+P[$=F%#7";MOL/N72>6OS-'&VN^4=0HU.=Q>\U8/^UU<%
MLOUXM8UC"#IW2W7,_KVMS@+#1KMWVR+989,Z%)8>=L0L<VI!]:@F3&K!DY1!
MQ`O=AB4SH[0U6\_I`^K9O?OL<"EW<T24C0ES`41[AO4KK&QLT=JTOEV50=>.
MP=']>KD,+7M`;2/)=:>E@7>WG$+F937CH9NX5:23J/U:(N&FX48$/>S[)2XV
MH;3L)6K*%"2ZF00#51J6S&8K[@+LH]R6[.DELSM"E[DE>)`<E`5D`C!/#06^
MDO((3I1E)YHZC$TM]@OM[:?N(6YV\OWL#45G,0N#<U"-O)9Y$1H^I`8>2F.P
MMX5E$3U(E.AJ6QW8#K^_!Z\C-MS)JFS1U(]W#?PU556C8@-TW`<!P'`<!P-<
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M-R/03MB0=G'W;<=E2`1L>$ZW=D6].!=U`<!)C0U:8U,T73-T)KNHB0?2;=D9
M`TA:RX_+X9K>D64CDW.B2/S_`)>`V&\!P'`<!P'`T^..R';XCZ?7W:J5P=:*
ME,J$OCN8%%MKS]*'Y.&+AG7BR[`!ZXC1VFT+@1FEB0UV@8Y.06W*GBV%OF(,
M&+I=XAAJ'Q'G:_N?8;.78-2'KQT^=T3U`Z[VSW1,[A!2NWH"EKVN0#.K&.JT
M#H"!L8`_J5Q3T<%1.DBD_EVFBD49-GB"SITWPT5"G,A[P/;VOJD+[\NJG0D%
MSUD?>VE7G9GKAJ/R[>P9^PN[0(!DEFN`:>E3#61'GU;REVC247"XBIQ7&\)-
M-7:RRJF5X@,F"O<][=3%]]"NII&XIM.QO<3I3KGV5&;.@J[GVXW18F:4[V9N
MB]ZR_IF5L!WL=R$4QH.,B@N7<NFJJV\^]<2+13,<W0>AM]Z#=ABOM1U)J&[S
MR(@80\(VI>.'3053?MQ5P:UC8!95A;,BS&5>RDK%#)$0A3F0CV3IV\<L6;I-
M!5RX43V6W"X/`<!P'`<"'>PQB65W0MSV""+#J!D!U:>&HUN6PLD1#.TN*#,E
M/,T9R$AB,0E9&-<JQ^$U4V\FR5\NWCJIC./M#6>6]F.]$C0/0[L)5DOU\=*W
MP+](/ZCI"6K8[GSJ[CB_Y(?D^P3,,(XNP(..IT7IVFGC\P8/U6)1CT\7)*2>
MC5DPPJ[##[9[>=ZY`5L*^J`D^O&U8M.X;7KWUNITKKLZ+;+[1HC5K#O7ZQAU
MJ5PAZ+QU?M\F80>$\25-HXA9Y&,(OGC)K%PSF2E@J[9_O"=EPD?ZT'$7`52Z
MB/<"N&]^O]"P$D,S26W7TJ"^\]2]3:D/+"(<&;-C8,#+`-@OB0I8;_@FB,^T
M;,&+[1FHHOD+CUYWJ[!$AF&`D@K6JB@5[K-L^WU<,OM7A.S=6*$P/7PMOVNS
MH%5V/D8P')FD1^#Q\]G9M/Q\B^2>[--(W&=4$0W.\!P'`<!P'`J1W/N*QJ)K
M.N#NN%@_U$KVSZ24X7L"\<EY_22K[LEV_I'KD9Z#KB)+!?\`ITLBX.UE7\>_
M<IRK5-=IA-1DIA3SIA6&V^SW9#K_`-N&#>QRJDI_JQ^3/9:\+4"@T"*4K)ZY
M4E1HNRE`RYSFX)>PDQV?=6D2MG4;I`J"\*EKNHY3CG<DF/RDBL%0+([Q^Y'U
MHKBL[]NZ,Z[%\;)]1NR?9NY>KX37)_&6)3@?273HFOM`N)+@>6"M!XV2[%,H
M>MG;+8=1;*-I]JLV6<.F[Q?4/8'O<"[E3?=L.]N)2?I)&V#*I@CL?I?:56D?
M]*QM=E?7NPIER`IUSM9*ZV29GV)"4MTWJDGOK_0CG9MNG^*_*DM@D[JCW<[D
M]BRKVY;87UH?6DN[M0/+..J&$P([?6=1U=1_6QL;*W7*W$^/OP)U'O.S3F.#
MDHI8<12_"R5AA%PY>M7SG`;ON`X#@.`X'__4[^.`X#@.`X$$]C^NM<]J:IE:
M7MG!,J!SDT)STLR%"B7#Y)Z^"2:+,AO52:@UVLFFU8D\&R>9334TU54;::J>
M9/.^FP50N3VJNKU_G]BV!;!%V>)][=&8D.LX"2[;]B1^G3@7@Q9Z)14&0TX-
M6)#UJ^C63&4>.DT<QF$])-ZX>ZXPZ755V"U<_P!<P`@O<![&+/3*.L>LZIL&
MEP[6'+)2/$8P"M*6$)XX8;!6F^XVZ?34Y70VZV=J-]E]%!]CC3;":6VFX1UC
MHOUYUKVPJTTB#A."N8T5/+VF$K5LE(]O6;=PZ8]),K7LA,GU/"<3D1]LA&;P
M?X@C#(PS9&*0:HQ6F&7`F&+HFK8.P0FS(47:Q!)6U0S-$U^A&*+,!T,JTAFP
M>?FQ<:&&NZ4%#M9)_6@_A79!#3?*$.T2\?EHZ:X"7N`X#@.`X#@5[L/K/7%F
MW53]_D;HT0L6BH<^@ZX<P1C,PD)%L+08QT8=>N@&"R<9-.)UA#,TLJNM%=V^
M&J>4,I[>;;8*P49[5/5.@#D$L(6?=AS&<K$X++*KQC<_:6_[L%0P\/8.P8$X
M*QL/L^P"<9AYPP0L^8<R;A!KHJ^D5DWBV=W*"*N@3?'=,JGAYSLN20\_<$)-
M]MC"`-[IE1^WSH<EI*;&A$=KR)W$IL?EHN<KM-O7@C%P>-H)S'KZ,&"/D4U7
MURMD/IZ=-.NJ*M%M6]?HM`[K/K".*,JMA+3,=4%?D(TF]1'#9I6+!^V#YPZ'
M$G^^8R6E6K]W%./O3/=N[SNOL'SZ)Z2=<^MQ:N:5,'24+-)ALE6XWI)EQ621
M8#6\P>RUGRM?UY$3\O(QP<(OSN95?J-&::>/!%HVQG#1BR;MPMCP'`<!P'`<
M"F%@=#Z.LDL[*FA!)6XQGNVE3A-)7.Y$[@/`S,I7%=/"5X(08XJ+R\4\#5(K
M^N)]'+F,5;.'+:=?)+[J:+8QJ'J]>^@5#=:)LK+:^EKR(#HP"4Z^?V%<?82X
M[W.XT72<:N=6(\3W"8FDE`ZYV9Q^F<-]M$\I0[#3R^5KIC@(WV_.N+6BP#K/
M,1Q\:4/7D\J1,ZS-K/.2(?,'F270Q:1UJ^IF=7]L"K$GQN\_!"):1AG:RF?5
MM7.-$L)A*^_6>LU;+,;G<;%SRW"P1DZ_8V%(&,[(3E<`DRZCI"5$JA;/G3B!
MJZ)EY:(9O)':&9M7,PZ8LU)%5WEDS^0&54Q1]7]?0O8"J873&1]R0$9?,*+R
M<R0D)4:&$JXG2TV-B\FD)@L-C0HF'6[A_+2KUX_=*9Q\Q7.-=<:A+'`<!P'`
M<!P-=QG[8O7,ZK?%5RY3V2BQG3L42=JDGH3V:N>NR]"[BJ<F"F4*6YN!%HX6
M(-4BN>=RK2/U=X8,9%31=NBGN@AE(/#(>UQU=>TQ*T:UD>P8^,DMQBO8`S+1
M;L[>PY<)];X2,!HF,'!W=42=MK2+9B*8UY!N=-WLJKXR<4U>[>+I%-74,@@_
M;1ZD0TF-RKD0-"YU!R%?$$YK8EMVA8;:TC:J7Q=*UU8UU-C(LFD;?L05ECB0
M=I3$_A\]<.L,E7.Z^\5%98AZL![8G3\79P*4"$ET?,A&U0-ZN,\6I9+LYIT>
MZ_L3Z(I4(J@K?D[N6"0&O(&UB>-;0K7?$>]CB&1;/TGB+M;3<+<U!4=>4+6(
M13E3C;<2KJNA]D,BD`W=/Y#9G&LM<_5?2LLZ?S,Y,2#E11R^D'SAP_D'JRKE
MRLJNJHIL$D<!P'`<!P,)LD!@[4K\TK0G5EDAH^&9D1(<P4HYA)92#(&*T9+-
MV,NRVT>1RSM@Y42^<CMJKIC?.==M=O#.`HD5>U=UE+LT1J^*.S\*UZY4VRH"
MM(T'[9=@*ZB-:C:O8]R[#2V)`ST<CSF/(6<)&,)C,LF[4F8Z(8MWNR^C5+&H
M>0^]J_JT?QE!PJDMV/!8KK56CJI:K95%VL["U%JS#Y5)D@3:$SFO+#'GIK.&
MR$<CI.R4LJ[?3.J>/5JJ^.?$,HDO;+Z9S&2Q*3JQX[BR7\Q%H@?R<G2,!5LI
M;EK#-[6<0TC%MB)!"FB0TNP+ARQR_'?P]RA/1B#IKLWWQOYPRI/H9U^:MJS0
MC6I]$N*O["DW:N/EHZR2]&;+;],D")D36#8\KO)JO#MU)Q9;(L<,G^RD:UCG
M&K-LW1;-VB2`7-X#@.`X#@.!!?83KT!=F0>'KZQWAHS'X*R*SMB/V!C.>!I7
M4WITUA[)K>27EAYTS?.&XO8(W&3*+??;*&[^-;;J:[X3\N0JD?\`M7=7[3M*
MP;6L.=[*E;^UGS![8H%)=K>P.M)&&D7":#4=&3U&,S]K4\E"L1[&S1)HK$;(
M)IJJ;:ZX4WVWR&5&GMN]<;(O$VOBP)._#"7LF/;0M@5C-]E;S6Z[&H]'C,P*
M1`T4]=D#IO3L\-PK&?>.&C%U#JMT9%RJ]QKZI517</31]L;J4V:)J-!VQ&ID
MA(1;QG;:5S6GFYV#.$IR2Z^Q(\PM-4K4,&@NQIR8=PVL?HZPVV4<JR>^NTPI
MO(Y#R!7MI]:J[N<<NL+?WX./1&'KL;':LB.R][1W7:-%Z@%-P^IQ;'7ED>-Z
MA=C=:QN^5X9DXB%4&4CG9[KKZK=17<+_`/`<!P'`<#__U>_C@.`X#@.`X#@.
M`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.
M`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X'_UN_C@:*_<<_[$7MV
M^V-=<?UWO"1MZP+A_#8*:+P^C0F`+EZSAR=ND_@'A])%9J!P[!U*0ZVDAI'L
MG#^5U8*HN-VNJ;EKLL&T;J;VQHCN[0@%V5ZW&[4^JBPV*[B'EDV[B.DHZ1CW
M2L?.#1)"OM$I"!)AZ4;J-GC1?3&VBFGFTRHCNFIN%BEM]DTE5-$5'&Z:>^^B
M".4M55]M=<[:HI97500PHIG'EUSOOIIXY^W;&/MX%>>MG9L`[14JQOT(CBH7
MKV2ECJ*9N;%8PXY([XK@JG`DME'#-G.S*<=$QY0,R+;55RJCE;1GLXTUV:J(
M+JAXX7M144[V+)NL#25=)60-U#65W)NG7X6D*%`+;1/90@(KATWI*J[D,EO-
MU--:.$$D,?)T0UWQMMC?'`FI4R$$&TB\7*AM%G#R"T3+.E9R,3;1<JWQME>,
MD5]W6$F4@AC3/G15SJIKX9\<8X&,D5RU*(JP;<FLL%@W)*9,*\'FTB4PS=U-
M'<FRD)-D(1C;=Y\]X1+142[=^DTURMHS:+K[:X114WU#)E3(00;2+Q<J&T6<
M/(+1,LZ5G(Q-M%RK?&V5XR17W=8292"&-,^=%7.JFOAGQQC@>2(+!6?W23@B
M8?FU%V[AVBG$3,=);K-6:Z+5VY2U9N5ME&[5TY334WQXZZ**:Z[9QG;&,A22
MO/<5IRUIVLMZ^`KP)ZBN:U)ZFZL[*QP+&;T6;&@S#'$K++Q4IN4ZGR`.HZ`'
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M2SMA3777.<XQC'`AR^.S(+0DG6`C*PQD?VG=Q%,BU.T_6T9%2A]8<H,#[HK*
MUX_<DG!0+&QT2&V>SN3F9^8B(9EC=%)1UAPY:HK!7N`]S?K692E6"H,G81C8
MUFV-9-7O*GC!N-B[0J\EI0V$:^NS\SPTL(1R1B6M4$IW%?BFL;^*NW+!UB0C
M4'[#79S@+&FW9VFZ\[!4=U@*BA./N+L4/VF256.?+U5Q-L:>C(2;,$G"VBOG
M8/,PTPHZ9:*:>#Q&-?9TV\6JF.!+CLR$(]ULQ?E0VR>Z?+\[-W.1C9UI\Y[O
M&I>9NLZT5U^;(I[-]?''Q+ZYTQ\6,XX'F5*AA'>736(X%+<?V9Z3VBLQ'I[P
MF\CGRQ^LOKLXQF-V?Y^Q'"WDRKG_`.'QX&(B5JCI2UDG;EO(!VC2P""NXI,S
M6@HM4LDH.1VCVDL*89S<EI*P93IC#F*VSLD[<M=]=]FZ><^7@90Y*(_:*))`
M?U_K-Z,IRJ;L>%I"#=33F:BFRJ^XPC^(RT9$L2!TLGA!-)^[9I:*[Z_.42T\
MV^H4GJ#W&J/N^0ZAL@D7MC+?NW3=B7Y2,O,#(_'16]65<L)Z%A(8JX+G#H5^
M2UL,;<(-U4=W*Z<^UTQI\]-ZBT"<B'M#5H[=-'48JXEI8D[!CMLDU>D<"VCY
M4#584LSA7IPC*DZ,IA-H^:IS[?5)-))?S[YVQMG3RYSP,;K;N%65JF)<*"D,
M;;,@*QK5K`O.Y!B.-0"#(:G$ZW.'SMS/Z%*ZJL"7"MGLGD(\2;J)N$FKO+C#
M7Y6GS0L=_5@K\E@X_J8?]/*2F8.,7_&8[Y,C-87W;9AV"OJ?([E,.4]D_3IY
MV5\^N=?+XXSC@>\RF8>2=2+&.E8U^]B%DV\LS9/FKIU%N%==MTD)%N@KNJR6
M4TTSG757&NV<8SG&/LX'TN`X%%O<>[ZUS[:74XY[=6L'&QX%`<T$0DB-5[K!
M;E+QP=%L2'QRK+4DEX.)RBS?2^BJWS'.FWRM=O+C;;PQD-"?6_\`[??27LOV
M'H7KB*=9NT\"4]@+HJZDAJ<(4*EQ`0L_:QQ!`D-+3F8VQWTCB'CI&>36<^G0
M66^3IMY--]O#7(=:O`@/LMV0K?JE5#VW[26E/Z?2+*[`8F+@D8U>=)3JV#X<
MK*OA6'Q-2D%!-WA`9E;)MLZD'S&-8([J.GKELT1673"NEG>Y305,=?A[L+:D
M!:8!#DEJ6/338`,1J!%K'CSJI(NWRD^93+,A+8P/C8^+K^BB4D9N]YK+><B&
MK?,5L^=R,<U=!DO8KOW4?6@LKX0,0JZBQ]950VK>H\YK2O<ER:-8T=H%.+9G
MY6*Q,1Y2S6"6%C0;A=GB/4>NM9'1-HDX73712#V[5[^]>ZQKWKM8T<_*+=C^
MV:<*\ZZ#]/02)07VS"3X3K84:1BL!*20ZJY@U1ATS5RKOOHIJK(M$O)\Q?77
M@1N9>ZCU0KR<.HTXD3P<@PN0MH58';@/WD1"QK3H98>8W%2U:*04A*D)+:81
M.E+2+U8;QS9M.RNCQK"N9)6,D]686MH;L`%]@X$PDQ>/)AD@K6PIVIK3KTWC
MV$:;5K9(['PLW(")0A#2I`/.'2PT3Q4LS=QDC(QK^*E&CILY526UVX$Y<!P'
M`HAU4]Q3KCW$O7N9U\ITC_%3OI);$55-EI[K-=FLRZD(!%9X0#>4E=EG$/!G
MT;/B[O.^N-DY,?6W^U%PVW4"]_`KSVI[-5QT[H@Z['V^W*MJMK)K'RAW(AT%
MDGEQZ`?2K*'5(=Q]NZ0E96-BW4@ELYT8)NGFB.<J:(;ZZ;YU#YH'VPJ>RC:3
M%Q!V\E!=A1]2=AV-RI/A'>FR2K[TD"R,JN9&RQ$I6?2*A:Y`9W*6NS%/1)*,
MRJKNFF[C]G@3=L=!&CO##<Q%='V=M-,,MB&(U=YW4::OT]<-\O,+>;=CMA;&
M/#QREG&^/A^W@5U[!=PP/KS/48-2H/:EF3'8V<*1FIFE/#\`9*$D^'UL3V_+
M1:2;DKA%L**5J$R\JV5TU4;.$F&Z6BF7"B"*P212'8NF.Q=75_<=0G<63@=G
M`;&RQ!^NF\'Y9X%OM]D,3,@,$;:*)8)-F^24:NM'S1NHT=I;HJZZ*:;:X"2D
M2\3<8B-FY0.KX(-M]('*,W&JXF]TM]TU-8C.CG;$ELGNGMKMA'SYQG7.,_\`
MIG@4J._<0J`1(+QBAT`O"WA_K)*-1WL/8M2@\40@52EKB%A25P'R\C+E0[,%
M9)`#A&P?SB`RPG=!QHZU4EMV6,;^0+JNR\38>LP^*!UEF.6:MY##N;C6WH7#
MY9TV9(//G.=/2K/'#)9-+7?R[*;H[ZZXSG3;&`_G)D(:NEV6Q4-ZO&RDHBY:
M9G(S#INK"-TW<TDNWRZ^:DI$-%M%76NV,9;I[XV4\N,XSP/J1LM%3*&[J'DX
M^5:IN%VBCF->MGR";IKO\MRVW6:J*IZN&ZF/+OIG/FTV^S.,9X'T.`X#@5"N
M?O!1'7GL#177FZ)`BKR6['L29*I[0)(3\.H^;/!I5EOI3CZS7#S2*@[:)XIP
MN_A8IWHEI*-V2R:*V764&ZX>YU+[GTQW9'[*.:`V+B*L*^M*?JF(MB2&EHBM
M[ADQ1K'X)"VD"-9RIK8E<Q)"Z<PN9M!-)HYE(QWJVRNWT2<K!;'@:\D/<SZ\
M.)R/63B;1Q3<U?SOJQ`=H-Q2+TZ^3W85F9R-:;5Q%D.27^M%6KBT(I88;E.\
M`F$N2#7T*4SNOGR\#W%?<IZXMNMM7]HWV#:.`+<MF%IH5@7T6.M[!P5SG8-K
MUC1=.Q78KSLX@6%JR3-!ZX8KO=VC-XBY43UTSOY`\/97W+.O?4^S2RL[>AK8
M;K5_1"?9VP"\6"$2\3"J#3,L@,S9<WI!S;HN5AQ@FUV2D&[*)=R*2.N7&C91
M#'S.!<_6S:WWB9R?P?A>(0839*DTON40B<<-IR3-K(Q^Q`\4>ZH0GK6#Y%9+
M#K9+*B2VFV/'7;&<A]QL3C3R6Q`M"&#=3FT?M+8AFTLP7ELQ6GX?YY/$<DXV
M>9C]/Q=IXK>3Y>/5)?;]33S!2"L/<0JNYY2O7U85=?YA3=KV9/U-7/9:-`8;
M6CRLI&4RK\6D6+MV8-[(:U^H\#7K2/*W0VW&)IU\E.-?N_GHYW"X;*SJVDL0
M^8ZP@=_@A<.VD!ED60+K$XZ8,FTD^;0^4'^_XFX9Q[Q%=71#S[)HJZ;[8QKM
MKG(>]@Z"-FZCS4Q%=FB*+!PJZP0Q&6Z3>46V;QBZB^'GRM$9%?3.B&V<XU6W
MQG&F<YQX<#T?S.K;_P#R$#_^U_ZW_P#=D#_[+_\`S?\`_;__`&O_`/B'_P!D
M_P#XG`__U^CG_P`'O9)__.M??N$W?_\`]+<#@U]]+VPZY'N^5A&O2CL[T>L"
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MFDSV3JQI6?NP=I.RXD6=669$`P<\7FUKR]A[UAJNVEX=)D4#SO3.)W9#>+R'
MS]ND75Z/6Z>SM^]L_:.D*]ZT1/0^K3>*(NQH$H#]HPFCF7:M&)NRSX<Q"<0.
MUU7=&E;_`'81#M:=:/-H<AVQ..D]E$VP2/5W3PC:79)&XAV9]K:5>/KMH.2&
MAL*[,)M]%)82L7W3HYDVA1$4I9@T$C6>!.R<VYAHULI*/G9)5DFW=23Q7\0F
MFH1YCI3U99*]+2;L/VS]H9Z#]=87HQ5QU#378.MU:Y[+@]%PW9)LA>!=!&0.
M@.*7%?0X;ZK,X-7,DRV3@I/&9Z10V2]`&UGVB!GKF]LOM+<M"'\/+TU9-F66
MVZ:5G+0J(855Y3C`W9DW;5Z$A4WK&&D76\WW?-)Z,4QM&LX]N@/0Z*.NR'HU
MEPQ6JNK]U-_:>+^DHWV(ZDYZ=Z=6KQJZJ/<#!;B()>5D.OTP$FC"N#0B#(H)
M@JJ'=AB"E6W]2$C"QI>-=L8ITX2;I;OO,P#7]977;IXP[.O>U?:"Z_:,C8)P
MI?LA.=7(:[J]L2%&[#ST]ZWUV/ZTH+%]7BSHXM!>2!8DG>M$XB)DF;6?AM&V
MCQ?5)X_",ND]`4<251UQ[8BEL>U_'0J5"]9*XM#IT:WX@.TZ4R@UTG[&C!9;
M%QR#JJVTI7W:DA#+)DI23C7`=)++"@F]TVFE$=UY-(/9C^C_`%W$*>L2DP/N
M+[1)I?3RR*47(+J/;]K)K=\OU_$/;@J[K'8\;-SC&O"LOK<D+;'`&5I9T15E
M4W[,C>Z;2;*4RW)%`L)7O2XB=JB@`1=I/;SB;+<W0T)Y2S:W[,.YN\(TB>^P
M:GT6M$6#XMU5PQ-RY&/#WIKW0\TK'+2X_P"5XZ0BTL:2?`AT_P"F]%$[FOK2
ML/LY[/XO%QL#"A1!4K7LH'(]>IR<%/;AORD@NRAY>;K)JS9'5AM[V%CB0C]H
MA7\'$P$>4;/I79)N^0#<\9T3,MS;VI+)!;8ZXR?:GK?1ML!P73AI;[V#"^S%
M6'E0TZ,7O,5::1(:2'KQ$#F1,1G&T^T#I=KJQ<ZMWK9KB31<H!6+K#U6&`3W
M#@:Z9_L9TP.+OG+0]R$WOZI1&XFLA8(Q;=_I])$6M>U0&/X)T2$#?K76E&A[
M*?=27]/R#ET9ZRFT=&:OD&;D,J[L]2C"U>P$I:RW:"AJL[B0W8[J65=!Z[+[
ML8P0DY#:>R<R\()GX2^JYU9$R=6W#O+S1V3&EG*+^%EG37&5M(%RX4#5->71
MZD3F<O5*/[9>T*`V2=2GNJQ[15?M"':%`">]KCGKG,5]*.E-:K8329AU.DZ[
M?LE]/(W=L%R'3T^[+9933<)J.>HE'P9@4*=D;G]H^4E87M[&V*8E%R]NR1P;
M']:;=[#6]W=>VB$VE!SE=`I2-3;`LKS,<TCGJ1+(.9=9=W%[)2,.^#)ZMZOT
M^$G+,\$K\]GX[ZPV1>7:K(L`$MU1LI7%2AQYVCZ\68-$U`Q0;$#8L06=7-A1
MHN,SPDT>CC#>07',:SJ*N4&*P7:]H^BK,I0C[6D"5J=(+O=F0'4K9HPZRWG(
M34&SL,*(;^7CUC`=AZA:Q]0!YXS*VZ;7*']1R3'2+70<*3KMHO*R(:U8;VX@
MY+K!U*`P'NMT>&W@?[5_<BE+-MAGVZ++!#[%%BECUX>+WM7@_,MVP_\`^/(O
M'U=%X.]V+B&CT8<UW;;KYT;,G#T)#M_H[M;9E<EBBG;GH!1JMF2O=^:(ZS">
MQZA)651$,ET^ZB5@>CL5Z`&K9:>A_DTN@56RJJS''$7#'F,JHN/E)NI$(KN_
MJ&*VDW[#2AMV!]GBGYJRA/W-F<[`0/;6.DARJ%>P_5KKQ3S]1>6EJ)"G<@SZ
MXGP(T+Y]XM'P^4G4\V<;(,'.^BJH5X[T1E)UY*Q&VN.E!AU:LD\[O6)-B-.W
M:4[=:FP(2_\`RYQ=]0<;;5;=+;_K^J;<VLNKXV5?/I$<%6T.W(--D".,W>N-
ME0Z//;CI61K"[^Z99"VW11165LV%)G,#4M6V+"VX3U*53G8#LY-F#.?*6P>.
M$(6.OIF770V$'<J51<*;LRG6&=1S#RQB(;<.!1$LHCHM+=N(2W"N<'$NVC%\
M.+PD2MV-.X6;W?1L`BP'=4Z2:6@P$9#92!TTVU3W@%=76OUM]5-L^?(:F?\`
ML_=9*O[']`9R-<'5*@?8:*F@G2GY6].T(KUQ"_P!>S0=W86KE2R[)!:MGUMX
MECIHCO*(NUT'&^FC39-977S!P<](O:Q)(GNAU$E;>[)>W!)5/&]GZ"D+0CA/
MW1^F;PID*[9VL)N#5D-,P#L`F=NB!T-)N4V:<+MK+[N=M-6><.,IYX'ZN1#5
M?5N0ZGMZF()2'3ZI)@XQ!MY56XRJ,A<A$8]B5AE?%T-SAH6*MU7C1IC21S/9
M7=YSC7=93"FV-@II>M1=30;V^BD%J:1Z>3G4'4XA'=SL.X'86>FNM9("2Q?$
M-#B")K\+Y"WI(&*,RSABL.OMMG&D81H,?(EKG;RY#4_;OMU=C]*+ZKAQGW@Z
MS-JK0*I?/4R4N#MC8DA'=9;P(^QD?=O4.1H4\*Z]=)>XA/`=3CC<$CXTT2%9
M.4'<R.D8Y:(R3Q+8)`J#J%4Y>QZ(+7+;OMS(]=J#Z]>X4'6I"=8^Y5@"0]=H
MX8O.L_\`Y%VRYEPR)J^-/!V!L*M'$A:,3).4!B'P;MXJ0U6_#D'DB%]_<O!*
M%M;K"`4P[D/;N!^O%KU3+U_4=Y7Y<T%6+RAY8CB`N(HRT.GL:Q`IH:/9857=
MQK^(9QA4&;Y>-8?#20\BFOE#7?V;Z"U\?0R(>5=XNH0#5@;W=[W=@NNUAEMU
MPB1<>]O[@MJ1,R?KY9(VNS'QR*:TI9$T7P)"E"SLQ/;)I-/G13%\U6UX&[GH
MQ6:H#(=RR4@/*K*+1NGN.36Q<014)MM8`W1)HK1/7ZO!^H9(D>PHH1.2A"I:
M\&2)]B4A(1WG<CQNFTPSW:K+!?/@:7"?I9[,LF2$,D3&($D22$Y+/B!-;OQ=
M$0JG-NW[AQ*Z*Q+7L:R;1BFC]13&S=-%+1'/P:Z:XUQK@,X[.4/3>OM6WS27
M425JM4/F@^98520V!VA/HZK8*RY8ZCWL`3DW8#!N2&B4>(V1NA(;,-);;206
M::Q.<:HN=D^!Q%>T1[3-A4=[@M5V,:]XO:\["`$.:)-[]K.G_<EW>66\BI*1
M48HD&8ZNU!Z>F20/-EFLHA'2+G5K*/&F6:^/O&V<!WK]O^O7M]W`;C,WV[GQ
MB(-HP5UBAI&<[.V%1SA46Q+R3O55$?$+9K]C+H_BSESCUBK997S8RG\WRZ8T
MU##32D*5'^D$Q6/3LFIMM6REF5[/(D%D]BC`@K=&1B[A!"><CGULS:MTS>)2
M<>0R,8S9;;*(ZO7J6FNNOCA-0-1)![?E10>]PV'U/[G=3#?I\6VGU$O.G>NU
MA=EU`RA(48@C+OX.VKU^2MNJ43-^%T&=W-<4N4U]O%(2*4:>#,E%IQ^&L5MJ
MH&,'7MXTD>'51376WO\`]+J549USU<8PP75UJ#!$DTMH*JTT&$)NMY4FG#8X
M(QF8]J6TBMG"(NY#9:?U'!DC<)I1;%WYPVO=O>O-:W05^URV$#VD!+KI4]D%
MY2-0K'LJ:4626C6S[IQ<M>1PIUP(:C;:2Q6S&:E+'I<Z183S%I("X\Y:N=OP
MMV[=M@U)63T5ZY&1'V!:=:^TGMG!-7'`;('W6&PHOLJ3ZF%9U7$=2Z?"#WKX
MO5`,9,:=4ZW%`,&PLQ/&[=Y(2#4)G%=?PG+I6.GV@3[TXZ^=/0CW!*NM0E._
M:@96&ZJ.X@\,HRJ>S#6^+C&[]).Q2!0;D]:3=Q0;6QSN8B;+'"UI(R[9`??L
MYN9D&/X:BLW=J/`F(VZFVQ+5S[@5+=>.PO6F0IWLAW%.K7D;U1[#&E97-U'N
MXG?`#NXZID(JK`DJACHB'YN`<K-&SLK"Y5FVEM6#U'?5+1RH%0&76GJK$DA@
M5UW<_L]RQQ"W[W]=W37,KV)`M80GJCLM$V[(AJUJF$96DL1PUH]6Q]B7H-H:
M3@Y!EF!R4IHRD7HXD%$PI'V5Z8,:`ZN]F<Z]M^DU^5O6O7[NT0-"9"[MYKLU
M9]O3?L?T=U?G!#%3Q882PBI5"/:\B;*>O-2EP\4AR=G(N6S%/71RX#H5]G,`
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MI6K0E:R31O4[2MY5O(/Y&3-%M9HND5&>K)JJWTV4=Y"2/;`Z4=6J3Z%WUUT/
MNP77/L3U$7L^!W">P53=H#-KN;TPT?BA#46UQD@M8S,.JRQ!\KQB'\0F6CH4
MD:-&RRC;15TX15#:HM2W3+>X.N)@M,P&+>KBN8L<ZZ-,WX:)OI&NVL/,,XMQ
M%`VMC:P]J-=H=X\SB5DH^8<K:XRKLXVV2UWT#5&VZFN$NCX?U<4[(=0'OMM0
M/<<?M5EVKS>3EJ9%=?Q7>;6_07K:LU:BF*H86`X[(:Q5<J&#8[7=O-4,^6#S
M-.<MM0I(PZ,R8Z(#`_)]O_;0(TCF?ZC.8*9,>QRJLC6DC07NQW/V39:]?)18
M!6_'5.PA.>NZTE6B>D,KN50&J&KA^IKLP;AM![;]9^NIU[CDE?O<"TNL33KN
M+]`F-?6#3=I]DIFMIQ46;]B]#&/MJV:OWR.`1Q0VYTNT'_3E+]U`*3.45<Z;
M/$D&_`UL.>A8XQ<M='O:+VVB4]J.\9`H-ER;M5<4$1=LZ[EK#[;0`T)]D7D$
M9:H=?IT1(+()9%!(;AB%&5L4>?*949Z-G3;@;"?;0I'J55MK=A&,"?\`MX'!
M6<572B@/_P"-%QQ9K:(9UV'>L=%`+N`W3FMY:SQ>G)*"@!Z9BI#)3,IR$5(Q
M3EPOY_3+J!",!T\L=MTCZ=T&Q[*=0B;J3UE=2975O:5AV1*A1EV<ZV0->V+"
MA59V6!B8"K43L2EHDG@_ZF($3`GAW&D'^):0^ZCC5N@%8*2Z1];FU)U=7-3]
MPO;&=0)3U:]NCKU9E@57=8`XF*[["]6[XC9-OV4ZZRXA!QR9E9O:F7)V*"VL
MLO!RZAA&0/S)":TT2:IA%]]U2'=>PZJ2:V;,]ON[*R96][?U:`\**V%+'7]4
M"\)[DURV:)6)94*TK$G8@0,35L=DXW)O6VA"Q9N!A^FCO((KKL6P1-_\M[I;
J_P#OZ]I'_P#7?_\`,#__`%`!O]OOTR/_`.<__H@__&?_`*W_`/I?@?_9
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g22611g61o27.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g22611g61o27.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0N64&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````+P```-D````&`&<`-@`Q
M`&\`,@`W`````0`````````````````````````!``````````````#9````
M+P`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````"/H````!````<````!@`
M``%0```?@```"-X`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``8`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#NL[J_6@[(;@].951C!Q?G]1O&/1[/I/K90W*R'U;?=ZES,6O^6B?5
MGJ74^I8#LGJ%=+07_J]^/Z@KNK+6/]>JO*:RYM6]SZZ['?TCT_M%7Z"RI<O]
M8.C_`%FZA]8>E8^9U.G9?=?;3A,Q?5Q:ZL=F[U\JN^X?:[7OLQZOTG\Q9?ZF
M.^M2O^NGUAO'V/`KQ'V8^?1B7]6K<78EWK/I]+'P:W>H_P"V>G<_[?6ZRVK!
MIQ[?UBRW(QTE/4=?OR6_8,.B\X@ZAE#'NR&`&QC/1R,K]`;-U==MUF-7C^H]
MEG\]^C_3>F@BN_H_4\"BFZ[(P>HOLQWUY-KKGUW,JLS*KZ;K_4OV65XF17?2
M^[T]_H>AZ/Z7U<,_67'^L[>MLJOJP>F=).,<'J-\-:[,%AOQ\IUUOZ%F*W(I
MQF>CZ>^^FW^<_3^DB/NZC];.I8F1TG(/2V]'8\Y5EE7K%F;>WT;>G^C;Z-7K
M]/H]7U[][]GVKT_3_G$E-[$R/K+U:R[JO3\S'JPF9%E&)@65[J[JZ'V8N1D9
M&6S]9IOR+ZW_`&;T?T%%-=?JT9+[5:Z[=E7]2Z;T6BQ^/5G"^[*OJ?LM%..*
M_P!#38!NK???E4;[:]EK*?5]+])^D7(?5[ZQ=5^KO2NB',<S.Z;U2W(K%--)
M&97:;+7Q557:]N4Q]^[?MI9Z>]7,_P"L6;D]9Q^LOZ7;@=/^KKV?;;<AQ];T
M>H5L98W[)BMOK;]D:_'SLJE]WVBJIE7Z.I)3LY?3Q]7;L/.Z8^[[-=EU8_4,
M:W(LN8]F2YN'7DM^UNR7,R*,JS&=^B?5ZU/J^K_@UJ=2Z_TKIEU>-E7'[5<)
MJQ:6/OO</=[VXV*RZ_T_8YOJ^GZ2I=?L^W9_1^DX[Y-V2S/O<V'`8V&6Y+7_
M`$O\-G?8:6?U[%MBJH6NN#&BU[6L=8`-Q:TN=6QSOI;6.MLV?\8])3@8WUP^
MW.L;TWHW4LH5N>SU357167UG997OSLC&<UU=@].S]']-3_:_7<=K>H]9Q\/I
M'2:6O=EA][\C(_=H97Z--6.U[[2SV,LRWV_S-/Z5$^IUS<GH3<M@(9EY.9D5
MS^Y;E9-U3O[=3V/0/KJ<(8&-;=F8^+DX655G8=>5:REES\<[G8[G6S_.5/>W
MV-_0W>E<DI(>M?6+(99=@="/H-9OJ&;DMQKK3K[*\9E69Z7_`*&V8G_";%L8
MF1]IQ:<@UV4&YC7FFT;;&;AN].UFNVQGT7KFA_C'Z.78]3<+J#[KC4VREN,[
M?4Z]K[:6VL>6/LW556VM^RMR/4JK_1J>-U_)PL7,RCTOJ]U/J6Y3K,TXM3:F
M?3?57ZV51;5B4M;^B]2I]B2GI@]A>:PX%[0'.;.H#I#7%O\`*V/7.]5^LV6W
MJ]'2>C559%[;ZZ\MUVX`@[+,FC&]/_"XN';]KRLJS]6Q/U;'_6,O-JH7.8%W
MUK;B'J>*,3$ZA];,@68S["<C(]-P:<1FQK,?'HQ^F=+KNRO4M^W>I_->A7;<
MNRZ#]6NF="J>,1KK,BXEV3F7N]2^UQ.]SK;G?R_?Z;/T7J?I/YRRQ)3_`/_0
MZ[ZP_4U_7.LXF9?GW_L^MME67@-?Z;75/:P^E59CMKM].Z^BK[57?8_U/\%9
M3Z2T,WZJ]#S.@?\`-YV,*NG!H;4RKVNK(.YMU3_=^G]3])ZC]_K?X?U?4M7S
M8DDI]['^+X^H7NZQEO-64,W#WLH=LOAC7Y&0TT^EFW_H]F+9;7^IT_HL>M:W
M1/JQB=#NLLPLC)<S(:#E576>JVV^??U*QUH-C,V_Z.1Z+ZZ+O]!^C8OFY))3
M]!=.^HF'2.CVYM]F1D='%A:UAVT/?;9]JWNI=ZCOT%^Q]7Z3_`T^JB]?^HO0
M^LNR,HTMJZE?L(RW`V-#JS6YCGXEC_L]F]M+*;O9ZEM'Z+U%\\))*?HGZN?5
M%O0\BW+&;;;;D;A;CL:QF(UN^V^FC#QGB^[$Q\9V1;Z5->7^>MW)J?=CVU5V
M.I?8QS6VLC<PN&UMC-WMW,^DOEE))3].]/Z8WIU&)BX]S_LN'CMQFT.#"';!
M6VN][PP6>LUE;OHO]+]+_-K"QO\`%[@8^7=F?M/J5F1DN#K[C>UECXCV.R<:
MFC*]+V_S3+O37S^DDI^@.H?XO.B7Y+,['8YN54R[VW666-OLM;L:>I7O>[.R
MZ&?G8_VK])7^B_FMZP^L?4OKF!TB[I/2\RR[I653B46L>Y]EOK_:/2M^RT3Z
M.%AV5WUW96S_``-'I^G_`(1>-I)*?=^NX/UCQ>HW?6#$<:\3I%56/@]/I:RQ
MUU!LQ[NIVO:]K_1W45NI8S'_`%G]6K_F_P##]FOE5))3_]DX0DE-!"$`````
M`%4````!`0````\`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O`'`````3
M`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P`"``-@`N`#`````!`#A"
M24T$!@``````!P`(``$``0$`_^X`#D%D;V)E`&1``````?_;`(0``0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("`@("
M`@("`P,#`P,#`P,#`P$!`0$!`0$!`0$!`@(!`@(#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#_\``$0@`+P#9`P$1
M``(1`0,1`?_=``0`'/_$`'0```,!``,!`0$```````````@)"@`%!@<+`@0!
M`0`````````````````````0```&`P`!!`(!`@0$!P````(#!`4&!P$("0`1
M$A,4%0H6(1="(S,D02)B-"8V1C<8&1H1`0````````````````````#_V@`,
M`P$``A$#$0`_`+^/`'Z\MLM7-8T8%^QNQM&T2G.;37=)BW+4A%>J7%N)/^H)
M4THI2]M:UW"-;Z$%A3%FC-49P4#`C!8#D//=?.A&C&U\I<H-K7MOKY=\U:6O
M+XOA];6I$)1*264!OPGNX(^W.AKLH:TAP@`/4%$C*3B,+P8(&3"_<!A^!O`2
MJ_[M;J;B77L!1G,J#49%*[UALMTHF[=U=JRY^]P[^^L54`36?45%41"`QB0V
M%)*KRJ)`XOCN_-+!]X>220*RP@-.#@KAV+Z-\T8\FN[;B2T?O#I='G1N)OBV
M*:IJ3:][*Z_1Q_7,[6*V5E4EV+:\`MFI(*M,-&])FH]MD:1$J"K"!42D48\!
MU,6E$=G$8CDTA[TVR6)2]A:)1%Y&S*BES0_QV0-Z=V9'IJ7$"&0L;75L5E'D
M&@SD!A1@18SZ9\!+.W_;6,45M4NTHU>U&V)Z";'P%A0S:_HAKN@;PLU&0I6U
M9?<!DLF="E:5QL)6RFICT#$`HDI:8L(2?>+7F@2"`I=!.I^JG10F<L-/N,X@
M5V5*82GN;6>](<OK"_JI4G'X2X')X,ZF'?;:\+!!)&N;E"U*0<862H&0H'@G
MP#!OZ]*SUDI2T=@[DD),5J^GH2_3Z;/AH<&F)F2/H35IR=O2>\!CD].1@`)4
M",K.3UJTXH@K`C#`AR$\=#-O6OLC'@[3.NUDSY8:,6(6-^U9I:C8=#'C:6SZ
MW5F@,B%O7!9\F2.H82CEK+G"UO;6<TQ,M3JPFY*^N6D6K@Z=><3Z;<*8XIVN
MAVV-T]2="8F<TK=J:9VRD1,KVAJJ(*7DE([VQ2EMGG)CI"E9A.N1JFA;@M$C
M2`#[TXDX#'!N"F&FK:@U]U+6EW5D\$R"O+:@L6L2%O!!B8T*^-2]F1OC2:;E
M(H5)RU6$:T(3BPF#^(X(@9SZASX'I7@;P-X&\`,)]T8T-J^U(31L[V]U\8+C
ML24,D+B%9&VA%5LV=)-)'$#0P-1\>;'%:Y-!CP[&@2IS%I:8DU0,)81Y&+&,
M@9_@<2[/[$P@2F/CTTLH%RH"%$-V<4;<!8M-QD1:-*)8<3A0J,P'.0E@]1YQ
MC^F/`Y;P-X&\#>!O``38+J3S]U6OZL=7-@=HJ[K2^+>4-2:%P!V#(5ZD&7Y8
M4WL*B:OC$QNL7JYO?UAV`(%4G7,Z9;Z"R0,S`!Y"!]^!_]"GS>/2/H'N-<B)
MB@_2&3:5::-T=8A+XIJ["#V#:.<2S*A4"3@=+Y<I#@R$M(48PY;#V9/[0B%[
M5*$X905!@!O9G+#@ES8JR7;$[GPV(VBN2-J(J67'N]/I%LA;EEO`B#SVEK88
ME,%[DW22>R(;`IRD0QJ.D*U>"E`0%_``[``\.Y;\Z3;HWRA_6E?I!4_-*@ZR
MJN4P#2K5VN8#%JWM^R&B?-K_`!Q7L5M0SPUO;&MKDC[7\G5)D#$H+,6D?.28
M:,7TP+70*M?`W@(SX>-W]MFCI3KL_NJ$RPZ=ZF;5O3^Q`(.2.J.&7:LC-MU=
M)EA*M*G6JFV:1B1"4H5A@U&#P%#`$W."?8`'-6+`XU:=?3NL9FWDNT/L>&R>
M!RMJ4!]Z=SC4O9%T??6\\'J'WDK6MQ-+%CUQZA%GP$*\1=D%L%_75H/8R7GB
MDQ>ONMVS;D8+*PY64ZQ75RR+QC+"D1J34C8H`VF1.LTQ*4L98!D)L`+SG.09
M%D.6_6BI`,&Y@5]L-+\&/>P&\LXLS:F_K#="V]1(YM))M/Y.DB9RUV3D!7'-
M:>%-Z-64D.--`F<')>:6$K*DP&`=DEH^H45S.>Q".NHFDO%ZK]+5;Q:25I3D
M3)VKM"]@D:*(N;N4$!Z]G1O905!0#??DL8<8#G`<8QX$_P!^U]*'MJY*O,*;
MGU9&F2Y=D]>*LG3TG)$-(AAJZ5*Y>L/>E`5*;")G)=X:B&:,61@-$$!`@^TW
M(@A1W&XXQ0^.L,2BS2A88S%F5KCD=8VP@"5M96)D0D-C0TMZ4O&"TR%N;TI9
M)18?Z`+!C&/Z8\#B;"@44M2`3BL)XT)Y!!['A\F@4R85>,Y2O<4F#*MCTB:%
M.,?URG<FAQ.)'_TCSX"&_P!8V0/_`/\`5X@I]^6KG4O5[9G9W7./O+@J"L/=
M8U#;0<I$U&@/P@;Q_50XF(T1(1!%["DH0@^,O`"2@(OH#V0J?2ZU&+5BK:0N
MW=G=^7Q4F91S5O76-+'9Y9HRN580M,IM2:8;W)KKN*N2O_E^<"5U6IRQ%GG(
MRTQQ)Y@)KWHZ_?L'Z]ZO6KMZ]<T]6-,**@7\0*,,O>[2+\MP0IK,8W7C20PQ
MNMIS`_MO!DHDA1N0N;&B`0@`8:(DP!?RC`@*UUL_9]V.A$'E%D=0]2-6HS83
M/&Y>K0TOK(TV+8,9CTI;T[QAC6H;(J^)%II`RHW$)9R=.\%"PJ3_`!?D!`R,
MT8>F_P#YUE5V&Y7]!>J717<TY0%W"X0M-:0:,I)46^EI4[NE253'S)@!B;7%
M(E^$Y*WNB8@PO.`B#G`<>`=M<<V>0?,.%.>PT7U@UOH9FHF/KI@X7Y.F0,RF
M\`:VA$:%:_)+5LI3,+`0.AR<T1(1(UWW5AAV""PF#-"6(%R,-O\`73L_E[DF
MK$X;^6W-MX>)$WUIL@LB"Z8[B;3U\2L+31ZR:XB,H(BHJ=@\T1(\K6YPR)K=
M"$ZT`TZER!C.<!W)H_5CYJ2@A?(=K9!M;NU=C^%.9)+ZV'V6LI=8*]4!&O).
M+1FPYVBR7#3A<O\`LD$N6'544,@L(E)H,GX/`AN7/+.\.75\WS7U=[+OEI<T
M9G!XX\4/1UL2%_D]KT/<8)`I4RULC2S#6BAB2LWAO7+51QB/ZJI>L4I0GI/F
M1'N#@#QO`X&4RF,P>,R"9S.0,L3B$397.1RB42-S1LL?CL?949SB\/CX\.)R
M=`UM+6@3F'J%!Y@"B2@"$(6`XSGP.NU5:M;7C7,.MVGYO&['K*P6-))(9-XB
MZ)GB/2)E6XS\*UO7I1C+'[#`"*-+%[34YY8RC0@,`,&`7AUJZ%'Z#Z\-H*M8
M$]E[D['21/2&E='EY`<X6/=<G4-S0C=U:,8BBLPNN,/9#J\&J#4B0S&$Z(Q4
ME&N*."$H6I_/"`=%KO#JY'EYFU$,JG8N)[#]A^L,D,;I"'9_8B,,\F5,6D&L
M;J]HG#+Y3$;5/"=.\+T!I:(Q.1E=@H"8;&!S#Z!G@?_1/_JC^U!6U"R^=:D<
MZ*QDFT&X+-*);6#M('*&RLNM:UG,45*6J1HVB)EH$LVN641YS;EI&4J(E"S!
M-3?8PN6$!R0<$\_.3?2Q(CT3O7HETJT%W5WRLV)"JN(&7(QZ[K4SOIE:"&,J
M%K]'TM1X);:NCBY$2K^",`6KF1U3MR##F42E6+5`"P^A-HGTGTTZ10!QG^I5
MQL\_#'#$Z><0=>G51BSZ[5K#59*,B<5^^%I)$R)W`Y`H"C6_$8W+\D&_54'8
M+'D(`]&.^^G-E=5(-RMIE%*K>F\D)LUEE-VPX:`ZJX/9U8P^8SI[KL0E&2W2
M6"1,<"<"E[LV8.;D+@8F3X&?C[QJ`#1WQZ2:V\[6RD%%[JI@[2+8>Y(I2M5U
M]6C"FE]A2)[D3@D1N<D3183JUK5$/A1"XDYV4I_G/!E0G3IR%"M4F3F@$5IM
MSOHSV;K/8@LE*7K?U7A,/U-MQ=]8'R0S<^E&J5/^N$B6K`IQ'`0W#607**IR
M"O0`G)L`:J,_[0&`)WLOMDTZ5<R=PKS5/J=@DR:FY7`:N4')/R(U%O6@VJ(#
M6I2=L^NJ"X?4E+^G6'@&#)($:4XP[(20&""$C%=]8K\I_A*JU*BO'S>T=-(M
M!K.IJ1[>/<.>(94C>XVA64T:7RY&S*6L#FEXKE/*I.J<3E^',L6$^,94*!J3
M,F#`F^9?[.VG>IFG&E>L&VVOFWM'_P`'I:HZS:;L452UOU02YH8F-A9UMC-9
MR61-4Z<8J4U+4[J+\0Q/2H]"/(B@'GC(+4!9[3UQ5AL!6,+N>EYNPV/5MB,I
M,AA4WC*K*QDD#0<8:1A4C.$`HT(BE)!A)Q1@`'$'EC+,`$P`@X!!_P"T?)M<
MG#D_?E16M>%9UI;K^CB=D4%#I1+V-KFT^E]5S=BE"MMA<74'YD#R8Y1]"O;?
ML)2?B(4+2@F&AR,(1@UOFMLXQ[DZ$:F;*L*_\@&T*3AJZ0FY+)*$EG\?0_Q"
MS6D9:<0B`F,5BQYT1"]F?;D2?/IC&/Z8`A[XN*)Z\TC;U\SQ26DA=,5G.+1E
M)QB@"7'X*"1MRDSD46<8$80J%"5M$65CVB$(P80X"+.<8R":_P!:"OY9#>/N
MNLHG+62TRR\Y-=6P#FF+2G)C%".T[=F#Q&'4\:G)BQ8%[AY3>L3G'&G&91'D
MA^06`XSX#M&RL:V9)[*;49J]@[19\Y9X_'IK8[9$V%!/9@P1+*[,58Y3,$J`
MJ0R!GC.713^/3*U!Q*+[!OPA!\@_4)]?VPE91'%#8)()2G*/=[(UW;D28W"0
M2AR5!NF'N/TF\*@L:@2S"=O,/SA-D)^223/7/Q?*'(411-O/:(K&6I47\*IL
MC[,WJ2OE`H^(]$W)DQQ?SEA`6=[#"LX]X<8"+T]<8QCP.P>`CW]CNF+5O;C7
MN5"Z>+=%\J:HW!K%<(^SEN)SA)X55UFPZP)XSD)VLLY6L,+B4=5K0I\%F!4#
M2!*%C&!^\('#S9V0IG:_1C6.Z*%5,O\`;Q[J&$LB>.LBA&:77[Y$X^WQN1UN
MO3HBDQ;<Y05X;36XPC))'H$@(P`P6,'J!P^``70%OZ/+H=4)G-Y_UV99JAN:
M*JKD3;#(7Y0UO=.BR:F?6^.*V5*O^DJ*4'@4+?:46O,1DBPB/+/Q@H\#]\"-
M;]M';EQ=XUJIR?K6SX77$OW,L2,RB[I/-YS%8/#(=2C)+DC/#!V4_P`B<6\F
M-0N164G,=C%AIJ<LPN''DA$;\@BL@4DS[]<;>7.N<!UCUDG[QMJ/7JJ&Z&Q*
MO=66X-BM9+%!4`&($GFUT&FH:L(;W9U3"5NSJD<W98(2@:SZI^#R?F!9E'<O
M-L?V%=FSNK&\$MF&IFEUJP]%!Z0UAB4D=E5RRW7!J^0LJ)ADBYF9V^`5G9D@
M)/>5[N%(<NE*=Q5B2(D2!8A6^!:M06OU+:M5%"Z&UZKB,U-4->-HVN(P:)HQ
M)6IL(4*E#@X*SC3S5+@[/3RZ*SEC@XK3E"]Q7'FJ51QQYIA@@]B\#__2O$9:
M\KN*/DAET>@\+C4EDYAZN5R=EC+&SODA--.PK4J9"](429>[&&'A^48U)IF<
MCQ[LY]?Z^!-G^OA<545YSVW1Z`7A:$!KJM-I.CNX.T;Q9T_D#)%FEIC<FE<;
MA+6DD#Z[9;`EJELABJLQ$C,]#CE#E@!!63#P@$"`+"4M':WM>L6<-E%EZB0<
M^FY#"MY=VX"U/=4Q^=0R4.CB7(YL?"6I1'7,U\FJ()#8S%+OQD@DCP0%<H(1
ME-9SF2!#P6/\[>1W:ZZ75T3IZWU_X^<V&HV$X4I"#;3NW9;8<,;4J7M<ZC)+
M46E:EDQ#8%<QEGIRD;>W)BTJ?V(6UJ4#`"YM0+KWEZR_LGZFW#?L<?H`]PJ5
M1F]XW5;G\R!LH75.*1M1<D"8"$"Q(0X`2S6-R!M.`O4)$ZF0JY*0O]A*981D
MH+">A^U6MF]-V6-PMKI7/7W:B94\^6XAO.N6DE\KO3>ZJB+!;-)R*SY:S/26
M10J3-4ZBK*9[DA6,EF.J%`:<`YQ"5X"K*#M6T?V,]L*%H+9RKY=6>N/+J,M<
MWZ!U@ZGMJ!'<'1IH>);5K5`,GQ=4>A#7S(=%GMX382F%F@1G.*$S!8CDBD(4
M8=E6=:^<FND")`$L1Y&EFQ;P/!IF"P_2CU721_<18%G&?4P+>V&Y`'_&/&`_
M\?`4/N3']?9K^IQ5CKL\@0N;)'^86GLX@*TQ>W,+VW;`I:*K$BFED3>%#6Y?
MBGIVL!U3-IX$Q&1+6EP6(1>B=2=CP$5<(:G[W;.Z#.M,:5;ET)IQK!2NQ=E5
M)+!S.`.!FRC#-#&V/V5/&)H"HIN3$@:RG*RTYV1"?&5Z3+,&)_F+3@^(8<MS
M-Y!T?=O:3=>9;+7S)MP-=>9<BC#-<]N;2EFEI-A-K!M2YLE":>)9F\N!"2MJ
MULV,2(XY`YNCZF<"FAO`K/6('$T.0/GAEO;K)SUWAVIXR'[+U/9NMCU<#M;F
M@M_1ZSF"800\JQ&ME>5^NSK.6YV<XUB6)T(R,)\A4DE+),B=2\>JER1)\@S'
M]@NTY5<D7UGX^T.]'$7WTQMJ.0^=*68HAS=:MU'A+N3*+OM5U;?>$XMI)0L>
M2_8,1`7%M0NY91F3"<@R%`U=0&*U37\'K"#-9+)"JZB,<@T29T^`A):XU%&A
M&Q,B`O``@#D*1M0E@]?3'K[?7P.Y>!,S^R>R?_(%AY>:`I',LE1N3TCJ)!,6
M;)S2$QWI2LVEZ46HK,3KUA2I2WQH4U:7`T)!(\C-()*R8$9I9*@*9O`_(Q@+
M`(PP00``$0QC&+`0``'&1"$(0LXP$(<8]<YS_3&/`3OMCWJY4ZAN68A8&TL/
MLBPSE!S9_:O7TA1?<WPXX3JQ_AG=%707IDC3HH-3X("E=UR`W)AY61!P6+(\
M!)G`Y3TSUXVSOS<+@CS4VUK#32W8Z^3NR:#W`K!%$*3G4E2I%4CS9E%5.LFD
M$ES;'7%E4)E;&CC+LI5J!&&-B0.4H"&Q,`J2ON?VVVJIJM)55V]U-1*[[1V2
M*UW@FB^MM*-;?LH\3$&6EQ3264BGM?O!C)`?D=$J-,H12)4D7*5?U59>3"%V
M$05!Q"$=[K^F.*T3]F^<%5S"NF<+/9D2UNH2"WG:"1"!B;X\"PK!AD_%DR.3
M!?)"C%HT2(QF9"%RC("\"3_&B*#^[/$[H4)N>W2]_P!C'>57&0(1N<K<:UC3
M;KT!M;6<MP.5."20I[=E94.0I&54=E4<3\9>3"P*#<YP04$L)V.`_*W67J_M
MMO'LELZMO#;+5.AIXDKG7EWOZR)O_-+:4NLADSQ')#:#\P.L:DBMPCE?M;:X
M+63!I"#"N1`*/`>46,LT'G;QZRT'L1N-K+P=U#IFM*4U6;6=FV^Z>@HN`QB'
ME?VE@;\F=:%I21R2(`1KV^86I.V_*U?^0R6]A1KVQW3'&@^?!@59L+"R15B9
M8Q&6AMC\<CC2W,,?869$G;6AD9&=&2WM30U-R0LI(@;6U`G+)()*`$LHH`0A
MQC&,8\#EO`W@?__3J;Z^-73^0:V)HUR]C](R>PI6Y2"(VTSVT[&,3X;6DKAS
MW'1K*U>5D@BT<;)"T.KF!88>K7%'%_`5E.$W_-),"$GCSP=V%ZRUD='MG]RI
M14NJ^D-X6501VKK":_R*S8%:"5W)G-JMK+%Y$E25'6BB1.<[&,<H+Q*%RQ4G
M-2'HOB2$^P/H@:(<_-6^;U'-U!:JU\7#HJ!04[2J1.:G#S/;)E>$2=`JF=AR
MD9"<Y]D"PE,'&`EE)D"(O_)1)DJ<("0@A?MU^O;*]U]F*XZ`Z8+:A3;5,C]7
MB:U*VV5R<ZZ^6FQ5XB&ABTI=F1/#I:I729I2(6QM<&M8$;([LJ$L(B2SRSL+
MP5)KSI7^QOJCNOOLPP&HJEM':O=YMK`R1]69<J:D-25-"2S'E98:JK\*XRR`
M$[.S[(&8D;$".G*F\N'ICB(\I3A3')P]"UMY)]_.=5V;DTII\FU[GS'NO)(V
M;+>K]HS-'_=J)1H2N3N;T\(8*[6>[V$T60:Y3-<N=#<1J2`4NGM/*7*#"TBA
M*!RUOP1W!Y-SZ!;-\@=@V6U+'65JT0;<77_;1S6MD"VM=2G0IU=IQ&9"R$*<
MUX_8>59ZIL3*C\GM)8!`"[J2U2]*O!U7:29-4.Y$]$'R287-Q+KI]<\.*3HR
MCG!6"265"7"OXTVCPVDK,F$J93*4B<\T./A`4,9@Q@*P(803CN5S:W0W`X'<
MI:2UP21TJ\M<X#HM;TSHVS%@8"T3\VO->B&1QKV2*#%34B)=HM)W\DY2D<%2
M(A9E&>,9Y:T"?/@-JXM:"SKGKI4WUO=;O'9+LK;MG6+L5LQ*(N=A8SO%OVFZ
ME*5Q"1RRW-67`+#&6QL;S30D@3C5)CAD>I(P"R`=;(?JY\M=H-B[4V4GK7?;
M')KIFBNR+&A,$MHF/UN_6$\/"Y]D\R_$*8JZR%$\2MQ=5IBS!#J6F`):>),4
MG&9D7@2LW%H)2?//9[J)II<_(K9?;2O]HW"M7WF-(=<6V4RQ=7K4TN-CG-J!
MAO!U2S::QMX+!-T"-ZP)+(59BR._`X-RQO5DJ1`S[E_QN[M:.W)4VZ.+4U.M
MZPK0KZO:QO"NMLYS<<\N"I*+3.+<JS6,0LA+'WQ,WNT5CR),6,EL<PMJ1<A(
M2E%+410OD"Y;P-X"6KETJN;8+MYJUM3.XRASJ/I!J-.7*IWA>_-BHY\VZO&7
MR2'RA*WP\AQ&Y$)8M4S0VKSW%8F+("O"@^ODXT`AI`-J9R[>-!N[3T1A%34N
M_:"OE3RI3<]L.<L<F^]X3="8<F4Q-!'(N)W)9GF!KDS<U)3PA0*%8E#H<?E0
MF+0X*5@LCOOHIT\Z$4W65!:%W_4]-U1('"3H]GX_.I5-Z_>[#:EX6%/#T`I;
M"H1.')PKMN)PZY?&0`$GY#)J?Y`+P!P22"L-*>`O8S3^"$PFD-YM"-.C52-+
MB33B@M36F[+;EJXIL&D4F2"Y[WKUILQ4G4*%!Q@"$[@B0H\GFX1)4A)IB<0'
M:1^N>[WTF0$=,.I6^.]C(2A;L.%2XGJJD:$<G9"N,5@7*ZV9'B7C&(HK!)83
MR%R1<,TKYAGY]2BB03C='ZIEV2OJ@O%J>:TZ+\Z8G7,);XI=$"M!ZDURNI#M
M7>8Y<45;FM?,5UEKK"F$C>7M*N6O2E+'_P"-+RRRS500":O`"K53A^_[];:[
M$VQRNF=L:`Z8:T-\LH&J]G95,;?/N/;6Z8EB1M<DE[<9^0A+Q%HW*I`$HB0B
M2%-2)F:@HR0,Y[J-S3I0XUE[=[I7/Q@O[01TL1RV,W<<7Z\:\F3^F9):IG=:
M<\:3IE-,[UM.V+/7(F^+RA<]HFIWCJ=P5JU#HL:U"L2T0UV4F3@I#XCJZ^Y-
M?KHQK:RY4Q:!K6P.R=S9P@291L[E+5=A.!:&HHXW+'-0!(KE%@0QIB+0V#-R
M6$U6M3DXQG&`B$$VFD753K+K!!]K>Q"W3>L9KK]LIM3`95M-L7:B66(9E/H,
M>\YK.!4?K;\]B1A.5`:B_(+FYO<4[0])D3B-*G6GF$HAH\A]-%I=4#XU-CVU
M'_:;'AO1.K<I^(XC["!P3%JT9_PJ"R5!/S)S@B]I@`C#Z^@L8SZX\#D/`W@?
M_]2_CP.CPC^VW_B_^V_\'_\`/#__`#W^$?@?_<G_`&G\I_E_X'_UQ_H?D/N_
M[_\`T_F_P^!WCP-X&\#>!O`W@;P-X&\#>!O`W@;P-X&\#>!O`W@;P-X$I&[^
ML/+>6\\NI4#Y.S_G5$]D;>@,87WW)H;M!4K6BC\1:+IASK.R;+F`K$<6VFH<
MX-J9T393J3&>/J'<THM6'USG(09W>NM_->9\R=9:3W5M"E1:6U[#=5_X/9,L
MOF.5A4$Q,K2(Q\FKUC;9B6416'2F,SR/(!A(3E*#$3JVK!&)@8%@@XH/SUNI
M?76_N.VSU0!LNBZBI>4T8RYI^P'RP*WK.AFF71M]C$HUV0AL)_=&FN8Y#Y-:
M+&P-1"G"HH@12T("!9&,&,@7O/A%;K9HKI\TWVUL+-<C-K=3;+8J",S!LG[(
I&2L\#8VQ8J1S-C7N[#(A.(4H5!RE`N<4`CS1X3+5A&"U1P&#X&\#_]D_
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g22611g72g60.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g22611g72g60.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0A:4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````'0```/(````&`&<`-P`R
M`&<`-@`P`````0`````````````````````````!``````````````#R````
M'0`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````!;X````!````<`````T`
M``%0```1$```!:(`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``-`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#T,=5M=C?:FU5^F+A0YKK"'-)M^R_I/T>UMC'.]]>[_BWV*GFW7Y8R
M+;;*L?%HL9BT6`/M)N>YE5EM;&FG],S)LKQ,3_0Y%=UO_!HG51B&VWT7N9:#
M4<TL:7L+193M99[ZJFYKZMOI6?S]='^"MJ]%4LAM,5^I9?L=GV_L\"L>S)^T
MGU/M3O6]&^GU?7^R^I]G_4_4_P"UWV=)3O974,7$LIIN>?5R"X4UL:Y[W;&^
MI:X5U->[:QOTG?\`I2M19U;IUEXQF7M=<;&U!HG5[JG9C&#3;_1:WW++QQ2.
MM8PM.2>IQD^H;!2`:?T4^V7.;@>I]D^S?8?\/_3_`-8^TH5G[#^R#?\`;/4^
MR5>E'J^M,W^E]GV_H_VOZOK[]GZS_P"@Z2G?JR\6ZVVBFZNRZB!=6QP<YA=.
MSU6-.ZO?M_/0,O/^S7BHPT>D^\N,DEM98VS:&_N>M6N7Q6](VW-QK,C[1]DH
M^UV65N]/Z-OV/[=3=;]I]3^F>I]LO^Q>MZOV[_M,KW7QTX_5?']`N;5Z(^QF
ML/)]+T7^IN&*6V>E]A]7?Z7_`*324[=&<+!E[V;3AO+'[3N!BNO(W,/M_-NV
M_P!=#9U5CLX8SF@,>VQU=@=)/I658KM[`WV;[KOT/O\`\&GRQ/2,L8IVN]*_
MTR`##_TGYK"S=^D_E;_])^D6'E#%^W5_97Y0_4\85"AM19O]2_[`]SKWC])N
M^T[Z[?U7^;]6W[1]F24]3/;N@Y&3Z%N.PMEN18:BZ8VG8^UFGYV[T]BY?#;D
M'ZT6`V93,\%IM=D5E['4>G9]F8]N);5AU8WJ?;OLEC'W?I_4^WU?;*\7U+O4
M&Y/[+Z8,RRT'[4TY)M8TW^EMO/IN;TZP5>OLV,LMQW?Z2WT?\"DIV\/,Q\W'
MKR:'35<"ZLD02T';O`/YJ?+RJL/%MRKI].EI>Z.3'YK/WGO^BQ8-%9_:6&,6
M\_:#C/.*ZND?91AS7^CN8,C])?ZOV?\`38ME?^#].C[+ZJJ.KSS;U,77WC*]
M?'#BZDEF_P"T3TQ^`VW(;B>GZ?V5E]6[_A,J[[5ZU22GH>G69C[+?M9/J[6.
M?4`/3J<[<[[-58UH?<^NOT_7M>[])O\`4K]"M_H5WEQ]#!ZC?L-V8*1FL^U%
MM0-;KQC_`*1MK;;QU"MS_P!7]V3ZK*NJ_P!,];]*MJJOK?V:MQO=$":[*:OM
M4?NVVLR?L/K?O.KI]-)3_]DX0DE-!"$``````%4````!`0````\`00!D`&\`
M8@!E`"``4`!H`&\`=`!O`',`:`!O`'`````3`$$`9`!O`&(`90`@`%``:`!O
M`'0`;P!S`&@`;P!P`"``-@`N`#`````!`#A"24T$!@``````!P`(``$``0$`
M_^X`#D%D;V)E`&1``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!
M`0$!`0$!`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#_\``$0@`'0#R`P$1``(1`0,1`?_=``0`'__$`'L`
M``(#``,!`0`````````````(!@<)`@4*`P0!`0`````````````````````0
M```%`P$'`@0#!0@#``````,$!08'`0((%0`2$Q06%Q@1"2$B)"4C)ADS-#8G
M-T%CHS5E5R@:9$75$0$`````````````````````_]H`#`,!``(1`Q$`/P#W
M\;`;!UJRLI+=1U5P+RD11D)"33RRM+"F:!(IJ4DIA44ZHJ2@=,7AER9$B3`O
M%%%$NML##LK==6E*5KL&3%D]PG-3!OR-RQR8/8TP))UI92QCBV[(UWXB.Y0B
MH4W5+:,KO-:84@1G+#B?TWJ`(Z@C(`:A:3(()U+(B)FNV'A*@]6)+O=C[@)F
MNAWW/`<TH*D@@-E5D)L'&8_7-%Z3)+O1H;>;U;"B225%)=CWB5/1%=0L,$$L
MQ<;.B7BIZ??=<2`!C]@-@-@-@-@-@-@B:4_6,NCW%D-Z--9,V\+>+I3C1U$>
MWCC6%P=X(H<&$IQC`MMEOP^:^ZEM/C6E-@EFP&P&P&P&P&P&P&P&P&P&P&P&
MP(([<T'%UZ=+1'"HDBPRQ9?C2$YAGA?D0JQFF4>3\E]LPVMH<))`+;=XTNK$
M*N)S"B/D8V*UTA,%("IA11458N?(IH/WL!L!L!L'_]#U0Q]$Z%E%,.3K:R:E
M#(!5?\3S`KIA&`6[-4JP;$C9@QPJ%%S'IYH+3AM;C"Z8&^_V4CABJ"VY#3G+
MAO,BX$HL(6TP4D6"O,M_;_Q0CA/@61&#CSCPDD2N6^,K0F<F\XI19!-2?&$P
M28EP5:R[17713+`JG<>46^LB'C=AF^XLE&`J4XIBE]`C>9/M\8'.U>QUQ):V
M(V-B`JY+3!8ZY#/(,*1N3<23CSCT3*2/,!M*5K6S>J-Y+>JQ5L1Z<'3!B9HJ
M$_:BEQ0A:<2@/F_&IB-@?"$PY`MW'^'XR;$2L-S2<OE8EBAA,Y>7[V:B*2F2
M1D$LW$1)$5W@NF/5.2"UN\8-'SH9<&EP@U+;@;-O*!]70$-554<PWE-31TQ0
M44`V.":-(9\Z2`,G$<R9+_3F#"88%N`O$#^2^ZRM;?A6FP+9D/EY'V.SY@2)
ME)KR!)<R9-.1ZMR%XFC`@U3+L==8V9QE^2$O#J+\=[!9#=:[-;@`8AT\I*Y0
M.@QLL"'Q!1K+*A-XTR"94C.50C\PG.R-I82$LVO*,22BBAMA\W-LB?()9MVM
MRTN>5FQ(;+)J*L3+&%MLJ:TD$SAP$J8,A&[Z`;!1A3W&\4%'&V<<LDM[KBG"
M6/+D<;7D9QE&,[N=YQ`+MI4)J;11C"0`HOEKO5L/5$6VVK)-AM.7T58)G20P
MH(]MVP//L%=LZ6XQD)<<K;8C[:[Q66<30#[F*-I7*+5J.4=`RZ70131M/$')
M?<1VPH666VB776WE!*74MK3XA8FP)=[B#?6''A=/H*.D&G11":J<_'"Q"OK?
M64F%&CI0)$DF'392M>$J),R1\UU-K'2(U+BY\FKBEAK;PA;[:A'5=IX=C@XR
M-UMXVX\/.+\F'0;%9JP#&\>EVB':%"3RF1N.='1AF89)+ZHX6TP_0J%2I0>T
MC:(9H)=:4J%>$/56F3Q7RHQ%8,`'UAO1AD`N3.R9%QP*&U99BYEM!DQ`[Y42
MYMB]KG#1TC!R>RY&045I&TYOV);54+I`!YDE<HV)XU`T+<.O:`N=+7)=CGT=
M3Z<O7`#)E%M7N2'TBY8+DC9`X82[5#AU,6!#@BWA;U+1++JTNH&?B#(2/GXT
M<6RY$TH)<-RMCI'&8,R-ELN<8H.XFE+3:(CP9$;C5R`S?=U8_?"V87U@X,3"
M)6K%K$TL]2Y-45`@9"$X39$-&.\64X!W+SR76BAYVY`8402IJ.JO1S.EO(&;
M,EX^PREDU42@J@YVRP6VD!$1EL88T)8W&X.HG3(XH1D:\-4=@XVWV75OMMNM
MNJ'=2P2EMU*ULOK9:)2V^E*^MMU;+[;O2OQ]*TK_`&[!RV!)L^DQ60,;I4R!
M92ZZD64\88Y>\]QM:E/9XH;86EZ*V^>?!AGO1J(ZI1KN=NR&CH1IMGQ%%+4C
M!),5S(A.VPQ2R[8.ESJSF0<.X):LKMUG&)L<LE/!H-6,62VUHJ0!<A%;LN<3
MI?!M>H740R#+8L:)JBN&3=@`U#5X!8B%]2?+;P/GL!L!L";9MR?(C/C%O1=!
M2\FMS(_)M[$H'@UP*18LH@,9:7$5<<[_`)A%1S)8\76+80A]JN%UER1@N(24
MU1*)IQBH89WB6A6LAPZT(W8N&6#<0-L2]G=U(U<ZF&HG#:HJ($2XI.5OSVXY
M$<RL.-0TOJCLF%MM)!5CAFTR,I*CUJ*/;7BBCAAHGL!L!L!L'__1]GN1T)OA
M7<[,R.Q\%0T_)&)$M60R*.Y#QM(9$\Q0N&BBB[($DQ23P30Z634CZ>"I-5QT
M+'#+.<H-AJP`TF'%Q)5@7W,R4VM+6"Z\Z#C24FTODI)Q)5%"*):)E&Z]H^DV
MS)J#G"PFZ]4LL96@$MQ$'C:FC$31`4^7-"V@F4T8V'>`(($V45<J%[J;32'(
M&7*F!L!'P-#QLR3#L&5A1L@V-?D&FIBH8##O$$2RR7'!@R4*7BUK8,&*9M#I
M86N$!//=)DU7DLN#'0;/.',4L7IWPFF7,Z2E>Z])9JR"CY>P8XQHB*#*Q()&
M=C7B^,BJE(<B&0C=@"(63D0F+>+4\H`E0T1G/,Z*H=.-EDMPNM3U.\AE39J+
M<>(3%;[FDY\%"0">9/N,Q506T=I1_'*,65BHJBZ7*I)"`4M,@!<T(;-%"Q@,
ML#A)^QA[L6,,OYD2$BK,S3I"3UC?&2&VV<<IB&8A,J;Z01)PCZ$!R2.$XWT^
MD.-PV^KO%VN5-)`.6A:XR$`WT\D02R8-[E*)([^S\Q'B-D1>\%QG)T*9$.&;
M90Y=;;#!:;%DI9BY@V-D60TV@(BDZ'&WT-QWE6^2'"/!+`**JWUM+$[Q+`K1
M:Q:5IHDG,O"%\8^KC6PGF)T-I\N60D]006RQ79%H6&&.6/+)A")TM`/"K1)R
M($C16H*B@*.3*$$1-;A("T(U18!N*A6LUY+>X"B>.&#[FQ%6GQ,4KJ3V2)'F
MQBSE"[#A&:88AMHB&G4KL1S/%]G)JC1S2BM++6+.I)--`ZNMYMK#A,-HRO&T
M@$]0$ZP^B!G8A^Z7-.2$JX^S@U5!SXT-.$&6^<=L4LA'AC3+DQN.1B!V;`HC
M:D=MR1E2/6/%3#CN,&*VE5<(MY/<R,UU!>#NN+W&#-H/%EBJ9C2\GP0MNQPK
M&'3=>&;^(S6@F)X\?:]6<'<CD)J17O+"OD<X6<L%V2;2W)`+(<EA:.R-RDF)
MP(HB@K*A\V"`G)X;A[!YK78[<@H"?L#X?0W'S##.XD^Y&E71>]977E@O'R?B
M[F+#&2+<Q_+DV>R`[G>XB<=TEQX,%-`XJ:6#%C(O<9-W5-W"AAL?CO"[>(/M
M\SN]Y.1\@\E#9.^%GG*J8UDYG-J/FXUU,)=481B-D%%5T#QXQRKK-:FK%CJX
MX%]25^'155CEB:F%DX.I]R:5%^$O;]S.E%H7`VO=J8U3".P.8MM$!OD119"P
MC1^"(7J8*WF[1WFI$;.`'?0<?>X85*B76VU"I8+CY?Q;QTR*D5LV]R%6-8L*
MQE"*$(&7++!J.,*(5I%K+8Z@;&N*$J]6S.V'DXRU`Q@R0`#MMI\@O,7WAD/'
M4FB-;&KVJ5"&'S;(F,OMZ&\<)Z]QJ26@GN]S'%=TY$8\28"NNL%12"YI.64V
M*W7+9B2I/1KN84&\C+J.IW`AVEK[*AJ_D][K6+$>0@X5K'6>82R/R">I4@Q<
M;8?B&16E*RY(<X2,I)#&A])6$IBKRF;0&*=D=WHH"PLG;BI)/*&J;PM1Q"X(
MP)GA`_LW<7#.&...3I]HRSEYFWE[GQ(N7#N<2[8V[2T30`1>C,;$EPVT$Y'2
MZ%62XD)H1M<AEP$DL4M3U<&P<(K>;%,EPV5=64$0,O(>+,7'$J.0C+DRMMVN
M=@%.A7H,T%<HS$XZLJZ8)(@2%<Q2CDO14A0.`)HBA0Z(53AQ*AVTX7%""^X,
MJ@H.!&;RX9N*V%T;$+)15'O/4]25@*=#+T."W'*4NLK4K;8#6HGQI\GK\:;!
MC9/,?O=^P.GS%+I16;Y>('+[7.#$,&'.I%S"6I#OW,[",3*Z<[U$6TQ<"W7V
M^322S39N^Z\T$GQ\H&0_4-1W*@Z?N"SX3C;)G`YP&@7,>AK&Z=G'+68SU;UY
M$ZS('8<HX\S;CQ"KFF,K<OD3I%!495EDLK7'+2)\N@(B"HK)^XB5+!#BAK.2
M7T)31"SF35I)4&V<30UDFX"2B3-HAI'%+T-A*I95`&$(#IHA2O%M'M$J%4/Y
MJ7>GQV#%=J>Y!(4G>XJUFU$)QGR5@&]%1&Q(C]^(*LB!)4H9=AL2<\BYD?\`
M&;[L0U8&26)`$2P+>VE4),4BZ9>Y5J\O8,9/%+P0`MW(":H^B3W`;)#EQ%=Q
M\M!F#U1(+1FRW+W<YY2D?)F?*-5\,&&F82"&77G+U@<#L\A:$1X="))SVU-B
M@DS0PP8+1`^1#_B7W'I46LYYIC*(0YKQB8&GL!U+R6B1)#TN-9^+"\3QBB:9
MW<72T=ZR*SX(D9L.1]%R:G=1P+CBO5$XD$E%P0"`,@WO<<(2CE'DV6@UP,67
M,1,)\0E>09S=3%KKCA=62+H<2BX6*QXV=("B(W7,@M:*8D<]JL*2L$*T6UDF
M6J:O&+&0"X/=`&3,(9--`N[8;DMDOJT`$`)T(K;<1-2<#%7Z!AT4VH]V]?0H
MY&@YD4Y=<7-$%4D1/`"V5M%`#N^6@6$_9,CN+$,XY9*?+38:`03U%5-*SM7T
MQ!)AIZ2#8.I&K15(R7H,&2"%LJ)N;U;=^VGIZW6TJ$0\C($_WBCC^C'D9_%Z
M+_03_>+]\_IQ_J_[E_>;!__2]_&P9F99^`GDWCYWYUSR/ZL@CHSH'NWQN2[X
MV>.OD%VR_)_:OR/_`(0Z]^U=6<SI7U&H;!9F=?@+T6R///M!H/5!OM;W%_B_
MJO21M>[7:+^?]0Z6X^M:)_Z3C\]]#QM@O>./'#L*F=I^R_C)T>M:5T)T5V0Z
M$]%/J3E=#_(_2_[[J'I]-Z\?C_'B;!#,8/"K2'9X7^+F@ZH2ZZ\8.T^D:UN'
M=.ZL[4_1ZIP^8X'.?B[O$W?AO;`QY[1>>1M2TO4N<,]/<]RG/:AIAWG-&X_U
M'.:/S/%X'S\MQ-[Y-[8.TV`V!9,K/#3MZC^</C)VIZT0NG_*SM7V][B;ASIK
M1^[OY;ZTX?,<CP/KO3B<+X;VP,.AZ+HJ/TWI?3NEI^@:'RFBZ+R@.E:/R'T.
ME\CP^7X/X7"W=SY?38$D!\4_)]F:[W_[W]R)$[5=VO-'M'W,[:O/K3LYW5_X
MVZOVEZCY#IOY-#U33?I^<V![]@Q3SW+P.-G'B$(NJ\\ILEEG5CF*^BD0MQCK
M;*6&G7*=M68QD9C47:Z6^XFT1LGFY:%)&VR55CES<L=01XO:7O`&##:S8$`]
MU(!GF?;LR^+OU3E!&:0T,.,-75H60V^YI33K;[BMI(XRF\['"TFPM+!=1J#=
M0LH*A`D,'2^T8<(.MU]`OS$[LKXS0/XY\/L;VL9G;#]KSO2FB%.0U[F?N'5G
MKO:SSGU^J\QS?U/%V#YXK^*/9)J^%'C_`..G,+O1GC%V][.<]KA_JGI_M=^3
MM0ZFYK4N!^-J'&X_XV_L"UY6VXL7XM3!8U1DLM9?)D,VDS&+1:&SLH@9179"
ML.F.8R$3<)LA'1N5`LFJH-R>$ZAP$T14I6T^)8!4>Z@*8^@\)P2C<"ST.Y/J
M.6@<CHUJ.>/)DHHV6IH6C0F;I8:'$KVTU9>.D,>+XDZSU,)H'#+<M2]7ZT$N
M5M7KL#EQ]^GGHN'/9_MIH'?20?%+M%KNF=]>QL\=U]8Z"^GUSM/UMU'UC]-J
M^[SOWW3=@C_O"%&X>]KO.LH]%^1&LQA\<)$L?SAB=H-Y_2$E1_I5U7V9;;.=
M;WC9NKYBC1H<M&`-+J:'4M<)=Q=ZVEMP"9X"_I;M_G.)^GKXR-S@ZAW)ZG[2
M=/I^F<QTW_.ONYSG"_</SGU5^Q^[;NP69B!X<=JI*\;/X5[@/+OYW-[I=WNZ
M&G$>K_)/R1_GOUQTOR&]UM]=T_R/"^V\IL".)W_7HZX<O(?I:ZYQ$_J#U\=^
M@]1]%_=X/'_EEU)O\YJ/*_<.-PN<_$Y;8*#Q=*>WH3Q>Q\LEI?E!Q((C`<`^
M&IH9H.IF/LFQA)/AG6$R&R&(KW?B2I93D\@:)>K'D4R5DTRL7'>6*`(EHF\%
M^/S],GG$7R3\G.[?.'^UO??S;\F=&]`.K?&O2?YJ]!\IR77'07T/+Z=U5\.0
MV!]VGX*^-3+T3QT\6>(4Z4ZBZ)[9ZWQ3>_SW6'T77FI\UJ.H?>]2YGG/JN/L
M%%N']-SS[9^H\MYF]#QKR'3O>_MQH.FR5V/[E])_\7>N-,ZCZ&ZL_,FYZZ+\
M>6V#]F8WZ//4X'Z@?Z:G6?$)<MYC>+O4_&TJW3N!WK^Z\31-W@;OQY7TW?P]
M@I2'?^OYU>+V1_21[CZ@F<QT9XD=R-2Y0QH?,<M^<>8Y#B\EO_'@[_!^3>V#
58;[5_I_^7_\`C?Y5_P#/_P`/8/_9
`
end

</TEXT>
</DOCUMENT>
</SUBMISSION>
